PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"31609155","Opioid-related respiratory and gastrointestinal adverse events in patients with acute postoperative pain: prevalence, predictors, and burden","Oderda GM, Senagore AJ, Morland K, Iqbal SU, Kugel M, Liu S, Habib AS.","J Pain Palliat Care Pharmacother. 2019 Sep-Dec;33(3-4):82-97. doi: 10.1080/15360288.2019.1668902. Epub 2019 Oct 14.","Oderda GM","J Pain Palliat Care Pharmacother","2019","2019/10/15","","","10.1080/15360288.2019.1668902"
"31603562","Examination of laryngeal function of healthy dogs by using sedation protocols with dexmedetomidine","DeGroot WD, Tobias KM, Browning DC, Zhu X.","Vet Surg. 2020 Jan;49(1):124-130. doi: 10.1111/vsu.13334. Epub 2019 Oct 11.","DeGroot WD","Vet Surg","2020","2019/10/12","","","10.1111/vsu.13334"
"31601494","A prospective randomized trial of intravenous ketorolac vs. acetaminophen administered with opioid patient-controlled analgesia in gynecologic surgery","Rakowski JA, Holloway RW, Ahmad S, Jeppson CN, James JA, Ghurani GB, Bigsby GE, Kendrick JE.","Gynecol Oncol. 2019 Dec;155(3):468-472. doi: 10.1016/j.ygyno.2019.09.019. Epub 2019 Oct 7.","Rakowski JA","Gynecol Oncol","2019","2019/10/12","","","10.1016/j.ygyno.2019.09.019"
"31398210","A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk","Kasper KJ, Manoharan I, Hallam B, Coleman CE, Koivu SL, Weir MA, McCormick JK, Silverman MS.","PLoS One. 2019 Aug 9;14(8):e0219777. doi: 10.1371/journal.pone.0219777. eCollection 2019.","Kasper KJ","PLoS One","2019","2019/08/10","PMC6688832","","10.1371/journal.pone.0219777"
"31390506","Cluster of Sphingomonas paucimobilis Bacteremias Linked to Diversion of Intravenous Hydromorphone","Wasiura J, Segal BH, Mullin KM.","N Engl J Med. 2019 Aug 8;381(6):584-585. doi: 10.1056/NEJMc1902973.","Wasiura J","N Engl J Med","2019","2019/08/08","","","10.1056/NEJMc1902973"
"31353195","Effect of heart rate on the pharmacokinetics of fentanyl in dogs anesthetized with isoflurane and hydromorphone","Machado ML, Soares JH, Pypendop BH, Henao-Guerrero N, Pavlisko ND, Ross J.","Vet Anaesth Analg. 2019 Nov;46(6):736-744. doi: 10.1016/j.vaa.2019.06.005. Epub 2019 Jun 29.","Machado ML","Vet Anaesth Analg","2019","2019/07/30","","","10.1016/j.vaa.2019.06.005"
"31343727","A case report of sweating caused by hydromorphone","Bode LE.","J Opioid Manag. 2019 May/Jun;15(3):261-262. doi: 10.5055/jom.2019.0509.","Bode LE","J Opioid Manag","2019","2019/07/26","","","10.5055/jom.2019.0509"
"31326087","Side effect profiles of different opioids in the perioperative setting: are they different and can we reduce them?","Shim H, Gan TJ.","Br J Anaesth. 2019 Sep;123(3):266-268. doi: 10.1016/j.bja.2019.06.009. Epub 2019 Jul 17.","Shim H","Br J Anaesth","2019","2019/07/22","","","10.1016/j.bja.2019.06.009"
"31320243","Possible biased analgesic of hydromorphone through the G protein-over β-arrestin-mediated pathway: cAMP, CellKey™, and receptor internalization analyses","Manabe S, Miyano K, Fujii Y, Ohshima K, Yoshida Y, Nonaka M, Uzu M, Matsuoka Y, Sato T, Uezono Y, Morimatsu H.","J Pharmacol Sci. 2019 Jun;140(2):171-177. doi: 10.1016/j.jphs.2019.06.005. Epub 2019 Jul 2.","Manabe S","J Pharmacol Sci","2019","2019/07/20","","","10.1016/j.jphs.2019.06.005"
"31265441","Analgesic Rescue With Opioid-Only Thoracic Epidural After Surgical Infiltration of Liposomal Bupivacaine: A Case Report","Swisher MW, Millar MB, Gabriel RA, Said ET.","A A Pract. 2019 Oct 15;13(8):292-294. doi: 10.1213/XAA.0000000000001057.","Swisher MW","A A Pract","2019","2019/07/03","","","10.1213/XAA.0000000000001057"
"31240797","Assessment of hydromorphone and dexmedetomidine for emesis induction in cats","Nystrom MR, Odunayo A, Okafor CC.","J Vet Emerg Crit Care (San Antonio). 2019 Jul;29(4):360-365. doi: 10.1111/vec.12866. Epub 2019 Jun 25.","Nystrom MR","J Vet Emerg Crit Care (San Antonio)","2019","2019/06/27","","","10.1111/vec.12866"
"31206429","Prospective Association of Serum Opioid Levels and Clinical Outcomes in Patients With Cancer Pain Treated With Intrathecal Opioid Therapy","Brogan SE, Sindt JE, Jackman CM, White J, Wilding V, Okifuji A.","Anesth Analg. 2020 Apr;130(4):1035-1044. doi: 10.1213/ANE.0000000000004276.","Brogan SE","Anesth Analg","2020","2019/06/18","","","10.1213/ANE.0000000000004276"
"31201808","Multimodal opioid-sparing postoperative pain regimen compared with the standard postoperative pain regimen in vaginal pelvic reconstructive surgery: a multicenter randomized controlled trial","Petrikovets A, Sheyn D, Sun HH, Chapman GC, Mahajan ST, Pollard RR, El-Nashar SA, Hijaz AK, Mangel J.","Am J Obstet Gynecol. 2019 Nov;221(5):511.e1-511.e10. doi: 10.1016/j.ajog.2019.06.002. Epub 2019 Jun 12.","Petrikovets A","Am J Obstet Gynecol","2019","2019/06/16","","","10.1016/j.ajog.2019.06.002"
"31171446","The antinociceptive effects of intravenous administration of three doses of butorphanol tartrate or naloxone hydrochloride following hydromorphone hydrochloride to healthy conscious cats","Simon BT, Scallan EM, Baetge CL, Coursey CD, Lizarraga I.","Vet Anaesth Analg. 2019 Jul;46(4):538-547. doi: 10.1016/j.vaa.2019.04.006. Epub 2019 Apr 30.","Simon BT","Vet Anaesth Analg","2019","2019/06/08","","","10.1016/j.vaa.2019.04.006"
"31166900","[Opioids for Cancer Pain and its Use under Particular Conditions: A Narrative Review]","Vieira C, Brás M, Fragoso M.","Acta Med Port. 2019 May 31;32(5):388-399. doi: 10.20344/amp.10500. Epub 2019 May 31.","Vieira C","Acta Med Port","2019","2019/06/06","","","10.20344/amp.10500"
"31133548","Acute suicidal ideations responsive to hydromorphone","Rotchford JK.","BMJ Case Rep. 2019 May 27;12(5):e228824. doi: 10.1136/bcr-2018-228824.","Rotchford JK","BMJ Case Rep","2019","2019/05/29","PMC6536192","","10.1136/bcr-2018-228824"
"31063208","Intravenous hydromorphone after thoracoscopic lobectomy: a double-blind up-and-down sequential allocation trial of effective doses","Zhang J, Yue Y, Zhao L.","Anaesthesia. 2019 Jun;74(6):820-821. doi: 10.1111/anae.14686.","Zhang J","Anaesthesia","2019","2019/05/08","","","10.1111/anae.14686"
"31027915","Satisfactory analgesia with minimal emesis in day surgeries: a randomised controlled trial of morphine versus hydromorphone","Shanthanna H, Paul J, Lovrics P, Vanniyasingam T, Devereaux PJ, Bhandari M, Thabane L.","Br J Anaesth. 2019 Jun;122(6):e107-e113. doi: 10.1016/j.bja.2019.03.036. Epub 2019 Apr 23.","Shanthanna H","Br J Anaesth","2019","2019/04/28","","","10.1016/j.bja.2019.03.036"
"31021987","Heating Injection Drug Preparation Equipment Used for Opioid Injection May Reduce HIV Transmission Associated With Sharing Equipment","Ball LJ, Venner C, Tirona RG, Arts E, Gupta K, Wiener JC, Koivu S, Silverman MS.","J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):e127-e134. doi: 10.1097/QAI.0000000000002063.","Ball LJ","J Acquir Immune Defic Syndr","2019","2019/04/26","PMC6905404","","10.1097/QAI.0000000000002063"
"31008745","High-Frequency Heart Rate Variability Index: A Prospective, Observational Trial Assessing Utility as a Marker for the Balance Between Analgesia and Nociception Under General Anesthesia","Anderson TA, Segaran JR, Toda C, Sabouri AS, De Jonckheere J.","Anesth Analg. 2020 Apr;130(4):1045-1053. doi: 10.1213/ANE.0000000000004180.","Anderson TA","Anesth Analg","2020","2019/04/23","","","10.1213/ANE.0000000000004180"
"30987164","Circulating miRNA Signature as a Potential Biomarker for the Prediction of Analgesic Efficacy of Hydromorphone","Kiyosawa N, Watanabe K, Toyama K, Ishizuka H.","Int J Mol Sci. 2019 Apr 3;20(7):1665. doi: 10.3390/ijms20071665.","Kiyosawa N","Int J Mol Sci","2019","2019/04/17","PMC6480077","","10.3390/ijms20071665"
"30944686","Postoperative Analgesic Effects of Different Doses of Epidural Hydromorphone Coadministered with Ropivacaine after Cesarean Section: A Randomized Controlled Trial","Yang M, Wang L, Chen H, Tang Y, Chen X.","Pain Res Manag. 2019 Mar 3;2019:9054538. doi: 10.1155/2019/9054538. eCollection 2019.","Yang M","Pain Res Manag","2019","2019/04/05","PMC6421812","","10.1155/2019/9054538"
"30930095","The pharmacokinetics and pharmacodynamics of intravenous hydromorphone in horses","Reed R, Barletta M, Mitchell K, Hanafi A, Bullington A, Knych H, Quandt J, Ryan C, Giguère S.","Vet Anaesth Analg. 2019 May;46(3):395-404. doi: 10.1016/j.vaa.2018.11.001. Epub 2018 Nov 22.","Reed R","Vet Anaesth Analg","2019","2019/04/02","","","10.1016/j.vaa.2018.11.001"
"30919948","Randomized clinical trial of liposomal bupivacaine transverse abdominis plane block versus intrathecal analgesia in colorectal surgery","Colibaseanu DT, Osagiede O, Merchea A, Ball CT, Bojaxhi E, Panchamia JK, Jacob AK, Kelley SR, Naessens JM, Larson DW.","Br J Surg. 2019 May;106(6):692-699. doi: 10.1002/bjs.11141. Epub 2019 Mar 28.","Colibaseanu DT","Br J Surg","2019","2019/03/29","","","10.1002/bjs.11141"
"30902361","Intranasal hydromorphone for treatment of acute pain in children: A pilot study","Tsze DS, Pan SS, DePeter KC, Wagh AM, Gordon SL, Dayan PS.","Am J Emerg Med. 2019 Jun;37(6):1128-1132. doi: 10.1016/j.ajem.2019.03.013. Epub 2019 Mar 13.","Tsze DS","Am J Emerg Med","2019","2019/03/24","","","10.1016/j.ajem.2019.03.013"
"30827804","Pharmacokinetics of subcutaneously administered hydromorphone in bearded dragons (Pogona vitticeps) and red-eared slider turtles (Trachemys scripta elegans)","Hawkins SJ, Cox S, Yaw TJ, Sladky K.","Vet Anaesth Analg. 2019 May;46(3):352-359. doi: 10.1016/j.vaa.2018.12.002. Epub 2019 Jan 18.","Hawkins SJ","Vet Anaesth Analg","2019","2019/03/05","","","10.1016/j.vaa.2018.12.002"
"30819520","Randomized Trial of Intravenous Lidocaine Versus Hydromorphone for Acute Abdominal Pain in the Emergency Department","Chinn E, Friedman BW, Naeem F, Irizarry E, Afrifa F, Zias E, Jones MP, Pearlman S, Chertoff A, Wollowitz A, Gallagher EJ.","Ann Emerg Med. 2019 Aug;74(2):233-240. doi: 10.1016/j.annemergmed.2019.01.021. Epub 2019 Feb 26.","Chinn E","Ann Emerg Med","2019","2019/03/02","PMC6764530","NIHMS1519000","10.1016/j.annemergmed.2019.01.021"
"30769311","Identification of opioids in surface and wastewaters by LC/QTOF-MS using retrospective data analysis","Campos-Mañas MC, Ferrer I, Thurman EM, Sánchez Pérez JA, Agüera A.","Sci Total Environ. 2019 May 10;664:874-884. doi: 10.1016/j.scitotenv.2019.01.389. Epub 2019 Jan 30.","Campos-Mañas MC","Sci Total Environ","2019","2019/02/16","","","10.1016/j.scitotenv.2019.01.389"
"30702897","The Development of a Macromolecular Analgesic for Arthritic Pain","Weber L, Wang X, Ren R, Wei X, Zhao G, Yang J, Yuan H, Pang H, Wang H, Wang D.","Mol Pharm. 2019 Mar 4;16(3):1234-1244. doi: 10.1021/acs.molpharmaceut.8b01197. Epub 2019 Feb 14.","Weber L","Mol Pharm","2019","2019/02/01","PMC6413733","NIHMS1010713","10.1021/acs.molpharmaceut.8b01197"
"30692105","The risk of infective endocarditis among people who inject drugs: a retrospective, population-based time series analysis","Weir MA, Slater J, Jandoc R, Koivu S, Garg AX, Silverman M.","CMAJ. 2019 Jan 28;191(4):E93-E99. doi: 10.1503/cmaj.180694.","Weir MA","CMAJ","2019","2019/01/30","PMC6342696","","10.1503/cmaj.180694"
"30661208","Preoperative Transversus Abdominis Plane (TAP) Block with Liposomal Bupivacaine for Bariatric Patients to Reduce the Use of Opioid Analgesics","Moon RC, Lastrapes L, Wier J, Nakajima M, Gaskins W, Teixeira AF, Jawad MA.","Obes Surg. 2019 Apr;29(4):1099-1104. doi: 10.1007/s11695-018-03668-5.","Moon RC","Obes Surg","2019","2019/01/21","","","10.1007/s11695-018-03668-5"
"30655310","Patient- and Nurse-Controlled Analgesia: 22-Year Experience in a Pediatric Hospital","Donado C, Solodiuk J, Rangel SJ, Nelson CP, Heeney MM, Mahan ST, Ullrich C, Tsegaye B, Berde CB.","Hosp Pediatr. 2019 Feb;9(2):129-133. doi: 10.1542/hpeds.2018-0179. Epub 2019 Jan 17.","Donado C","Hosp Pediatr","2019","2019/01/19","","","10.1542/hpeds.2018-0179"
"30567490","Effects of patient-controlled analgesia with hydromorphone or sufentanil on postoperative pulmonary complications in patients undergoing thoracic surgery: a quasi-experimental study","Yan G, Chen J, Yang G, Duan G, Du Z, Yu Z, Peng J, Liao W, Li H.","BMC Anesthesiol. 2018 Dec 19;18(1):192. doi: 10.1186/s12871-018-0657-7.","Yan G","BMC Anesthesiol","2018","2018/12/21","PMC6300916","","10.1186/s12871-018-0657-7"
"30531478","Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study","Göhler K, Sokolowska M, Schoedel KA, Nemeth R, Kleideiter E, Szeto I, Eerdekens MH.","J Clin Psychopharmacol. 2019 Jan/Feb;39(1):46-56. doi: 10.1097/JCP.0000000000000995.","Göhler K","J Clin Psychopharmacol","2019","2018/12/12","PMC6319565","","10.1097/JCP.0000000000000995"
"30439607","The effect of hydromorphone as an adjuvant to ropivacaine in brachial plexus block","Saisai H.","J Clin Anesth. 2019 May;54:111. doi: 10.1016/j.jclinane.2018.10.028. Epub 2018 Nov 12.","Saisai H","J Clin Anesth","2019","2018/11/16","","","10.1016/j.jclinane.2018.10.028"
"30418214","Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals","Huhn AS, Strain EC, Bigelow GE, Smith MT, Edwards RR, Tompkins DA.","Anesthesiology. 2019 Jan;130(1):131-141. doi: 10.1097/ALN.0000000000002492.","Huhn AS","Anesthesiology","2019","2018/11/13","PMC6295244","NIHMS1508476","10.1097/ALN.0000000000002492"
"30407692","Trends in the consumption of opioids for the treatment of severe pain in Europe, 1990-2016","Bosetti C, Santucci C, Radrezza S, Erthal J, Berterame S, Corli O.","Eur J Pain. 2019 Apr;23(4):697-707. doi: 10.1002/ejp.1337. Epub 2018 Dec 4.","Bosetti C","Eur J Pain","2019","2018/11/09","","","10.1002/ejp.1337"
"30391868","Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: A comparison of oral fluid and urine using paired collections and LC-MS/MS","West R, Mikel C, Hofilena D, Guevara M.","Drug Alcohol Depend. 2018 Dec 1;193:183-191. doi: 10.1016/j.drugalcdep.2018.07.023. Epub 2018 Sep 1.","West R","Drug Alcohol Depend","2018","2018/11/05","","","10.1016/j.drugalcdep.2018.07.023"
"30391451","Retrograde placement of an intrathecal catheter for chronic low pelvic cancer pain","Urits I, Petro J, Viswanath O, Aner M.","J Clin Anesth. 2019 May;54:43-44. doi: 10.1016/j.jclinane.2018.10.020. Epub 2018 Nov 2.","Urits I","J Clin Anesth","2019","2018/11/05","","","10.1016/j.jclinane.2018.10.020"
"30377010","National opioid prescribing trends in emergency departments by provider type: 2005-2015","Yang BK, Storr CL, Trinkoff AM, Sohn M, Idzik SK, McKinnon M.","Am J Emerg Med. 2019 Aug;37(8):1439-1445. doi: 10.1016/j.ajem.2018.10.041. Epub 2018 Oct 22.","Yang BK","Am J Emerg Med","2019","2018/11/01","","","10.1016/j.ajem.2018.10.041"
"30292778","Liposomal bupivacaine reduces narcotic use and time to flatus in a retrospective cohort of patients who underwent laparotomy","Burnett A, Faley B, Nyirenda T, Bamboat ZM.","Int J Surg. 2018 Nov;59:55-60. doi: 10.1016/j.ijsu.2018.09.018. Epub 2018 Oct 5.","Burnett A","Int J Surg","2018","2018/10/08","","","10.1016/j.ijsu.2018.09.018"
"30290794","Determination of ED50 and time to effectiveness for intrathecal hydromorphone in laboring patients using Dixon's up-and-down sequential allocation method","O'Reilly-Shah V, Lynde GC.","BMC Anesthesiol. 2018 Oct 5;18(1):140. doi: 10.1186/s12871-018-0603-8.","O'Reilly-Shah V","BMC Anesthesiol","2018","2018/10/07","PMC6173834","","10.1186/s12871-018-0603-8"
"30289795","Prescription Opioid Type and the Likelihood of Prolonged Opioid Use After Orthopaedic Surgery","Basilico M, Bhashyam AR, Harris MB, Heng M.","J Am Acad Orthop Surg. 2019 May 1;27(9):e423-e429. doi: 10.5435/JAAOS-D-17-00663.","Basilico M","J Am Acad Orthop Surg","2019","2018/10/06","PMC6590520","NIHMS1527971","10.5435/JAAOS-D-17-00663"
"30284586","Effect of preoperative hydromorphone in patients undergoing laparoscopic radical gastrectomy. A double-blind, randomized and controlled trial","Wang J, Wang N, Zhou H, Wang Y.","Saudi Med J. 2018 Oct;39(10):1023-1027. doi: 10.15537/smj.2018.10.22852.","Wang J","Saudi Med J","2018","2018/10/05","PMC6201035","","10.15537/smj.2018.10.22852"
"30274680","[Opioid switch and change of route of administration in cancer patients treated by morphine]","Michenot N, Rostaing S, Baron L, Faure S, Jovenin N, Hubault P, Delorme T, Collin E, Filbet M, Chvetzoff G, Delorme C, Minello C, Magnet M, Ammar D, Krakowski I, Poulain P.","Bull Cancer. 2018 Nov;105(11):1052-1073. doi: 10.1016/j.bulcan.2018.06.011. Epub 2018 Sep 29.","Michenot N","Bull Cancer","2018","2018/10/03","","","10.1016/j.bulcan.2018.06.011"
"30267781","Sustained-Release Hydromorphone Microparticles Produced by Supercritical Fluid Polymer Encapsulation","Han FY, Whittaker A, Howdle SM, Naylor A, Shabir-Ahmed A, Smith MT.","J Pharm Sci. 2019 Feb;108(2):811-814. doi: 10.1016/j.xphs.2018.09.021. Epub 2018 Sep 26.","Han FY","J Pharm Sci","2019","2018/09/30","","","10.1016/j.xphs.2018.09.021"
"30236878","Hydromorphone protects CA1 neurons by activating mTOR pathway","Xie W, Xie W, Kang Z, Jiang C, Liu N.","Neurosci Lett. 2018 Nov 20;687:49-54. doi: 10.1016/j.neulet.2018.09.029. Epub 2018 Sep 17.","Xie W","Neurosci Lett","2018","2018/09/22","","","10.1016/j.neulet.2018.09.029"
"30234923","Trends in and predictors of hydromorphone administration in US emergency departments (2007-2014)","Mazer-Amirshahi M, Ladkany D, Mullins PM, Motov S, Perrone J, Nelson LS, Pines JM.","J Opioid Manag. 2018 Jul/Aug;14(4):265-272. doi: 10.5055/jom.2018.0458.","Mazer-Amirshahi M","J Opioid Manag","2018","2018/09/21","","","10.5055/jom.2018.0458"
"30234674","Implementation of a Risk-Stratified Opioid and Benzodiazepine Weaning Protocol in a Pediatric Cardiac ICU","Amirnovin R, Sanchez-Pinto LN, Okuhara C, Lieu P, Koh JY, Rodgers JW, Nelson LP.","Pediatr Crit Care Med. 2018 Nov;19(11):1024-1032. doi: 10.1097/PCC.0000000000001719.","Amirnovin R","Pediatr Crit Care Med","2018","2018/09/21","","","10.1097/PCC.0000000000001719"
"30229847","Effects of hydromorphone and morphine intravenous analgesia on plasma motilin and postoperative nausea and vomiting in patients undergoing total hysterectomy","Liu Y, Yang L, Tao SJ.","Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5697-5703. doi: 10.26355/eurrev_201809_15837.","Liu Y","Eur Rev Med Pharmacol Sci","2018","2018/09/20","","","10.26355/eurrev_201809_15837"
"30226729","At-a-glance - The role of opioid toxicity in suicide deaths in Alberta, 2000 to 2016","Chan EYL, McDonald BM, Brooks-Lim E, Jones GR, Klein KB, Svenson LW.","Health Promot Chronic Dis Prev Can. 2018 Sep;38(9):343-347. doi: 10.24095/hpcdp.38.9.07.","Chan EYL","Health Promot Chronic Dis Prev Can","2018","2018/09/19","PMC6169706","","10.24095/hpcdp.38.9.07"
"30178006","Nalbuphine for Opioid-Induced Urine Retention","Ibrahim AM, Obaidi Z, Ruan G, Adaramola D, Onguti S.","Ann Intern Med. 2018 Dec 18;169(12):894-895. doi: 10.7326/L18-0387. Epub 2018 Sep 4.","Ibrahim AM","Ann Intern Med","2018","2018/09/05","","","10.7326/L18-0387"
"30139035","[Effects of patient-controlled intravenous analgesia using hydromorphone supplement with dexmedetomidine on patients undergoing transcatheter arterial chemoembolization]","Wang HW, Li LL, Li ZS, Cheng LN.","Zhonghua Zhong Liu Za Zhi. 2018 Aug 23;40(8):626-630. doi: 10.3760/cma.j.issn.0253-3766.2018.08.012.","Wang HW","Zhonghua Zhong Liu Za Zhi","2018","2018/08/24","","","10.3760/cma.j.issn.0253-3766.2018.08.012"
"30119941","Randomized Controlled Trial of Intravenous Acetaminophen Versus Intravenous Hydromorphone for the Treatment of Acute Pain in the Emergency Department","Barnaby DP, Chertoff AE, Restivo AJ, Campbell CM, Pearlman S, White D, Bijur PE, Gallagher EJ.","Ann Emerg Med. 2019 Feb;73(2):133-140. doi: 10.1016/j.annemergmed.2018.06.019. Epub 2018 Aug 14.","Barnaby DP","Ann Emerg Med","2019","2018/08/19","","","10.1016/j.annemergmed.2018.06.019"
"30118582","Randomized Clinical Trial of Intravenous Acetaminophen as an Analgesic Adjunct for Older Adults With Acute Severe Pain","Chang AK, Bijur PE, Ata A, Campbell C, Pearlman S, White D, Chertoff A, Restivo A, Gallagher EJ.","Acad Emerg Med. 2019 Apr;26(4):402-409. doi: 10.1111/acem.13556. Epub 2018 Nov 20.","Chang AK","Acad Emerg Med","2019","2018/08/18","PMC6378123","NIHMS985907","10.1111/acem.13556"
"30113350","Low-dose ketamine infusion reduces postoperative hydromorphone requirements in opioid-tolerant patients following spinal fusion: A randomised controlled trial","Boenigk K, Echevarria GC, Nisimov E, von Bergen Granell AE, Cuff GE, Wang J, Atchabahian A.","Eur J Anaesthesiol. 2019 Jan;36(1):8-15. doi: 10.1097/EJA.0000000000000877.","Boenigk K","Eur J Anaesthesiol","2019","2018/08/17","","","10.1097/EJA.0000000000000877"
"30082181","Comparison of fentanyl and hydromorphone constant rate infusions for pain management in dogs in an intensive care unit","Biello P, Bateman SW, Kerr CL.","Vet Anaesth Analg. 2018 Sep;45(5):673-683. doi: 10.1016/j.vaa.2018.05.005. Epub 2018 Jun 7.","Biello P","Vet Anaesth Analg","2018","2018/08/08","","","10.1016/j.vaa.2018.05.005"
"30078280","[Study of the effects of hydromorphone on emergence agitation of children anesthetized by sevoflurane]","Chu LY, Pan CX.","Zhonghua Yi Xue Za Zhi. 2018 Jul 24;98(28):2250-2253. doi: 10.3760/cma.j.issn.0376-2491.2018.28.008.","Chu LY","Zhonghua Yi Xue Za Zhi","2018","2018/08/06","","","10.3760/cma.j.issn.0376-2491.2018.28.008"
"30074252","Development of a method for the determination of hydromorphone in plasma by LC-MS","Cox S, Bergman J, Hawkins S, Sladky K.","Biomed Chromatogr. 2018 Dec;32(12):e4357. doi: 10.1002/bmc.4357. Epub 2018 Aug 30.","Cox S","Biomed Chromatogr","2018","2018/08/04","","","10.1002/bmc.4357"
"30059368","Emergency Department Use of Intravenous Prochlorperazine for Acute Migraine","Cook C, Newberry B.","Adv Emerg Nurs J. 2018 Jul/Sep;40(3):148-154. doi: 10.1097/TME.0000000000000203.","Cook C","Adv Emerg Nurs J","2018","2018/07/31","","","10.1097/TME.0000000000000203"
"30058846","Evaluation of the thermal antinociceptive effects and pharmacokinetics of hydromorphone hydrochloride after intramuscular administration to cockatiels (Nymphicus hollandicus)","Houck EL, Guzman DS, Beaufrère H, Knych HK, Paul-Murphy JR.","Am J Vet Res. 2018 Aug;79(8):820-827. doi: 10.2460/ajvr.79.8.820.","Houck EL","Am J Vet Res","2018","2018/07/31","","","10.2460/ajvr.79.8.820"
"30041855","An Unusual Case of Hearing Loss","Kadiri JA, Hayes BD, Lev MH, Sajed D, Miller ES.","J Emerg Med. 2018 Sep;55(3):411-414. doi: 10.1016/j.jemermed.2018.06.005. Epub 2018 Jul 21.","Kadiri JA","J Emerg Med","2018","2018/07/26","","","10.1016/j.jemermed.2018.06.005"
"30020849","Parenteral Opioid Shortage - Treating Pain during the Opioid-Overdose Epidemic","Bruera E.","N Engl J Med. 2018 Aug 16;379(7):601-603. doi: 10.1056/NEJMp1807117. Epub 2018 Jul 18.","Bruera E","N Engl J Med","2018","2018/07/19","","","10.1056/NEJMp1807117"
"30020107","Methylnaltrexone-Associated Bowel Perforation in Postoperative Opioid-Induced Constipation and Ogilvie Syndrome: A Case Report","Blackney KA, Kamdar NV, Liu CA, Edwards DA.","A A Pract. 2019 Jan 15;12(2):44-46. doi: 10.1213/XAA.0000000000000840.","Blackney KA","A A Pract","2019","2018/07/19","","","10.1213/XAA.0000000000000840"
"30013710","Patient Preference for Pain Medication in the Emergency Department Is Associated with Non-fatal Overdose History","Whiteside LK, Goldstick J, Dora-Laskey A, Thomas L, Walton M, Cunningham R, Bohnert ASB.","West J Emerg Med. 2018 Jul;19(4):722-730. doi: 10.5811/westjem.2018.4.37019. Epub 2018 Jun 11.","Whiteside LK","West J Emerg Med","2018","2018/07/18","PMC6040914","","10.5811/westjem.2018.4.37019"
"30013704","Opioid Administration and Prescribing in Older Adults in U.S. Emergency Departments (2005-2015)","Marra EM, Mazer-Amirshahi M, Mullins P, Pines JM.","West J Emerg Med. 2018 Jul;19(4):678-688. doi: 10.5811/westjem.2018.5.37853. Epub 2018 Jun 11.","Marra EM","West J Emerg Med","2018","2018/07/18","PMC6040900","","10.5811/westjem.2018.5.37853"
"30004301","Hydromorphone-induced chorea as an atypical presentation of opioid neurotoxicity: A case report and review of the literature","Martin EJ, Vaughan CL, Atayee R, Hirst JM, O'Donnell K, Edmonds KP.","Palliat Med. 2018 Oct;32(9):1529-1532. doi: 10.1177/0269216318786861. Epub 2018 Jul 13.","Martin EJ","Palliat Med","2018","2018/07/14","","","10.1177/0269216318786861"
"29934395","Satisfactory Analgesia with Minimal Emesis in Day Surgeries (SAME DayS): a protocol for a randomised controlled trial of morphine versus hydromorphone","Shanthanna H, Paul J, Lovrics P, Devereaux PJ, Bhandari M, Thabane L.","BMJ Open. 2018 Jun 22;8(6):e022504. doi: 10.1136/bmjopen-2018-022504.","Shanthanna H","BMJ Open","2018","2018/06/24","PMC6020940","","10.1136/bmjopen-2018-022504"
"29911823","Evaluating the early impacts of delisting high-strength opioids on patterns of prescribing in Ontario","Guan Q, Khuu W, Martins D, Tadrous M, Chiu M, Do MT, Gomes T.","Health Promot Chronic Dis Prev Can. 2018 Jun;38(6):256-262. doi: 10.24095/hpcdp.38.6.07.","Guan Q","Health Promot Chronic Dis Prev Can","2018","2018/06/19","PMC6034971","","10.24095/hpcdp.38.6.07"
"29883035","Commentary on Bansback et al. (2018): Estimating the cost of stigma against injection","Linas BP.","Addiction. 2018 Jul;113(7):1274-1275. doi: 10.1111/add.14219.","Linas BP","Addiction","2018","2018/06/09","","","10.1111/add.14219"
"29849846","Patient-Controlled Intravenous Analgesia for Advanced Cancer Patients with Pain: A Retrospective Series Study","Peng Z, Zhang Y, Guo J, Guo X, Feng Z.","Pain Res Manag. 2018 Apr 4;2018:7323581. doi: 10.1155/2018/7323581. eCollection 2018.","Peng Z","Pain Res Manag","2018","2018/06/01","PMC5904766","","10.1155/2018/7323581"
"29847382","Intraoperative Methadone in Same-Day Ambulatory Surgery: A Randomized, Double-Blinded, Dose-Finding Pilot Study","Komen H, Brunt LM, Deych E, Blood J, Kharasch ED.","Anesth Analg. 2019 Apr;128(4):802-810. doi: 10.1213/ANE.0000000000003464.","Komen H","Anesth Analg","2019","2018/05/31","PMC6995343","NIHMS1068862","10.1213/ANE.0000000000003464"
"29792978","Authors' Response","Reddy A, Heung Y, Bruera E.","J Pain Symptom Manage. 2018 Sep;56(3):e3-e5. doi: 10.1016/j.jpainsymman.2018.05.012. Epub 2018 May 22.","Reddy A","J Pain Symptom Manage","2018","2018/05/25","","","10.1016/j.jpainsymman.2018.05.012"
"29792977","Hydromorphone Conversion Dilemma: A Millennial Problem","Foxwell AM, Uritsky TJ.","J Pain Symptom Manage. 2018 Sep;56(3):e2-e3. doi: 10.1016/j.jpainsymman.2018.05.014. Epub 2018 May 22.","Foxwell AM","J Pain Symptom Manage","2018","2018/05/25","","","10.1016/j.jpainsymman.2018.05.014"
"29784079","Analgesic Efficacy and Safety of Hydromorphone in Chinchillas (Chinchilla lanigera)","Evenson EA, Mans C.","J Am Assoc Lab Anim Sci. 2018 May 1;57(3):282-285.","Evenson EA","J Am Assoc Lab Anim Sci","2018","2018/05/23","PMC5966236","",""
"29771804","Preemptive Analgesia Decreases Pain Following Anorectal Surgery: A Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial","Van Backer JT, Jordan MR, Leahy DT, Moore JS, Callas P, Dominick T, Cataldo PA.","Dis Colon Rectum. 2018 Jul;61(7):824-829. doi: 10.1097/DCR.0000000000001069.","Van Backer JT","Dis Colon Rectum","2018","2018/05/18","","","10.1097/DCR.0000000000001069"
"29710198","Storing and Disposing of Opioid Analgesics: What Does Our Medicine Tell Us?","Doucette ML, Shields WC, Haring RS, Frattaroli S.","Ann Intern Med. 2018 Aug 7;169(3):198-199. doi: 10.7326/M17-3381. Epub 2018 Apr 17.","Doucette ML","Ann Intern Med","2018","2018/05/01","","","10.7326/M17-3381"
"29684728","Bilateral automatized intermittent bolus erector spinae plane analgesic blocks for sternotomy in a cardiac patient who underwent cardiopulmonary bypass: A new era of Cardiac Regional Anesthesia","Tsui BCH, Navaratnam M, Boltz G, Maeda K, Caruso TJ.","J Clin Anesth. 2018 Aug;48:9-10. doi: 10.1016/j.jclinane.2018.04.005. Epub 2018 May 26.","Tsui BCH","J Clin Anesth","2018","2018/04/24","","","10.1016/j.jclinane.2018.04.005"
"29673620","Effects of opioid- and non-opioid analgesics on responses to psychosocial stress in humans","Bershad AK, Miller MA, Norman GJ, de Wit H.","Horm Behav. 2018 Jun;102:41-47. doi: 10.1016/j.yhbeh.2018.04.009. Epub 2018 Apr 24.","Bershad AK","Horm Behav","2018","2018/04/21","PMC6004330","NIHMS963544","10.1016/j.yhbeh.2018.04.009"
"29659913","A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients","Inoue S, Saito Y, Tsuneto S, Aruga E, Takahashi H, Uemori M.","Jpn J Clin Oncol. 2018 Jun 1;48(6):542-547. doi: 10.1093/jjco/hyy038.","Inoue S","Jpn J Clin Oncol","2018","2018/04/17","PMC5974780","","10.1093/jjco/hyy038"
"29655955","Employment and paid work among participants in a randomized controlled trial comparing diacetylmorphine and hydromorphone","Nikoo M, Vogel M, Choi F, Song MJ, Burghardt J, Zafari Z, Tabi K, Frank A, Barbic S, Schütz C, Jang K, Krausz M.","Int J Drug Policy. 2018 Jul;57:18-24. doi: 10.1016/j.drugpo.2018.03.021. Epub 2018 Apr 12.","Nikoo M","Int J Drug Policy","2018","2018/04/16","","","10.1016/j.drugpo.2018.03.021"
"29649890","What Parenteral Opioids to Use in Face of Shortages of Morphine, Hydromorphone, and Fentanyl","Davis MP, McPherson ML, Mehta Z, Behm B, Fernandez C.","Am J Hosp Palliat Care. 2018 Aug;35(8):1118-1122. doi: 10.1177/1049909118771374. Epub 2018 Apr 12.","Davis MP","Am J Hosp Palliat Care","2018","2018/04/14","","","10.1177/1049909118771374"
"29636011","Prospective investigation of intravenous patient-controlled analgesia with hydromorphone or sufentanil: impact on mood, opioid adverse effects, and recovery","Yang Y, Wu J, Li H, Ye S, Xu X, Cheng L, Zhu L, Peng Z, Feng Z.","BMC Anesthesiol. 2018 Apr 10;18(1):37. doi: 10.1186/s12871-018-0500-1.","Yang Y","BMC Anesthesiol","2018","2018/04/12","PMC5894128","","10.1186/s12871-018-0500-1"
"29635632","A double-blind, randomized comparative study to investigate the morphine to hydromorphone conversion ratio in Japanese cancer patients","Inoue S, Saito Y, Tsuneto S, Aruga E, Ogata T, Uemori M.","Jpn J Clin Oncol. 2018 May 1;48(5):442-449. doi: 10.1093/jjco/hyy046.","Inoue S","Jpn J Clin Oncol","2018","2018/04/11","PMC5926545","","10.1093/jjco/hyy046"
"29605036","Ketamine versus hydromorphone patient-controlled analgesia for acute pain in trauma patients","Takieddine SC, Droege CA, Ernst N, Droege ME, Webb M, Branson RD, Gerlach TW, Robinson BRH, Johannigman JA, Mueller EW.","J Surg Res. 2018 May;225:6-14. doi: 10.1016/j.jss.2017.12.019. Epub 2018 Jan 8.","Takieddine SC","J Surg Res","2018","2018/04/02","","","10.1016/j.jss.2017.12.019"
"29589873","Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial","Bansback N, Guh D, Oviedo-Joekes E, Brissette S, Harrison S, Janmohamed A, Krausz M, MacDonald S, Marsh DC, Schechter MT, Anis AH.","Addiction. 2018 Jul;113(7):1264-1273. doi: 10.1111/add.14171. Epub 2018 Mar 28.","Bansback N","Addiction","2018","2018/03/29","","","10.1111/add.14171"
"29563006","Opioid Rotation in Cancer Pain Treatment","Schuster M, Bayer O, Heid F, Laufenberg-Feldmann R.","Dtsch Arztebl Int. 2018 Mar 2;115(9):135-142. doi: 10.3238/arztebl.2018.0135.","Schuster M","Dtsch Arztebl Int","2018","2018/03/23","PMC5876542","","10.3238/arztebl.2018.0135"
"29554666","IV prochlorperazine + diphenhydramine improved migraine pain relief more than IV hydromorphone in the ED","Chessman AW.","Ann Intern Med. 2018 Mar 20;168(6):JC28. doi: 10.7326/ACPJC-2018-168-6-028.","Chessman AW","Ann Intern Med","2018","2018/03/20","","","10.7326/ACPJC-2018-168-6-028"
"29554298","Development of a Quantitative LC-MS-MS Assay for Codeine, Morphine, 6-Acetylmorphine, Hydrocodone, Hydromorphone, Oxycodone and Oxymorphone in Neat Oral Fluid","Grabenauer M, Moore KN, Bynum ND, White RM, Mitchell JM, Hayes ED, Flegel R.","J Anal Toxicol. 2018 Jul 1;42(6):392-399. doi: 10.1093/jat/bky021.","Grabenauer M","J Anal Toxicol","2018","2018/03/20","","","10.1093/jat/bky021"
"29516486","Opioid-Induced ""Likeability"" and ""Feeling Good"" Are Not Associated With Return Visits to an ED Among Migraine Patients Administered IV Hydromorphone","Friedman BW, Latev A, Campbell C, White D.","Headache. 2018 May;58(5):750-754. doi: 10.1111/head.13292. Epub 2018 Mar 8.","Friedman BW","Headache","2018","2018/03/09","","","10.1111/head.13292"
"29508897","Hydromorphone use for acute pain: Misconceptions, controversies, and risks","Mazer-Amirshahi M, Motov S, Nelson LS.","J Opioid Manag. 2018 Jan/Feb;14(1):61-71. doi: 10.5055/jom.2018.0430.","Mazer-Amirshahi M","J Opioid Manag","2018","2018/03/07","","","10.5055/jom.2018.0430"
"29483406","[New Opioid Options in Japan - Methadone, Tapentadol and Hydromorphone]","Takagi Y, Aruga E.","Gan To Kagaku Ryoho. 2018 Feb;45(2):205-211.","Takagi Y","Gan To Kagaku Ryoho","2018","2018/02/28","","",""
"29462321","Discordant Umbilical Cord Drug Testing Results in Monozygotic Twins","Alexander A, Abbas L, Jones M, Jones J, Lewis D, Negrusz A.","J Anal Toxicol. 2018 Jun 1;42(5):e47-e49. doi: 10.1093/jat/bky009.","Alexander A","J Anal Toxicol","2018","2018/02/21","","","10.1093/jat/bky009"
"29371005","Perception and Practice Among Emergency Medicine Health Care Providers Regarding Discharging Patients After Opioid Administration","Surmaitis RM, Amaducci A, Henry K, Jong M, Kiernan EA, Kincaid H, Houck LJ, Sabbatini SJ, Greenberg MR, Katz KD.","Clin Ther. 2018 Feb;40(2):214-223.e5. doi: 10.1016/j.clinthera.2018.01.001. Epub 2018 Jan 20.","Surmaitis RM","Clin Ther","2018","2018/01/27","","","10.1016/j.clinthera.2018.01.001"
"29351102","Fatal Sickling Triggered by Massive Foreign Particle Embolism: A Case Report of Unrecognized Indwelling Venous Catheter Drug Abuse in Sickle Cell Disease","Febres-Aldana CA, Hernandez Howard L.","Am J Forensic Med Pathol. 2018 Jun;39(2):152-156. doi: 10.1097/PAF.0000000000000378.","Febres-Aldana CA","Am J Forensic Med Pathol","2018","2018/01/20","","","10.1097/PAF.0000000000000378"
"29298186","Evaluation of the Relative Abuse of an OROS Extended-release Hydromorphone HCI Product: Results From 3 Postmarket Surveillance Studies","Butler SF, McNaughton EC, Black RA, Cassidy TA.","Clin J Pain. 2018 Jul;34(7):618-628. doi: 10.1097/AJP.0000000000000585.","Butler SF","Clin J Pain","2018","2018/01/04","","","10.1097/AJP.0000000000000585"
"29270641","Characterizing the subjective, observer-rated, and physiological effects of hydromorphone relative to heroin in a human laboratory study","Dunn KE, Brands B, Marsh DC, Bigelow GE.","Psychopharmacology (Berl). 2018 Apr;235(4):971-981. doi: 10.1007/s00213-017-4814-3. Epub 2017 Dec 21.","Dunn KE","Psychopharmacology (Berl)","2018","2017/12/23","PMC5871549","NIHMS930063","10.1007/s00213-017-4814-3"
"29206315","Intrathecal Trialing of Continuous Infusion Combination Therapy With Hydromorphone and Bupivacaine in Failed Back Surgery Patients","Galica RJ, Hayek SM, Veizi E, McEwan MT, Katta S, Ali O, Aziz N, Sondhi N.","Neuromodulation. 2018 Oct;21(7):648-654. doi: 10.1111/ner.12737. Epub 2017 Dec 5.","Galica RJ","Neuromodulation","2018","2017/12/06","","","10.1111/ner.12737"
"29186453","Detection and quantification of codeine-6-glucuronide, hydromorphone-3-glucuronide, oxymorphone-3-glucuronide, morphine 3-glucuronide and morphine-6-glucuronide in human hair from opioid users by LC-MS-MS","Grabenauer M, Bynum ND, Moore KN, White RM, Mitchell JM, Hayes ED, Flegel R.","J Anal Toxicol. 2018 Mar 1;42(2):115-125. doi: 10.1093/jat/bkx086.","Grabenauer M","J Anal Toxicol","2018","2017/11/30","","","10.1093/jat/bkx086"
"29169696","Efficacy and feasibility of opioids for burn analgesia: An evidence-based qualitative review of randomized controlled trials","Yang C, Xu XM, He GZ.","Burns. 2018 Mar;44(2):241-248. doi: 10.1016/j.burns.2017.10.012. Epub 2017 Nov 21.","Yang C","Burns","2018","2017/11/25","","","10.1016/j.burns.2017.10.012"
"29149155","Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance","Krock K, Pesce A, Ritz D, Thomas R, Cua A, Rogers R, Lipnick P, Kilbourn K.","Pain Physician. 2017 Nov;20(7):E1107-E1113.","Krock K","Pain Physician","2017","2017/11/18","","",""
"29141373","[A concentration-response observation of hydromorphone combined with ropivacaine in labor analgesia]","Lu YY, Huang H, Mao WL, Liu RH, Hu MJ, Shao LX, Hu MP, Li J.","Zhonghua Yi Xue Za Zhi. 2017 Nov 14;97(42):3297-3300. doi: 10.3760/cma.j.issn.0376-2491.2017.42.005.","Lu YY","Zhonghua Yi Xue Za Zhi","2017","2017/11/17","","","10.3760/cma.j.issn.0376-2491.2017.42.005"
"29114811","Interpretation of Urine Drug Screens: Metabolites and Impurities","Nagpal G, Heiman H, Haymond S.","JAMA. 2017 Nov 7;318(17):1704-1705. doi: 10.1001/jama.2017.10910.","Nagpal G","JAMA","2017","2017/11/09","","","10.1001/jama.2017.10910"
"29046364","Randomized study of IV prochlorperazine plus diphenhydramine vs IV hydromorphone for migraine","Friedman BW, Irizarry E, Solorzano C, Latev A, Rosa K, Zias E, Vinson DR, Bijur PE, Gallagher EJ.","Neurology. 2017 Nov 14;89(20):2075-2082. doi: 10.1212/WNL.0000000000004642. Epub 2017 Oct 18.","Friedman BW","Neurology","2017","2017/10/20","PMC5711508","","10.1212/WNL.0000000000004642"
"28951506","Digital ischaemia after intra-arterial drug injection","Neuss MJ, Holland TL.","BMJ Case Rep. 2017 Sep 25;2017:bcr2017222141. doi: 10.1136/bcr-2017-222141.","Neuss MJ","BMJ Case Rep","2017","2017/09/28","PMC5747780","","10.1136/bcr-2017-222141"
"28926935","Identification of Circulating miRNAs Differentially Regulated by Opioid Treatment","Toyama K, Kiyosawa N, Watanabe K, Ishizuka H.","Int J Mol Sci. 2017 Sep 16;18(9):1991. doi: 10.3390/ijms18091991.","Toyama K","Int J Mol Sci","2017","2017/09/21","PMC5618640","","10.3390/ijms18091991"
"28835059","[Efficacy of patient-controlled intravenous analgesia with hydromorphone hydrochloride plus flurbiprofen axetil after endoscopic sinus surgery]","Jiang XY, Shu LW, Pan CX.","Zhonghua Yi Xue Za Zhi. 2017 Aug 22;97(32):2516-2519. doi: 10.3760/cma.j.issn.0376-2491.2017.32.009.","Jiang XY","Zhonghua Yi Xue Za Zhi","2017","2017/08/25","","","10.3760/cma.j.issn.0376-2491.2017.32.009"
"28711751","The Conversion Ratio From Intravenous Hydromorphone to Oral Opioids in Cancer Patients","Reddy A, Vidal M, Stephen S, Baumgartner K, Dost S, Nguyen A, Heung Y, Kwan S, Wong A, Pangemanan I, Azhar A, Tayjasanant S, Rodriguez E, Waletich J, Lim KH, Wu J, Liu D, Williams J, Yennurajalingam S, Bruera E.","J Pain Symptom Manage. 2017 Sep;54(3):280-288. doi: 10.1016/j.jpainsymman.2017.07.001. Epub 2017 Jul 13.","Reddy A","J Pain Symptom Manage","2017","2017/07/17","","","10.1016/j.jpainsymman.2017.07.001"
"28708699","Flumazenil for Mixed Drug Overdose","Parthvi R, Mehra S.","Am J Ther. 2018 Nov/Dec;25(6):e676-e677. doi: 10.1097/MJT.0000000000000620.","Parthvi R","Am J Ther","2018","2017/07/15","","","10.1097/MJT.0000000000000620"
"28690041","Intravenous vs Oral Acetaminophen as an Adjunct to Multimodal Analgesia After Total Knee Arthroplasty: A Prospective, Randomized, Double-Blind Clinical Trial","O'Neal JB, Freiberg AA, Yelle MD, Jiang Y, Zhang C, Gu Y, Kong X, Jian W, O'Neal WT, Wang J.","J Arthroplasty. 2017 Oct;32(10):3029-3033. doi: 10.1016/j.arth.2017.05.019. Epub 2017 May 18.","O'Neal JB","J Arthroplasty","2017","2017/07/11","PMC5605416","NIHMS894412","10.1016/j.arth.2017.05.019"
"28683172","Opioids for cancer pain - an overview of Cochrane reviews","Wiffen PJ, Wee B, Derry S, Bell RF, Moore RA.","Cochrane Database Syst Rev. 2017 Jul 6;7(7):CD012592. doi: 10.1002/14651858.CD012592.pub2.","Wiffen PJ","Cochrane Database Syst Rev","2017","2017/07/07","PMC6483487","","10.1002/14651858.CD012592.pub2"
"28682644","Assessing analgesia equivalence and appetite following alfaxalone- or ketamine-based injectable anesthesia for feline castration as an example of enhanced recovery after surgery","Armstrong T, Wagner MC, Cheema J, Pang DS.","J Feline Med Surg. 2018 Feb;20(2):73-82. doi: 10.1177/1098612X17693517. Epub 2017 Feb 1.","Armstrong T","J Feline Med Surg","2018","2017/07/07","","","10.1177/1098612X17693517"
"28655025","Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial","Walsh SL, Comer SD, Lofwall MR, Vince B, Levy-Cooperman N, Kelsh D, Coe MA, Jones JD, Nuzzo PA, Tiberg F, Sheldon B, Kim S.","JAMA Psychiatry. 2017 Sep 1;74(9):894-902. doi: 10.1001/jamapsychiatry.2017.1874.","Walsh SL","JAMA Psychiatry","2017","2017/06/28","PMC5710238","","10.1001/jamapsychiatry.2017.1874"
"28644158","Radiology Case of the Month: Idiopathic CD4 Lymphocytopenia","Malone C, Gupta ND, Kothari A, Palacios E, Neitzschman H.","J La State Med Soc. 2017 May-Jun;169(3):85-87. Epub 2017 Jun 23.","Malone C","J La State Med Soc","2017","2017/06/24","","",""
"28606595","A Multisite Retrospective Study Evaluating the Implementation of the Pasero Opioid-Induced Sedation Scale (POSS) and Its Effect on Patient Safety Outcomes","Davis C, Geik C, Arthur K, Fuller J, Johnston E, Levitt F, Leung E, McCart G, McMichael D, Painter J, Staublin T, Walroth T.","Pain Manag Nurs. 2017 Aug;18(4):193-201. doi: 10.1016/j.pmn.2017.03.006. Epub 2017 Jun 9.","Davis C","Pain Manag Nurs","2017","2017/06/14","","","10.1016/j.pmn.2017.03.006"
"28595427","Challenging equipotency calculation for hydromorphone after long-term intravenous application","Luchting B, Rachinger-Adam B, Hulde N, Heyn J, Azad SC.","Ann Palliat Med. 2017 Aug;6(Suppl 1):S90-S94. doi: 10.21037/apm.2017.03.01. Epub 2017 Mar 16.","Luchting B","Ann Palliat Med","2017","2017/06/10","","","10.21037/apm.2017.03.01"
"28593748","Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence","Oviedo-Joekes E, Palis H, Guh D, Marchand K, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT.","Drug Alcohol Rev. 2018 Jan;37(1):137-146. doi: 10.1111/dar.12573. Epub 2017 Jun 8.","Oviedo-Joekes E","Drug Alcohol Rev","2018","2017/06/09","","","10.1111/dar.12573"
"28549620","The Effect of Opioid Prescribing Guidelines on Prescriptions by Emergency Physicians in Ohio","Weiner SG, Baker O, Poon SJ, Rodgers AF, Garner C, Nelson LS, Schuur JD.","Ann Emerg Med. 2017 Dec;70(6):799-808.e1. doi: 10.1016/j.annemergmed.2017.03.057. Epub 2017 May 23.","Weiner SG","Ann Emerg Med","2017","2017/05/28","","","10.1016/j.annemergmed.2017.03.057"
"28526048","Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder","Palis H, Marchand K, Guh D, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT, Oviedo-Joekes E.","Subst Abuse Treat Prev Policy. 2017 May 19;12(1):25. doi: 10.1186/s13011-017-0110-9.","Palis H","Subst Abuse Treat Prev Policy","2017","2017/05/21","PMC5437624","","10.1186/s13011-017-0110-9"
"28521199","Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder","Oviedo-Joekes E, Brissette S, MacDonald S, Guh D, Marchand K, Jutha S, Harrison S, Janmohamed A, Zhang DZ, Anis AH, Krausz M, Marsh DC, Schechter MT.","Drug Alcohol Depend. 2017 Jul 1;176:55-62. doi: 10.1016/j.drugalcdep.2017.02.021. Epub 2017 May 10.","Oviedo-Joekes E","Drug Alcohol Depend","2017","2017/05/19","","","10.1016/j.drugalcdep.2017.02.021"
"28500651","Predictors of Response in Emergency Department Patients Receiving Intravenous Opioids for Severe Pain","Radcliff JA, Rafeq RM, Bowen JF, Pontiggia L, Sen S.","Pharmacotherapy. 2017 Jul;37(7):799-805. doi: 10.1002/phar.1949.","Radcliff JA","Pharmacotherapy","2017","2017/05/14","","","10.1002/phar.1949"
"28405945","The Comparative Risk of Delirium with Different Opioids: A Systematic Review","Swart LM, van der Zanden V, Spies PE, de Rooij SE, van Munster BC.","Drugs Aging. 2017 Jun;34(6):437-443. doi: 10.1007/s40266-017-0455-9.","Swart LM","Drugs Aging","2017","2017/04/14","PMC5427092","","10.1007/s40266-017-0455-9"
"28392133","Patients at Risk: Large Opioid Prescriptions After Total Knee Arthroplasty","Hernandez NM, Parry JA, Taunton MJ.","J Arthroplasty. 2017 Aug;32(8):2395-2398. doi: 10.1016/j.arth.2017.02.060. Epub 2017 Mar 2.","Hernandez NM","J Arthroplasty","2017","2017/04/11","","","10.1016/j.arth.2017.02.060"
"28346627","Just Another Drug Seeker","Lindsay DR.","Fam Med. 2017 Mar;49(3):230-231.","Lindsay DR","Fam Med","2017","2017/03/28","","",""
"28287363","Nebulized Fentanyl for Dyspnea in a Hospice Patient with True Allergy to Morphine and Hydromorphone","Wahler RG Jr, Smith DB, Mulcahy KB.","J Pain Palliat Care Pharmacother. 2017 Mar;31(1):38-42. doi: 10.1080/15360288.2017.1279499. Epub 2017 Feb 22.","Wahler RG Jr","J Pain Palliat Care Pharmacother","2017","2017/03/14","","","10.1080/15360288.2017.1279499"
"28259526","Review of Intranasally Administered Medications for Use in the Emergency Department","Bailey AM, Baum RA, Horn K, Lewis T, Morizio K, Schultz A, Weant K, Justice SN.","J Emerg Med. 2017 Jul;53(1):38-48. doi: 10.1016/j.jemermed.2017.01.020. Epub 2017 Mar 1.","Bailey AM","J Emerg Med","2017","2017/03/06","","","10.1016/j.jemermed.2017.01.020"
"28237682","The influence of demeanor on scores from two validated feline pain assessment scales during the perioperative period","Buisman M, Hasiuk MMM, Gunn M, Pang DSJ.","Vet Anaesth Analg. 2017 May;44(3):646-655. doi: 10.1016/j.vaa.2016.09.001. Epub 2017 Jan 8.","Buisman M","Vet Anaesth Analg","2017","2017/02/27","","","10.1016/j.vaa.2016.09.001"
"28213593","Randomised, double-blind, parallel group, placebo-controlled study to evaluate the analgesic efficacy and safety of VVZ-149 injections for postoperative pain following laparoscopic colorectal surgery","Nedeljkovic SS, Correll DJ, Bao X, Zamor N, Zeballos JL, Zhang Y, Young MJ, Ledley J, Sorace J, Eng K, Hamsher CP, Maniam R, Chin JW, Tsui B, Cho S, Lee DH.","BMJ Open. 2017 Feb 17;7(2):e011035. doi: 10.1136/bmjopen-2016-011035.","Nedeljkovic SS","BMJ Open","2017","2017/02/19","PMC5318554","","10.1136/bmjopen-2016-011035"
"28185794","Neuraxial opioids for post-cesarean delivery analgesia: can hydromorphone replace morphine? A retrospective study","Marroquin B, Feng C, Balofsky A, Edwards K, Iqbal A, Kanel J, Jackson M, Newton M, Rothstein D, Wong E, Wissler R.","Int J Obstet Anesth. 2017 May;30:16-22. doi: 10.1016/j.ijoa.2016.12.008. Epub 2016 Dec 30.","Marroquin B","Int J Obstet Anesth","2017","2017/02/11","","","10.1016/j.ijoa.2016.12.008"
"28143397","Retrospective case-control non-inferiority analysis of intravenous lidocaine in a colorectal surgery enhanced recovery program","Naik BI, Tsang S, Knisely A, Yerra S, Durieux ME.","BMC Anesthesiol. 2017 Jan 31;17(1):16. doi: 10.1186/s12871-017-0306-6.","Naik BI","BMC Anesthesiol","2017","2017/02/02","PMC5282801","","10.1186/s12871-017-0306-6"
"28111065","Changes in Provider Prescribing Patterns After Implementation of an Emergency Department Prescription Opioid Policy","Osborn SR, Yu J, Williams B, Vasilyadis M, Blackmore CC.","J Emerg Med. 2017 Apr;52(4):538-546. doi: 10.1016/j.jemermed.2016.07.120. Epub 2017 Jan 19.","Osborn SR","J Emerg Med","2017","2017/01/24","","","10.1016/j.jemermed.2016.07.120"
"28067687","A Case of Toxic Breast-feeding?","Schultz ML, Kostic M, Kharasch S.","Pediatr Emerg Care. 2019 Jan;35(1):e9-e10. doi: 10.1097/PEC.0000000000001009.","Schultz ML","Pediatr Emerg Care","2019","2017/01/10","","","10.1097/PEC.0000000000001009"
"28025364","""Managing"" the Placebo Effect: The Single-Blind Placebo Lead-in Response in Two Pain Models","Harden RN, Saracoglu M, Connolly S, Kirsling A, Comstock K, Khazey K, Gerson T, Burns J.","Pain Med. 2016 Dec;17(12):2305-2310. doi: 10.1093/pm/pnv109. Epub 2016 Feb 18.","Harden RN","Pain Med","2016","2016/12/28","","","10.1093/pm/pnv109"
"28012310","Physico-chemical profiling of semisynthetic opioids","Mazák K, Hosztafi S, Kraszni M, Noszál B.","J Pharm Biomed Anal. 2017 Feb 20;135:97-105. doi: 10.1016/j.jpba.2016.12.014. Epub 2016 Dec 15.","Mazák K","J Pharm Biomed Anal","2017","2016/12/25","","","10.1016/j.jpba.2016.12.014"
"28002229","Evaluation of Ultrasound-Assisted Thoracic Epidural Placement in Patients Undergoing Upper Abdominal and Thoracic Surgery: A Randomized, Double-Blind Study","Auyong DB, Hostetter L, Yuan SC, Slee AE, Hanson NA.","Reg Anesth Pain Med. 2017 Mar/Apr;42(2):204-209. doi: 10.1097/AAP.0000000000000540.","Auyong DB","Reg Anesth Pain Med","2017","2016/12/22","","","10.1097/AAP.0000000000000540"
"27878902","A retrospective comparison of intrathecal morphine and epidural hydromorphone for analgesia following posterior spinal fusion in adolescents with idiopathic scoliosis","Hong RA, Gibbons KM, Li GY, Holman A, Voepel-Lewis T.","Paediatr Anaesth. 2017 Jan;27(1):91-97. doi: 10.1111/pan.13037. Epub 2016 Nov 22.","Hong RA","Paediatr Anaesth","2017","2016/11/24","","","10.1111/pan.13037"
"27871585","Optimal epidural analgesia for patients diagnosed as having gynecologic cancer undergoing interstitial brachytherapy","Amsbaugh AK, Amsbaugh MJ, El-Ghamry MN, Derhake BM.","J Clin Anesth. 2016 Dec;35:509-515. doi: 10.1016/j.jclinane.2016.08.025. Epub 2016 Oct 20.","Amsbaugh AK","J Clin Anesth","2016","2016/11/23","","","10.1016/j.jclinane.2016.08.025"
"27839957","Randomized Prospective Trial Comparing the Use of Intravenous versus Oral Acetaminophen in Total Joint Arthroplasty","Politi JR, Davis RL 2nd, Matrka AK.","J Arthroplasty. 2017 Apr;32(4):1125-1127. doi: 10.1016/j.arth.2016.10.018. Epub 2016 Oct 21.","Politi JR","J Arthroplasty","2017","2016/11/15","","","10.1016/j.arth.2016.10.018"
"27822929","Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study","Park CK, Kang HW, Oh IJ, Kim YC, Kim YK, Na KJ, Ahn SJ, Kim TO, Choi YJ, Song GA, Lee MK.","J Korean Med Sci. 2016 Dec;31(12):1914-1921. doi: 10.3346/jkms.2016.31.12.1914.","Park CK","J Korean Med Sci","2016","2016/11/09","PMC5102854","","10.3346/jkms.2016.31.12.1914"
"27810148","Introduction of a novel ultrasound-guided extrathoracic sub-paraspinal block for control of perioperative pain in Nuss procedure patients","Bryskin RB, Robie DK, Mansfield FM, Freid EB, Sukumvanich S.","J Pediatr Surg. 2017 Mar;52(3):484-491. doi: 10.1016/j.jpedsurg.2016.09.065. Epub 2016 Oct 14.","Bryskin RB","J Pediatr Surg","2017","2016/11/05","","","10.1016/j.jpedsurg.2016.09.065"
"27777355","Analgesia in the surgical intensive care unit","Ehieli E, Yalamuri S, Brudney CS, Pyati S.","Postgrad Med J. 2017 Jan;93(1095):38-45. doi: 10.1136/postgradmedj-2016-134047. Epub 2016 Oct 24.","Ehieli E","Postgrad Med J","2017","2016/11/01","","","10.1136/postgradmedj-2016-134047"
"27775447","A pediatric fatality due to accidental hydromorphone ingestion","Cantrell FL, Sherrard J, Andrade M, Schaber B, McIntyre IM.","Clin Toxicol (Phila). 2017 Jan;55(1):60-62. doi: 10.1080/15563650.2016.1247958. Epub 2016 Oct 24.","Cantrell FL","Clin Toxicol (Phila)","2017","2016/10/25","","","10.1080/15563650.2016.1247958"
"27764026","Suitability of the DRI Hydrocodone/Hydromorphone Immunoassay in the Clinical Environment at a Lower Cutoff: Validation With LC-MS/MS Analysis","Dixon RB, Dasgupta A.","Ther Drug Monit. 2016 Dec;38(6):787-790. doi: 10.1097/FTD.0000000000000339.","Dixon RB","Ther Drug Monit","2016","2016/10/21","","","10.1097/FTD.0000000000000339"
"27751704","When Hydromorphone Is Not Working, Try Loratadine: An Emergency Department Case of Loratadine as Abortive Therapy for Severe Pegfilgrastim-Induced Bone Pain","Moore K, Haroz R.","J Emerg Med. 2017 Feb;52(2):e29-e31. doi: 10.1016/j.jemermed.2016.08.018. Epub 2016 Oct 14.","Moore K","J Emerg Med","2017","2016/10/19","","","10.1016/j.jemermed.2016.08.018"
"27727452","Hydromorphone for cancer pain","Bao YJ, Hou W, Kong XY, Yang L, Xia J, Hua BJ, Knaggs R.","Cochrane Database Syst Rev. 2016 Oct 11;10(10):CD011108. doi: 10.1002/14651858.CD011108.pub2.","Bao YJ","Cochrane Database Syst Rev","2016","2016/10/12","PMC6457981","","10.1002/14651858.CD011108.pub2"
"27723230","Effect of morphine, methadone, hydromorphone or oxymorphone on the thermal threshold, following intravenous or buccal administration to cats","Pypendop BH, Shilo-Benjamini Y, Ilkiw JE.","Vet Anaesth Analg. 2016 Nov;43(6):635-642. doi: 10.1111/vaa.12356. Epub 2016 Mar 1.","Pypendop BH","Vet Anaesth Analg","2016","2016/10/11","","","10.1111/vaa.12356"
"27702939","Degradation of Opioids and Opiates During Acid Hydrolysis Leads to Reduced Recovery Compared to Enzymatic Hydrolysis","Sitasuwan P, Melendez C, Marinova M, Mastrianni KR, Darragh A, Ryan E, Lee LA.","J Anal Toxicol. 2016 Oct;40(8):601-607. doi: 10.1093/jat/bkw085.","Sitasuwan P","J Anal Toxicol","2016","2016/10/06","","","10.1093/jat/bkw085"
"27687384","Effect of thoracic epidural analgesia on recovery of bowel function after major upper abdominal surgery","Ahn JH, Ahn HJ.","J Clin Anesth. 2016 Nov;34:247-52. doi: 10.1016/j.jclinane.2016.04.042. Epub 2016 May 13.","Ahn JH","J Clin Anesth","2016","2016/10/01","","","10.1016/j.jclinane.2016.04.042"
"27641091","Determination of ED(50) of hydromorphone for postoperative analgesia following cesarean delivery","Lynde GC.","Int J Obstet Anesth. 2016 Dec;28:17-21. doi: 10.1016/j.ijoa.2016.07.005. Epub 2016 Jul 16.","Lynde GC","Int J Obstet Anesth","2016","2016/09/20","","","10.1016/j.ijoa.2016.07.005"
"27620291","Ketamine use in sedation management in patients receiving extracorporeal membrane oxygenation","Dzierba AL, Brodie D, Bacchetta M, Muir J, Wasson L, Colabraro M, Gannon W, Connolly K, Biscotti M, Rietdijk W, Moitra V, Bakker J.","Intensive Care Med. 2016 Nov;42(11):1822-1823. doi: 10.1007/s00134-016-4519-9. Epub 2016 Sep 12.","Dzierba AL","Intensive Care Med","2016","2016/09/14","","","10.1007/s00134-016-4519-9"
"27562969","Evaluation of a Newly Formulated Enzyme Immunoassay for the Detection of Hydrocodone and Hydromorphone in Pain Management Compliance Testing","Nascimento R, Poklis A, Wolf CE.","J Anal Toxicol. 2016 Oct;40(8):583-587. doi: 10.1093/jat/bkw080. Epub 2016 Aug 25.","Nascimento R","J Anal Toxicol","2016","2016/08/27","PMC5048711","","10.1093/jat/bkw080"
"27552239","A Rare Case of Hydromorphone-Induced Angioedema Effectively Managed by a Difficult Airway Response Team","Masson S, Villerot M, Dalal B.","A A Case Rep. 2016 Nov 1;7(9):188-189. doi: 10.1213/XAA.0000000000000379.","Masson S","A A Case Rep","2016","2016/08/24","","","10.1213/XAA.0000000000000379"
"27505059","Primary Hydromorphone-Related Intrathecal Catheter Tip Granulomas: Is There a Role for Dose and Concentration?","Veizi IE, Hayek SM, Hanes M, Galica R, Katta S, Yaksh T.","Neuromodulation. 2016 Oct;19(7):760-769. doi: 10.1111/ner.12481. Epub 2016 Aug 9.","Veizi IE","Neuromodulation","2016","2016/08/10","","","10.1111/ner.12481"
"27497017","Pain Management in the Individual with Serious Illness and Comorbid Substance Use Disorder","Walsh AF, Broglio K.","Nurs Clin North Am. 2016 Sep;51(3):433-47. doi: 10.1016/j.cnur.2016.05.003.","Walsh AF","Nurs Clin North Am","2016","2016/08/07","","","10.1016/j.cnur.2016.05.003"
"27474362","Identification of Drugs in Parenteral Pharmaceutical Preparations from a Quality Assurance and a Diversion Program by Direct Analysis in Real-Time AccuTOFTM-Mass Spectrometry (DART-MS)","Poklis JL, Mohs AJ, Wolf CE, Poklis A, Peace MR.","J Anal Toxicol. 2016 Oct;40(8):608-616. doi: 10.1093/jat/bkw065. Epub 2016 Jul 29.","Poklis JL","J Anal Toxicol","2016","2016/07/31","PMC5048709","","10.1093/jat/bkw065"
"27454263","Synergistic Effect of Intravenous Ibuprofen and Hydromorphone for Postoperative Pain: Prospective Randomized Controlled Trial","Oh E, Ahn HJ, Sim WS, Lee JY.","Pain Physician. 2016 Jul;19(6):341-8.","Oh E","Pain Physician","2016","2016/07/26","","",""
"27435437","Abuse deterrence testing: A dose ratio escalation study examining naloxone coadministered with intravenous hydromorphone in non-treatment-seeking, opioid-dependent drug users","Levy-Cooperman N, Schoedel KA, Reiz JL, Thompson D, Chakaraborty B, Geoffroy P, Michalko KJ.","J Opioid Manag. 2016 May-Jun;12(3):165-80. doi: 10.5055/jom.2016.0329.","Levy-Cooperman N","J Opioid Manag","2016","2016/07/21","","","10.5055/jom.2016.0329"
"27405368","Prescription Opioids. VI. Metabolism and Excretion of Hydromorphone in Urine Following Controlled Single-Dose Administration","DePriest AZ, Heltsley R, Black DL, Mitchell JM, LoDico C, Flegel R, Cone EJ.","J Anal Toxicol. 2016 Oct;40(8):575-582. doi: 10.1093/jat/bkw066. Epub 2016 Jul 11.","DePriest AZ","J Anal Toxicol","2016","2016/07/14","","","10.1093/jat/bkw066"
"27399959","Evidence for Neurotoxicity Due to Morphine or Hydromorphone Use in Renal Impairment: A Systematic Review","Lee KA, Ganta N, Horton JR, Chai E.","J Palliat Med. 2016 Nov;19(11):1179-1187. doi: 10.1089/jpm.2016.0101. Epub 2016 Jul 11.","Lee KA","J Palliat Med","2016","2016/07/12","","","10.1089/jpm.2016.0101"
"27281726","Epidural Versus Paravertebral Nerve Block for Postoperative Analgesia in Patients Undergoing Open Liver Resection: A Randomized Clinical Trial","Schreiber KL, Chelly JE, Lang RS, Abuelkasem E, Geller DA, Marsh JW, Tsung A, Sakai T.","Reg Anesth Pain Med. 2016 Jul-Aug;41(4):460-8. doi: 10.1097/AAP.0000000000000422.","Schreiber KL","Reg Anesth Pain Med","2016","2016/06/10","","","10.1097/AAP.0000000000000422"
"27216018","Hydromorphone for neuropathic pain in adults","Stannard C, Gaskell H, Derry S, Aldington D, Cole P, Cooper TE, Knaggs R, Wiffen PJ, Moore RA.","Cochrane Database Syst Rev. 2016 May 24;2016(5):CD011604. doi: 10.1002/14651858.CD011604.pub2.","Stannard C","Cochrane Database Syst Rev","2016","2016/05/25","PMC6491092","","10.1002/14651858.CD011604.pub2"
"27168565","En Route Use of Analgesics in Nonintubated, Critically Ill Patients Transported by U.S. Air Force Critical Care Air Transport Teams","Mora AG, Ganem VJ, Ervin AT, Maddry JK, Bebarta VS.","Mil Med. 2016 May;181(5 Suppl):145-51. doi: 10.7205/MILMED-D-15-00194.","Mora AG","Mil Med","2016","2016/05/12","","","10.7205/MILMED-D-15-00194"
"27067523","Hair analysis for opiates: hydromorphone and hydrocodone as indicators of heroin use","Madry MM, Bosshard MM, Kraemer T, Baumgartner MR.","Bioanalysis. 2016 May;8(9):953-64. doi: 10.4155/bio-2016-0019. Epub 2016 Apr 12.","Madry MM","Bioanalysis","2016","2016/04/13","","","10.4155/bio-2016-0019"
"27052850","LC-MS-MS Method for Analysis of Opiates in Wastewater During Football Games II","Gul W, Stamper B, Godfrey M, Gul SW, ElSohly MA.","J Anal Toxicol. 2016 Jun;40(5):330-7. doi: 10.1093/jat/bkw022. Epub 2016 Apr 6.","Gul W","J Anal Toxicol","2016","2016/04/08","","","10.1093/jat/bkw022"
"27049826","Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial","Oviedo-Joekes E, Guh D, Brissette S, Marchand K, MacDonald S, Lock K, Harrison S, Janmohamed A, Anis AH, Krausz M, Marsh DC, Schechter MT.","JAMA Psychiatry. 2016 May 1;73(5):447-55. doi: 10.1001/jamapsychiatry.2016.0109.","Oviedo-Joekes E","JAMA Psychiatry","2016","2016/04/07","","","10.1001/jamapsychiatry.2016.0109"
"27003917","The Effect of Dexmedetomidine on Postoperative Opioid Consumption and Pain After Major Spine Surgery","Naik BI, Nemergut EC, Kazemi A, Fernández L, Cederholm SK, McMurry TL, Durieux ME.","Anesth Analg. 2016 May;122(5):1646-53. doi: 10.1213/ANE.0000000000001226.","Naik BI","Anesth Analg","2016","2016/03/23","","","10.1213/ANE.0000000000001226"
"26990069","Resolution of Intrathecal Hydromorphone or Morphine-induced Peripheral Edema by Opioid Rotation to Fentanyl: A Case Series","Veizi E, Tornero-Bold M, Hayek SM.","Pain Pract. 2016 Jul;16(6):E94-8. doi: 10.1111/papr.12443. Epub 2016 Mar 15.","Veizi E","Pain Pract","2016","2016/03/19","","","10.1111/papr.12443"
"26974022","Intrathecal Hydromorphone and Morphine for Postcesarean Delivery Analgesia: Determination of the ED90 Using a Sequential Allocation Biased-Coin Method","Sviggum HP, Arendt KW, Jacob AK, Niesen AD, Johnson RL, Schroeder DR, Tien M, Mantilla CB.","Anesth Analg. 2016 Sep;123(3):690-7. doi: 10.1213/ANE.0000000000001229.","Sviggum HP","Anesth Analg","2016","2016/03/15","","","10.1213/ANE.0000000000001229"
"26919594","Antinociceptive effects of intravenous administration of hydromorphone hydrochloride alone or followed by buprenorphine hydrochloride or butorphanol tartrate to healthy conscious cats","Simon BT, Steagall PV, Monteiro BP, Troncy E, Lizarraga I.","Am J Vet Res. 2016 Mar;77(3):245-51. doi: 10.2460/ajvr.77.3.245.","Simon BT","Am J Vet Res","2016","2016/02/27","","","10.2460/ajvr.77.3.245"
"26890432","The effects of acupuncture point Pericardium 6 on hydromorphone-induced nausea and vomiting in healthy dogs","Scallan EM, Simon BT.","Vet Anaesth Analg. 2016 Sep;43(5):495-501. doi: 10.1111/vaa.12347. Epub 2016 Feb 18.","Scallan EM","Vet Anaesth Analg","2016","2016/02/19","","","10.1111/vaa.12347"
"26824884","Efficacy of a new once daily hydromorphone formulation in comparison with twice daily administration in chronic pain: a randomized, double-blind, cross-over study","Nold GE, Maritz MA, Schwittay A, Schumann C, Rey H.","Curr Med Res Opin. 2016 May;32(5):869-77. doi: 10.1185/03007995.2016.1149052. Epub 2016 Mar 2.","Nold GE","Curr Med Res Opin","2016","2016/01/30","","","10.1185/03007995.2016.1149052"
"26814257","Intrathecal Hydromorphone and Bupivacaine Combination Therapy for Post-Laminectomy Syndrome Optimized with Patient-Activated Bolus Device","Hayek SM, Veizi E, Hanes M.","Pain Med. 2016 Mar;17(3):561-571. doi: 10.1093/pm/pnv021. Epub 2015 Dec 14.","Hayek SM","Pain Med","2016","2016/01/28","","","10.1093/pm/pnv021"
"26797808","External Validation of a Recently Developed Population Pharmacokinetic Model for Hydromorphone During Postoperative Pain Therapy","Ihmsen H, Rohde D, Schüttler J, Jeleazcov C.","Eur J Drug Metab Pharmacokinet. 2017 Feb;42(1):17-28. doi: 10.1007/s13318-015-0318-x.","Ihmsen H","Eur J Drug Metab Pharmacokinet","2017","2016/01/23","","","10.1007/s13318-015-0318-x"
"26778766","Hydromorphone vs fentanyl for epidural analgesia and anesthesia","Nguyen MN, Zimmerman LH, Meloche K, Dolman HS, Baylor AE, Fuleihan S, Wilson RF, Tyburski JG.","Am J Surg. 2016 Mar;211(3):565-70. doi: 10.1016/j.amjsurg.2015.12.003. Epub 2015 Dec 29.","Nguyen MN","Am J Surg","2016","2016/01/19","","","10.1016/j.amjsurg.2015.12.003"
"26759658","The Changing Use of Intravenous Opioids in an Emergency Department","Sutter ME, Wintemute GJ, Clarke SO, Roche BM, Chenoweth JA, Gutierrez R, Albertson TE.","West J Emerg Med. 2015 Dec;16(7):1079-83. doi: 10.5811/westjem.2015.10.28454. Epub 2015 Dec 14.","Sutter ME","West J Emerg Med","2015","2016/01/14","PMC4703147","","10.5811/westjem.2015.10.28454"
"26739277","Opioid Pharmacokinetics-Pharmacodynamics: Clinical Implications in Acute Pain Management in Trauma","MacKenzie M, Zed PJ, Ensom MH.","Ann Pharmacother. 2016 Mar;50(3):209-18. doi: 10.1177/1060028015625659. Epub 2016 Jan 5.","MacKenzie M","Ann Pharmacother","2016","2016/01/08","","","10.1177/1060028015625659"
"26659198","Ketamine added to morphine or hydromorphone patient-controlled analgesia for acute postoperative pain in adults: a systematic review and meta-analysis of randomized trials","Wang L, Johnston B, Kaushal A, Cheng D, Zhu F, Martin J.","Can J Anaesth. 2016 Mar;63(3):311-25. doi: 10.1007/s12630-015-0551-4. Epub 2015 Dec 10.","Wang L","Can J Anaesth","2016","2015/12/15","","","10.1007/s12630-015-0551-4"
"26650971","Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder","Nasser AF, Greenwald MK, Vince B, Fudala PJ, Twumasi-Ankrah P, Liu Y, Jones JP 3rd, Heidbreder C.","J Clin Psychopharmacol. 2016 Feb;36(1):18-26. doi: 10.1097/JCP.0000000000000434.","Nasser AF","J Clin Psychopharmacol","2016","2015/12/10","PMC5549150","NIHMS884533","10.1097/JCP.0000000000000434"
"26606204","Postoperative Analgesia Provided by Liposomal Hydromorphone in Client-Owned Dogs Undergoing Limb Amputation","Krugner-Higby L, Smith LJ, Schmidt B, Steagall PV, Brown C, Heath TD.","J Am Anim Hosp Assoc. 2016 Jan-Feb;52(1):13-21. doi: 10.5326/JAAHA-MS-6113. Epub 2015 Nov 25.","Krugner-Higby L","J Am Anim Hosp Assoc","2016","2015/11/26","","","10.5326/JAAHA-MS-6113"
"26603302","ED ultrasound-guided posterior tibial nerve blocks for calcaneal fracture analagesia","Clattenburg E, Herring A, Hahn C, Johnson B, Nagdev A.","Am J Emerg Med. 2016 Jun;34(6):1183.e1-3. doi: 10.1016/j.ajem.2015.11.002. Epub 2015 Nov 9.","Clattenburg E","Am J Emerg Med","2016","2015/11/26","","","10.1016/j.ajem.2015.11.002"
"26556729","Patient-controlled Analgesia with Target-controlled Infusion of Hydromorphone in Postoperative Pain Therapy","Jeleazcov C, Ihmsen H, Saari TI, Rohde D, Mell J, Fröhlich K, Krajinovic L, Fechner J, Schwilden H, Schüttler J.","Anesthesiology. 2016 Jan;124(1):56-68. doi: 10.1097/ALN.0000000000000937.","Jeleazcov C","Anesthesiology","2016","2015/11/12","","","10.1097/ALN.0000000000000937"
"26489482","Prevalence, risk factors, and outcomes associated with physical restraint use in mechanically ventilated adults","Rose L, Burry L, Mallick R, Luk E, Cook D, Fergusson D, Dodek P, Burns K, Granton J, Ferguson N, Devlin JW, Steinberg M, Keenan S, Reynolds S, Tanios M, Fowler RA, Jacka M, Olafson K, Skrobik Y, Mehta S.","J Crit Care. 2016 Feb;31(1):31-5. doi: 10.1016/j.jcrc.2015.09.011. Epub 2015 Sep 25.","Rose L","J Crit Care","2016","2015/10/23","","","10.1016/j.jcrc.2015.09.011"
"26474382","A prospective multicentre study to evaluate the efficacy and tolerability of osmotic release oral system (OROS) hydromorphone in opioid-naive cancer patients: Results of the Korean South West Oncology Group study","Song EK, Shim H, Han HS, Sun D, Lee SI, Kang MH, Lee K, Cho D, Cho IS, Park SY, Kim S, Yim CY.","Pain Res Manag. 2015 Nov-Dec;20(6):293-9. doi: 10.1155/2015/458389. Epub 2015 Oct 16.","Song EK","Pain Res Manag","2015","2015/10/17","PMC4676498","","10.1155/2015/458389"
"26426576","Comparison of efficacy and safety of lateral-to-medial continuous transversus abdominis plane block with thoracic epidural analgesia in patients undergoing abdominal surgery: A randomised, open-label feasibility study","Ganapathy S, Sondekoppam RV, Terlecki M, Brookes J, Das Adhikary S, Subramanian L.","Eur J Anaesthesiol. 2015 Nov;32(11):797-804. doi: 10.1097/EJA.0000000000000345.","Ganapathy S","Eur J Anaesthesiol","2015","2015/10/02","","","10.1097/EJA.0000000000000345"
"26350273","Effects of paroxetine, a CYP2D6 inhibitor, on the pharmacokinetic properties of hydrocodone after coadministration with a single-entity, once-daily, extended-release hydrocodone tablet","Kapil RP, Friedman K, Cipriano A, Michels G, Shet M, Mondal SA, Harris SC.","Clin Ther. 2015 Oct 1;37(10):2286-96. doi: 10.1016/j.clinthera.2015.08.007. Epub 2015 Sep 6.","Kapil RP","Clin Ther","2015","2015/09/10","","","10.1016/j.clinthera.2015.08.007"
"26342726","Methadone Use and the Risk of Hypoglycemia for Inpatients With Cancer Pain","Flory JH, Wiesenthal AC, Thaler HT, Koranteng L, Moryl N.","J Pain Symptom Manage. 2016 Jan;51(1):79-87.e1. doi: 10.1016/j.jpainsymman.2015.08.003. Epub 2015 Sep 3.","Flory JH","J Pain Symptom Manage","2016","2015/09/07","PMC5484401","NIHMS815835","10.1016/j.jpainsymman.2015.08.003"
"26312962","Decreased responsiveness to oxycodone: A case of a pharmacokinetic drug interaction?","Pon D, Hwang J, Lo T, Zyl CV.","J Opioid Manag. 2015 Jul-Aug;11(4):357-61. doi: 10.5055/jom.2015.0284.","Pon D","J Opioid Manag","2015","2015/08/28","","","10.5055/jom.2015.0284"
"26309104","Pharmacokinetics of hydrocodone and tramadol administered for control of postoperative pain in dogs following tibial plateau leveling osteotomy","Benitez ME, Roush JK, KuKanich B, McMurphy R.","Am J Vet Res. 2015 Sep;76(9):763-70. doi: 10.2460/ajvr.76.9.763.","Benitez ME","Am J Vet Res","2015","2015/08/27","","","10.2460/ajvr.76.9.763"
"26306434","Opiate refractory pain from an intestinal obstruction responsive to an intravenous lidocaine infusion","Bafuma PJ, Nandi A, Weisberg M.","Am J Emerg Med. 2015 Oct;33(10):1544.e3-4. doi: 10.1016/j.ajem.2015.07.027. Epub 2015 Jul 21.","Bafuma PJ","Am J Emerg Med","2015","2015/08/27","","","10.1016/j.ajem.2015.07.027"
"26288036","Cost Savings of Patient-Controlled Intrathecal Analgesia","Bolash RB.","Reg Anesth Pain Med. 2015 Sep-Oct;40(5):639-40. doi: 10.1097/AAP.0000000000000281.","Bolash RB","Reg Anesth Pain Med","2015","2015/08/20","","","10.1097/AAP.0000000000000281"
"26286816","No correlation between body size and hydromorphone analgesia in obese patients in ED","Xia S, Chew E, Choe D, Hernandez L, Birnbaum A.","Am J Emerg Med. 2015 Oct;33(10):1522-3. doi: 10.1016/j.ajem.2015.07.020. Epub 2015 Jul 21.","Xia S","Am J Emerg Med","2015","2015/08/20","","","10.1016/j.ajem.2015.07.020"
"26280453","Structural Determinants for the Binding of Morphinan Agonists to the μ-Opioid Receptor","Cong X, Campomanes P, Kless A, Schapitz I, Wagener M, Koch T, Carloni P.","PLoS One. 2015 Aug 17;10(8):e0135998. doi: 10.1371/journal.pone.0135998. eCollection 2015.","Cong X","PLoS One","2015","2015/08/18","PMC4539194","","10.1371/journal.pone.0135998"
"26179573","Effect of pretreatment with hydromorphone or buprenorphine on thermal antinociception induced by fentanyl in awake cats","Ambros B.","J Feline Med Surg. 2016 Oct;18(10):818-25. doi: 10.1177/1098612X15595835. Epub 2015 Jul 15.","Ambros B","J Feline Med Surg","2016","2015/07/17","","","10.1177/1098612X15595835"
"26170088","[New option in the management of cancer pain in Hungary: short acting oral opioid therapy]","Kullmann T, Sipőcz I, Csikós Á, Pintér T.","Orv Hetil. 2015 Jun 21;156(25):1003-6. doi: 10.1556/650.2015.30171.","Kullmann T","Orv Hetil","2015","2015/07/15","","","10.1556/650.2015.30171"
"26118474","The development of a high-performance liquid chromatography-tandem mass spectrometric method for simultaneous quantification of morphine, morphine-3-β-glucuronide, morphine-6-β-glucuronide, hydromorphone, and normorphine in serum","Sartori D, Lewis T, Breaud A, Clarke W.","Clin Biochem. 2015 Dec;48(18):1283-90. doi: 10.1016/j.clinbiochem.2015.05.023. Epub 2015 Jun 26.","Sartori D","Clin Biochem","2015","2015/06/30","PMC4679425","NIHMS723677","10.1016/j.clinbiochem.2015.05.023"
"26111087","Effects of oxymorphone hydrochloride or hydromorphone hydrochloride on minimal alveolar concentration of desflurane in sheep","Sayre RS, Lepiz MA, Horsley KT, Pashmakova MB, Barr JW, Washburn SE.","Am J Vet Res. 2015 Jul;76(7):583-90. doi: 10.2460/ajvr.76.7.583.","Sayre RS","Am J Vet Res","2015","2015/06/26","","","10.2460/ajvr.76.7.583"
"26100690","Pectus excavatum: Benefit of randomization","Dalton BG, Gonzalez KW, Millspaugh DL, Desai AA, Sharp SW, St Peter SD.","J Pediatr Surg. 2015 Nov;50(11):1937-9. doi: 10.1016/j.jpedsurg.2015.05.009. Epub 2015 Jun 1.","Dalton BG","J Pediatr Surg","2015","2015/06/24","","","10.1016/j.jpedsurg.2015.05.009"
"26095481","A pilot evaluation of a hydromorphone dose substitution policy and the effects on patient safety and pain management","Ricket A, Mateyoke G, Vallabh M, Owen C, Peppin J.","J Pain Palliat Care Pharmacother. 2015 Jun;29(2):120-4. doi: 10.3109/15360288.2015.1035829.","Ricket A","J Pain Palliat Care Pharmacother","2015","2015/06/23","","","10.3109/15360288.2015.1035829"
"26088567","Effects of ketamine and alfaxalone on application of a feline pain assessment scale","Buisman M, Wagner MC, Hasiuk MM, Prebble M, Law L, Pang DS.","J Feline Med Surg. 2016 Aug;18(8):643-51. doi: 10.1177/1098612X15591590. Epub 2015 Jun 18.","Buisman M","J Feline Med Surg","2016","2015/06/20","","","10.1177/1098612X15591590"
"26074387","Efficacy of an Acute Pain Titration Protocol Driven by Patient Response to a Simple Query: Do You Want More Pain Medication?","Chang AK, Bijur PE, Holden L, Gallagher EJ.","Ann Emerg Med. 2016 May;67(5):565-72. doi: 10.1016/j.annemergmed.2015.04.035. Epub 2015 Jun 11.","Chang AK","Ann Emerg Med","2016","2015/06/16","","","10.1016/j.annemergmed.2015.04.035"
"26056836","Lactescent Serum and Abdominal Pain","Kazakin A, Haronian T, Binder W.","R I Med J (2013). 2015 Mar 3;98(3):36-8.","Kazakin A","R I Med J (2013)","2015","2015/06/10","","",""
"25962610","Prescription Opioids. IV: Disposition of Hydrocodone in Oral Fluid and Blood Following Single-Dose Administration","Cone EJ, DePriest AZ, Heltsley R, Black DL, Mitchell JM, LoDico C, Flegel R.","J Anal Toxicol. 2015 Sep;39(7):510-8. doi: 10.1093/jat/bkv050. Epub 2015 May 10.","Cone EJ","J Anal Toxicol","2015","2015/05/13","","","10.1093/jat/bkv050"
"25962563","The Benefits of Authorized Agent Controlled Analgesia (AACA) to Control Pain and Other Symptoms at the End of Life","Webb RJ, Shelton CP.","J Pain Symptom Manage. 2015 Sep;50(3):371-4. doi: 10.1016/j.jpainsymman.2015.03.015. Epub 2015 May 9.","Webb RJ","J Pain Symptom Manage","2015","2015/05/13","","","10.1016/j.jpainsymman.2015.03.015"
"25925401","Non-invasive respiratory volume monitoring identifies opioid-induced respiratory depression in an orthopedic surgery patient with diagnosed obstructive sleep apnea: a case report","Fleming E, Voscopoulos C, George E.","J Med Case Rep. 2015 Apr 29;9:94. doi: 10.1186/s13256-015-0577-9.","Fleming E","J Med Case Rep","2015","2015/05/01","PMC4437550","","10.1186/s13256-015-0577-9"
"25923819","Prospective Observational Study of Patient-Controlled Intrathecal Analgesia: Impact on Cancer-Associated Symptoms, Breakthrough Pain Control, and Patient Satisfaction","Brogan SE, Winter NB, Okifuji A.","Reg Anesth Pain Med. 2015 Jul-Aug;40(4):369-75. doi: 10.1097/AAP.0000000000000251.","Brogan SE","Reg Anesth Pain Med","2015","2015/04/30","","","10.1097/AAP.0000000000000251"
"25914912","Effectiveness of opioid analgesics in chronic noncancer pain","Ferrari R, Zanolin ME, Duse G, Visentin M.","Pain Pract. 2015 Mar;15(3):272-8. doi: 10.1111/papr.12176.","Ferrari R","Pain Pract","2015","2015/04/28","","","10.1111/papr.12176"
"25901483","Intractable pruritus during outpatient epidural hydromorphone infusion: a case report and a focused review of the literature","Ruan X, Ma L, Couch JP, Chen T, Bumgarner GW.","J Opioid Manag. 2015 Mar-Apr;11(2):184-90. doi: 10.5055/jom.2015.0267.","Ruan X","J Opioid Manag","2015","2015/04/23","","","10.5055/jom.2015.0267"
"25887830","Narcotic-only Epidural Infusion for Posterior Spinal Fusion Patients: A Single-Center, Retrospective Review","Hong R, Gauger V, Caird MS, Burke C.","J Pediatr Orthop. 2016 Jul-Aug;36(5):526-9. doi: 10.1097/BPO.0000000000000490.","Hong R","J Pediatr Orthop","2016","2015/04/19","","","10.1097/BPO.0000000000000490"
"25807927","Single-dose evaluation of safety, tolerability and pharmacokinetics of newly formulated hydromorphone immediate-release and hydrophilic matrix extended-release tablets in healthy Japanese subjects without co-administration of an opioid antagonist","Toyama K, Uchida N, Ishizuka H, Sambe T, Kobayashi S.","J Clin Pharmacol. 2015 Sep;55(9):975-84. doi: 10.1002/jcph.501. Epub 2015 May 6.","Toyama K","J Clin Pharmacol","2015","2015/03/27","","","10.1002/jcph.501"
"25801584","Separation of opiate isomers using electrospray ionization and paper spray coupled to high-field asymmetric waveform ion mobility spectrometry","Manicke NE, Belford M.","J Am Soc Mass Spectrom. 2015 May;26(5):701-5. doi: 10.1007/s13361-015-1096-z. Epub 2015 Mar 24.","Manicke NE","J Am Soc Mass Spectrom","2015","2015/03/25","","","10.1007/s13361-015-1096-z"
"25727307","Outcomes after adenotonsillectomy using a fixed anesthesia protocol in children with obstructive sleep apnea","Isaiah A, Pereira KD.","Int J Pediatr Otorhinolaryngol. 2015 May;79(5):638-43. doi: 10.1016/j.ijporl.2015.01.034. Epub 2015 Feb 9.","Isaiah A","Int J Pediatr Otorhinolaryngol","2015","2015/03/03","","","10.1016/j.ijporl.2015.01.034"
"25719847","Application of fast-track surgery principles to evaluate effects of atipamezole on recovery and analgesia following ovariohysterectomy in cats anesthetized with dexmedetomidine-ketamine-hydromorphone","Hasiuk MM, Brown D, Cooney C, Gunn M, Pang DS.","J Am Vet Med Assoc. 2015 Mar 15;246(6):645-53. doi: 10.2460/javma.246.6.645.","Hasiuk MM","J Am Vet Med Assoc","2015","2015/02/27","","","10.2460/javma.246.6.645"
"25664525","Mu opioid mediated discriminative-stimulus effects of tramadol: an individual subjects analysis","Strickland JC, Rush CR, Stoops WW.","J Exp Anal Behav. 2015 Mar;103(2):361-74. doi: 10.1002/jeab.137. Epub 2015 Feb 9.","Strickland JC","J Exp Anal Behav","2015","2015/02/10","PMC4596260","NIHMS725849","10.1002/jeab.137"
"25619263","The SALOME study: recruitment experiences in a clinical trial offering injectable diacetylmorphine and hydromorphone for opioid dependency","Oviedo-Joekes E, Marchand K, Lock K, MacDonald S, Guh D, Schechter MT.","Subst Abuse Treat Prev Policy. 2015 Jan 26;10:3. doi: 10.1186/1747-597X-10-3.","Oviedo-Joekes E","Subst Abuse Treat Prev Policy","2015","2015/01/27","PMC4355145","","10.1186/1747-597X-10-3"
"25576257","Exploratory study on association of single-nucleotide polymorphisms with hydromorphone analgesia in ED","Xia S, Persaud S, Birnbaum A.","Am J Emerg Med. 2015 Mar;33(3):444-7. doi: 10.1016/j.ajem.2014.12.008. Epub 2014 Dec 18.","Xia S","Am J Emerg Med","2015","2015/01/11","PMC4385400","NIHMS650629","10.1016/j.ajem.2014.12.008"
"25503691","[Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks]","Häuser W, Bernardy K, Maier C.","Schmerz. 2015 Feb;29(1):96-108. doi: 10.1007/s00482-014-1452-0.","Häuser W","Schmerz","2015","2014/12/16","","","10.1007/s00482-014-1452-0"
"25454570","Opioid pharmacokinetics depends on lipid solubility","Schwartz AE.","Ann Emerg Med. 2014 Dec;64(6):685. doi: 10.1016/j.annemergmed.2014.06.026. Epub 2014 Nov 20.","Schwartz AE","Ann Emerg Med","2014","2014/12/03","","","10.1016/j.annemergmed.2014.06.026"
"25452049","Predictors of non-use of illicit heroin in opioid injection maintenance treatment of long-term heroin dependence","Oviedo-Joekes E, Sordo L, Guh D, Marsh DC, Lock K, Brissette S, Anis AH, Schechter MT.","Addict Behav. 2015 Feb;41:81-6. doi: 10.1016/j.addbeh.2014.10.003. Epub 2014 Oct 7.","Oviedo-Joekes E","Addict Behav","2015","2014/12/03","","","10.1016/j.addbeh.2014.10.003"
"25427288","Bilateral Paravertebral Blockade (T7-10) Versus Incisional Local Anesthetic Administration for Pediatric Laparoscopic Cholecystectomy: A Prospective, Randomized Clinical Study","Visoiu M, Cassara A, Yang CI.","Anesth Analg. 2015 May;120(5):1106-13. doi: 10.1213/ANE.0000000000000545.","Visoiu M","Anesth Analg","2015","2014/11/27","","","10.1213/ANE.0000000000000545"
"25414239","Alternating hemidystonia following traumatic brain injury as an unusual presentation of paroxysmal autonomic instability with dystonia syndrome","Buerger KJ, Salazar R.","BMJ Case Rep. 2014 Nov 20;2014:bcr2014206102. doi: 10.1136/bcr-2014-206102.","Buerger KJ","BMJ Case Rep","2014","2014/11/22","PMC4244337","","10.1136/bcr-2014-206102"
"25350473","Hydromorphone extended release for neuropathic and non-neuropathic/nociceptive chronic low back pain: a post hoc analysis of data from a randomized, multicenter, double-blind, placebo-controlled clinical trial","Nalamachu S, Hale M, Khan A.","J Opioid Manag. 2014 Sep-Oct;10(5):311-22. doi: 10.5055/jom.2014.0221.","Nalamachu S","J Opioid Manag","2014","2014/10/29","","","10.5055/jom.2014.0221"
"25344135","[Clinical experience in opioid switch for noncancer chronic pain treatment]","López-Pérez FJ, Mínguez-Martí A, Vicario-Sánchez E, Pastor-Clérigues A, Sanfeliu-García J, Ortega-García MP.","Farm Hosp. 2014 Sep 16;38(5):411-7. doi: 10.7399/fh.2014.38.5.7549.","López-Pérez FJ","Farm Hosp","2014","2014/10/26","","","10.7399/fh.2014.38.5.7549"
"25332055","Effects of opioids on human serotonin transporters","Barann M, Stamer UM, Lyutenska M, Stüber F, Bönisch H, Urban B.","Naunyn Schmiedebergs Arch Pharmacol. 2015 Jan;388(1):43-9. doi: 10.1007/s00210-014-1056-3. Epub 2014 Oct 22.","Barann M","Naunyn Schmiedebergs Arch Pharmacol","2015","2014/10/22","","","10.1007/s00210-014-1056-3"
"25313812","Effect of dosing interval on efficacy of maropitant for prevention of hydromorphone-induced vomiting and signs of nausea in dogs","Hay Kraus BL.","J Am Vet Med Assoc. 2014 Nov 1;245(9):1015-20. doi: 10.2460/javma.245.9.1015.","Hay Kraus BL","J Am Vet Med Assoc","2014","2014/10/15","","","10.2460/javma.245.9.1015"
"25299483","Auditory symptoms as an unrecognized manifestation of opioid toxicity: two case reports","Cran A, Kiely F, O'Brien T.","J Pain Palliat Care Pharmacother. 2014 Dec;28(4):378-81. doi: 10.3109/15360288.2014.959233. Epub 2014 Oct 9.","Cran A","J Pain Palliat Care Pharmacother","2014","2014/10/10","","","10.3109/15360288.2014.959233"
"25288720","Sensitivity of an opiate immunoassay for detecting hydrocodone and hydromorphone in urine from a clinical population: analysis of subthreshold results","Bertholf RL, Johannsen LM, Reisfield GM.","J Anal Toxicol. 2015 Jan-Feb;39(1):24-8. doi: 10.1093/jat/bku109. Epub 2014 Oct 6.","Bertholf RL","J Anal Toxicol","2015","2014/10/08","","","10.1093/jat/bku109"
"25279807","Comparative effects of morning vs. evening dosing of extended-release hydromorphone on sleep physiology in patients with low back pain: a pilot study","Webster LR, Smith MD, Mackin S, Iverson M.","Pain Med. 2015 Mar;16(3):460-71. doi: 10.1111/pme.12577. Epub 2014 Oct 3.","Webster LR","Pain Med","2015","2014/10/04","","","10.1111/pme.12577"
"25263424","Dexmedetomidine and hydromorphone: a novel pain management strategy for the oncology ward setting during anti-GD2 immunotherapy for high-risk neuroblastoma in children","Görges M, West N, Deyell R, Winton P, Cheung W, Lauder G.","Pediatr Blood Cancer. 2015 Jan;62(1):29-34. doi: 10.1002/pbc.25197. Epub 2014 Sep 26.","Görges M","Pediatr Blood Cancer","2015","2014/09/30","","","10.1002/pbc.25197"
"25262567","A chance to stop and breathe: participants' experiences in the North American Opiate Medication Initiative clinical trial","Oviedo-Joekes E, Marchand K, Lock K, Chettiar J, Marsh DC, Brissette S, Anis AH, Schechter MT.","Addict Sci Clin Pract. 2014 Sep 29;9(1):21. doi: 10.1186/1940-0640-9-21.","Oviedo-Joekes E","Addict Sci Clin Pract","2014","2014/09/30","PMC4181618","","10.1186/1940-0640-9-21"
"25255074","Pharmacokinetics of hydromorphone after intravenous and intramuscular administration in male rhesus macaques (Macaca mulatta)","Kelly KR, Pypendop BH, Christe KL.","J Am Assoc Lab Anim Sci. 2014 Sep;53(5):512-6.","Kelly KR","J Am Assoc Lab Anim Sci","2014","2014/09/26","PMC4181693","",""
"25219395","The effect of hydromorphone therapy on psychophysical measurements of the descending inhibitory pain systems in patients with chronic radicular pain","Suzan E, Treister R, Pud D, Haddad M, Eisenberg E.","Pain Med. 2015 Jan;16(1):168-75. doi: 10.1111/pme.12565. Epub 2014 Sep 12.","Suzan E","Pain Med","2015","2014/09/16","","","10.1111/pme.12565"
"25217537","Multi-drug and metabolite quantification in postmortem blood by liquid chromatography-high-resolution mass spectrometry: comparison with nominal mass technology","Rosano TG, Na S, Ihenetu K, Swift TA, Wood M.","J Anal Toxicol. 2014 Oct;38(8):495-506. doi: 10.1093/jat/bku066.","Rosano TG","J Anal Toxicol","2014","2014/09/14","","","10.1093/jat/bku066"
"25151135","A microbial biomanufacturing platform for natural and semisynthetic opioids","Thodey K, Galanie S, Smolke CD.","Nat Chem Biol. 2014 Oct;10(10):837-44. doi: 10.1038/nchembio.1613. Epub 2014 Aug 24.","Thodey K","Nat Chem Biol","2014","2014/08/25","PMC4167936","NIHMS609585","10.1038/nchembio.1613"
"25146756","Effects of maropitant citrate or acepromazine on the incidence of adverse events associated with hydromorphone premedication in dogs","Claude AK, Dedeaux A, Chiavaccini L, Hinz S.","J Vet Intern Med. 2014 Sep-Oct;28(5):1414-7. doi: 10.1111/jvim.12414. Epub 2014 Aug 21.","Claude AK","J Vet Intern Med","2014","2014/08/23","PMC4895585","","10.1111/jvim.12414"
"25002456","Unauthorized drug use in the US Army based on medical review officer evaluations","Platteborze PL, Kippenberger DJ, Martin TM.","J Anal Toxicol. 2014 Nov-Dec;38(9):653-9. doi: 10.1093/jat/bku079. Epub 2014 Jul 6.","Platteborze PL","J Anal Toxicol","2014","2014/07/09","","","10.1093/jat/bku079"
"25001621","Influence of intensive care treatment on the protein binding of sufentanil and hydromorphone during pain therapy in postoperative cardiac surgery patients","Saari TI, Ihmsen H, Mell J, Fröhlich K, Fechner J, Schüttler J, Jeleazcov C.","Br J Anaesth. 2014 Oct;113(4):677-87. doi: 10.1093/bja/aeu160. Epub 2014 Jul 6.","Saari TI","Br J Anaesth","2014","2014/07/09","","","10.1093/bja/aeu160"
"24944068","Observations on hydrocodone and its metabolites in oral fluid specimens of the pain population: comparison with urine","Cao JM, Ma JD, Morello CM, Atayee RS, Best BM.","J Opioid Manag. 2014 May-Jun;10(3):177-86. doi: 10.5055/jom.2014.0206.","Cao JM","J Opioid Manag","2014","2014/06/20","","","10.5055/jom.2014.0206"
"24931480","Treatment of medically refractory cancer pain with a combination of intrathecal neuromodulation and neurosurgical ablation: case series and literature review","Bentley JN, Viswanathan A, Rosenberg WS, Patil PG.","Pain Med. 2014 Sep;15(9):1488-95. doi: 10.1111/pme.12481. Epub 2014 Jun 14.","Bentley JN","Pain Med","2014","2014/06/17","","","10.1111/pme.12481"
"24930329","[Oral osmotic hydromorphone (OROS) in patients with chronic severe pain due to osteoarthritis under daily routine conditions]","Müller-Schwefe GH, Blimke B, Hesselbarth S, Giesecke T.","MMW Fortschr Med. 2014 Apr 17;156 Suppl 1:23-9. doi: 10.1007/s15006-014-2879-z.","Müller-Schwefe GH","MMW Fortschr Med","2014","2014/06/17","","","10.1007/s15006-014-2879-z"
"24866507","Pharmacokinetics of hydromorphone hydrochloride after intravenous and intramuscular administration of a single dose to American kestrels (Falco sparverius)","Guzman DS, KuKanich B, Drazenovich TL, Olsen GH, Paul-Murphy JR.","Am J Vet Res. 2014 Jun;75(6):527-31. doi: 10.2460/ajvr.75.6.527.","Guzman DS","Am J Vet Res","2014","2014/05/29","","","10.2460/ajvr.75.6.527"
"24846822","Safety and efficacy of once-daily hydromorphone extended-release versus twice-daily oxycodone hydrochloride controlled-release in chinese patients with cancer pain: a phase 3, randomized, double-blind, multicenter study","Yu S, Shen W, Yu L, Hou Y, Han J, Richards HM.","J Pain. 2014 Aug;15(8):835-44. doi: 10.1016/j.jpain.2014.04.008. Epub 2014 May 15.","Yu S","J Pain","2014","2014/05/22","","","10.1016/j.jpain.2014.04.008"
"24800858","Monitoring of internet forums to evaluate reactions to the introduction of reformulated OxyContin to deter abuse","McNaughton EC, Coplan PM, Black RA, Weber SE, Chilcoat HD, Butler SF.","J Med Internet Res. 2014 May 2;16(5):e119. doi: 10.2196/jmir.3397.","McNaughton EC","J Med Internet Res","2014","2014/05/08","PMC4026575","","10.2196/jmir.3397"
"24786163","Efficacy of orally administered maropitant citrate in preventing vomiting associated with hydromorphone administration in dogs","Hay Kraus BL.","J Am Vet Med Assoc. 2014 May 15;244(10):1164-9. doi: 10.2460/javma.244.10.1164.","Hay Kraus BL","J Am Vet Med Assoc","2014","2014/05/03","","","10.2460/javma.244.10.1164"
"24781110","The slow death of lethal injection","Dyer O.","BMJ. 2014 Apr 29;348:g2670. doi: 10.1136/bmj.g2670.","Dyer O","BMJ","2014","2014/05/01","","","10.1136/bmj.g2670"
"24706503","The effect of UGT2B7*2 polymorphism on the pharmacokinetics of OROS® hydromorphone in Taiwanese subjects","Vandenbossche J, Richards H, Francke S, Van Den Bergh A, Lu CC, Franc MA.","J Clin Pharmacol. 2014 Oct;54(10):1170-9. doi: 10.1002/jcph.305. Epub 2014 Apr 15.","Vandenbossche J","J Clin Pharmacol","2014","2014/04/08","","","10.1002/jcph.305"
"24649783","Marked variability in peri-partum anesthetic management of patients on buprenorphine maintenance therapy (BMT): can there be an underlying acute opioid induced hyperalgesia precipitated by neuraxial opioids in BMT patients?","Gupta D, Christensen C, Soskin V.","Middle East J Anaesthesiol. 2013 Oct;22(3):273-81.","Gupta D","Middle East J Anaesthesiol","2013","2014/03/22","","",""
"24646474","""SALOME gave my dignity back"": the role of randomized heroin trials in transforming lives in the Downtown Eastside of Vancouver, Canada","Jozaghi E.","Int J Qual Stud Health Well-being. 2014 Mar 13;9:23698. doi: 10.3402/qhw.v9.23698. eCollection 2014.","Jozaghi E","Int J Qual Stud Health Well-being","2014","2014/03/21","PMC3955773","","10.3402/qhw.v9.23698"
"24644041","Short chemoenzymatic total synthesis of ent-hydromorphone: an oxidative dearomatization/intramolecular [4+2] cycloaddition/amination sequence","Varghese V, Hudlicky T.","Angew Chem Int Ed Engl. 2014 Apr 22;53(17):4355-8. doi: 10.1002/anie.201400286. Epub 2014 Mar 18.","Varghese V","Angew Chem Int Ed Engl","2014","2014/03/20","","","10.1002/anie.201400286"
"24628748","Rising opioid prescribing in adult U.S. emergency department visits: 2001-2010","Mazer-Amirshahi M, Mullins PM, Rasooly I, van den Anker J, Pines JM.","Acad Emerg Med. 2014 Mar;21(3):236-43. doi: 10.1111/acem.12328.","Mazer-Amirshahi M","Acad Emerg Med","2014","2014/03/18","","","10.1111/acem.12328"
"24597962","Cost-effectiveness of intravenous acetaminophen for pediatric tonsillectomy","Subramanyam R, Varughese A, Kurth CD, Eckman MH.","Paediatr Anaesth. 2014 May;24(5):467-75. doi: 10.1111/pan.12359. Epub 2014 Mar 5.","Subramanyam R","Paediatr Anaesth","2014","2014/03/07","","","10.1111/pan.12359"
"24590650","What is your gut feeling about opioid rotation?","Didwaniya N, Reddy A, Gottumukkala RS, Bruera E.","J Clin Oncol. 2015 Jan 20;33(3):e11-2. doi: 10.1200/JCO.2013.49.8204. Epub 2014 Mar 3.","Didwaniya N","J Clin Oncol","2015","2014/03/05","","","10.1200/JCO.2013.49.8204"
"24567278","Long-term efficacy of OROS® hydromorphone combined with pregabalin for chronic non-cancer neuropathic pain","Dauri M, Lazzari M, Casali M, Tufaro G, Sabato E, Sabato AF.","Clin Drug Investig. 2014 May;34(5):309-16. doi: 10.1007/s40261-014-0176-3.","Dauri M","Clin Drug Investig","2014","2014/02/26","","","10.1007/s40261-014-0176-3"
"24524251","Chemical coping versus pseudoaddiction in patients with cancer pain","Kwon JH, Tanco K, Hui D, Reddy A, Bruera E.","Palliat Support Care. 2014 Oct;12(5):413-7. doi: 10.1017/S1478951513001351. Epub 2014 Feb 13.","Kwon JH","Palliat Support Care","2014","2014/02/15","","","10.1017/S1478951513001351"
"24519631","The addition of epidural local anesthetic to systemic multimodal analgesia following lumbar spinal fusion: a randomized controlled trial","Choi S, Rampersaud YR, Chan VW, Persaud O, Koshkin A, Tumber P, Brull R.","Can J Anaesth. 2014 Apr;61(4):330-9. doi: 10.1007/s12630-014-0115-z. Epub 2014 Feb 12.","Choi S","Can J Anaesth","2014","2014/02/13","","","10.1007/s12630-014-0115-z"
"24472398","Dose proportionality and pharmacokinetics of extended-release (OROS®) hydromorphone: a phase 1, open-label, randomized, crossover study in healthy Taiwanese subjects","Vandenbossche J, Richards HM, Lu CC, Richarz U.","Int J Clin Pharmacol Ther. 2014 Mar;52(3):217-26. doi: 10.5414/CP201953.","Vandenbossche J","Int J Clin Pharmacol Ther","2014","2014/01/30","","","10.5414/CP201953"
"24446134","New drug combination for execution in US leaves hospitals in short supply","Dyer C.","BMJ. 2014 Jan 20;348:g384. doi: 10.1136/bmj.g384.","Dyer C","BMJ","2014","2014/01/22","","","10.1136/bmj.g384"
"24401769","Adductor canal block versus femoral nerve block for total knee arthroplasty: a prospective, randomized, controlled trial","Kim DH, Lin Y, Goytizolo EA, Kahn RL, Maalouf DB, Manohar A, Patt ML, Goon AK, Lee YY, Ma Y, Yadeau JT.","Anesthesiology. 2014 Mar;120(3):540-50. doi: 10.1097/ALN.0000000000000119.","Kim DH","Anesthesiology","2014","2014/01/10","","","10.1097/ALN.0000000000000119"
"24396053","Observations on the urine metabolic profile of codeine in pain patients","Yee DA, Atayee RS, Best BM, Ma JD.","J Anal Toxicol. 2014 Mar;38(2):86-91. doi: 10.1093/jat/bkt101. Epub 2014 Jan 6.","Yee DA","J Anal Toxicol","2014","2014/01/08","","","10.1093/jat/bkt101"
"24381338","The use of medetomidine-based sedation protocols to perform urohydropropulsion and cystoscopy in the dog","Webb JA, Rosati M, Naigamwalla DZ, Defarges A.","Can Vet J. 2014 Jan;55(1):1213-8.","Webb JA","Can Vet J","2014","2014/01/02","PMC3866850","",""
"24336542","Ascites in patients with cirrhosis","Perri GA.","Can Fam Physician. 2013 Dec;59(12):1297-9; e538-40.","Perri GA","Can Fam Physician","2013","2013/12/17","PMC3860926","",""
"24330310","Maropitant prevented vomiting but not gastroesophageal reflux in anesthetized dogs premedicated with acepromazine-hydromorphone","Johnson RA.","Vet Anaesth Analg. 2014 Jul;41(4):406-10. doi: 10.1111/vaa.12120. Epub 2013 Dec 16.","Johnson RA","Vet Anaesth Analg","2014","2013/12/17","PMC4296575","NIHMS653752","10.1111/vaa.12120"
"24324012","Canada in breach of ethical standards for clinical trials","Fletcher J.","CMAJ. 2014 Jan 7;186(1):11. doi: 10.1503/cmaj.131744. Epub 2013 Dec 9.","Fletcher J","CMAJ","2014","2013/12/11","PMC3883813","","10.1503/cmaj.131744"
"24290733","Hydromorphone: evolving to meet the challenges of today's health care environment","Gregory TB.","Clin Ther. 2013 Dec;35(12):2007-27. doi: 10.1016/j.clinthera.2013.09.027. Epub 2013 Nov 28.","Gregory TB","Clin Ther","2013","2013/12/03","","","10.1016/j.clinthera.2013.09.027"
"24261806","Onset and quality of sedation after intramuscular administration of dexmedetomidine and hydromorphone in various muscle groups in dogs","Carter JE, Lewis C, Beths T.","J Am Vet Med Assoc. 2013 Dec 1;243(11):1569-72. doi: 10.2460/javma.243.11.1569.","Carter JE","J Am Vet Med Assoc","2013","2013/11/23","","","10.2460/javma.243.11.1569"
"24236993","Bioavailability of morphine, methadone, hydromorphone, and oxymorphone following buccal administration in cats","Pypendop BH, Ilkiw JE, Shilo-Benjamini Y.","J Vet Pharmacol Ther. 2014 Jun;37(3):295-300. doi: 10.1111/jvp.12090. Epub 2013 Nov 18.","Pypendop BH","J Vet Pharmacol Ther","2014","2013/11/19","","","10.1111/jvp.12090"
"24210367","Does initial hydromorphone relieve pain best if dosing is fixed or weight based?","Xia S, Choe D, Hernandez L, Birnbaum A.","Ann Emerg Med. 2014 Jun;63(6):692-8.e4. doi: 10.1016/j.annemergmed.2013.10.003. Epub 2013 Nov 7.","Xia S","Ann Emerg Med","2014","2013/11/12","","","10.1016/j.annemergmed.2013.10.003"
"24203087","A prospective, open-label, multicenter study of the clinical efficacy of extended-release hydromorphone in treating cancer pain inadequately controlled by other analgesics","Han HS, Lee KH, Lee KH, Ryu JS, Kim YC, Park SW, Oh HS, Park KT, Kwon JH, Lee PB, Lee WS, Kim YS, Ahn JB, Jeon SW, Lee SY, Seol YM, Kang JH, Yuh YJ, Oh SY, Kim SR, Ahn JS.","Support Care Cancer. 2014 Mar;22(3):741-50. doi: 10.1007/s00520-013-2030-1. Epub 2013 Nov 8.","Han HS","Support Care Cancer","2014","2013/11/09","","","10.1007/s00520-013-2030-1"
"24162935","WITHDRAWN: Hydromorphone for acute and chronic pain","Quigley C.","Cochrane Database Syst Rev. 2013 Oct 25;(10):CD003447. doi: 10.1002/14651858.CD003447.pub2.","Quigley C","Cochrane Database Syst Rev","2013","2013/10/29","","","10.1002/14651858.CD003447.pub2"
"24158418","[Palliative sedation for psycho-existential suffering]","Weichselbaumer E, Weixler D.","Wien Med Wochenschr. 2014 May;164(9-10):172-8. doi: 10.1007/s10354-013-0246-9. Epub 2013 Oct 25.","Weichselbaumer E","Wien Med Wochenschr","2014","2013/10/26","","","10.1007/s10354-013-0246-9"
"24141031","Comparative pathophysiology, toxicology, and human cancer risk assessment of pharmaceutical-induced hibernoma","Radi Z, Bartholomew P, Elwell M, Vogel WM.","Toxicol Appl Pharmacol. 2013 Dec 15;273(3):456-63. doi: 10.1016/j.taap.2013.10.011. Epub 2013 Oct 18.","Radi Z","Toxicol Appl Pharmacol","2013","2013/10/22","","","10.1016/j.taap.2013.10.011"
"24121607","Aberrant intrathecal pump refill: ultrasound-guided aspiration of a substantial quantity of subcutaneous hydromorphone","Peccora CD, Ross EL, Hanna GM.","Reg Anesth Pain Med. 2013 Nov-Dec;38(6):544-6. doi: 10.1097/AAP.0000000000000008.","Peccora CD","Reg Anesth Pain Med","2013","2013/10/15","","","10.1097/AAP.0000000000000008"
"24095887","Effects of postoperative epidural analgesia on recurrence-free and overall survival in patients with nonsmall cell lung cancer","Cata JP, Gottumukkala V, Thakar D, Keerty D, Gebhardt R, Liu DD.","J Clin Anesth. 2014 Feb;26(1):3-17. doi: 10.1016/j.jclinane.2013.06.007. Epub 2013 Oct 4.","Cata JP","J Clin Anesth","2014","2013/10/08","","","10.1016/j.jclinane.2013.06.007"
"24088238","[Therapy of acute pain with opiates - titrate or bolus administration?]","Markun S.","Praxis (Bern 1994). 2013 Oct 2;102(20):1261-2. doi: 10.1024/1661-8157/a001413.","Markun S","Praxis (Bern 1994)","2013","2013/10/04","","","10.1024/1661-8157/a001413"
"24057426","The median local analgesic dose of intrathecal bupivacaine with hydromorphone for labour: a double-blind randomized controlled trial","Mhyre JM, Hong RW, Greenfield ML, Pace NL, Polley LS.","Can J Anaesth. 2013 Nov;60(11):1061-9. doi: 10.1007/s12630-013-0023-7. Epub 2013 Sep 21.","Mhyre JM","Can J Anaesth","2013","2013/09/24","","","10.1007/s12630-013-0023-7"
"23995596","In vivo activity of norhydrocodone: an active metabolite of hydrocodone","Navani DM, Yoburn BC.","J Pharmacol Exp Ther. 2013 Nov;347(2):497-505. doi: 10.1124/jpet.113.207548. Epub 2013 Aug 30.","Navani DM","J Pharmacol Exp Ther","2013","2013/09/03","","","10.1124/jpet.113.207548"
"23973378","Intradialytic clearance of opioids: methadone versus hydromorphone","Perlman R, Giladi H, Brecht K, Ware MA, Hebert TE, Joseph L, Shir Y.","Pain. 2013 Dec;154(12):2794-800. doi: 10.1016/j.pain.2013.08.015. Epub 2013 Aug 20.","Perlman R","Pain","2013","2013/08/27","","","10.1016/j.pain.2013.08.015"
"23965210","Analgesia after Cesarean delivery: a retrospective comparison of intrathecal hydromorphone and morphine","Beatty NC, Arendt KW, Niesen AD, Wittwer ED, Jacob AK.","J Clin Anesth. 2013 Aug;25(5):379-383. doi: 10.1016/j.jclinane.2013.01.014. Epub 2013 Aug 17.","Beatty NC","J Clin Anesth","2013","2013/08/23","","","10.1016/j.jclinane.2013.01.014"
"23958818","Population pharmacokinetic modeling of hydromorphone in cardiac surgery patients during postoperative pain therapy","Jeleazcov C, Saari TI, Ihmsen H, Mell J, Fröhlich K, Krajinovic L, Fechner J, Schüttler J.","Anesthesiology. 2014 Feb;120(2):378-91. doi: 10.1097/ALN.0b013e3182a76d05.","Jeleazcov C","Anesthesiology","2014","2013/08/21","","","10.1097/ALN.0b013e3182a76d05"
"23946451","Prescription opioids. II. Metabolism and excretion patterns of hydrocodone in urine following controlled single-dose administration","Cone EJ, Heltsley R, Black DL, Mitchell JM, Lodico CP, Flegel RR.","J Anal Toxicol. 2013 Oct;37(8):486-94. doi: 10.1093/jat/bkt066. Epub 2013 Aug 14.","Cone EJ","J Anal Toxicol","2013","2013/08/16","","","10.1093/jat/bkt066"
"23930920","Incidence of hydromorphone-induced neuroexcitation in hospice patients","Kullgren J, Le V, Wheeler W.","J Palliat Med. 2013 Oct;16(10):1205-9. doi: 10.1089/jpm.2012.0467. Epub 2013 Aug 9.","Kullgren J","J Palliat Med","2013","2013/08/13","","","10.1089/jpm.2012.0467"
"23846749","Randomized clinical trial of an intravenous hydromorphone titration protocol versus usual care for management of acute pain in older emergency department patients","Chang AK, Bijur PE, Davitt M, Gallagher EJ.","Drugs Aging. 2013 Sep;30(9):747-54. doi: 10.1007/s40266-013-0103-y.","Chang AK","Drugs Aging","2013","2013/07/13","PMC3758665","NIHMS505111","10.1007/s40266-013-0103-y"
"23836812","Multimodal analgesia therapy reduces length of hospitalization in patients undergoing fusions of the ankle and hindfoot","Michelson JD, Addante RA, Charlson MD.","Foot Ankle Int. 2013 Nov;34(11):1526-34. doi: 10.1177/1071100713496224. Epub 2013 Jul 8.","Michelson JD","Foot Ankle Int","2013","2013/07/10","","","10.1177/1071100713496224"
"23796369","Case of the season: ectopic pancreas","O'Malley RB, Maturen KE, Al-Hawary MM, Mathur AK.","Semin Roentgenol. 2013 Jul;48(3):188-91. doi: 10.1053/j.ro.2013.03.011.","O'Malley RB","Semin Roentgenol","2013","2013/06/26","","","10.1053/j.ro.2013.03.011"
"23748253","Life-threatening adverse events following therapeutic opioid administration in adults: is pharmacogenetic analysis useful?","Madadi P, Sistonen J, Silverman G, Gladdy R, Ross CJ, Carleton BC, Carvalho JC, Hayden MR, Koren G.","Pain Res Manag. 2013 May-Jun;18(3):133-6. doi: 10.1155/2013/518012.","Madadi P","Pain Res Manag","2013","2013/06/11","PMC3673930","","10.1155/2013/518012"
"23718647","Evaluation of thermal antinociceptive effects after intramuscular administration of hydromorphone hydrochloride to American kestrels (Falco sparverius)","Guzman DS, Drazenovich TL, Olsen GH, Willits NH, Paul-Murphy JR.","Am J Vet Res. 2013 Jun;74(6):817-22. doi: 10.2460/ajvr.74.6.817.","Guzman DS","Am J Vet Res","2013","2013/05/31","","","10.2460/ajvr.74.6.817"
"23715067","Tremors and agitation following low-dose intravenous hydromorphone administration in a patient with kidney dysfunction","Gagnon DJ, Jwo K.","Ann Pharmacother. 2013 Jul-Aug;47(7-8):e34. doi: 10.1345/aph.1R784. Epub 2013 May 28.","Gagnon DJ","Ann Pharmacother","2013","2013/05/30","","","10.1345/aph.1R784"
"23709303","Open-label study to evaluate the efficacy and safety of extended-release hydromorphone in patients with chronic neuropathic pain","Nalamachu S, Ruck D, Nalamasu R, Fasbinder S, Bansal R.","J Opioid Manag. 2013 Jan-Feb;9(1):43-9. doi: 10.5055/jom.2013.0146.","Nalamachu S","J Opioid Manag","2013","2013/05/28","","","10.5055/jom.2013.0146"
"23703421","The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone","Boswell MV, Stauble ME, Loyd GE, Langman L, Ramey-Hartung B, Baumgartner RN, Tucker WW, Jortani SA.","Pain Physician. 2013 May-Jun;16(3):E227-35.","Boswell MV","Pain Physician","2013","2013/05/25","","",""
"23698222","Hydromorphone does not influence the immune response in patients affected by chronic pain","Coaccioli S, Di Cato L, Panaccione A, Crapa ME, Paladini A, Piroli A, Marinangeli F.","Clin Ter. 2013;164(2):e97-9. doi: 10.7417/CT.2013.1539.","Coaccioli S","Clin Ter","2013","2013/05/24","","","10.7417/CT.2013.1539"
"23694801","Randomized clinical trial of the 2 mg hydromorphone bolus protocol versus the ""1+1"" hydromorphone titration protocol in treatment of acute, severe pain in the first hour of emergency department presentation","Chang AK, Bijur PE, Lupow JB, Gallagher EJ.","Ann Emerg Med. 2013 Oct;62(4):304-10. doi: 10.1016/j.annemergmed.2013.02.023. Epub 2013 May 18.","Chang AK","Ann Emerg Med","2013","2013/05/23","","","10.1016/j.annemergmed.2013.02.023"
"23685099","The efficacy of automated intermittent boluses for continuous femoral nerve block: a prospective, randomized comparison to continuous infusions","Hillegass MG, Field LC, Stewart SR, Borckardt JJ, Dong L, Kotlowski PE, Demos HA, Del Schutte H, Reeves ST.","J Clin Anesth. 2013 Jun;25(4):281-8. doi: 10.1016/j.jclinane.2012.11.015. Epub 2013 May 16.","Hillegass MG","J Clin Anesth","2013","2013/05/21","","","10.1016/j.jclinane.2012.11.015"
"23647815","Acute pain control challenges with buprenorphine/naloxone therapy in a patient with compartment syndrome secondary to McArdle's disease: a case report and review","McCormick Z, Chu SK, Chang-Chien GC, Joseph P.","Pain Med. 2013 Aug;14(8):1187-91. doi: 10.1111/pme.12135. Epub 2013 May 3.","McCormick Z","Pain Med","2013","2013/05/08","","","10.1111/pme.12135"
"23602757","Effective analgesia with low-dose ketamine and reduced dose hydromorphone in ED patients with severe pain","Ahern TL, Herring AA, Stone MB, Frazee BW.","Am J Emerg Med. 2013 May;31(5):847-51. doi: 10.1016/j.ajem.2013.02.008. Epub 2013 Apr 18.","Ahern TL","Am J Emerg Med","2013","2013/04/23","","","10.1016/j.ajem.2013.02.008"
"23601353","Pharmacokinetics of ammonium sulfate gradient loaded liposome-encapsulated oxymorphone and hydromorphone in healthy dogs","Smith LJ, Kukanich BK, Krugner-Higby LA, Schmidt BH, Heath TD.","Vet Anaesth Analg. 2013 Sep;40(5):537-45. doi: 10.1111/vaa.12042. Epub 2013 Apr 20.","Smith LJ","Vet Anaesth Analg","2013","2013/04/23","PMC3740050","NIHMS464878","10.1111/vaa.12042"
"23527666","Pilot study of human recombinant hyaluronidase-enhanced subcutaneous hydration and opioid administration for sickle cell disease acute pain episodes","Sandoval M, Coleman P, Govani R, Siddiqui S, Todd KH.","J Pain Palliat Care Pharmacother. 2013 Mar;27(1):10-8. doi: 10.3109/15360288.2012.758683.","Sandoval M","J Pain Palliat Care Pharmacother","2013","2013/03/27","","","10.3109/15360288.2012.758683"
"23523877","Quantitative method for analysis of hydrocodone, hydromorphone and norhydrocodone in human plasma by liquid chromatography-tandem mass spectrometry","Valtier S, Mueck RL, Bebarta VS.","J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Apr 15;925:40-5. doi: 10.1016/j.jchromb.2013.02.030. Epub 2013 Mar 1.","Valtier S","J Chromatogr B Analyt Technol Biomed Life Sci","2013","2013/03/26","","","10.1016/j.jchromb.2013.02.030"
"23475406","Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study","Gálvez R, Schäfer M, Hans G, Falke D, Steigerwald I.","Adv Ther. 2013 Mar;30(3):229-59. doi: 10.1007/s12325-013-0015-6. Epub 2013 Mar 7.","Gálvez R","Adv Ther","2013","2013/03/12","","","10.1007/s12325-013-0015-6"
"23453464","Aortocaval compression during early pregnancy: are there other causes?","Powell MF, Sakawi Y.","Int J Obstet Anesth. 2013 Apr;22(2):171-2. doi: 10.1016/j.ijoa.2012.12.007. Epub 2013 Feb 27.","Powell MF","Int J Obstet Anesth","2013","2013/03/05","","","10.1016/j.ijoa.2012.12.007"
"23430163","Miotic and subject-rated effects of therapeutic doses of tapentadol, tramadol, and hydromorphone in occasional opioid users","Stoops WW, Glaser PE, Rush CR.","Psychopharmacology (Berl). 2013 Jul;228(2):255-62. doi: 10.1007/s00213-013-3031-y. Epub 2013 Feb 21.","Stoops WW","Psychopharmacology (Berl)","2013","2013/02/23","PMC3683084","NIHMS448506","10.1007/s00213-013-3031-y"
"23413271","Cardiovascular and respiratory effects, and quality of anesthesia produced by alfaxalone administered intramuscularly to cats sedated with dexmedetomidine and hydromorphone","Grubb TL, Greene SA, Perez TE.","J Feline Med Surg. 2013 Oct;15(10):858-65. doi: 10.1177/1098612X13478265. Epub 2013 Feb 14.","Grubb TL","J Feline Med Surg","2013","2013/02/16","","","10.1177/1098612X13478265"
"23406078","Randomized clinical trial of efficacy and safety of a single 2-mg intravenous dose of hydromorphone versus usual care in the management of acute pain","Chang AK, Bijur PE, Lupow JB, John Gallagher E.","Acad Emerg Med. 2013 Feb;20(2):185-92. doi: 10.1111/acem.12071.","Chang AK","Acad Emerg Med","2013","2013/02/15","","","10.1111/acem.12071"
"23369542","The role of fentanyl in refractory opioid-related acute colonic pseudo-obstruction","Hannon B, Zimmermann C, Bryson JR.","J Pain Symptom Manage. 2013 Mar;45(3):e1-3. doi: 10.1016/j.jpainsymman.2012.11.002. Epub 2013 Jan 29.","Hannon B","J Pain Symptom Manage","2013","2013/02/02","","","10.1016/j.jpainsymman.2012.11.002"
"23340535","A negative correlation between hyperalgesia and analgesia in patients with chronic radicular pain: is hydromorphone therapy a double-edged sword?","Suzan E, Eisenberg E, Treister R, Haddad M, Pud D.","Pain Physician. 2013 Jan;16(1):65-76.","Suzan E","Pain Physician","2013","2013/01/24","","",""
"23333788","Abdominal compartment syndrome following opioid-induced postoperative ileus","Van Noord BA, Roffey P, Thangathurai D.","J Clin Anesth. 2013 Mar;25(2):146-9. doi: 10.1016/j.jclinane.2012.07.004. Epub 2013 Jan 17.","Van Noord BA","J Clin Anesth","2013","2013/01/22","","","10.1016/j.jclinane.2012.07.004"
"23321702","[Oral therapy algorithm for the treatment of postoperative pain. A prospective observational study]","Pogatzki-Zahn EM, Englbrecht JS, Pöpping D, Boche R, Zahn PK.","Schmerz. 2013 Feb;27(1):26-37. doi: 10.1007/s00482-012-1279-5.","Pogatzki-Zahn EM","Schmerz","2013","2013/01/17","","","10.1007/s00482-012-1279-5"
"23264318","Why do emergency providers choose one opioid over another? A prospective cohort analysis","O'Connor AB, Rao A.","J Opioid Manag. 2012 Nov-Dec;8(6):403-13. doi: 10.5055/jom.2012.0140.","O'Connor AB","J Opioid Manag","2012","2012/12/25","","","10.5055/jom.2012.0140"
"23256273","Intrathecal hydromorphone for cesarean delivery: in search of improved postoperative pain management: a case report","Rauch E.","AANA J. 2011 Oct;79(5):427-32.","Rauch E","AANA J","2011","2012/12/22","","",""
"23250234","Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective","Wielage R, Bansal M, Wilson K, Klein R, Happich M.","Spine (Phila Pa 1976). 2013 May 15;38(11):936-46. doi: 10.1097/BRS.0b013e31828264f9.","Wielage R","Spine (Phila Pa 1976)","2013","2012/12/20","","","10.1097/BRS.0b013e31828264f9"
"23248827","Intrathecal hydromorphone for postoperative analgesia after cesarean delivery: a retrospective study","Rauch E.","AANA J. 2012 Aug;80(4 Suppl):S25-32.","Rauch E","AANA J","2012","2012/12/20","","",""
"23247907","Safety and tolerability of OROS® hydromorphone ER in adults with chronic noncancer and cancer pain: pooled analysis of 13 studies","Hale ME, Wallace MS, Taylor DR, Kutch M, Nalamachu S.","J Opioid Manag. 2012 Sep-Oct;8(5):299-314. doi: 10.5055/jom.2012.0130.","Hale ME","J Opioid Manag","2012","2012/12/19","","","10.5055/jom.2012.0130"
"23218935","Postoperative subcutaneous instillation of low-dose ketorolac but not hydromorphone reduces wound exudate concentrations of interleukin-6 and interleukin-10 and improves analgesia following cesarean delivery","Carvalho B, Lemmens HJ, Ting V, Angst MS.","J Pain. 2013 Jan;14(1):48-56. doi: 10.1016/j.jpain.2012.10.002. Epub 2012 Dec 4.","Carvalho B","J Pain","2013","2012/12/11","","","10.1016/j.jpain.2012.10.002"
"23216100","Evaluation of topical epidural analgesia delivered in gelfoam for postoperative hemilaminectomy pain control","Barker JR, Clark-Price SC, Gordon-Evans WJ.","Vet Surg. 2013 Jan;42(1):79-84. doi: 10.1111/j.1532-950X.2012.01082.x. Epub 2012 Dec 5.","Barker JR","Vet Surg","2013","2012/12/11","","","10.1111/j.1532-950X.2012.01082.x"
"23202875","Treating burn-associated joint contracture: results of an inpatient rehabilitation stretching protocol","Godleski M, Oeffling A, Bruflat AK, Craig E, Weitzenkamp D, Lindberg G.","J Burn Care Res. 2013 Jul-Aug;34(4):420-6. doi: 10.1097/BCR.0b013e3182700178.","Godleski M","J Burn Care Res","2013","2012/12/04","","","10.1097/BCR.0b013e3182700178"
"23183991","[Prescription of high-potency opioids in 2011]","Hoffmann F, Glaeske G, Windt R.","Schmerz. 2012 Dec;26(6):707-14. doi: 10.1007/s00482-012-1240-7.","Hoffmann F","Schmerz","2012","2012/11/28","","","10.1007/s00482-012-1240-7"
"23162986","Survey draws attention to HYDROmorphone knowledge deficits","","Alta RN. 2012 Fall;68(3):12-3.","","Alta RN","2012","2012/11/21","","",""
"23098635","Pharmacokinetics of hydrocodone and hydromorphone after oral hydrocodone in healthy Greyhound dogs","KuKanich B, Spade J.","Vet J. 2013 May;196(2):266-8. doi: 10.1016/j.tvjl.2012.09.008. Epub 2012 Oct 23.","KuKanich B","Vet J","2013","2012/10/27","PMC4219551","NIHMS417431","10.1016/j.tvjl.2012.09.008"
"23082784","Efficacy of maropitant in preventing vomiting in dogs premedicated with hydromorphone","Hay Kraus BL.","Vet Anaesth Analg. 2013 Jan;40(1):28-34. doi: 10.1111/j.1467-2995.2012.00788.x. Epub 2012 Oct 20.","Hay Kraus BL","Vet Anaesth Analg","2013","2012/10/23","","","10.1111/j.1467-2995.2012.00788.x"
"23082538","Antinociceptive efficacy of buprenorphine and hydromorphone in red-eared slider turtles (Trachemys scripta elegans)","Mans C, Lahner LL, Baker BB, Johnson SM, Sladky KK.","J Zoo Wildl Med. 2012 Sep;43(3):662-5. doi: 10.1638/2011-0260R.1.","Mans C","J Zoo Wildl Med","2012","2012/10/23","","","10.1638/2011-0260R.1"
"23013512","Controlled trial of morphine vs hydromorphone for patient-controlled analgesia in children with postoperative pain","Karl HW, Tyler DC, Miser AW.","Pain Med. 2012 Dec;13(12):1658-9. doi: 10.1111/j.1526-4637.2012.01496.x. Epub 2012 Sep 26.","Karl HW","Pain Med","2012","2012/09/28","","","10.1111/j.1526-4637.2012.01496.x"
"22941852","Clinical effectiveness and safety of OROS® hydromorphone in break-through cancer pain treatment: a multicenter, prospective, open-label study in Korean patients","Lee KH, Kim MK, Hyun MS, Kim JY, Park KU, Song HS, Lee SA, Lee WS, Bae SH, Ryoo HM, Cho YY.","J Opioid Manag. 2012 Jul-Aug;8(4):243-52. doi: 10.5055/jom.2012.0122.","Lee KH","J Opioid Manag","2012","2012/09/04","","","10.5055/jom.2012.0122"
"22925158","Morphine and hydromorphone-induced hyperalgesia in a hospice patient","Juba KM, Wahler RG, Daron SM.","J Palliat Med. 2013 Jul;16(7):809-12. doi: 10.1089/jpm.2011.0502. Epub 2012 Aug 27.","Juba KM","J Palliat Med","2013","2012/08/29","","","10.1089/jpm.2011.0502"
"22884788","Analysis of total and unbound hydromorphone in human plasma by ultrafiltration and LC-MS/MS: application to clinical trial in patients undergoing open heart surgery","Saari TI, Fechner J, Ihmsen H, Schüttler J, Jeleazcov C.","J Pharm Biomed Anal. 2012 Dec;71:63-70. doi: 10.1016/j.jpba.2012.07.025. Epub 2012 Jul 31.","Saari TI","J Pharm Biomed Anal","2012","2012/08/14","","","10.1016/j.jpba.2012.07.025"
"22863282","Patient-controlled versus scheduled, nurse-administered analgesia following vaginal reconstructive surgery: a randomized trial","Crisp CC, Bandi S, Kleeman SD, Oakley SH, Vaccaro CM, Estanol MV, Fellner AN, Pauls RN.","Am J Obstet Gynecol. 2012 Nov;207(5):433.e1-6. doi: 10.1016/j.ajog.2012.06.040. Epub 2012 Jun 20.","Crisp CC","Am J Obstet Gynecol","2012","2012/08/07","","","10.1016/j.ajog.2012.06.040"
"22812471","Frequency of vomiting during the postoperative period in hydromorphone-treated dogs undergoing orthopedic surgery","Stern LC, Palmisano MP.","J Am Vet Med Assoc. 2012 Aug 1;241(3):344-7. doi: 10.2460/javma.241.3.344.","Stern LC","J Am Vet Med Assoc","2012","2012/07/21","","","10.2460/javma.241.3.344"
"22795050","Safety and Tolerability of Once-Daily OROS(®) hydromorphone extended-release in opioid-tolerant adults with moderate-to-severe chronic cancer and noncancer pain: pooled analysis of 11 clinical studies","Nalamachu SR, Kutch M, Hale ME.","J Pain Symptom Manage. 2012 Dec;44(6):852-65. doi: 10.1016/j.jpainsymman.2011.12.280. Epub 2012 Jul 11.","Nalamachu SR","J Pain Symptom Manage","2012","2012/07/17","","","10.1016/j.jpainsymman.2011.12.280"
"22782534","Excretion profile of hydrocodone, hydromorphone and norhydrocodone in urine following single dose administration of hydrocodone to healthy volunteers","Valtier S, Bebarta VS.","J Anal Toxicol. 2012 Sep;36(7):507-14. doi: 10.1093/jat/bks058. Epub 2012 Jul 10.","Valtier S","J Anal Toxicol","2012","2012/07/12","","","10.1093/jat/bks058"
"22735251","Postoperative global amnesia reversed with flumazenil","Rinehart JB, Baker B, Raphael D.","Neurologist. 2012 Jul;18(4):216-8. doi: 10.1097/NRL.0b013e31825bbef4.","Rinehart JB","Neurologist","2012","2012/06/28","","","10.1097/NRL.0b013e31825bbef4"
"22623016","Pharmacodynamic profile of tramadol in humans: influence of naltrexone pretreatment","Stoops WW, Lofwall MR, Nuzzo PA, Craig LB, Siegel AJ, Walsh SL.","Psychopharmacology (Berl). 2012 Oct;223(4):427-38. doi: 10.1007/s00213-012-2739-4. Epub 2012 May 24.","Stoops WW","Psychopharmacology (Berl)","2012","2012/05/25","PMC3439600","NIHMS380999","10.1007/s00213-012-2739-4"
"22616315","Continuous hydromorphone for pain and sedation in mechanically ventilated infants and children","Reiter PD, Ng J, Dobyns EL.","J Opioid Manag. 2012 Mar-Apr;8(2):99-104. doi: 10.5055/jom.2012.0102.","Reiter PD","J Opioid Manag","2012","2012/05/24","","","10.5055/jom.2012.0102"
"22537100","Results of a double-blind, placebo-controlled, fixed-dose assessment of once-daily OROS® hydromorphone ER in patients with moderate to severe pain associated with chronic osteoarthritis","Rauck R, Rapoport R, Thipphawong J.","Pain Pract. 2013 Jan;13(1):18-29. doi: 10.1111/j.1533-2500.2012.00555.x. Epub 2012 Apr 27.","Rauck R","Pain Pract","2013","2012/04/28","","","10.1111/j.1533-2500.2012.00555.x"
"22511700","Relationship between the concentration of hydrocodone and its conversion to hydromorphone in chronic pain patients using urinary excretion data","Barakat NH, Atayee RS, Best BM, Pesce AJ.","J Anal Toxicol. 2012 May;36(4):257-64. doi: 10.1093/jat/bks019.","Barakat NH","J Anal Toxicol","2012","2012/04/19","","","10.1093/jat/bks019"
"22511699","Observations on the metabolism of morphine to hydromorphone in pain patients","Hughes MM, Atayee RS, Best BM, Pesce AJ.","J Anal Toxicol. 2012 May;36(4):250-6. doi: 10.1093/jat/bks021.","Hughes MM","J Anal Toxicol","2012","2012/04/19","","","10.1093/jat/bks021"
"22510252","Sustained safety and efficacy of once-daily hydromorphone extended-release (OROS® hydromorphone ER) compared with twice-daily oxycodone controlled-release over 52 weeks in patients with moderate to severe chronic noncancer pain","Richarz U, Waechter S, Sabatowski R, Szczepanski L, Binsfeld H.","Pain Pract. 2013 Jan;13(1):30-40. doi: 10.1111/j.1533-2500.2012.00553.x. Epub 2012 Apr 18.","Richarz U","Pain Pract","2013","2012/04/19","","","10.1111/j.1533-2500.2012.00553.x"
"22476240","Addition of pregabalin to multimodal analgesic therapy following ankle surgery: a randomized double-blind, placebo-controlled trial","Yadeau JT, Paroli L, Kahn RL, Jules-Elysee KM, Lasala VR, Liu SS, Lin E, Powell K, Buschiazzo VL, Wukovits B, Roberts MM, Levine DS.","Reg Anesth Pain Med. 2012 May-Jun;37(3):302-7. doi: 10.1097/AAP.0b013e31824c6846.","Yadeau JT","Reg Anesth Pain Med","2012","2012/04/06","","","10.1097/AAP.0b013e31824c6846"
"22459126","Outpatient unicompartment knee arthroplasty with indwelling femoral nerve catheter","Dervin GF, Madden SM, Crawford-Newton BA, Lane AT, Evans HC.","J Arthroplasty. 2012 Jun;27(6):1159-65.e1. doi: 10.1016/j.arth.2012.01.009. Epub 2012 Mar 28.","Dervin GF","J Arthroplasty","2012","2012/03/31","","","10.1016/j.arth.2012.01.009"
"22458858","Overdose deaths demand a new paradigm for opioid rotation","Webster LR, Fine PG.","Pain Med. 2012 Apr;13(4):571-4. doi: 10.1111/j.1526-4637.2012.01356.x. Epub 2012 Mar 28.","Webster LR","Pain Med","2012","2012/03/31","","","10.1111/j.1526-4637.2012.01356.x"
"22424912","Dose equivalence of immediate-release hydromorphone and once-daily osmotic-controlled extended-release hydromorphone: a randomized, double-blind trial incorporating a measure of assay sensitivity","Cruciani RA, Katz N, Portenoy RK.","J Pain. 2012 Apr;13(4):379-89. doi: 10.1016/j.jpain.2012.01.007. Epub 2012 Mar 15.","Cruciani RA","J Pain","2012","2012/03/20","","","10.1016/j.jpain.2012.01.007"
"22337779","Dilute and shoot: analysis of drugs of abuse using selected reaction monitoring for quantification and full scan product ion spectra for identification","Fitzgerald RL, Griffin TL, Yun YM, Godfrey RA, West R, Pesce AJ, Herold DA.","J Anal Toxicol. 2012 Mar;36(2):106-11. doi: 10.1093/jat/bkr024.","Fitzgerald RL","J Anal Toxicol","2012","2012/02/17","","","10.1093/jat/bkr024"
"22284318","Nerve stimulator versus ultrasound guidance for placement of popliteal catheters for foot and ankle surgery","Maalouf D, Liu SS, Movahedi R, Goytizolo E, Memtsoudis SG, Yadeau JT, Gordon MA, Urban M, Ma Y, Wukovits B, Marcello D, Reid S, Cook A.","J Clin Anesth. 2012 Feb;24(1):44-50. doi: 10.1016/j.jclinane.2011.06.008.","Maalouf D","J Clin Anesth","2012","2012/01/31","","","10.1016/j.jclinane.2011.06.008"
"22170194","Swallowing difficulties: a prognostic signpost","Gallagher R.","Can Fam Physician. 2011 Dec;57(12):1407-9, e465-7.","Gallagher R","Can Fam Physician","2011","2011/12/16","PMC3237514","",""
"22169470","Determination of hydromorphone in human plasma by a sensitive RP-HPLC-ESI-MS method and its application to a clinical pharmacokinetic study in postoperative patients after low dose intravenous administration with infusion pump","Sun L, Pan Y, Ding L, Luo X, Yan Z, Liu C, Qian Y, Chu Y.","J Pharm Biomed Anal. 2012 Mar 5;61:15-21. doi: 10.1016/j.jpba.2011.11.012. Epub 2011 Nov 20.","Sun L","J Pharm Biomed Anal","2012","2011/12/16","","","10.1016/j.jpba.2011.11.012"
"22165036","Potency ratio of hydromorphone and diacetylmorphine in substitution treatment for long-term opioid dependency","Oviedo-Joekes E, Marsh DC, Guh D, Brissette S, Schechter MT.","J Opioid Manag. 2011 Sep-Oct;7(5):371-6. doi: 10.5055/jom.2011.0078.","Oviedo-Joekes E","J Opioid Manag","2011","2011/12/15","","","10.5055/jom.2011.0078"
"22136049","Hydrophilic interaction LC-MS/MS analysis of opioids in urine: significance of glucuronide metabolites","French D, Wu A, Lynch K.","Bioanalysis. 2011 Dec;3(23):2603-12. doi: 10.4155/bio.11.266.","French D","Bioanalysis","2011","2011/12/06","","","10.4155/bio.11.266"
"22127266","Intrathecal hydromorphone instead of the old intrathecal morphine: the best is the enemy of the good?","Georges P, Lavand'homme P.","Eur J Anaesthesiol. 2012 Jan;29(1):3-4. doi: 10.1097/EJA.0b013e32834de322.","Georges P","Eur J Anaesthesiol","2012","2011/12/01","","","10.1097/EJA.0b013e32834de322"
"22126165","Transitioning a cancer patient from high-dose intravenous hydromorphone therapy to intravenous methadone","LeBaron V, Brody J, Lee EM, Hardin C, Snyder L.","J Pain Palliat Care Pharmacother. 2011;25(4):356-61. doi: 10.3109/15360288.2011.620688.","LeBaron V","J Pain Palliat Care Pharmacother","2011","2011/12/01","","","10.3109/15360288.2011.620688"
"22105062","Prescription opioid misuse: characteristics of earliest and most recent memory of hydromorphone use","Fulton HG, Barrett SP, Stewart SH, Macisaac C.","J Addict Med. 2012 Jun;6(2):137-44. doi: 10.1097/ADM.0b013e3182351550.","Fulton HG","J Addict Med","2012","2011/11/23","","","10.1097/ADM.0b013e3182351550"
"22087721","Evaluation of dexmedetomidine and ketamine in combination with various opioids as injectable anesthetic combinations for castration in cats","Ko JC, Austin BR, Barletta M, Weil AB, Krimins RA, Payton ME.","J Am Vet Med Assoc. 2011 Dec 1;239(11):1453-62. doi: 10.2460/javma.239.11.1453.","Ko JC","J Am Vet Med Assoc","2011","2011/11/18","","","10.2460/javma.239.11.1453"
"22084475","Pharmacists' experiences with dispensing opioids: provincial survey","Kahan M, Wilson L, Wenghofer EF, Srivastava A, Resnick A, Janecek E, Sheehan C.","Can Fam Physician. 2011 Nov;57(11):e448-54.","Kahan M","Can Fam Physician","2011","2011/11/16","PMC3215629","",""
"22084455","Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population","Kahan M, Mailis-Gagnon A, Wilson L, Srivastava A; National Opioid Use Guideline Group.","Can Fam Physician. 2011 Nov;57(11):1257-66, e407-18.","Kahan M","Can Fam Physician","2011","2011/11/16","PMC3215602","",""
"22079773","Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: dose-effects and time-course","Bigelow GE, Preston KL, Schmittner J, Dong Q, Gastfriend DR.","Drug Alcohol Depend. 2012 Jun 1;123(1-3):57-65. doi: 10.1016/j.drugalcdep.2011.10.018. Epub 2011 Nov 12.","Bigelow GE","Drug Alcohol Depend","2012","2011/11/15","PMC3880792","NIHMS523730","10.1016/j.drugalcdep.2011.10.018"
"22077957","The use of high doses of OROS hydromorphone in an acute palliative care unit","Mercadante S.","Curr Med Res Opin. 2011 Dec;27(12):2373-6. doi: 10.1185/03007995.2011.628982. Epub 2011 Nov 14.","Mercadante S","Curr Med Res Opin","2011","2011/11/15","","","10.1185/03007995.2011.628982"
"22059263","Questions regarding management of cardiopulmonary arrest","Chapman M.","J Am Vet Med Assoc. 2011 Oct 1;239(7):919-20; author reply 920.","Chapman M","J Am Vet Med Assoc","2011","2011/11/09","","",""
"22056761","Management of symptomatic intrathecal catheter-associated inflammatory masses","Tomycz ND, Ortiz V, McFadden KA, Urgo L, Moossy JJ.","Clin Neurol Neurosurg. 2012 Feb;114(2):190-5. doi: 10.1016/j.clineuro.2011.10.012. Epub 2011 Nov 5.","Tomycz ND","Clin Neurol Neurosurg","2012","2011/11/08","","","10.1016/j.clineuro.2011.10.012"
"22045112","Use of OROS® hydromorphone in the treatment of osteoarthritis and osteoporosis: A pooled analysis of three non-interventional studies focusing on different starting doses","Ringe JD, Schäfer S, Wimmer AM, Giesecke T.","Wien Klin Wochenschr. 2012 Jan;124(1-2):25-31. doi: 10.1007/s00508-011-0076-y. Epub 2011 Nov 4.","Ringe JD","Wien Klin Wochenschr","2012","2011/11/03","","","10.1007/s00508-011-0076-y"
"21972884","The influence of patient position on withdrawal force of thoracic epidural catheters","Sim WS, Choi JW, Lee CJ, Nahm FS, Lee SH, Shin BS, Cho HS.","Anaesthesia. 2012 Jan;67(1):19-22. doi: 10.1111/j.1365-2044.2011.06913.x. Epub 2011 Oct 4.","Sim WS","Anaesthesia","2012","2011/10/07","","","10.1111/j.1365-2044.2011.06913.x"
"21968264","Understanding and treating opioid addiction in a patient with cancer pain","Kircher S, Zacny J, Apfelbaum SM, Passik S, Kirsch K, Burbage M, Lofwall M.","J Pain. 2011 Oct;12(10):1025-31. doi: 10.1016/j.jpain.2011.07.006.","Kircher S","J Pain","2011","2011/10/05","","","10.1016/j.jpain.2011.07.006"
"21957828","Economic evaluation of OROS hydromorphone for chronic pain: a Pan-European perspective","Hauber AB, Fleischmann J, Lothgren M, Wilson M, Lam A, Dubois D, Sabatowski R.","J Opioid Manag. 2011 Jul-Aug;7(4):287-96. doi: 10.5055/jom.2011.0070.","Hauber AB","J Opioid Manag","2011","2011/10/01","","","10.5055/jom.2011.0070"
"21953763","Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes","Dampier CD, Smith WR, Kim HY, Wager CG, Bell MC, Minniti CP, Keefer J, Hsu L, Krishnamurti L, Mack AK, McClish D, McKinlay SM, Miller ST, Osunkwo I, Seaman P, Telen MJ, Weiner DL; Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN).","Am J Hematol. 2011 Dec;86(12):E70-3. doi: 10.1002/ajh.22176. Epub 2011 Sep 22.","Dampier CD","Am J Hematol","2011","2011/09/29","PMC4573530","NIHMS435967","10.1002/ajh.22176"
"21946150","Rewarding electrical brain stimulation in rats after peripheral nerve injury: decreased facilitation by commonly abused prescription opioids","Ewan EE, Martin TJ.","Anesthesiology. 2011 Dec;115(6):1271-80. doi: 10.1097/ALN.0b013e3182330448.","Ewan EE","Anesthesiology","2011","2011/09/28","PMC3226848","NIHMS325669","10.1097/ALN.0b013e3182330448"
"21918158","Case report: Anti-N-methyl-D-aspartate receptor encephalitis and its anesthetic implications","Pryzbylkowski PG, Dunkman WJ, Liu R, Chen L.","Anesth Analg. 2011 Nov;113(5):1188-91. doi: 10.1213/ANE.0b013e31822b8a7d. Epub 2011 Sep 14.","Pryzbylkowski PG","Anesth Analg","2011","2011/09/16","PMC3404887","NIHMS390550","10.1213/ANE.0b013e31822b8a7d"
"21868431","Feigning terminal illness to get narcotics: a cautionary tale for hospices","Gonzalez F, Galante M.","Am J Hosp Palliat Care. 2012 Aug;29(5):399-400. doi: 10.1177/1049909111418780. Epub 2011 Aug 25.","Gonzalez F","Am J Hosp Palliat Care","2012","2011/08/27","","","10.1177/1049909111418780"
"21861200","Efficacy of opioid rotation to continuous parenteral hydromorphone in advanced cancer patients failing on other opioids","Oldenmenger WH, Lieverse PJ, Janssen PJ, Taal W, van der Rijt CC, Jager A.","Support Care Cancer. 2012 Aug;20(8):1639-47. doi: 10.1007/s00520-011-1254-1. Epub 2011 Aug 23.","Oldenmenger WH","Support Care Cancer","2012","2011/08/24","PMC3390689","","10.1007/s00520-011-1254-1"
"21841049","Comparative clinical effects of hydromorphone and morphine: a meta-analysis","Felden L, Walter C, Harder S, Treede RD, Kayser H, Drover D, Geisslinger G, Lötsch J.","Br J Anaesth. 2011 Sep;107(3):319-28. doi: 10.1093/bja/aer232. Epub 2011 Aug 5.","Felden L","Br J Anaesth","2011","2011/08/16","","","10.1093/bja/aer232"
"21838980","Epidural administration of liposome-encapsulated hydromorphone provides extended analgesia in a rodent model of stifle arthritis","Schmidt JR, Krugner-Higby L, Heath TD, Sullivan R, Smith LJ.","J Am Assoc Lab Anim Sci. 2011 Jul;50(4):507-12.","Schmidt JR","J Am Assoc Lab Anim Sci","2011","2011/08/16","PMC3148635","",""
"21836545","Extended-release hydromorphone (Exalgo) for pain","","Med Lett Drugs Ther. 2011 Aug 25;53(1370):62-3.","","Med Lett Drugs Ther","2011","2011/08/13","","",""
"21823925","Adverse effects in hospice patients with chronic kidney disease receiving hydromorphone","Paramanandam G, Prommer E, Schwenke DC.","J Palliat Med. 2011 Sep;14(9):1029-33. doi: 10.1089/jpm.2011.0103. Epub 2011 Aug 8.","Paramanandam G","J Palliat Med","2011","2011/08/10","","","10.1089/jpm.2011.0103"
"21821512","A prospective survey of patient-controlled epidural analgesia with bupivacaine and clonidine after total hip replacement: a pre- and postchange comparison with bupivacaine and hydromorphone in 1,000 patients","Liu SS, Bae JJ, Bieltz M, Wukovits B, Ma Y.","Anesth Analg. 2011 Nov;113(5):1213-7. doi: 10.1213/ANE.0b013e318228fc8b. Epub 2011 Aug 4.","Liu SS","Anesth Analg","2011","2011/08/09","","","10.1213/ANE.0b013e318228fc8b"
"21801042","Anesthesia case of the month. Vagally-mediated cardiopulmonary arrest due to concurrent opioid administration and tracheal extubation in a brachycephalic dog","Mathews LA, Killos MB, Graham LF.","J Am Vet Med Assoc. 2011 Aug 1;239(3):307-12. doi: 10.2460/javma.239.3.307.","Mathews LA","J Am Vet Med Assoc","2011","2011/08/02","","","10.2460/javma.239.3.307"
"21793978","Dexmedetomidine for co-analgesia in chemotherapy-induced severe enterocolitis","Winton P, Whyte E, Reimer EJ, Davis J, Whyte S.","Paediatr Anaesth. 2011 Sep;21(9):980-1. doi: 10.1111/j.1460-9592.2011.03575.x.","Winton P","Paediatr Anaesth","2011","2011/07/29","","","10.1111/j.1460-9592.2011.03575.x"
"21779774","Robotic-assisted laparoscopic myomectomy versus abdominal myomectomy: a comparative analysis of surgical outcomes and costs","Nash K, Feinglass J, Zei C, Lu G, Mengesha B, Lewicky-Gaupp C, Lin A.","Arch Gynecol Obstet. 2012 Feb;285(2):435-40. doi: 10.1007/s00404-011-1999-2. Epub 2011 Jul 22.","Nash K","Arch Gynecol Obstet","2012","2011/07/23","","","10.1007/s00404-011-1999-2"
"21710117","Clinical efficacy of OROS® hydromorphone in patients suffering from severe chronic pain: A Study undertaken in routine clinical practice","Stepanović A, Pirc J, Lahajnar Čavlović S.","Wien Klin Wochenschr. 2011 Sep;123(17-18):531-5. doi: 10.1007/s00508-011-1593-4. Epub 2011 Jun 28.","Stepanović A","Wien Klin Wochenschr","2011","2011/06/29","","","10.1007/s00508-011-1593-4"
"21708853","The role of hydromorphone in cancer pain treatment: a systematic review","Pigni A, Brunelli C, Caraceni A.","Palliat Med. 2011 Jul;25(5):471-7. doi: 10.1177/0269216310387962.","Pigni A","Palliat Med","2011","2011/06/29","","","10.1177/0269216310387962"
"21676160","Successful reversal of hyperalgesia/myoclonus complex with low-dose ketamine infusion","Forero M, Chan PS, Restrepo-Garces CE.","Pain Pract. 2012 Feb;12(2):154-8. doi: 10.1111/j.1533-2500.2011.00475.x. Epub 2011 Jun 16.","Forero M","Pain Pract","2012","2011/06/17","","","10.1111/j.1533-2500.2011.00475.x"
"21667674","PCA oversedation: application of Healthcare Failure Mode Effect (HFMEA) Analysis","Cronrath P, Lynch TW, Gilson LJ, Nishida C, Sembar MC, Spencer PJ, West DF.","Nurs Econ. 2011 Mar-Apr;29(2):79-87.","Cronrath P","Nurs Econ","2011","2011/06/15","","",""
"21620461","Intravenous HYDROmorphone: can you manage the risk?","Paparella S.","J Emerg Nurs. 2011 Jul;37(4):377-80; quiz 424. doi: 10.1016/j.jen.2011.03.010. Epub 2011 May 26.","Paparella S","J Emerg Nurs","2011","2011/05/31","","","10.1016/j.jen.2011.03.010"
"21606765","Breast milk hydrocodone and hydromorphone levels in mothers using hydrocodone for postpartum pain","Koren G.","Obstet Gynecol. 2011 Jun;117(6):1439; author reply 1439. doi: 10.1097/AOG.0b013e31821e291e.","Koren G","Obstet Gynecol","2011","2011/05/25","","","10.1097/AOG.0b013e31821e291e"
"21562420","Intrathecal hydromorphone added to hyperbaric bupivacaine for postoperative pain relief after knee arthroscopic surgery: a prospective, randomised, controlled trial","Lee YS, Park YC, Kim JH, Kim WY, Yoon SZ, Moon MG, Min TJ.","Eur J Anaesthesiol. 2012 Jan;29(1):17-21. doi: 10.1097/EJA.0b013e3283476055.","Lee YS","Eur J Anaesthesiol","2012","2011/05/13","","","10.1097/EJA.0b013e3283476055"
"21507527","Randomized clinical trial comparing the safety and efficacy of a hydromorphone titration protocol to usual care in the management of adult emergency department patients with acute severe pain","Chang AK, Bijur PE, Gallagher EJ.","Ann Emerg Med. 2011 Oct;58(4):352-9. doi: 10.1016/j.annemergmed.2011.03.003. Epub 2011 Apr 19.","Chang AK","Ann Emerg Med","2011","2011/04/22","","","10.1016/j.annemergmed.2011.03.003"
"21498589","Experimental pharmacodynamics and analgesic efficacy of liposome-encapsulated hydromorphone in dogs","Krugner-Higby L, Smith L, Schmidt B, Wunsch L, Smetana A, Brown C, Heath TD.","J Am Anim Hosp Assoc. 2011 May-Jun;47(3):185-95. doi: 10.5326/JAAHA-MS-5599. Epub 2011 Apr 15.","Krugner-Higby L","J Am Anim Hosp Assoc","2011","2011/04/19","","","10.5326/JAAHA-MS-5599"
"21470608","Feasibility, safety, and effectiveness of transcranial direct current stimulation for decreasing post-ERCP pain: a randomized, sham-controlled, pilot study","Borckardt JJ, Romagnuolo J, Reeves ST, Madan A, Frohman H, Beam W, George MS.","Gastrointest Endosc. 2011 Jun;73(6):1158-64. doi: 10.1016/j.gie.2011.01.050. Epub 2011 Apr 5.","Borckardt JJ","Gastrointest Endosc","2011","2011/04/08","","","10.1016/j.gie.2011.01.050"
"21404039","Pharmacokinetics and behavioral effects of liposomal hydromorphone suitable for perioperative use in rhesus macaques","Krugner-Higby L, KuKanich B, Schmidt B, Heath TD, Brown C.","Psychopharmacology (Berl). 2011 Aug;216(4):511-23. doi: 10.1007/s00213-011-2239-y. Epub 2011 Mar 15.","Krugner-Higby L","Psychopharmacology (Berl)","2011","2011/03/16","PMC3142292","NIHMS299857","10.1007/s00213-011-2239-y"
"21396229","Quantitation of opioids in whole blood by electron impact-gas chromatography-mass spectrometry","Tiscione NB, Shan X, Alford I, Yeatman DT.","J Anal Toxicol. 2011 Mar;35(2):99-107. doi: 10.1093/anatox/35.2.99.","Tiscione NB","J Anal Toxicol","2011","2011/03/15","","","10.1093/anatox/35.2.99"
"21384514","Epidural analgesia provides better pain management after live liver donation: a retrospective study","Clarke H, Chandy T, Srinivas C, Ladak S, Okubo N, Mitsakakis N, Holtzman S, Grant D, McCluskey SA, Katz J.","Liver Transpl. 2011 Mar;17(3):315-23. doi: 10.1002/lt.22221.","Clarke H","Liver Transpl","2011","2011/03/09","","","10.1002/lt.22221"
"21344260","The effects of preoperative intravenous acetaminophen in patients undergoing abdominal hysterectomy","Moon YE, Lee YK, Lee J, Moon DE.","Arch Gynecol Obstet. 2011 Dec;284(6):1455-60. doi: 10.1007/s00404-011-1860-7. Epub 2011 Feb 23.","Moon YE","Arch Gynecol Obstet","2011","2011/02/24","","","10.1007/s00404-011-1860-7"
"21343764","Breast milk hydrocodone and hydromorphone levels in mothers using hydrocodone for postpartum pain","Sauberan JB, Anderson PO, Lane JR, Rafie S, Nguyen N, Rossi SS, Stellwagen LM.","Obstet Gynecol. 2011 Mar;117(3):611-7. doi: 10.1097/AOG.0b013e31820ca504.","Sauberan JB","Obstet Gynecol","2011","2011/02/24","","","10.1097/AOG.0b013e31820ca504"
"21297541","Prolonged sinus pauses with hydromorphone in the absence of cardiac conduction disease","Snarr BS, Rowley CP, Phan SV, Achanti A, Hendrix GH.","South Med J. 2011 Mar;104(3):239-40. doi: 10.1097/SMJ.0b013e318206f6d3.","Snarr BS","South Med J","2011","2011/02/08","","","10.1097/SMJ.0b013e318206f6d3"
"21199302","Open-label study on the long-term efficacy, safety, and impact on quality of life of OROS hydromorphone ER in patients with chronic low back pain","Wallace M, Thipphawong J.","Pain Med. 2010 Oct;11(10):1477-88. doi: 10.1111/j.1526-4637.2010.00956.x.","Wallace M","Pain Med","2010","2011/01/05","","","10.1111/j.1526-4637.2010.00956.x"
"21172762","Oral hydromorphone extended-release","Guay DR.","Consult Pharm. 2010 Dec;25(12):816-28. doi: 10.4140/TCP.n.2010.816.","Guay DR","Consult Pharm","2010","2010/12/22","","","10.4140/TCP.n.2010.816"
"21102402","OROS® hydromorphone in chronic pain management: when drug delivery technology matches clinical needs","Coluzzi F, Mattia C.","Minerva Anestesiol. 2010 Dec;76(12):1072-84. Epub 2010 Nov 24.","Coluzzi F","Minerva Anestesiol","2010","2010/11/25","","",""
"21098693","Teaching from catastrophe: using therapeutic misadventures from hydromorphone to teach key principles in clinical pharmacology","Lehmann DF.","J Clin Pharmacol. 2011 Nov;51(11):1596-602. doi: 10.1177/0091270010384482. Epub 2010 Nov 23.","Lehmann DF","J Clin Pharmacol","2011","2010/11/25","","","10.1177/0091270010384482"
"21098692","A randomized study of the effects of food on the pharmacokinetics of once-daily extended-release hydromorphone in healthy volunteers","Moore KT, St-Fleur D, Marricco NC, Ariyawansa J, Pagé V, Natarajan J, Morelli G, Richarz U.","J Clin Pharmacol. 2011 Nov;51(11):1571-9. doi: 10.1177/0091270010383858. Epub 2010 Nov 23.","Moore KT","J Clin Pharmacol","2011","2010/11/25","","","10.1177/0091270010383858"
"21078483","Triage nurses influence safety by cutting the color: removal of non-health care colored wristbands reduces risk for error","Dean C.","J Emerg Nurs. 2010 Nov;36(6):599-600. doi: 10.1016/j.jen.2010.07.020. Epub 2010 Oct 8.","Dean C","J Emerg Nurs","2010","2010/11/17","","","10.1016/j.jen.2010.07.020"
"21077877","Accidental death from hydromorphone ingestion","Meatherall R, Lee C, Phillips S.","J Forensic Sci. 2011 Jan;56 Suppl 1:S271-4. doi: 10.1111/j.1556-4029.2010.01618.x. Epub 2010 Nov 15.","Meatherall R","J Forensic Sci","2011","2010/11/17","","","10.1111/j.1556-4029.2010.01618.x"
"21073386","Effects of acepromazine, hydromorphone, or an acepromazine-hydromorphone combination on the degree of sedation in clinically normal dogs","Hofmeister EH, Chandler MJ, Read MR.","J Am Vet Med Assoc. 2010 Nov 15;237(10):1155-9. doi: 10.2460/javma.237.10.1155.","Hofmeister EH","J Am Vet Med Assoc","2010","2010/11/16","","","10.2460/javma.237.10.1155"
"21046932","Steady-state pharmacokinetics of extended-release hydromorphone (OROS hydromorphone): a randomized study in healthy volunteers","Moore KT, St-Fleur D, Marricco NC, Ariyawansa J, Pagé V, Natarajan J, Morelli G, Richarz U.","J Opioid Manag. 2010 Sep-Oct;6(5):351-8. doi: 10.5055/jom.2010.0032.","Moore KT","J Opioid Manag","2010","2010/11/05","","","10.5055/jom.2010.0032"
"21029352","Stability and tolerability of high concentrations of intrathecal bupivacaine and opioid mixtures in chronic noncancer pain: an open-label pilot study","Goucke CR, Dusci LJ, Van Leeuwen S, Fairclough D, Ilett KF.","Pain Med. 2010 Nov;11(11):1612-8. doi: 10.1111/j.1526-4637.2010.00958.x. Epub 2010 Oct 1.","Goucke CR","Pain Med","2010","2010/10/30","","","10.1111/j.1526-4637.2010.00958.x"
"21004426","Studies on analgesics; the time-action curves of morphine, codeine, dilaudid and demerol by various methods of administration; analgesic activity of acetylsalicylic acid and aminopyrine","ERCOLI N, LEWIS MN.","J Pharmacol Exp Ther. 1945 Aug;84:301-17.","ERCOLI N","J Pharmacol Exp Ther","1945","2010/10/29","","",""
"20932710","A cautionary tale from critical care: resolution of myoclonus after fentanyl rotation to hydromorphone","Essandoh S, Sakae M, Miller J, Glare PA.","J Pain Symptom Manage. 2010 Nov;40(5):e4-6. doi: 10.1016/j.jpainsymman.2010.08.005. Epub 2010 Oct 8.","Essandoh S","J Pain Symptom Manage","2010","2010/10/12","","","10.1016/j.jpainsymman.2010.08.005"
"20881947","Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers","Greenwald MK, Lundahl LH, Steinmiller CL.","Version 2. Neuropsychopharmacology. 2010 Dec;35(13):2624-37. doi: 10.1038/npp.2010.175. Epub 2010 Sep 29.","Greenwald MK","Neuropsychopharmacology","2010","2010/10/01","PMC2978797","NIHMS232470","10.1038/npp.2010.175"
"20878378","Opioid conversions and patient-controlled analgesia parameters in opioid-dependent patients","Eipe N, Penning J.","Can J Anaesth. 2010 Dec;57(12):1129-30. doi: 10.1007/s12630-010-9384-3. Epub 2010 Sep 28.","Eipe N","Can J Anaesth","2010","2010/09/30","","","10.1007/s12630-010-9384-3"
"20855171","History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment","Oviedo-Joekes E, Marchand K, Guh D, Marsh DC, Brissette S, Krausz M, Anis A, Schechter MT.","Addict Behav. 2011 Jan-Feb;36(1-2):55-60. doi: 10.1016/j.addbeh.2010.08.020. Epub 2010 Sep 19.","Oviedo-Joekes E","Addict Behav","2011","2010/09/22","","","10.1016/j.addbeh.2010.08.020"
"20825766","Intravenous opioid dosing and outcomes in emergency patients: a prospective cohort analysis","O'Connor AB, Zwemer FL, Hays DP, Feng C.","Am J Emerg Med. 2010 Nov;28(9):1041-1050.e6. doi: 10.1016/j.ajem.2009.06.009. Epub 2010 Mar 25.","O'Connor AB","Am J Emerg Med","2010","2010/09/10","","","10.1016/j.ajem.2009.06.009"
"20737811","Characteristics and response to treatment among Aboriginal people receiving heroin-assisted treatment","Oviedo-Joekes E, Guh D, Marsh DC, Brissette S, Nosyk B, Krausz M, Anis A, Christian WM, Spittal P, Schechter MT.","Can J Public Health. 2010 May-Jun;101(3):210-2. doi: 10.1007/BF03404375.","Oviedo-Joekes E","Can J Public Health","2010","2010/08/27","PMC6973743","","10.1007/BF03404375"
"20718640","Efficacy of the sustained-release hydromorphone in neuropathic pain management: pooled analysis of three open-label studies","Moulin DE, Richarz U, Wallace M, Jacobs A, Thipphawong J.","J Pain Palliat Care Pharmacother. 2010 Sep;24(3):200-12. doi: 10.3109/15360288.2010.502213.","Moulin DE","J Pain Palliat Care Pharmacother","2010","2010/08/20","","","10.3109/15360288.2010.502213"
"20607876","Prospective survey of patient-controlled epidural analgesia with bupivacaine and hydromorphone in 3736 postoperative orthopedic patients","Liu SS, Bieltz M, Wukovits B, John RS.","Reg Anesth Pain Med. 2010 Jul-Aug;35(4):351-4. doi: 10.1097/aap.0b013e3181e6ac3a.","Liu SS","Reg Anesth Pain Med","2010","2010/07/09","","","10.1097/aap.0b013e3181e6ac3a"
"20589494","Physical dependence potential of daily tramadol dosing in humans","Lanier RK, Lofwall MR, Mintzer MZ, Bigelow GE, Strain EC.","Psychopharmacology (Berl). 2010 Sep;211(4):457-66. doi: 10.1007/s00213-010-1919-3. Epub 2010 Jun 30.","Lanier RK","Psychopharmacology (Berl)","2010","2010/07/01","PMC3028382","NIHMS255273","10.1007/s00213-010-1919-3"
"20588149","Epidural hydromorphone: a step closer to the view from the top","Mulroy MF.","Reg Anesth Pain Med. 2010 Jul-Aug;35(4):333-4. doi: 10.1097/AAP.0b013e3181e8d5ee.","Mulroy MF","Reg Anesth Pain Med","2010","2010/07/01","","","10.1097/AAP.0b013e3181e8d5ee"
"20577717","Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers","Duke AN, Correia CJ, Walsh SL, Bigelow GE, Strain EC.","Psychopharmacology (Berl). 2010 Aug;211(3):303-12. doi: 10.1007/s00213-010-1898-4. Epub 2010 Jun 25.","Duke AN","Psychopharmacology (Berl)","2010","2010/06/26","PMC2941639","NIHMS233016","10.1007/s00213-010-1898-4"
"20537815","Effects of experimental Unemployment, Employment and Punishment analogs on opioid seeking and consumption in heroin-dependent volunteers","Greenwald MK.","Drug Alcohol Depend. 2010 Sep 1;111(1-2):64-73. doi: 10.1016/j.drugalcdep.2010.03.020. Epub 2010 May 26.","Greenwald MK","Drug Alcohol Depend","2010","2010/06/12","PMC2930063","NIHMS204282","10.1016/j.drugalcdep.2010.03.020"
"20521870","Factors affecting acceptability of titrated oxymorphone extended release in chronic low back pain - an individual patient analysis","Peniston JH, Xiang Q, Gould EM.","Curr Med Res Opin. 2010 Aug;26(8):1861-71. doi: 10.1185/03007995.2010.490457.","Peniston JH","Curr Med Res Opin","2010","2010/06/05","","","10.1185/03007995.2010.490457"
"20481173","Correlation between myoclonus and the 3-glucuronide metabolites in patients treated with morphine or hydromorphone: a pilot study","McCann S, Yaksh TL, von Gunten CF.","J Opioid Manag. 2010 Mar-Apr;6(2):87-94. doi: 10.5055/jom.2010.0008.","McCann S","J Opioid Manag","2010","2010/05/21","","","10.5055/jom.2010.0008"
"20456078","Recurrent cellulitis associated with long-term intrathecal opioid infusion therapy: a case report and review of the literature","Ruan X, Liu H, Couch JP, Wang F, Chiravuri S.","Pain Med. 2010 Jun;11(6):972-6. doi: 10.1111/j.1526-4637.2010.00854.x. Epub 2010 Apr 29.","Ruan X","Pain Med","2010","2010/05/12","","","10.1111/j.1526-4637.2010.00854.x"
"20454781","Solution to quality assurance challenge 9","Reichenbächer M, Einax JW.","Anal Bioanal Chem. 2010 Jul;397(5):1641-3. doi: 10.1007/s00216-010-3769-6.","Reichenbächer M","Anal Bioanal Chem","2010","2010/05/11","","","10.1007/s00216-010-3769-6"
"20429852","Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain","Hale M, Khan A, Kutch M, Li S.","Curr Med Res Opin. 2010 Jun;26(6):1505-18. doi: 10.1185/03007995.2010.484723.","Hale M","Curr Med Res Opin","2010","2010/05/01","","","10.1185/03007995.2010.484723"
"20417053","A case report of porphyria variegata management in the emergency department","Chen BC, Griffey RT.","J Emerg Med. 2012 Oct;43(4):e235-8. doi: 10.1016/j.jemermed.2010.02.028. Epub 2010 Apr 22.","Chen BC","J Emerg Med","2012","2010/04/27","","","10.1016/j.jemermed.2010.02.028"
"20402557","Hydromorphone-OROS formulation","Goforth HW.","Expert Opin Pharmacother. 2010 May;11(7):1207-14. doi: 10.1517/14656566.2010.482099.","Goforth HW","Expert Opin Pharmacother","2010","2010/04/21","","","10.1517/14656566.2010.482099"
"20384968","A randomized study to demonstrate noninferiority of once-daily OROS(®) hydromorphone with twice-daily sustained-release oxycodone for moderate to severe chronic noncancer pain","Binsfeld H, Szczepanski L, Waechter S, Richarz U, Sabatowski R.","Pain Pract. 2010 Sep-Oct;10(5):404-15. doi: 10.1111/j.1533-2500.2009.00342.x.","Binsfeld H","Pain Pract","2010","2010/04/14","","","10.1111/j.1533-2500.2009.00342.x"
"20361803","Use of hydromorphone, with particular reference to the OROS formulation, in the elderly","Lussier D, Richarz U, Finco G.","Drugs Aging. 2010 Apr 1;27(4):327-35. doi: 10.2165/11318320-000000000-00000.","Lussier D","Drugs Aging","2010","2010/04/06","","","10.2165/11318320-000000000-00000"
"20359843","Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study","Oviedo-Joekes E, Guh D, Brissette S, Marsh DC, Nosyk B, Krausz M, Anis A, Schechter MT.","J Subst Abuse Treat. 2010 Jun;38(4):408-11. doi: 10.1016/j.jsat.2010.03.003. Epub 2010 Mar 31.","Oviedo-Joekes E","J Subst Abuse Treat","2010","2010/04/03","","","10.1016/j.jsat.2010.03.003"
"20297858","OROS hydromorphone prolonged release: a review of its use in the management of chronic, moderate to severe pain","Carter NJ, Keating GM.","CNS Drugs. 2010 Apr;24(4):337-61. doi: 10.2165/11202580-000000000-00000.","Carter NJ","CNS Drugs","2010","2010/03/20","","","10.2165/11202580-000000000-00000"
"20233019","Tabling hydromorphone: do we have it right?","Davis MP, McPherson ML.","J Palliat Med. 2010 Apr;13(4):365-6. doi: 10.1089/jpm.2009.0366.","Davis MP","J Palliat Med","2010","2010/03/18","","","10.1089/jpm.2009.0366"
"20223099","Evaluation of the usefulness of an oxycodone immunoassay in combination with a traditional opiate immunoassay for the screening of opiates in urine","Gingras M, Laberge MH, Lefebvre M.","J Anal Toxicol. 2010 Mar;34(2):78-83. doi: 10.1093/jat/34.2.78.","Gingras M","J Anal Toxicol","2010","2010/03/13","","","10.1093/jat/34.2.78"
"20205085","[Controlled release hydromorphone for visceral, somatic and neuropathic pain]","Alon E, Cachin C.","Praxis (Bern 1994). 2010 Mar 3;99(5):283-91. doi: 10.1024/1661-8157/a000050.","Alon E","Praxis (Bern 1994)","2010","2010/03/06","","","10.1024/1661-8157/a000050"
"20201126","Formation of two consecutive intrathecal catheter tip granulomas within nine months","Hoederath P, Gautschi OP, Land M, Hildebrandt G, Fournier JY.","Cent Eur Neurosurg. 2010 Feb;71(1):39-42. doi: 10.1055/s-0029-1202359.","Hoederath P","Cent Eur Neurosurg","2010","2010/03/05","","","10.1055/s-0029-1202359"
"20088194","Navigating clinical care at the intersection of pain and addiction","Krupnick SL.","Medsurg Nurs. 2009 Nov-Dec;18(6):381-4.","Krupnick SL","Medsurg Nurs","2009","2010/01/22","","",""
"20077093","Quantitation of morphine, codeine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and 6-monoacetylmorphine (6-MAM) in urine, blood, serum, or plasma using liquid chromatography with tandem mass spectrometry detection","Dahn T, Gunn J, Kriger S, Terrell AR.","Methods Mol Biol. 2010;603:411-22. doi: 10.1007/978-1-60761-459-3_40.","Dahn T","Methods Mol Biol","2010","2010/01/16","","","10.1007/978-1-60761-459-3_40"
"20077092","Quantitation of opioids in blood and urine using gas chromatography-mass spectrometry (GC-MS)","Goldberger BA, Chronister CW, Merves ML.","Methods Mol Biol. 2010;603:399-410. doi: 10.1007/978-1-60761-459-3_39.","Goldberger BA","Methods Mol Biol","2010","2010/01/16","","","10.1007/978-1-60761-459-3_39"
"20075644","Evaluation of the abuse potential of extended release hydromorphone versus immediate release hydromorphone","Shram MJ, Sathyan G, Khanna S, Tudor IC, Nath R, Thipphawong J, Sellers EM.","J Clin Psychopharmacol. 2010 Feb;30(1):25-33. doi: 10.1097/JCP.0b013e3181c8f088.","Shram MJ","J Clin Psychopharmacol","2010","2010/01/16","","","10.1097/JCP.0b013e3181c8f088"
"20066529","Quality assurance challenge 9","Reichenbächer M, Einax JW.","Anal Bioanal Chem. 2010 Mar;396(5):1627-9. doi: 10.1007/s00216-009-3408-2.","Reichenbächer M","Anal Bioanal Chem","2010","2010/01/13","","","10.1007/s00216-009-3408-2"
"20017817","Effects of opioids and anesthetic drugs on body temperature in cats","Posner LP, Pavuk AA, Rokshar JL, Carter JE, Levine JF.","Vet Anaesth Analg. 2010 Jan;37(1):35-43. doi: 10.1111/j.1467-2995.2009.00508.x.","Posner LP","Vet Anaesth Analg","2010","2009/12/19","","","10.1111/j.1467-2995.2009.00508.x"
"20014429","A mathematical relationship for hydromorphone loading into liposomes with trans-membrane ammonium sulfate gradients","Tu S, McGinnis T, Krugner-Higby L, Heath TD.","J Pharm Sci. 2010 Jun;99(6):2672-80. doi: 10.1002/jps.22017.","Tu S","J Pharm Sci","2010","2009/12/17","PMC4240746","NIHMS641945","10.1002/jps.22017"
"19961358","The pharmacokinetics of a long-acting OROS hydromorphone formulation","Turgeon J, Gröning R, Sathyan G, Thipphawong J, Richarz U.","Expert Opin Drug Deliv. 2010 Jan;7(1):137-44. doi: 10.1517/17425240903386658.","Turgeon J","Expert Opin Drug Deliv","2010","2009/12/08","","","10.1517/17425240903386658"
"19949319","The reinforcing, self-reported performance and physiological effects of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in cannabis users","Lile JA, Kelly TH, Hays LR.","Behav Pharmacol. 2010 Feb;21(1):29-38. doi: 10.1097/FBP.0b013e32833470d7.","Lile JA","Behav Pharmacol","2010","2009/12/02","PMC2903043","NIHMS202801","10.1097/FBP.0b013e32833470d7"
"19863749","The role of OROS hydromorphone in the management of cancer pain","Gardner-Nix J, Mercadante S.","Pain Pract. 2010 Jan-Feb;10(1):72-7. doi: 10.1111/j.1533-2500.2009.00313.x. Epub 2009 Oct 20.","Gardner-Nix J","Pain Pract","2010","2009/10/30","","","10.1111/j.1533-2500.2009.00313.x"
"19858166","A preliminary investigation into the practicality of use and duration of action of slow-release preparations of morphine and hydromorphone in laboratory rats","Leach MC, Bailey HE, Dickinson AL, Roughan JV, Flecknell PA.","Lab Anim. 2010 Jan;44(1):59-65. doi: 10.1258/la.2009.007160. Epub 2009 Oct 26.","Leach MC","Lab Anim","2010","2009/10/28","","","10.1258/la.2009.007160"
"19843811","Ultrasound-guided paravertebral block using an intercostal approach","Ben-Ari A, Moreno M, Chelly JE, Bigeleisen PE.","Anesth Analg. 2009 Nov;109(5):1691-4. doi: 10.1213/ANE.0b013e3181b72d50.","Ben-Ari A","Anesth Analg","2009","2009/10/22","","","10.1213/ANE.0b013e3181b72d50"
"19795932","Antinociceptive effects of epidural administration of hydromorphone in conscious cats","Ambros B, Steagall PV, Mantovani F, Gilbert P, Duke-Novakovski T.","Am J Vet Res. 2009 Oct;70(10):1187-92. doi: 10.2460/ajvr.70.10.1187.","Ambros B","Am J Vet Res","2009","2009/10/03","","","10.2460/ajvr.70.10.1187"
"19786588","Commentary","Gourlay D, Heit HA.","Clin Chem. 2009 Oct;55(10):1769. doi: 10.1373/clinchem.2009.132381.","Gourlay D","Clin Chem","2009","2009/09/30","","","10.1373/clinchem.2009.132381"
"19786587","Commentary","Broussard LA.","Clin Chem. 2009 Oct;55(10):1768. doi: 10.1373/clinchem.2009.132365.","Broussard LA","Clin Chem","2009","2009/09/30","","","10.1373/clinchem.2009.132365"
"19786586","Unexpected urine drug testing results in a hospice patient on high-dose morphine therapy","Reisfield GM, Chronister CW, Goldberger BA, Bertholf RL.","Clin Chem. 2009 Oct;55(10):1765-8. doi: 10.1373/clinchem.2008.122754.","Reisfield GM","Clin Chem","2009","2009/09/30","","","10.1373/clinchem.2008.122754"
"19780509","Texas court overturns motion granting new trial Case on point: In Re Columbia Med. Ctr. of Las Colinas, Subsidiary, L.R-0707.1263(7/3/2009)-TX","","Nurs Law Regan Rep. 2009 Aug;50(3):4.","","Nurs Law Regan Rep","2009","2009/09/29","","",""
"19769895","The ""1+1"" protocol: risks, benefits, and alternatives","O'Connor AB.","Ann Emerg Med. 2009 Oct;54(4):637-8; author reply 638-9. doi: 10.1016/j.annemergmed.2009.04.024.","O'Connor AB","Ann Emerg Med","2009","2009/09/23","","","10.1016/j.annemergmed.2009.04.024"
"19715249","The epidural works, but the patient hurts! Acute pain management of the chronic pain patient","Grewal PK, Firnhaber-Burgos JB.","J Ark Med Soc. 2009 Aug;106(2):43-5.","Grewal PK","J Ark Med Soc","2009","2009/09/01","","",""
"19700988","Epidural analgesia compared with intravenous analgesia after pediatric posterior spinal fusion","Gauger VT, Voepel-Lewis TD, Burke CN, Kostrzewa AJ, Caird MS, Wagner DS, Farley FA.","J Pediatr Orthop. 2009 Sep;29(6):588-93. doi: 10.1097/BPO.0b013e3181b2ba08.","Gauger VT","J Pediatr Orthop","2009","2009/08/25","","","10.1097/BPO.0b013e3181b2ba08"
"19692689","Diacetylmorphine versus methadone for the treatment of opioid addiction","Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, Schechter MT.","N Engl J Med. 2009 Aug 20;361(8):777-86. doi: 10.1056/NEJMoa0810635.","Oviedo-Joekes E","N Engl J Med","2009","2009/08/21","PMC5127701","CAMS373","10.1056/NEJMoa0810635"
"19692102","A comparison of the effects of hydromorphone HCl and a novel extended release hydromorphone on arterial blood gas values in conscious healthy dogs","Wunsch LA, Schmidt BK, Krugner-Higby LA, Smith LJ.","Res Vet Sci. 2010 Feb;88(1):154-8. doi: 10.1016/j.rvsc.2009.07.008. Epub 2009 Aug 18.","Wunsch LA","Res Vet Sci","2010","2009/08/21","PMC4235959","NIHMS641949","10.1016/j.rvsc.2009.07.008"
"19672166","Does postoperative delirium limit the use of patient-controlled analgesia in older surgical patients?","Leung JM, Sands LP, Paul S, Joseph T, Kinjo S, Tsai T.","Anesthesiology. 2009 Sep;111(3):625-31. doi: 10.1097/ALN.0b013e3181acf7e6.","Leung JM","Anesthesiology","2009","2009/08/13","PMC2762324","NIHMS125739","10.1097/ALN.0b013e3181acf7e6"
"19662927","Dexmedetomidine as a novel therapeutic for postoperative pain in a patient treated with buprenorphine","Brummett CM, Trivedi KA, Dubovoy AV, Berland DW.","J Opioid Manag. 2009 May-Jun;5(3):175-9. doi: 10.5055/jom.2009.0018.","Brummett CM","J Opioid Manag","2009","2009/08/11","","","10.5055/jom.2009.0018"
"19592310","A multicenter, open-label, exploratory dose-ranging trial of intranasal hydromorphone for managing acute pain from traumatic injury","Wermeling DP, Clinch T, Rudy AC, Dreitlein D, Suner S, Lacouture PG.","J Pain. 2010 Jan;11(1):24-31. doi: 10.1016/j.jpain.2009.05.002. Epub 2009 Jul 9.","Wermeling DP","J Pain","2010","2009/07/14","","","10.1016/j.jpain.2009.05.002"
"19560838","Randomized clinical trial comparing a patient-driven titration protocol of intravenous hydromorphone with traditional physician-driven management of emergency department patients with acute severe pain","Chang AK, Bijur PE, Davitt M, Gallagher EJ.","Ann Emerg Med. 2009 Oct;54(4):561-567.e2. doi: 10.1016/j.annemergmed.2009.05.003. Epub 2009 Jun 28.","Chang AK","Ann Emerg Med","2009","2009/06/30","","","10.1016/j.annemergmed.2009.05.003"
"19507806","Long-term safety, tolerability, and efficacy of OROS hydromorphone in patients with chronic pain","Wallace M, Moulin DE, Rauck RL, Khanna S, Tudor IC, Skowronski R, Thipphawong J.","J Opioid Manag. 2009 Mar-Apr;5(2):97-105. doi: 10.5055/jom.2009.0011.","Wallace M","J Opioid Manag","2009","2009/06/11","","","10.5055/jom.2009.0011"
"19507803","Two milligrams i.v. hydromorphone is efficacious for treating pain but is associated with oxygen desaturation","Chang AK, Bijur PE, Napolitano A, Lupow J, Gallagher EJ.","J Opioid Manag. 2009 Mar-Apr;5(2):75-80. doi: 10.5055/jom.2009.0008.","Chang AK","J Opioid Manag","2009","2009/06/11","","","10.5055/jom.2009.0008"
"19480749","Calcific uremic arteriolopathy (calciphylaxis): successful treatment with sodium thiosulfate in spite of elevated serum phosphate","Kalisiak M, Courtney M, Lin A, Brassard A.","J Cutan Med Surg. 2009 May-Jun;13 Suppl 1:S29-34. doi: 10.2310/7750.2009.00007.","Kalisiak M","J Cutan Med Surg","2009","2009/06/02","","","10.2310/7750.2009.00007"
"19464125","Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of alternative reinforcer magnitude and post-session drug supply","Greenwald MK, Steinmiller CL.","Drug Alcohol Depend. 2009 Sep 1;104(1-2):84-93. doi: 10.1016/j.drugalcdep.2009.04.006. Epub 2009 May 21.","Greenwald MK","Drug Alcohol Depend","2009","2009/05/26","PMC2724970","NIHMS114987","10.1016/j.drugalcdep.2009.04.006"
"19426295","Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis","O'Connor AB, Zwemer FL, Hays DP, Feng C.","Acad Emerg Med. 2009 Jun;16(6):477-87. doi: 10.1111/j.1553-2712.2009.00405.x. Epub 2009 May 7.","O'Connor AB","Acad Emerg Med","2009","2009/05/12","","","10.1111/j.1553-2712.2009.00405.x"
"19341053","[Clinical care of pregnant patients under the influence of opiates]","Durand S, Brodeur J, Thibault C.","Perspect Infirm. 2009 Jan-Feb;6(1):28-34.","Durand S","Perspect Infirm","2009","2009/04/04","","",""
"19301934","Pediatric palliative care: use of opioids for the management of pain","Zernikow B, Michel E, Craig F, Anderson BJ.","Paediatr Drugs. 2009;11(2):129-51. doi: 10.2165/00148581-200911020-00004.","Zernikow B","Paediatr Drugs","2009","2009/03/24","","","10.2165/00148581-200911020-00004"
"19281935","Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial","Chang AK, Bijur PE, Baccelieri A, Gallagher EJ.","Am J Geriatr Pharmacother. 2009 Feb;7(1):1-10. doi: 10.1016/j.amjopharm.2009.02.002.","Chang AK","Am J Geriatr Pharmacother","2009","2009/03/14","","","10.1016/j.amjopharm.2009.02.002"
"19227610","[The role of hydromorphone in pain killing]","Telekes A.","Lege Artis Med. 2008 Oct;18(10):675-9.","Telekes A","Lege Artis Med","2008","2009/02/21","","",""
"19207239","Two-tuohy needle and catheter technique for fluoroscopically guided percutaneous drainage of spinal epidural abscess: a case report","Perez-Toro MR, Burton AW, Hamid B, Koyyalagunta D.","Pain Med. 2009 Apr;10(3):501-5. doi: 10.1111/j.1526-4637.2008.00552.x. Epub 2009 Jan 16.","Perez-Toro MR","Pain Med","2009","2009/02/12","","","10.1111/j.1526-4637.2008.00552.x"
"19192761","Pain management in chronic kidney disease: the pharmacokinetics and pharmacodynamics of hydromorphone and hydromorphone-3-glucuronide in hemodialysis patients","Davison SN, Mayo PR.","J Opioid Manag. 2008 Nov-Dec;4(6):335-6, 339-44.","Davison SN","J Opioid Manag","2008","2009/02/06","","",""
"19172563","Iatrogenic occipital osteomyelitis","Medvedev G, Palacios E, Jones W.","Ear Nose Throat J. 2009 Jan;88(1):720-1.","Medvedev G","Ear Nose Throat J","2009","2009/01/28","","",""
"19134999","Prevalence of dihydrocodeine in hydrocodone positive postmortem specimens","Jenkins AJ, Lavins ES, Hunek C.","J Forensic Leg Med. 2009 Feb;16(2):64-6. doi: 10.1016/j.jflm.2008.08.002. Epub 2008 Sep 26.","Jenkins AJ","J Forensic Leg Med","2009","2009/01/13","","","10.1016/j.jflm.2008.08.002"
"19018520","Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol","Lile JA, Kelly TH, Pinsky DJ, Hays LR.","Psychopharmacology (Berl). 2009 Apr;203(2):241-50. doi: 10.1007/s00213-008-1393-3. Epub 2008 Nov 19.","Lile JA","Psychopharmacology (Berl)","2009","2008/11/20","PMC2712322","NIHMS116879","10.1007/s00213-008-1393-3"
"19000260","Pharmacokinetics of a controlled-release liposome-encapsulated hydromorphone administered to healthy dogs","Smith LJ, KuKanich B, Hogan BK, Brown C, Heath TD, Krugner-Higby LA.","J Vet Pharmacol Ther. 2008 Oct;31(5):415-22. doi: 10.1111/j.1365-2885.2008.00974.x.","Smith LJ","J Vet Pharmacol Ther","2008","2008/11/13","PMC4240744","NIHMS641951","10.1111/j.1365-2885.2008.00974.x"
"18996674","Intracavernous epinephrine: a minimally invasive treatment for priapism in the emergency department","Roberts JR, Price C, Mazzeo T.","J Emerg Med. 2009 Apr;36(3):285-9. doi: 10.1016/j.jemermed.2007.10.051. Epub 2008 Nov 8.","Roberts JR","J Emerg Med","2009","2008/11/11","","","10.1016/j.jemermed.2007.10.051"
"18996618","Safety and efficacy of rapid titration using 1mg doses of intravenous hydromorphone in emergency department patients with acute severe pain: the ""1+1"" protocol","Chang AK, Bijur PE, Campbell CM, Murphy MK, Gallagher EJ.","Ann Emerg Med. 2009 Aug;54(2):221-5. doi: 10.1016/j.annemergmed.2008.09.017. Epub 2008 Nov 8.","Chang AK","Ann Emerg Med","2009","2008/11/11","","","10.1016/j.annemergmed.2008.09.017"
"18977159","Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine","Wirz S, Wittmann M, Schenk M, Schroeck A, Schaefer N, Mueller M, Standop J, Kloecker N, Nadstawek J.","Eur J Pain. 2009 Aug;13(7):737-43. doi: 10.1016/j.ejpain.2008.09.005. Epub 2008 Oct 31.","Wirz S","Eur J Pain","2009","2008/11/04","","","10.1016/j.ejpain.2008.09.005"
"18936600","Parent/nurse-controlled analgesia for children with developmental delay","Czarnecki ML, Ferrise AS, Jastrowski Mano KE, Garwood MM, Sharp M, Davies H, Weisman SJ.","Clin J Pain. 2008 Nov-Dec;24(9):817-24. doi: 10.1097/AJP.0b013e3181773b69.","Czarnecki ML","Clin J Pain","2008","2008/10/22","","","10.1097/AJP.0b013e3181773b69"
"18922379","Re: relief of incident dyspnea in palliative cancer patients","Cuervo Pinna MA.","J Pain Symptom Manage. 2008 Oct;36(4):e5-6. doi: 10.1016/j.jpainsymman.2008.07.004.","Cuervo Pinna MA","J Pain Symptom Manage","2008","2008/10/17","","","10.1016/j.jpainsymman.2008.07.004"
"18906081","Klinische Versuche mit dem Kombinationspräparat Scolaudol","KONIG W.","Ther Umsch. 1947-1948;4(8):112.","KONIG W","Ther Umsch","1947","1947/01/01","","",""
"18906080","Ueber das Scolaudol","GORDONOFF T.","Ther Umsch. 1947-1948;4(8):110-2.","GORDONOFF T","Ther Umsch","1947","1947/01/01","","",""
"18840803","Palliative care intervention for choice and use of opioids in the last hours of life","Bailey FA, Ferguson L, Williams BR, Woodby LL, Redden DT, Durham RM, Goode PS, Burgio KL.","J Gerontol A Biol Sci Med Sci. 2008 Sep;63(9):974-8. doi: 10.1093/gerona/63.9.974.","Bailey FA","J Gerontol A Biol Sci Med Sci","2008","2008/10/09","","","10.1093/gerona/63.9.974"
"18837206","Edema caused by continuous epidural hydromorphone infusion: a case report and review of the literature","Ruan X, Tadia R, Liu H, Couch JP, Lee JK.","J Opioid Manag. 2008 Jul-Aug;4(4):255-9. doi: 10.5055/jom.2008.0029.","Ruan X","J Opioid Manag","2008","2008/10/08","","","10.5055/jom.2008.0029"
"18828695","Evaluation of the efficacy and safety for use of two sedation and analgesia protocols to facilitate assisted ventilation of healthy dogs","Ethier MR, Mathews KA, Valverde A, Kerr C, Bersenas AM, Nykamp SG, Davis C.","Am J Vet Res. 2008 Oct;69(10):1351-9. doi: 10.2460/ajvr.69.10.1351.","Ethier MR","Am J Vet Res","2008","2008/10/03","","","10.2460/ajvr.69.10.1351"
"18825546","Transdermal iontophoresis of hydromorphone across hairless rat skin in vitro","Kumar MG, Lin S.","Pharm Dev Technol. 2009;14(1):106-15. doi: 10.1080/10837450802409479.","Kumar MG","Pharm Dev Technol","2009","2008/10/01","","","10.1080/10837450802409479"
"18819731","[Excessive sweating related to hydromorphone]","Vinit J, Devilliers H, Audia S, Leguy V, Mura H, Falvo N, Berthier S, Besancenot JF, Bonnotte B, Lorcerie B.","Rev Med Interne. 2009 Feb;30(2):190-1. doi: 10.1016/j.revmed.2008.05.009. Epub 2008 Sep 25.","Vinit J","Rev Med Interne","2009","2008/09/30","","","10.1016/j.revmed.2008.05.009"
"18806056","The side effects of morphine and hydromorphone patient-controlled analgesia","Hong D, Flood P, Diaz G.","Anesth Analg. 2008 Oct;107(4):1384-9. doi: 10.1213/ane.0b013e3181823efb.","Hong D","Anesth Analg","2008","2008/09/23","","","10.1213/ane.0b013e3181823efb"
"18789923","Hydromorphone efficacy and treatment protocol impact on tolerance and mu-opioid receptor regulation","Kumar P, Sunkaraneni S, Sirohi S, Dighe SV, Walker EA, Yoburn BC.","Eur J Pharmacol. 2008 Nov 12;597(1-3):39-45. doi: 10.1016/j.ejphar.2008.08.025. Epub 2008 Aug 30.","Kumar P","Eur J Pharmacol","2008","2008/09/16","PMC2586831","NIHMS76534","10.1016/j.ejphar.2008.08.025"
"18782959","OH: Patient given Dilaudid--told not to drive: pt. drove from hospital--nurse called police","","Nurs Law Regan Rep. 2008 Aug;49(3):3.","","Nurs Law Regan Rep","2008","2008/09/12","","",""
"18774623","The underrecognized toll of prescription opioid abuse on young children","Bailey JE, Campagna E, Dart RC; RADARS System Poison Center Investigators.","Ann Emerg Med. 2009 Apr;53(4):419-24. doi: 10.1016/j.annemergmed.2008.07.015. Epub 2008 Sep 6.","Bailey JE","Ann Emerg Med","2009","2008/09/09","","","10.1016/j.annemergmed.2008.07.015"
"18699872","Stability and compatibility of drug mixtures in an implantable infusion system","Bianchi F, Ginggen A, Tardy Y.","Anaesthesia. 2008 Sep;63(9):972-8. doi: 10.1111/j.1365-2044.2008.05516.x.","Bianchi F","Anaesthesia","2008","2008/08/14","","","10.1111/j.1365-2044.2008.05516.x"
"18696270","Unmasking of focal neurologic deficits by sedatives-a question of lack of redundancy?","Schulz-Stübner S.","Neurocrit Care. 2008;9(3):411. doi: 10.1007/s12028-008-9127-2. Epub 2008 Aug 12.","Schulz-Stübner S","Neurocrit Care","2008","2008/08/13","","","10.1007/s12028-008-9127-2"
"18686890","Dr. ordered 30 mgs Dilaudid: RN questioned order resulting in change. Case on point: Wall v. Hillside Hosp., 2008 TNCIV M2005-02529-COA-R-3 (01/31/2008) -TN","","Nurs Law Regan Rep. 2008 Jun;49(1):4.","","Nurs Law Regan Rep","2008","2008/08/09","","",""
"18676920","Femoral nerve block for diaphyseal and distal femoral fractures in the emergency department","Rogers BA, Rang S.","J Bone Joint Surg Am. 2008 Aug;90(8):1787-8; author reply 1788-9.","Rogers BA","J Bone Joint Surg Am","2008","2008/08/05","","",""
"18675572","Antinociceptive and side-effects of hydromorphone after subcutaneous administration in cats","Robertson SA, Wegner K, Lascelles BD.","J Feline Med Surg. 2009 Feb;11(2):76-81. doi: 10.1016/j.jfms.2008.05.003. Epub 2008 Aug 3.","Robertson SA","J Feline Med Surg","2009","2008/08/05","","","10.1016/j.jfms.2008.05.003"
"18638294","Pharmacokinetics and physiological effects of intravenous hydromorphone in conscious dogs","Guedes AG, Papich MG, Rude EP, Rider MA.","J Vet Pharmacol Ther. 2008 Aug;31(4):334-43. doi: 10.1111/j.1365-2885.2008.00966.x.","Guedes AG","J Vet Pharmacol Ther","2008","2008/07/22","","","10.1111/j.1365-2885.2008.00966.x"
"18635474","The effects of fentanyl-like opioids and hydromorphone on human 5-HT3A receptors","Wittmann M, Schaaf T, Peters I, Wirz S, Urban BW, Barann M.","Anesth Analg. 2008 Jul;107(1):107-12. doi: 10.1213/ane.0b013e31817342c2.","Wittmann M","Anesth Analg","2008","2008/07/19","","","10.1213/ane.0b013e31817342c2"
"18619109","Case of the month. Cauda equina syndrome","Cornine JE.","JAAPA. 2008 Jun;21(6):70. doi: 10.1097/01720610-200806000-00094.","Cornine JE","JAAPA","2008","2008/07/16","","","10.1097/01720610-200806000-00094"
"18616432","Interpreting urine drug tests: prevalence of morphine metabolism to hydromorphone in chronic pain patients treated with morphine","Wasan AD, Michna E, Janfaza D, Greenfield S, Teter CJ, Jamison RN.","Pain Med. 2008 Oct;9(7):918-23. doi: 10.1111/j.1526-4637.2007.00354.x. Epub 2007 Aug 28.","Wasan AD","Pain Med","2008","2008/07/12","","","10.1111/j.1526-4637.2007.00354.x"
"18606504","The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers","Walsh SL, Nuzzo PA, Lofwall MR, Holtman JR Jr.","Drug Alcohol Depend. 2008 Dec 1;98(3):191-202. doi: 10.1016/j.drugalcdep.2008.05.007. Epub 2008 Jul 7.","Walsh SL","Drug Alcohol Depend","2008","2008/07/09","PMC2668197","NIHMS74216","10.1016/j.drugalcdep.2008.05.007"
"18598152","Effect of orally administered tramadol alone or with an intravenously administered opioid on minimum alveolar concentration of sevoflurane in cats","Ko JC, Abbo LA, Weil AB, Johnson BM, Inoue T, Payton ME.","J Am Vet Med Assoc. 2008 Jun 15;232(12):1834-40. doi: 10.2460/javma.232.12.1834.","Ko JC","J Am Vet Med Assoc","2008","2008/07/05","","","10.2460/javma.232.12.1834"
"18538538","The use of topical opioids for systemic pain management","Turris M.","J Pain Symptom Manage. 2008 Jul;36(1):e13-4. doi: 10.1016/j.jpainsymman.2008.02.004. Epub 2008 Jun 6.","Turris M","J Pain Symptom Manage","2008","2008/06/10","","","10.1016/j.jpainsymman.2008.02.004"
"18523509","Intrathecal granuloma in a patient receiving high dose hydromorphone","Ramsey CN, Owen RD, Witt WO, Grider JS.","Pain Physician. 2008 May-Jun;11(3):369-73.","Ramsey CN","Pain Physician","2008","2008/06/05","","",""
"18515253","Equianalgesia: applying evidence-based practice guidelines","Bond BS.","Clin J Oncol Nurs. 2008 Jun;12(3):527-9. doi: 10.1188/08.CJON.527-529.","Bond BS","Clin J Oncol Nurs","2008","2008/06/03","","","10.1188/08.CJON.527-529"
"18503626","Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone)","Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.","Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.","Pergolizzi J","Pain Pract","2008","2008/05/28","","","10.1111/j.1533-2500.2008.00204.x"
"18483817","[Differential therapeutic aspects of analgesia with oral sustained-release strong opioids: application intervals, metabolism and immunosuppression]","Güttler K, Sabatowski R.","Schmerz. 2008 Oct;22(5):562, 564-8, 570. doi: 10.1007/s00482-008-0657-5.","Güttler K","Schmerz","2008","2008/05/17","","","10.1007/s00482-008-0657-5"
"18482427","Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)","Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH.","Addiction. 2008 Jun;103(6):1048-50. doi: 10.1111/j.1360-0443.2008.02209.x.","Boyer EW","Addiction","2008","2008/05/17","PMC3670991","NIHMS51959","10.1111/j.1360-0443.2008.02209.x"
"18471228","The detection of hydromorphone in urine specimens with high morphine concentrations","McDonough PC, Levine B, Vorce S, Jufer RA, Fowler D.","J Forensic Sci. 2008 May;53(3):752-4. doi: 10.1111/j.1556-4029.2008.00730.x.","McDonough PC","J Forensic Sci","2008","2008/05/13","","","10.1111/j.1556-4029.2008.00730.x"
"18454609","A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain","Watanabe S, Pereira J, Tarumi Y, Hanson J, Bruera E.","J Palliat Med. 2008 May;11(4):570-4. doi: 10.1089/jpm.2007.0176.","Watanabe S","J Palliat Med","2008","2008/05/06","","","10.1089/jpm.2007.0176"
"18447788","Cardiopulmonary effects of anesthetic induction with thiopental, propofol, or a combination of ketamine hydrochloride and diazepam in dogs sedated with a combination of medetomidine and hydromorphone","Enouri SS, Kerr CL, McDonell WN, Dyson DH.","Am J Vet Res. 2008 May;69(5):586-95. doi: 10.2460/ajvr.69.5.586.","Enouri SS","Am J Vet Res","2008","2008/05/02","","","10.2460/ajvr.69.5.586"
"18430301","Evidence that morphine is metabolized to hydromorphone but not to oxymorphone","Cone EJ, Caplan YH, Moser F, Robert T, Black D.","J Anal Toxicol. 2008 May;32(4):319-23. doi: 10.1093/jat/32.4.319.","Cone EJ","J Anal Toxicol","2008","2008/04/24","","","10.1093/jat/32.4.319"
"18380946","Conversion from standard opioid therapy to once-daily oral extended-release hydromorphone in patients with chronic cancer pain","Wallace M, Rauck RL, Moulin D, Thipphawong J, Khanna S, Tudor IC.","J Int Med Res. 2008 Mar-Apr;36(2):343-52. doi: 10.1177/147323000803600218.","Wallace M","J Int Med Res","2008","2008/04/03","","","10.1177/147323000803600218"
"18372384","Opioid withdrawal syndrome on switching from hydromorphone to alfentanil","McMunnigall F, Welsh J.","Palliat Med. 2008 Mar;22(2):191-2. doi: 10.1177/0269216307085391.","McMunnigall F","Palliat Med","2008","2008/03/29","","","10.1177/0269216307085391"
"18363580","Comparison of the analgesic efficacy of hydromorphone and oxymorphone in dogs and cats: a randomized blinded study","Bateman SW, Haldane S, Stephens JA.","Vet Anaesth Analg. 2008 Jul;35(4):341-7. doi: 10.1111/j.1467-2995.2007.00387.x. Epub 2008 Mar 19.","Bateman SW","Vet Anaesth Analg","2008","2008/03/28","","","10.1111/j.1467-2995.2007.00387.x"
"18358689","Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline","Charles MA, Reymond L, Israel F.","J Pain Symptom Manage. 2008 Jul;36(1):29-38. doi: 10.1016/j.jpainsymman.2007.08.016. Epub 2008 Mar 20.","Charles MA","J Pain Symptom Manage","2008","2008/03/25","","","10.1016/j.jpainsymman.2007.08.016"
"18339171","Spontaneously breathing technique for opioid tolerance","Eipe N, Kay J.","Acta Anaesthesiol Scand. 2008 Apr;52(4):575-6. doi: 10.1111/j.1399-6576.2007.01556.x.","Eipe N","Acta Anaesthesiol Scand","2008","2008/03/15","","","10.1111/j.1399-6576.2007.01556.x"
"18327673","Opioid detoxification via single 7-day application of a buprenorphine transdermal patch: an open-label evaluation","Lanier RK, Umbricht A, Harrison JA, Nuwayser ES, Bigelow GE.","Psychopharmacology (Berl). 2008 Jun;198(2):149-58. doi: 10.1007/s00213-008-1105-z. Epub 2008 Mar 9.","Lanier RK","Psychopharmacology (Berl)","2008","2008/03/11","","","10.1007/s00213-008-1105-z"
"18299094","Perioperative interscalene block versus intra-articular injection of local anesthetics for postoperative analgesia in shoulder surgery","Beaudet V, Williams SR, Tétreault P, Perrault MA.","Reg Anesth Pain Med. 2008 Mar-Apr;33(2):134-8. doi: 10.1016/j.rapm.2007.10.005.","Beaudet V","Reg Anesth Pain Med","2008","2008/02/27","","","10.1016/j.rapm.2007.10.005"
"18296064","A novel approach to evaluate the extent and the effect of cross-contribution to the intensity of ions designating the analyte and the internal standard in quantitative GC-MS analysis","Chen BG, Chang CD, Wang CT, Chen YJ, Chang WT, Wang SM, Liu RH.","J Am Soc Mass Spectrom. 2008 Apr;19(4):598-608. doi: 10.1016/j.jasms.2008.01.004. Epub 2008 Jan 31.","Chen BG","J Am Soc Mass Spectrom","2008","2008/02/26","","","10.1016/j.jasms.2008.01.004"
"18286984","Hydromorphone: handle with care","Borg E.","Can Nurse. 2008 Jan;104(1):35.","Borg E","Can Nurse","2008","2008/02/22","","",""
"18282253","Pharmacokinetics of hydromorphone hydrochloride in healthy dogs","KuKanich B, Hogan BK, Krugner-Higby LA, Smith LJ.","Vet Anaesth Analg. 2008 May;35(3):256-64. doi: 10.1111/j.1467-2995.2007.00379.x. Epub 2008 Feb 18.","KuKanich B","Vet Anaesth Analg","2008","2008/02/20","","","10.1111/j.1467-2995.2007.00379.x"
"18261371","Hydromorphone in the management of cancer-related pain: an update on routes of administration and dosage forms","Kumar MG, Lin S.","J Pharm Pharm Sci. 2007;10(4):504-18. doi: 10.18433/j3vc75.","Kumar MG","J Pharm Pharm Sci","2007","2008/02/12","","","10.18433/j3vc75"
"18146394","Verwendung des Scolaudol (Knoll) in der Ophthalmologie","STEIGER M.","Schweiz Med Wochenschr. 1949 Jun 4;79(22):495-7.","STEIGER M","Schweiz Med Wochenschr","1949","1949/06/04","","",""
"18132012","Die Verwendung von Scolaudol bei chirurgischen Eingriffen in Lokalanästhesie","STUCKI N.","Ther Umsch. 1949 May;6(2):20.","STUCKI N","Ther Umsch","1949","1949/05/01","","",""
"18124793","Effects of morphine, codeine, and dilaudid on blood flow","HUGGINS RA, HANDLEY CA, LA FORGE M.","J Pharmacol Exp Ther. 1949 Mar;95(3):318-21.","HUGGINS RA","J Pharmacol Exp Ther","1949","1949/03/01","","",""
"18124284","Use of methadone to combat withdrawal symptoms of dilaudid addiction; case report","POWERS BR.","J Tn State Med Assoc. 1949 Mar;42(3):83.","POWERS BR","J Tn State Med Assoc","1949","1949/03/01","","",""
"18095008","Less nausea, emesis, and constipation comparing hydromorphone and morphine? A prospective open-labeled investigation on cancer pain","Wirz S, Wartenberg HC, Nadstawek J.","Support Care Cancer. 2008 Sep;16(9):999-1009. doi: 10.1007/s00520-007-0368-y. Epub 2007 Dec 20.","Wirz S","Support Care Cancer","2008","2007/12/21","","","10.1007/s00520-007-0368-y"
"18093069","An estimate of the proportion of drug-facilitation of sexual assault in four U.S. localities","Juhascik MP, Negrusz A, Faugno D, Ledray L, Greene P, Lindner A, Haner B, Gaensslen RE.","J Forensic Sci. 2007 Nov;52(6):1396-400. doi: 10.1111/j.1556-4029.2007.00583.x.","Juhascik MP","J Forensic Sci","2007","2007/12/21","","","10.1111/j.1556-4029.2007.00583.x"
"18090443","Persistent hiccup associated with intrathecal morphine infusion pump therapy","Ruan X, Couch JP, Shah R, Wang F, Liu HN.","Am J Phys Med Rehabil. 2007 Dec;86(12):1019-22. doi: 10.1097/PHM.0b013e31815206c8.","Ruan X","Am J Phys Med Rehabil","2007","2007/12/20","","","10.1097/PHM.0b013e31815206c8"
"18080807","Amplification of acute focal ischemic deficit by narcotics","Dubow J, Bernstein RA.","Neurocrit Care. 2008;8(3):427-9. doi: 10.1007/s12028-007-9023-1.","Dubow J","Neurocrit Care","2008","2007/12/18","","","10.1007/s12028-007-9023-1"
"18077748","Multiple opioids in pain management","Gallagher R.","Can Fam Physician. 2007 Dec;53(12):2119-20.","Gallagher R","Can Fam Physician","2007","2007/12/14","PMC2231548","",""
"18062845","Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence of alcohol","Sathyan G, Sivakumar K, Thipphawong J.","Curr Med Res Opin. 2008 Jan;24(1):297-305. doi: 10.1185/030079908x253861.","Sathyan G","Curr Med Res Opin","2008","2007/12/08","","","10.1185/030079908x253861"
"18056490","Femoral nerve block for diaphyseal and distal femoral fractures in the emergency department","Mutty CE, Jensen EJ, Manka MA Jr, Anders MJ, Bone LB.","J Bone Joint Surg Am. 2007 Dec;89(12):2599-603. doi: 10.2106/JBJS.G.00413.","Mutty CE","J Bone Joint Surg Am","2007","2007/12/07","","","10.2106/JBJS.G.00413"
"18049062","How to try this: detecting delirium","Waszynski CM.","Am J Nurs. 2007 Dec;107(12):50-9; quiz 59-60. doi: 10.1097/01.NAJ.0000301029.87489.35.","Waszynski CM","Am J Nurs","2007","2007/12/01","","","10.1097/01.NAJ.0000301029.87489.35"
"18032351","Correlates of nonmedical use of hydromorphone and hydrocodone:results from a national household survey","Smith MY, Haddox JD, Di Marino ME.","J Pain Palliat Care Pharmacother. 2007;21(3):5-17.","Smith MY","J Pain Palliat Care Pharmacother","2007","2007/11/23","","",""
"17991219","Comparison of plasma histamine levels after intravenous administration of hydromorphone and morphine in dogs","Guedes AG, Papich MG, Rude EP, Rider MA.","J Vet Pharmacol Ther. 2007 Dec;30(6):516-22. doi: 10.1111/j.1365-2885.2007.00911.x.","Guedes AG","J Vet Pharmacol Ther","2007","2007/11/10","","","10.1111/j.1365-2885.2007.00911.x"
"17981511","Metoclopramide versus hydromorphone for the emergency department treatment of migraine headache","Griffith JD, Mycyk MB, Kyriacou DN.","J Pain. 2008 Jan;9(1):88-94. doi: 10.1016/j.jpain.2007.09.001. Epub 2007 Nov 5.","Griffith JD","J Pain","2008","2007/11/06","","","10.1016/j.jpain.2007.09.001"
"17980179","Randomized trial comparing 3 methods of postoperative analgesia in gynecology patients: patient-controlled intravenous, scheduled intravenous, and scheduled subcutaneous","Bell JG, Shaffer LE, Schrickel-Feller T.","Am J Obstet Gynecol. 2007 Nov;197(5):472.e1-7. doi: 10.1016/j.ajog.2007.03.039.","Bell JG","Am J Obstet Gynecol","2007","2007/11/06","","","10.1016/j.ajog.2007.03.039"
"17955789","[Pharmacotherapy of chronic, non-tumour related pain. Efficacy, tolerability and patient benefit of an oral osmotic system with hydromorphone]","Sabatowski R, Giesecke T.","MMW Fortschr Med. 2007 Sep 13;149 Suppl 3:119-24.","Sabatowski R","MMW Fortschr Med","2007","2007/10/25","","",""
"17949924","Behavioral economic analysis of drug preference using multiple choice procedure data","Greenwald MK.","Drug Alcohol Depend. 2008 Jan 11;93(1-2):103-10. doi: 10.1016/j.drugalcdep.2007.09.002. Epub 2007 Oct 18.","Greenwald MK","Drug Alcohol Depend","2008","2007/10/24","PMC2248460","NIHMS38503","10.1016/j.drugalcdep.2007.09.002"
"17933616","The management of pain in children with life-limiting illnesses","Friedrichsdorf SJ, Kang TI.","Pediatr Clin North Am. 2007 Oct;54(5):645-72, x. doi: 10.1016/j.pcl.2007.07.007.","Friedrichsdorf SJ","Pediatr Clin North Am","2007","2007/10/16","","","10.1016/j.pcl.2007.07.007"
"17929063","Effect of hydromorphone on ventilation in palliative care patients with dyspnea","Clemens KE, Klaschik E.","Support Care Cancer. 2008 Jan;16(1):93-9. doi: 10.1007/s00520-007-0310-3. Epub 2007 Oct 11.","Clemens KE","Support Care Cancer","2008","2007/10/12","","","10.1007/s00520-007-0310-3"
"17893580","Awareness during general anesthesia: analysis of contributing causes aided by automatic data capture","Driscoll WD, Columbia MA, Peterfreund RA.","J Neurosurg Anesthesiol. 2007 Oct;19(4):268-72. doi: 10.1097/ANA.0b013e318139f7df.","Driscoll WD","J Neurosurg Anesthesiol","2007","2007/09/26","","","10.1097/ANA.0b013e318139f7df"
"17877652","Once-daily OROS hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study","Wallace M, Rauck RL, Moulin D, Thipphawong J, Khanna S, Tudor IC.","Int J Clin Pract. 2007 Oct;61(10):1671-6. doi: 10.1111/j.1742-1241.2007.01500.x.","Wallace M","Int J Clin Pract","2007","2007/09/20","PMC2040191","","10.1111/j.1742-1241.2007.01500.x"
"17853348","[Symptomatic treatment of dyspnoea in patients receiving palliative care: nasal delivery of oxygen compared with opioid administration]","Clemens KE, Klaschik E.","Dtsch Med Wochenschr. 2007 Sep;132(38):1939-43. doi: 10.1055/s-2007-985621.","Clemens KE","Dtsch Med Wochenschr","2007","2007/09/14","","","10.1055/s-2007-985621"
"17716326","Placement of an implantable drug delivery system under the breast","Compoginis JM, Richeimer SH, Brody GS.","Pain Med. 2007 Sep;8(6):521-4. doi: 10.1111/j.1526-4637.2006.00286.x.","Compoginis JM","Pain Med","2007","2007/08/25","","","10.1111/j.1526-4637.2006.00286.x"
"17697906","Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis","Hale M, Tudor IC, Khanna S, Thipphawong J.","Clin Ther. 2007 May;29(5):874-888. doi: 10.1016/j.clinthera.2007.05.016.","Hale M","Clin Ther","2007","2007/08/19","","","10.1016/j.clinthera.2007.05.016"
"17697453","Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone","Ward A, Bozkaya D, Fleischmann J, Dubois D, Sabatowski R, Caro JJ.","Curr Med Res Opin. 2007 Oct;23(10):2333-45. doi: 10.1185/030079907X219643.","Ward A","Curr Med Res Opin","2007","2007/08/19","","","10.1185/030079907X219643"
"17697450","Mapping MOS Sleep Scale scores to SF-6D utility index","Yang M, Dubois D, Kosinski M, Sun X, Gajria K.","Curr Med Res Opin. 2007 Sep;23(9):2269-82. doi: 10.1185/030079907X210796.","Yang M","Curr Med Res Opin","2007","2007/08/19","","","10.1185/030079907X210796"
"17667220","Use of hydromorphone (Dilaudid) and morphine for patients with hepatic and renal impairment","Razaq M, Balicas M, Mankan N.","Am J Ther. 2007 Jul-Aug;14(4):414-6. doi: 10.1097/01.pap.0000249926.89087.d8.","Razaq M","Am J Ther","2007","2007/08/02","","","10.1097/01.pap.0000249926.89087.d8"
"17643287","Strategies to induce labor analgesia with epidural hydromorphone","Mhyre JM.","Int J Obstet Anesth. 2008 Jan;17(1):81-2. doi: 10.1016/j.ijoa.2007.03.005. Epub 2007 Jul 20.","Mhyre JM","Int J Obstet Anesth","2008","2007/07/24","","","10.1016/j.ijoa.2007.03.005"
"17591317","Use of naloxone in hydromorphone-induced anaphylactoid reaction","Mushlin N, Vahid B, Roberts R.","South Med J. 2007 Jun;100(6):611. doi: 10.1097/SMJ.0b013e318030ef88.","Mushlin N","South Med J","2007","2007/06/27","","","10.1097/SMJ.0b013e318030ef88"
"17573279","Opioid safety: is your patient at risk for respiratory depression?","Smith LH.","Clin J Oncol Nurs. 2007 Apr;11(2):293-6. doi: 10.1188/07.CJON.293-296.","Smith LH","Clin J Oncol Nurs","2007","2007/06/19","","","10.1188/07.CJON.293-296"
"17525787","Topical lidocaine and epidural bupivacaine/hydromorphone in the treatment of complex regional pain syndrome type 2","Vorobeychik Y, Giampetro DM.","Pain Physician. 2007 May;10(3):513-4.","Vorobeychik Y","Pain Physician","2007","2007/05/26","","",""
"17520987","Urine drug test interpretation: what do physicians know?","Reisfield GM, Bertholf R, Barkin RL, Webb F, Wilson G.","J Opioid Manag. 2007 Mar-Apr;3(2):80-6. doi: 10.5055/jom.2007.0044.","Reisfield GM","J Opioid Manag","2007","2007/05/25","","","10.5055/jom.2007.0044"
"17519302","Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study","Clemens KE, Klaschik E.","Jpn J Clin Oncol. 2007 Apr;37(4):302-9. doi: 10.1093/jjco/hym017. Epub 2007 May 22.","Clemens KE","Jpn J Clin Oncol","2007","2007/05/24","","","10.1093/jjco/hym017"
"17519065","Efficacy and safety evaluation of once-daily OROS hydromorphone in patients with chronic low back pain: a pilot open-label study (DO-127)","Wallace M, Skowronski R, Khanna S, Tudor IC, Thipphawong J.","Curr Med Res Opin. 2007 May;23(5):981-9. doi: 10.1185/030079907x182040.","Wallace M","Curr Med Res Opin","2007","2007/05/24","","","10.1185/030079907x182040"
"17513626","A comparison of single-dose caudal clonidine, morphine, or hydromorphone combined with ropivacaine in pediatric patients undergoing ureteral reimplantation","Vetter TR, Carvallo D, Johnson JL, Mazurek MS, Presson RG Jr.","Anesth Analg. 2007 Jun;104(6):1356-63, table of contents. doi: 10.1213/01.ane.0000261521.52562.de.","Vetter TR","Anesth Analg","2007","2007/05/22","","","10.1213/01.ane.0000261521.52562.de"
"17389078","Simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, oxycodone, and 6-acetylmorphine in urine, serum, plasma, whole blood, and meconium by LC-MS-MS","Coles R, Kushnir MM, Nelson GJ, McMillin GA, Urry FM.","J Anal Toxicol. 2007 Jan-Feb;31(1):1-14. doi: 10.1093/jat/31.1.1.","Coles R","J Anal Toxicol","2007","2007/03/29","","","10.1093/jat/31.1.1"
"17381039","Issues in medical malpractice VII","Tan SY.","Hawaii Med J. 2007 Jan;66(1):20-1.","Tan SY","Hawaii Med J","2007","2007/03/27","","",""
"17371484","Secondary adrenal failure and secondary amenorrhoea following hydromorphone treatment","Müssig K, Knaus-Dittmann D, Schmidt H, Mörike K, Häring HU.","Clin Endocrinol (Oxf). 2007 Apr;66(4):604-5. doi: 10.1111/j.1365-2265.2007.02779.x.","Müssig K","Clin Endocrinol (Oxf)","2007","2007/03/21","","","10.1111/j.1365-2265.2007.02779.x"
"17319255","Pump tampering possible by patients in opioid administration","","J Opioid Manag. 2005 May-Jun;1(2):109. doi: 10.5055/jom.2005.0024.","","J Opioid Manag","2005","2007/02/27","","","10.5055/jom.2005.0024"
"17316394","Dose-related thermal antinociceptive effects of intravenous hydromorphone in cats","Wegner K, Robertson SA.","Vet Anaesth Analg. 2007 Mar;34(2):132-8. doi: 10.1111/j.1467-2995.2006.00311.x.","Wegner K","Vet Anaesth Analg","2007","2007/02/24","","","10.1111/j.1467-2995.2006.00311.x"
"17316389","The effects of surgery and anesthesia on blood magnesium and calcium concentrations in canine and feline patients","Brainard BM, Campbell VL, Drobatz KJ, Perkowski SZ.","Vet Anaesth Analg. 2007 Mar;34(2):89-98. doi: 10.1111/j.1467-2995.2006.00300.x.","Brainard BM","Vet Anaesth Analg","2007","2007/02/24","","","10.1111/j.1467-2995.2006.00300.x"
"17315417","The metamorphosis of hydromorphone","Reisfield GM, Wilson GR.","J Opioid Manag. 2005 Jul-Aug;1(3):139-45. doi: 10.5055/jom.2005.0033.","Reisfield GM","J Opioid Manag","2005","2007/02/24","","","10.5055/jom.2005.0033"
"17310258","Successful reduction of neuropathic pain associated with spinal cord injury via of a combination of intrathecal hydromorphone and ziconotide: a case report","Saulino M.","Spinal Cord. 2007 Nov;45(11):749-52. doi: 10.1038/sj.sc.3102027. Epub 2007 Feb 20.","Saulino M","Spinal Cord","2007","2007/02/21","","","10.1038/sj.sc.3102027"
"17270058","Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphone","Sathyan G, Xu E, Thipphawong J, Gupta SK.","BMC Clin Pharmacol. 2007 Feb 2;7:3. doi: 10.1186/1472-6904-7-3.","Sathyan G","BMC Clin Pharmacol","2007","2007/02/03","PMC1808051","","10.1186/1472-6904-7-3"
"17270055","Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence and absence of food","Sathyan G, Xu E, Thipphawong J, Gupta SK.","BMC Clin Pharmacol. 2007 Feb 2;7:2. doi: 10.1186/1472-6904-7-2.","Sathyan G","BMC Clin Pharmacol","2007","2007/02/03","PMC1810515","","10.1186/1472-6904-7-2"
"17264726","Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics","Martin TJ, Kim SA, Buechler NL, Porreca F, Eisenach JC.","Anesthesiology. 2007 Feb;106(2):312-22. doi: 10.1097/00000542-200702000-00020.","Martin TJ","Anesthesiology","2007","2007/02/01","","","10.1097/00000542-200702000-00020"
"17238961","Post-anesthetic hyperthermia in cats","Posner LP, Gleed RD, Erb HN, Ludders JW.","Vet Anaesth Analg. 2007 Jan;34(1):40-7. doi: 10.1111/j.1467-2995.2006.00287.x.","Posner LP","Vet Anaesth Analg","2007","2007/01/24","","","10.1111/j.1467-2995.2006.00287.x"
"17219779","A single dose of liposome-encapsulated hydromorphone provides extended analgesia in a rat model of neuropathic pain","Smith LJ, Valenzuela JR, Krugner-Higby LA, Brown C, Heath TD.","Comp Med. 2006 Dec;56(6):487-92.","Smith LJ","Comp Med","2006","2007/01/16","","",""
"17182514","Equianalgesic dosing of opioids","Berdine HJ, Nesbit SA.","J Pain Palliat Care Pharmacother. 2006;20(4):79-84.","Berdine HJ","J Pain Palliat Care Pharmacother","2006","2006/12/22","","",""
"17094451","Induction of non-apoptotic cell death by morphinone in human promyelocytic leukemia HL-60 cells","Takeuchi R, Hoshijima H, Nagasaka H, Chowdhury SA, Kikuchi H, Kanda Y, Kunii S, Kawase M, Sakagami H.","Anticancer Res. 2006 Sep-Oct;26(5A):3343-8.","Takeuchi R","Anticancer Res","2006","2006/11/11","","",""
"17083610","Postanesthetic hyperthermia in cats: a retrospective comparison between hydromorphone and buprenorphine","Niedfeldt RL, Robertson SA.","Vet Anaesth Analg. 2006 Nov;33(6):381-9. doi: 10.1111/j.1467-2995.2005.00275.x.","Niedfeldt RL","Vet Anaesth Analg","2006","2006/11/07","","","10.1111/j.1467-2995.2005.00275.x"
"17057558","Managing cancer pain and symptoms of outpatients by rotation to sustained-release hydromorphone: a prospective clinical trial","Wirz S, Wartenberg HC, Elsen C, Wittmann M, Diederichs M, Nadstawek J.","Clin J Pain. 2006 Nov-Dec;22(9):770-5. doi: 10.1097/01.ajp.0000210925.33783.4d.","Wirz S","Clin J Pain","2006","2006/10/24","","","10.1097/01.ajp.0000210925.33783.4d"
"17047136","A myoclonic reaction with low-dose hydromorphone","Patel S, Roshan VR, Lee KC, Cheung RJ.","Ann Pharmacother. 2006 Nov;40(11):2068-70. doi: 10.1345/aph.1H243. Epub 2006 Oct 17.","Patel S","Ann Pharmacother","2006","2006/10/19","","","10.1345/aph.1H243"
"17013637","Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period","Correia CJ, Walsh SL, Bigelow GE, Strain EC.","Psychopharmacology (Berl). 2006 Dec;189(3):297-306. doi: 10.1007/s00213-006-0571-4. Epub 2006 Sep 30.","Correia CJ","Psychopharmacology (Berl)","2006","2006/10/03","","","10.1007/s00213-006-0571-4"
"16950210","Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices","Greenwald M, Johanson CE, Bueller J, Chang Y, Moody DE, Kilbourn M, Koeppe R, Zubieta JK.","Biol Psychiatry. 2007 Jan 1;61(1):101-10. doi: 10.1016/j.biopsych.2006.04.043. Epub 2006 Sep 1.","Greenwald M","Biol Psychiatry","2007","2006/09/05","","","10.1016/j.biopsych.2006.04.043"
"16905085","Post-dural headache associated with thoracic paravertebral blocks","Lin HM, Chelly JE.","J Clin Anesth. 2006 Aug;18(5):376-8. doi: 10.1016/j.jclinane.2005.12.013.","Lin HM","J Clin Anesth","2006","2006/08/15","","","10.1016/j.jclinane.2005.12.013"
"16872564","Disposition of hydrocodone in hair","Moore C, Feldman M, Harrison E, Rana S, Coulter C, Kuntz D, Agrawal A, Vincent M, Soares J.","J Anal Toxicol. 2006 Jul-Aug;30(6):353-9. doi: 10.1093/jat/30.6.353.","Moore C","J Anal Toxicol","2006","2006/07/29","","","10.1093/jat/30.6.353"
"16857467","Safety and efficacy of hydromorphone as an analgesic alternative to morphine in acute pain: a randomized clinical trial","Chang AK, Bijur PE, Meyer RH, Kenny MK, Solorzano C, Gallagher EJ.","Ann Emerg Med. 2006 Aug;48(2):164-72. doi: 10.1016/j.annemergmed.2006.03.005. Epub 2006 Apr 27.","Chang AK","Ann Emerg Med","2006","2006/07/22","","","10.1016/j.annemergmed.2006.03.005"
"16844959","Myoclonus as an acute complication of low-dose hydromorphone in multiple system atrophy","Hofmann A, Tangri N, Lafontaine AL, Postuma RB.","J Neurol Neurosurg Psychiatry. 2006 Aug;77(8):994-5. doi: 10.1136/jnnp.2005.076588.","Hofmann A","J Neurol Neurosurg Psychiatry","2006","2006/07/18","PMC2077632","","10.1136/jnnp.2005.076588"
"16815169","Continuous hydromorphone infusion for opioid intolerance","Tcheurekdjian H, Gundling K.","J Allergy Clin Immunol. 2006 Jul;118(1):282-4. doi: 10.1016/j.jaci.2006.03.026. Epub 2006 May 11.","Tcheurekdjian H","J Allergy Clin Immunol","2006","2006/07/04","","","10.1016/j.jaci.2006.03.026"
"16803655","Hydromorphone-related fatalities in ontario","Wallage HR, Palmentier JP.","J Anal Toxicol. 2006 Apr;30(3):202-9. doi: 10.1093/jat/30.3.202.","Wallage HR","J Anal Toxicol","2006","2006/06/29","","","10.1093/jat/30.3.202"
"16797428","Anesthesia and pain management for pediatric patients with dystrophic epidermolysis bullosa","Lin YC, Golianu B.","J Clin Anesth. 2006 Jun;18(4):268-71. doi: 10.1016/j.jclinane.2005.11.004.","Lin YC","J Clin Anesth","2006","2006/06/27","","","10.1016/j.jclinane.2005.11.004"
"16790677","Intrathecal therapy-associated masses","Meta G, Ghaleb A, Gentry WB, Firnhaber J.","Anesth Analg. 2006 Jul;103(1):260-1. doi: 10.1213/01.ANE.0000215231.36309.09.","Meta G","Anesth Analg","2006","2006/06/23","","","10.1213/01.ANE.0000215231.36309.09"
"16756415","Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans","Carroll CP, Walsh SL, Bigelow GE, Strain EC, Preston KL.","Exp Clin Psychopharmacol. 2006 May;14(2):109-20. doi: 10.1037/1064-1297.14.2.109.","Carroll CP","Exp Clin Psychopharmacol","2006","2006/06/08","","","10.1037/1064-1297.14.2.109"
"16736708","[Delayed action and rapidly effective in combination. Hydromorphone--already a WHO stage 3 drug]","","MMW Fortschr Med. 2006 May 11;148(19):47.","","MMW Fortschr Med","2006","2006/06/02","","",""
"16718649","Capillary electrophoresis contributions to the hydromorphone metabolism in man","Baldacci A, Thormann W.","Electrophoresis. 2006 Jun;27(12):2444-57. doi: 10.1002/elps.200500867.","Baldacci A","Electrophoresis","2006","2006/05/24","","","10.1002/elps.200500867"
"16620524","Evidence of morphine metabolism to hydromorphone in pain patients chronically treated with morphine","Cone EJ, Heit HA, Caplan YH, Gourlay D.","J Anal Toxicol. 2006 Jan-Feb;30(1):1-5. doi: 10.1093/jat/30.1.1.","Cone EJ","J Anal Toxicol","2006","2006/04/20","","","10.1093/jat/30.1.1"
"16616994","Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of unit price and pre-session drug supply","Greenwald MK, Hursh SR.","Drug Alcohol Depend. 2006 Oct 15;85(1):35-48. doi: 10.1016/j.drugalcdep.2006.03.007. Epub 2006 Apr 17.","Greenwald MK","Drug Alcohol Depend","2006","2006/04/18","","","10.1016/j.drugalcdep.2006.03.007"
"16533191","Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study","Du Pen S, Du Pen A, Hillyer J.","Pain Med. 2006 Jan-Feb;7(1):10-5. doi: 10.1111/j.1526-4637.2006.00083.x.","Du Pen S","Pain Med","2006","2006/03/15","","","10.1111/j.1526-4637.2006.00083.x"
"16524188","[Determination of opiates in biological human samples by liquid chromatography-tandem mass spectrometry]","Xiang P, Shen M, Shen BH, Ma D, Bu J, Jiang Y, Zhuo XY.","Fa Yi Xue Za Zhi. 2006 Feb;22(1):52-4, 57.","Xiang P","Fa Yi Xue Za Zhi","2006","2006/03/10","","",""
"16515252","[An error causes a crisis]","","Krankenpfl J. 2005;43(7-10):175.","","Krankenpfl J","2005","2006/03/07","","",""
"16490582","Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain","Weinstein SM, Shi M, Buckley BJ, Kwarcinski MA.","Clin Ther. 2006 Jan;28(1):86-98. doi: 10.1016/j.clinthera.2006.01.010.","Weinstein SM","Clin Ther","2006","2006/02/24","","","10.1016/j.clinthera.2006.01.010"
"16446485","Controlled-release opioids and alcohol","Darke AC.","CMAJ. 2006 Jan 31;174(3):352. doi: 10.1503/cmaj.1050210.","Darke AC","CMAJ","2006","2006/02/01","PMC1373723","","10.1503/cmaj.1050210"
"16426205","Analgesic effects of epidural administration of hydromorphone in horses","Natalini CC, Linardi RL.","Am J Vet Res. 2006 Jan;67(1):11-5. doi: 10.2460/ajvr.67.1.11.","Natalini CC","Am J Vet Res","2006","2006/01/24","","","10.2460/ajvr.67.1.11"
"16419284","FDA asks Purdue Pharma to withdraw Palladone","","FDA Consum. 2005 Sep-Oct;39(5):7.","","FDA Consum","2005","2006/01/20","","",""
"16412134","Effects of oxymorphone and hydromorphone on the minimum alveolar concentration of isoflurane in dogs","Machado CE, Dyson DH, Grant Maxie M.","Vet Anaesth Analg. 2006 Jan;33(1):70-7. doi: 10.1111/j.1467-2995.2005.00215.x.","Machado CE","Vet Anaesth Analg","2006","2006/01/18","","","10.1111/j.1467-2995.2005.00215.x"
"16350425","Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices","Stearns L, Boortz-Marx R, Du Pen S, Friehs G, Gordon M, Halyard M, Herbst L, Kiser J.","J Support Oncol. 2005 Nov-Dec;3(6):399-408.","Stearns L","J Support Oncol","2005","2005/12/15","","",""
"16330640","Advertisement woes","Rashiq S.","CMAJ. 2005 Dec 6;173(12):1485. doi: 10.1503/cmaj.1050130.","Rashiq S","CMAJ","2005","2005/12/07","PMC1316165","","10.1503/cmaj.1050130"
"16330639","Advertisement woes","Chepesiuk R.","CMAJ. 2005 Dec 6;173(12):1485. doi: 10.1503/cmaj.1050239.","Chepesiuk R","CMAJ","2005","2005/12/07","PMC1316166","","10.1503/cmaj.1050239"
"16330638","Advertisement woes","Vautour G.","CMAJ. 2005 Dec 6;173(12):1485-6. doi: 10.1503/cmaj.1050240.","Vautour G","CMAJ","2005","2005/12/07","PMC1316167","","10.1503/cmaj.1050240"
"16308048","Look-alike and sound-alike drugs: errors just waiting to happen","Tuohy N, Paparella S.","J Emerg Nurs. 2005 Dec;31(6):569-71. doi: 10.1016/j.jen.2005.07.012.","Tuohy N","J Emerg Nurs","2005","2005/11/26","","","10.1016/j.jen.2005.07.012"
"16305370","Pain control via opioid analgesic-local anesthetic loaded IPNs","Keskin DS, Wise DL, Hasirci V.","Curr Drug Deliv. 2004 Jan;1(1):57-64. doi: 10.2174/1567201043480081.","Keskin DS","Curr Drug Deliv","2004","2005/11/25","","","10.2174/1567201043480081"
"16284583","A prospective, randomized, double-blind study evaluating the efficacy of postoperative continuous local anesthetic infusion at the iliac crest bone graft site after spinal arthrodesis","Singh K, Samartzis D, Strom J, Manning D, Campbell-Hupp M, Wetzel FT, Gupta P, Phillips FM.","Spine (Phila Pa 1976). 2005 Nov 15;30(22):2477-83. doi: 10.1097/01.brs.0000186323.11285.b1.","Singh K","Spine (Phila Pa 1976)","2005","2005/11/15","","","10.1097/01.brs.0000186323.11285.b1"
"16261943","[Controlled-release hydromorphone in elderly patients with severe pain of different etiologies. Results of an observational study]","Junker U, Figge V.","MMW Fortschr Med. 2005 Oct 6;147 Suppl 3:91-6.","Junker U","MMW Fortschr Med","2005","2005/11/03","","",""
"16238568","Protracted pain following partial splenic embolization in an adolescent female with hypersplenism","Ganesh A, Rose JB, Maxwell LG.","Paediatr Anaesth. 2005 Nov;15(11):1013-5. doi: 10.1111/j.1460-9592.2005.01575.x.","Ganesh A","Paediatr Anaesth","2005","2005/10/22","","","10.1111/j.1460-9592.2005.01575.x"
"16235476","Postoperative pain management following bilateral lung volume reduction surgery for severe emphysema","Hooten WM, Karanikolas M, Swarm R, Huntoon MA.","Anaesth Intensive Care. 2005 Oct;33(5):591-6. doi: 10.1177/0310057X0503300507.","Hooten WM","Anaesth Intensive Care","2005","2005/10/21","","","10.1177/0310057X0503300507"
"16226953","Postoperative day one: a high risk period for respiratory events","Taylor S, Kirton OC, Staff I, Kozol RA.","Am J Surg. 2005 Nov;190(5):752-6. doi: 10.1016/j.amjsurg.2005.07.015.","Taylor S","Am J Surg","2005","2005/10/18","","","10.1016/j.amjsurg.2005.07.015"
"16164391","Pain evaluation in patients receiving intravenous patient-controlled analgesia after surgery","Larijani GE, Sharaf I, Warshal DP, Marr A, Gratz I, Goldberg ME.","Pharmacotherapy. 2005 Sep;25(9):1168-73. doi: 10.1592/phco.2005.25.9.1168.","Larijani GE","Pharmacotherapy","2005","2005/09/17","","","10.1592/phco.2005.25.9.1168"
"16150957","Alcohol-associated rapid release of a long-acting opioid","Murray S, Wooltorton E.","CMAJ. 2005 Sep 27;173(7):756. doi: 10.1503/cmaj.051083. Epub 2005 Sep 8.","Murray S","CMAJ","2005","2005/09/10","PMC1216315","","10.1503/cmaj.051083"
"16139186","Opioid switch in palliative care, opioid choice by clinical need and opioid availability","Müller-Busch HC, Lindena G, Tietze K, Woskanjan S.","Eur J Pain. 2005 Oct;9(5):571-9. doi: 10.1016/j.ejpain.2004.12.003. Epub 2005 Jan 20.","Müller-Busch HC","Eur J Pain","2005","2005/09/06","","","10.1016/j.ejpain.2004.12.003"
"16116010","The effects of femoral nerve blockade in conjunction with epidural analgesia after total knee arthroplasty","YaDeau JT, Cahill JB, Zawadsky MW, Sharrock NE, Bottner F, Morelli CM, Kahn RL, Sculco TP.","Anesth Analg. 2005 Sep;101(3):891-5, table of contents. doi: 10.1213/01.ANE.0000159150.79908.21.","YaDeau JT","Anesth Analg","2005","2005/08/24","","","10.1213/01.ANE.0000159150.79908.21"
"16111163","Evaluation of induction by use of a combination of oxymorphone and diazepam or hydromorphone and diazepam and maintenance of anesthesia by use of isoflurane in dogs with experimentally induced hypovolemia","Machado CG, Dyson DH, Mathews KA.","Am J Vet Res. 2005 Jul;66(7):1227-37. doi: 10.2460/ajvr.2005.66.1227.","Machado CG","Am J Vet Res","2005","2005/08/23","","","10.2460/ajvr.2005.66.1227"
"16105253","GC-MS quantitation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in blood","Meatherall R.","J Anal Toxicol. 2005 Jul-Aug;29(5):301-8. doi: 10.1093/jat/29.5.301.","Meatherall R","J Anal Toxicol","2005","2005/08/18","","","10.1093/jat/29.5.301"
"16101709","Perioperative management of a child with short-chain acyl-CoA dehydrogenase deficiency","Turpin B, Tobias JD.","Paediatr Anaesth. 2005 Sep;15(9):771-7. doi: 10.1111/j.1460-9592.2005.01507.x.","Turpin B","Paediatr Anaesth","2005","2005/08/17","","","10.1111/j.1460-9592.2005.01507.x"
"16084182","Eliminating analgesic meperidine use with a supported formulary restriction","O'Connor AB, Lang VJ, Quill TE.","Am J Med. 2005 Aug;118(8):885-9. doi: 10.1016/j.amjmed.2005.01.061.","O'Connor AB","Am J Med","2005","2005/08/09","","","10.1016/j.amjmed.2005.01.061"
"16078132","The use of a sum of inverse Gaussian functions to describe the absorption profile of drugs exhibiting complex absorption","Csajka C, Drover D, Verotta D.","Pharm Res. 2005 Aug;22(8):1227-35. doi: 10.1007/s11095-005-5266-8. Epub 2005 Aug 3.","Csajka C","Pharm Res","2005","2005/08/04","","","10.1007/s11095-005-5266-8"
"16061458","Rotation to methadone after opioid dose escalation: How should individualization of dosing occur?","Zimmermann C, Seccareccia D, Booth CM, Cottrell W.","J Pain Palliat Care Pharmacother. 2005;19(2):25-31.","Zimmermann C","J Pain Palliat Care Pharmacother","2005","2005/08/03","","",""
"16050714","Decoration of the aromatic ring of dihydrocodeinone (hydrocodone) and 14-hydroxydihydrocodeinone (oxycodone)","Wilson ML, Carroll PJ, Dalton DR.","J Org Chem. 2005 Aug 5;70(16):6492-5. doi: 10.1021/jo050264+.","Wilson ML","J Org Chem","2005","2005/07/30","","","10.1021/jo050264+"
"16041941","[Observational data in elderly pain patients show that fear of opioid therapy is unfounded]","Junker U, Figge V.","MMW Fortschr Med. 2005 Jul 7;147(27-28):43.","Junker U","MMW Fortschr Med","2005","2005/07/27","","",""
"15997113","Bioactivation of morphine in human liver: isolation and identification of morphinone, a toxic metabolite","Todaka T, Ishida T, Kita H, Narimatsu S, Yamano S.","Biol Pharm Bull. 2005 Jul;28(7):1275-80. doi: 10.1248/bpb.28.1275.","Todaka T","Biol Pharm Bull","2005","2005/07/06","","","10.1248/bpb.28.1275"
"15963867","Comparative efficacy of oral extended-release hydromorphone and immediate-release hydromorphone in patients with persistent moderate to severe pain: two randomized controlled trials","Grosset AB, Roberts MS, Woodson ME, Shi M, Swanton RE, Reder RF, Buckley BJ.","J Pain Symptom Manage. 2005 Jun;29(6):584-94. doi: 10.1016/j.jpainsymman.2004.10.008.","Grosset AB","J Pain Symptom Manage","2005","2005/06/21","","","10.1016/j.jpainsymman.2004.10.008"
"15951653","The effect of opioids on driving and psychomotor performance in patients with chronic pain","Byas-Smith MG, Chapman SL, Reed B, Cotsonis G.","Clin J Pain. 2005 Jul-Aug;21(4):345-52. doi: 10.1097/01.ajp.0000125244.29279.c1.","Byas-Smith MG","Clin J Pain","2005","2005/06/14","","","10.1097/01.ajp.0000125244.29279.c1"
"15940943","[Pain therapy. Extensive possibilities not adequately utilized]","","MMW Fortschr Med. 2005 May 12;147(19):60-1.","","MMW Fortschr Med","2005","2005/06/09","","",""
"15923838","The efficacy of continuous local anesthetic infiltration in breast surgery: reduction mammaplasty and reconstruction","Lu L, Fine NA.","Plast Reconstr Surg. 2005 Jun;115(7):1927-34; discussion 1935-6. doi: 10.1097/01.prs.0000163332.04220.bd.","Lu L","Plast Reconstr Surg","2005","2005/06/01","","","10.1097/01.prs.0000163332.04220.bd"
"15907647","Hydromorphone","Murray A, Hagen NA.","J Pain Symptom Manage. 2005 May;29(5 Suppl):S57-66. doi: 10.1016/j.jpainsymman.2005.01.007.","Murray A","J Pain Symptom Manage","2005","2005/05/24","","","10.1016/j.jpainsymman.2005.01.007"
"15838207","Use of the infusion pain pump following transverse rectus abdominis muscle flap breast reconstruction","Losken A, Parris JJ, Douglas TD, Codner MA.","Ann Plast Surg. 2005 May;54(5):479-82. doi: 10.1097/01.sap.0000155277.74482.4c.","Losken A","Ann Plast Surg","2005","2005/04/20","","","10.1097/01.sap.0000155277.74482.4c"
"15831778","Clinical pharmacology and pharmacokinetics of once-daily hydromorphone hydrochloride extended-release capsules","Vashi V, Harris S, El-Tahtawy A, Wu D, Cipriano A.","J Clin Pharmacol. 2005 May;45(5):547-54. doi: 10.1177/0091270005274552.","Vashi V","J Clin Pharmacol","2005","2005/04/16","","","10.1177/0091270005274552"
"15828941","Opioids heal ischemic wounds in the rat","Poonawala T, Levay-Young BK, Hebbel RP, Gupta K.","Wound Repair Regen. 2005 Mar-Apr;13(2):165-74. doi: 10.1111/j.1067-1927.2005.130207.x.","Poonawala T","Wound Repair Regen","2005","2005/04/15","","","10.1111/j.1067-1927.2005.130207.x"
"15806533","The use of opioids in the postoperative setting: focus on morphine, hydromorphone, and fentanyl","Golembiewski J, Torrecer S, Katke J.","J Perianesth Nurs. 2005 Apr;20(2):141-3. doi: 10.1016/j.jopan.2005.02.007.","Golembiewski J","J Perianesth Nurs","2005","2005/04/05","","","10.1016/j.jopan.2005.02.007"
"15767975","Palladone for chronic pain","","Med Lett Drugs Ther. 2005 Mar 14;47(1204):21-3.","","Med Lett Drugs Ther","2005","2005/03/16","","",""
"15761703","Contribution to variability in response to opioids","Hanks GW, Reid C.","Support Care Cancer. 2005 Mar;13(3):145-52. doi: 10.1007/s00520-004-0730-2. Epub 2004 Dec 10.","Hanks GW","Support Care Cancer","2005","2005/03/12","","","10.1007/s00520-004-0730-2"
"15716559","The risk of cesarean delivery with neuraxial analgesia given early versus late in labor","Wong CA, Scavone BM, Peaceman AM, McCarthy RJ, Sullivan JT, Diaz NT, Yaghmour E, Marcus RJ, Sherwani SS, Sproviero MT, Yilmaz M, Patel R, Robles C, Grouper S.","N Engl J Med. 2005 Feb 17;352(7):655-65. doi: 10.1056/NEJMoa042573.","Wong CA","N Engl J Med","2005","2005/02/18","","","10.1056/NEJMoa042573"
"15696936","[Determination of hydromorphone in Beagle dogs plasma by liquid chromatography-tandem mass spectrometry]","Li XY, Chen XY, Yan QY, Zhang ZH, Xu JH, Jin X, Zhong DF.","Yao Xue Xue Bao. 2004 Nov;39(11):929-32.","Li XY","Yao Xue Xue Bao","2004","2005/02/09","","",""
"15667467","Prospective audit of short-term concurrent ketamine, opioid and anti-inflammatory ('triple-agent') therapy for episodes of acute on chronic pain","Good P, Tullio F, Jackson K, Goodchild C, Ashby M.","Intern Med J. 2005 Jan;35(1):39-44. doi: 10.1111/j.1445-5994.2004.00727.x.","Good P","Intern Med J","2005","2005/01/26","","","10.1111/j.1445-5994.2004.00727.x"
"15662898","[Pain reduced and quality of life improved by sustained-release hydromorphone. Results of an observational study]","Sittig HB.","MMW Fortschr Med. 2004 Dec 9;146(Suppl 3-4):95-8.","Sittig HB","MMW Fortschr Med","2004","2005/01/25","","",""
"15646717","[Pain reduced and quality of life improved by sustained-release hydromorphone. Results of an observational study]","Sittig HB.","MMW Fortschr Med. 2004 Dec 2;146(49):45.","Sittig HB","MMW Fortschr Med","2004","2005/01/14","","",""
"15644759","Postoperative analgesia following surgical correction for adolescent idiopathic scoliosis: a comparison of continuous epidural analgesia and patient-controlled analgesia","Sucato DJ, Duey-Holtz A, Elerson E, Safavi F.","Spine (Phila Pa 1976). 2005 Jan 15;30(2):211-7. doi: 10.1097/01.brs.0000150832.53604.64.","Sucato DJ","Spine (Phila Pa 1976)","2005","2005/01/13","","","10.1097/01.brs.0000150832.53604.64"
"15638351","Reports of epidural infusion errors","Koczmara C.","Dynamics. 2004 Winter;15(4):8.","Koczmara C","Dynamics","2004","2005/01/11","","",""
"15589085","Stability of clonidine in clonidine-hydromorphone mixture from implanted intrathecal infusion pumps in chronic pain patients","Rudich Z, Peng P, Dunn E, McCartney C.","J Pain Symptom Manage. 2004 Dec;28(6):599-602. doi: 10.1016/j.jpainsymman.2004.02.018.","Rudich Z","J Pain Symptom Manage","2004","2004/12/14","","","10.1016/j.jpainsymman.2004.02.018"
"15532435","Successful treatment of hydromorphone-induced neurotoxicity and hyperalgesia","Chung KS, Carson S, Glassman D, Vadivelu N.","Conn Med. 2004 Oct;68(9):547-9.","Chung KS","Conn Med","2004","2004/11/10","","",""
"15502034","A multiple-dose phase I study of intranasal hydromorphone hydrochloride in healthy volunteers","Rudy AC, Coda BA, Archer SM, Wermeling DP.","Anesth Analg. 2004 Nov;99(5):1379-86; table of contents. doi: 10.1213/01.ANE.0000132927.47528.8B.","Rudy AC","Anesth Analg","2004","2004/10/27","","","10.1213/01.ANE.0000132927.47528.8B"
"15500571","Pharmacokinetic and pharmacodynamic evaluation of intravenous hydromorphone in cats","Wegner K, Robertson SA, Kollias-Baker C, Sams RA, Muir WW 3rd.","J Vet Pharmacol Ther. 2004 Oct;27(5):329-36. doi: 10.1111/j.1365-2885.2004.00593.x.","Wegner K","J Vet Pharmacol Ther","2004","2004/10/27","","","10.1111/j.1365-2885.2004.00593.x"
"15488893","Identification and synthesis of norhydromorphone, and determination of antinociceptive activities in the rat formalin test","Zheng M, McErlane KM, Ong MC.","Life Sci. 2004 Nov 12;75(26):3129-46. doi: 10.1016/j.lfs.2004.06.008.","Zheng M","Life Sci","2004","2004/10/19","","","10.1016/j.lfs.2004.06.008"
"15452522","A shift from demerol (meperidine) to dilaudid (hydromorphone) improves pain control and decreases admissions for patients in sickle cell crisis","Perlman KM, Myers-Phariss S, Rhodes JC.","J Emerg Nurs. 2004 Oct;30(5):439-46. doi: 10.1016/j.jen.2004.06.016.","Perlman KM","J Emerg Nurs","2004","2004/09/29","","","10.1016/j.jen.2004.06.016"
"15353098","Hydromorphone neuroexcitation","Thwaites D, McCann S, Broderick P.","J Palliat Med. 2004 Aug;7(4):545-50. doi: 10.1089/jpm.2004.7.545.","Thwaites D","J Palliat Med","2004","2004/09/09","","","10.1089/jpm.2004.7.545"
"15344360","Evaluation of the effects of premedication on gastroduodenoscopy in cats","Smith AA, Posner LP, Goldstein RE, Ludders JW, Erb HN, Simpson KW, Gleed RD.","J Am Vet Med Assoc. 2004 Aug 15;225(4):540-4. doi: 10.2460/javma.2004.225.540.","Smith AA","J Am Vet Med Assoc","2004","2004/09/04","","","10.2460/javma.2004.225.540"
"15336340","Massive hydromorphone dose delivered subcutaneously instead of intrathecally: guidelines for prevention and management of opioid, local anesthetic, and clonidine overdose","Coyne PJ, Hansen LA, Laird J, Buster P, Smith TJ.","J Pain Symptom Manage. 2004 Sep;28(3):273-6. doi: 10.1016/j.jpainsymman.2003.11.011.","Coyne PJ","J Pain Symptom Manage","2004","2004/09/01","","","10.1016/j.jpainsymman.2003.11.011"
"15310785","Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial","Stockler M, Vardy J, Pillai A, Warr D.","J Clin Oncol. 2004 Aug 15;22(16):3389-94. doi: 10.1200/JCO.2004.09.122.","Stockler M","J Clin Oncol","2004","2004/08/18","","","10.1200/JCO.2004.09.122"
"15281651","Comparative cardiovascular, analgesic, and sedative effects of medetomidine, medetomidine-hydromorphone, and medetomidine-butorphanol in dogs","Kuo WC, Keegan RD.","Am J Vet Res. 2004 Jul;65(7):931-7. doi: 10.2460/ajvr.2004.65.931.","Kuo WC","Am J Vet Res","2004","2004/07/30","","","10.2460/ajvr.2004.65.931"
"15271246","Correlation between withdrawal symptoms and medication pump residual volume in patients with implantable SynchroMed pumps","Taha J, Favre J, Janszen M, Galarza M, Taha A.","Neurosurgery. 2004 Aug;55(2):390-3; discussion 393-4. doi: 10.1227/01.neu.0000129698.73730.e4.","Taha J","Neurosurgery","2004","2004/07/24","","","10.1227/01.neu.0000129698.73730.e4"
"15268978","Role of individual human cytochrome P450 enzymes in the in vitro metabolism of hydromorphone","Benetton SA, Borges VM, Chang TK, McErlane KM.","Xenobiotica. 2004 Apr;34(4):335-44. doi: 10.1080/00498250310001657559.","Benetton SA","Xenobiotica","2004","2004/07/23","","","10.1080/00498250310001657559"
"15148975","Fluoxetine + hydromorphone: serotonin syndrome?","","Prescrire Int. 2004 Apr;13(70):57.","","Prescrire Int","2004","2004/05/20","","",""
"15105246","Epidural treatment in advanced cancer patients","Mercadante S.","Anesth Analg. 2004 May;98(5):1503; auhtor reply 1503-4. doi: 10.1213/01.ane.0000114585.53663.2b.","Mercadante S","Anesth Analg","2004","2004/04/24","","","10.1213/01.ane.0000114585.53663.2b"
"15099916","A laboratory study of hydromorphone and cyclazocine on smoking behavior in residential polydrug users","Pickworth WB, Lee EM, Abreu ME, Umbricht A, Preston KL.","Pharmacol Biochem Behav. 2004 Apr;77(4):711-5. doi: 10.1016/j.pbb.2004.01.022.","Pickworth WB","Pharmacol Biochem Behav","2004","2004/04/22","","","10.1016/j.pbb.2004.01.022"
"15099699","Receptor mechanisms mediating cyanide generation in PC12 cells and rat brain","Gunasekar PG, Prabhakaran K, Li L, Zhang L, Isom GE, Borowitz JL.","Neurosci Res. 2004 May;49(1):13-8. doi: 10.1016/j.neures.2004.01.006.","Gunasekar PG","Neurosci Res","2004","2004/04/22","","","10.1016/j.neures.2004.01.006"
"15098525","Postoperative respiratory depression and unresponsiveness following epidural opiate administration: a case report","Holmes J, Maye JP.","AANA J. 2004 Apr;72(2):126-8.","Holmes J","AANA J","2004","2004/04/22","","",""
"15096909","Cyclazocine: comparison to hydromorphone and interaction with cocaine","Preston KL, Umbricht A, Schroeder JR, Abreu ME, Epstein DH, Pickworth WB.","Behav Pharmacol. 2004 Mar;15(2):91-102. doi: 10.1097/00008877-200403000-00001.","Preston KL","Behav Pharmacol","2004","2004/04/21","","","10.1097/00008877-200403000-00001"
"15067146","Personal accounts: a truly invisible handicap","Reiter E.","Psychiatr Serv. 2004 Apr;55(4):363-4. doi: 10.1176/appi.ps.55.4.363.","Reiter E","Psychiatr Serv","2004","2004/04/07","","","10.1176/appi.ps.55.4.363"
"15058769","Antinociceptive effects of hydromorphone, butorphanol, or the combination in cats","Lascelles BD, Robertson SA.","J Vet Intern Med. 2004 Mar-Apr;18(2):190-5. doi: 10.1892/0891-6640(2004)18<190:aeohbo>2.0.co;2.","Lascelles BD","J Vet Intern Med","2004","2004/04/03","","","10.1892/0891-6640(2004)18<190:aeohbo>2.0.co;2"
"14998425","CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes","Hutchinson MR, Menelaou A, Foster DJ, Coller JK, Somogyi AA.","Br J Clin Pharmacol. 2004 Mar;57(3):287-97. doi: 10.1046/j.1365-2125.2003.02002.x.","Hutchinson MR","Br J Clin Pharmacol","2004","2004/03/05","PMC1884456","","10.1046/j.1365-2125.2003.02002.x"
"14998329","Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone]","Ananthan S, Khare NK, Saini SK, Seitz LE, Bartlett JL, Davis P, Dersch CM, Porreca F, Rothman RB, Bilsky EJ.","J Med Chem. 2004 Mar 11;47(6):1400-12. doi: 10.1021/jm030311v.","Ananthan S","J Med Chem","2004","2004/03/05","","","10.1021/jm030311v"
"14996233","Continuous intrathecal infusion of hydromorphone: safety in the sheep model and clinical implications","Johansen MJ, Satterfield WC, Baze WB, Hildebrand KR, Gradert TL, Hassenbusch SJ.","Pain Med. 2004 Mar;5(1):14-25. doi: 10.1111/j.1526-4637.2004.04010.x.","Johansen MJ","Pain Med","2004","2004/03/05","","","10.1111/j.1526-4637.2004.04010.x"
"14901621","A further report on the use of dilaudid as an analgesic in urology","LAIBE JE.","Urol Cutaneous Rev. 1952 Jan;56(1):26.","LAIBE JE","Urol Cutaneous Rev","1952","1952/01/01","","",""
"14804053","Dilaudid suppositories for the suppression of the cough reflex; with review of medication by rectal administration in childhood diseases","DONELSON K.","J Mich State Med Soc. 1951 Jan;50(1):61; passim.","DONELSON K","J Mich State Med Soc","1951","1951/01/01","","",""
"14751453","Precipitated opioid withdrawal across acute physical dependence induction methods","Compton P, Miotto K, Elashoff D.","Pharmacol Biochem Behav. 2004 Feb;77(2):263-8. doi: 10.1016/j.pbb.2003.10.017.","Compton P","Pharmacol Biochem Behav","2004","2004/01/31","","","10.1016/j.pbb.2003.10.017"
"14748271","Dr. Nancy Morrison and her dying patient: a case of medical necessity","Sneiderman B, Deutscher R.","Health Law J. 2002;10:1-30.","Sneiderman B","Health Law J","2002","2004/01/30","","",""
"14740785","Effect of fluticasone propionate nasal spray on bioavailability of intranasal hydromorphone hydrochloride in patients with allergic rhinitis","Davis GA, Rudy AC, Archer SM, Wermeling DP, McNamara PJ.","Pharmacotherapy. 2004 Jan;24(1):26-32. doi: 10.1592/phco.24.1.26.34810.","Davis GA","Pharmacotherapy","2004","2004/01/27","","","10.1592/phco.24.1.26.34810"
"14687955","Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification","Sobel BF, Sigmon SC, Walsh SL, Johnson RE, Liebson IA, Nuwayser ES, Kerrigan JH, Bigelow GE.","Drug Alcohol Depend. 2004 Jan 7;73(1):11-22. doi: 10.1016/j.drugalcdep.2003.08.006.","Sobel BF","Drug Alcohol Depend","2004","2003/12/23","","","10.1016/j.drugalcdep.2003.08.006"
"14622682","A randomized study of the effect of oral lamotrigine and hydromorphone on pain and hyperalgesia following heat/capsaicin sensitization","Petersen KL, Maloney A, Hoke F, Dahl JB, Rowbotham MC.","J Pain. 2003 Sep;4(7):400-6. doi: 10.1016/s1526-5900(03)00718-1.","Petersen KL","J Pain","2003","2003/11/19","","","10.1016/s1526-5900(03)00718-1"
"14603608","[Pain therapy in patients with tumors. According to graduated schedule and hourly plan]","","MMW Fortschr Med. 2003 Oct 2;145(40):53.","","MMW Fortschr Med","2003","2003/11/08","","",""
"14598667","[Combined use of intrathecal morphine and diclofenac suppository for postoperative analgesia after caesarean section]","Hidaka I, Asai T, Miki T, Kubota T, Kawachi S.","Masui. 2003 Oct;52(10):1056-61.","Hidaka I","Masui","2003","2003/11/06","","",""
"14587190","[Pain therapy with semisynthetic opioids. Patients have opioid-type side effects more rarely]","Sohn W.","MMW Fortschr Med. 2003 Jul 10;145(27-28):50.","Sohn W","MMW Fortschr Med","2003","2003/11/01","","",""
"14572875","Antihyperalgesic effect of simultaneously released hydromorphone and bupivacaine from polymer fibers in the rat chronic constriction injury model","Hasirci V, Bonney I, Goudas LC, Shuster L, Carr DB, Wise DL.","Life Sci. 2003 Nov 14;73(26):3323-37. doi: 10.1016/s0024-3205(03)00615-5.","Hasirci V","Life Sci","2003","2003/10/24","","","10.1016/s0024-3205(03)00615-5"
"14562820","Oral vs. i.v. hydromorphone. Add a measure of caution","Cohen MR.","Nursing. 2003 Sep;33(9):12. doi: 10.1097/00152193-200309000-00011.","Cohen MR","Nursing","2003","2003/10/18","","","10.1097/00152193-200309000-00011"
"14516504","Calculating opioid dose conversions #36","Arnold R, Weissman DE.","J Palliat Med. 2003 Aug;6(4):619-20. doi: 10.1089/109662103768253731.","Arnold R","J Palliat Med","2003","2003/10/01","","","10.1089/109662103768253731"
"14453567","A peri-surgical evaluation of oxymorphone","KANE AA.","West Med Med J West. 1962 Jan;3:8-10.","KANE AA","West Med Med J West","1962","1962/01/01","","",""
"14446819","Numorphan in labor. A preliminary report","SIMECKOVA M, SHAW W, POOL E, NICHOLS EE.","Obstet Gynecol. 1960 Jul;16:119-23.","SIMECKOVA M","Obstet Gynecol","1960","1960/07/01","","",""
"14444630","The use of oxymorphone hydrochloride during anesthesia for operations on the head and neck. A preliminary report","SEIGLEMAN M, WASMUTH CE.","Cleve Clin Q. 1960 Jul;27:157-61. doi: 10.3949/ccjm.27.3.157.","SEIGLEMAN M","Cleve Clin Q","1960","1960/07/01","","","10.3949/ccjm.27.3.157"
"14393929","[Use of dilaudid-atropine as analgesic and pre-narcotic in urology]","GODENA S.","Minerva Urol. 1955 Mar-Apr;7(2):55-9.","GODENA S","Minerva Urol","1955","1955/03/01","","",""
"14366318","[Dialudid in pre-anesthesia]","MANNELLI A, VILLEVIELLE L, ZARA A.","G Ital Chir. 1954 Oct;10(10):836-48.","MANNELLI A","G Ital Chir","1954","1954/10/01","","",""
"14301008","COMPARATIVE DISTRIBUTION OF TRITIUM-LABELED DIHYDROMORPHINE BETWEEN MATERNAL AND FETAL RATS","SANNER JH, WOODS LA.","J Pharmacol Exp Ther. 1965 May;148:176-84.","SANNER JH","J Pharmacol Exp Ther","1965","1965/05/01","","",""
"14293547","RELATIVE POTENCY OF CODEINE, METHADONE AND DIHYDROMORPHINONE TO MORPHINE IN SELF-MAINTAINED ADDICT RATS","COLLINS RJ, WEEKS JR.","Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1965 Jan 8;249:509-14. doi: 10.1007/BF00246557.","COLLINS RJ","Naunyn Schmiedebergs Arch Exp Pathol Pharmakol","1965","1965/01/08","","","10.1007/BF00246557"
"14286207","ORAL HYDROMORPHONE IN TRAUMA","GOLDBERG RI, SHUMAN FI.","Curr Ther Res Clin Exp. 1965 May;7:284-8.","GOLDBERG RI","Curr Ther Res Clin Exp","1965","1965/05/01","","",""
"14286206","A CONTROLLED CLINICAL EVALUATION OF THE ANALGESIC EFFECT OF ORAL HYDROMORPHONE","CASS LJ, FREDERIK WS.","Curr Ther Res Clin Exp. 1965 May;7:275-83.","CASS LJ","Curr Ther Res Clin Exp","1965","1965/05/01","","",""
"14282720","SOME RELATIONSHIPS BETWEEN CATECHOLAMINES AND MORPHINE-LIKE DRUGS","SMITH AA, GAVITT JA, KAPLAN M.","Recent Adv Biol Psychiatry. 1963;6:208-13.","SMITH AA","Recent Adv Biol Psychiatry","1963","1963/01/01","","",""
"14234072","[ACUTE COR PULMONALE]","HERBERG D.","Dtsch Med Wochenschr. 1965 Jan 8;90:66-9. doi: 10.1055/s-0028-1111295.","HERBERG D","Dtsch Med Wochenschr","1965","1965/01/08","","","10.1055/s-0028-1111295"
"14194766","A RAPID SCREENING TEST FOR POTENTIAL ADDICTION LIABILITY OF NEW ANALGESIC AGENTS","SHEMANO I, WENDEL H.","Toxicol Appl Pharmacol. 1964 May;6:334-9. doi: 10.1016/0041-008x(64)90075-4.","SHEMANO I","Toxicol Appl Pharmacol","1964","1964/05/01","","","10.1016/0041-008x(64)90075-4"
"14191433","[PHARMACOLOGICAL STUDIES ON MORPHINE DERIVATIVES. 3. ON THE CHEMICAL STRUCTURE-ACTIVITY RELATIONSHIPS OF 14-HYDROXYMORPHINE DERIVATIVES]","SEKI I, TAKAGI H, KOBAYASHI S.","Yakugaku Zasshi. 1964 Mar;84:280-6.","SEKI I","Yakugaku Zasshi","1964","1964/03/01","","",""
"14177953","WEBER-CHRISTIAN DISEASE, AMENORRHEA AND PREGNANCY. A CASE REPORT","MCCALL JO Jr.","Am J Obstet Gynecol. 1964 Jun 1;89:362-5. doi: 10.1016/0002-9378(64)90694-5.","MCCALL JO Jr","Am J Obstet Gynecol","1964","1964/06/01","","","10.1016/0002-9378(64)90694-5"
"14169837","STUDY OF LYSERGIC ACID DIETHYLAMIDE AS AN ANALGESIC AGENT","KAST EC, COLLINS VJ.","Anesth Analg. 1964 May-Jun;43:285-91.","KAST EC","Anesth Analg","1964","1964/05/01","","",""
"14165988","[ASSISTED SPINAL ANESTHESIA]","FAGARASANU I.","Lyon Chir. 1964 May;60:347-59.","FAGARASANU I","Lyon Chir","1964","1964/05/01","","",""
"14165239","THE CLINICAL EVALUATION OF MORPHINE AND ITS SUBSTITUTES AS ANALGESICS","LASAGNA L.","Pharmacol Rev. 1964 Mar;16:47-83.","LASAGNA L","Pharmacol Rev","1964","1964/03/01","","",""
"14160510","BARBITURATE USE IN NARCOTIC ADDICTS","HAMBURGER E.","JAMA. 1964 Aug 3;189:366-9. doi: 10.1001/jama.1964.03070050032007.","HAMBURGER E","JAMA","1964","1964/08/03","","","10.1001/jama.1964.03070050032007"
"14134729","DIHYDROMORPHINE IN PERIPHERAL NERVOUS TISSUE","KOSTERLITZ HW, THOMPSON JW, WALLIS DI.","Nature. 1964 Feb 15;201:719. doi: 10.1038/201719a0.","KOSTERLITZ HW","Nature","1964","1964/02/15","","","10.1038/201719a0"
"14130285","ANALGESICS FOR THE RELIEF OF PAIN. I. NARCOTIC ANALGESICS","WANG RI.","Wis Med J. 1964 Mar;63:164-5.","WANG RI","Wis Med J","1964","1964/03/01","","",""
"14125891","THE EFFECT OF MORPHINE AND RELATED SUBSTANCES ON THE TOXICITY OF VENOMS. I. CENTRUROIDES SCULPTURATUS EWING SCORPION VENOM","STAHNKE HL, DENGLER AH.","Am J Trop Med Hyg. 1964 Mar;13:346-51. doi: 10.4269/ajtmh.1964.13.346.","STAHNKE HL","Am J Trop Med Hyg","1964","1964/03/01","","","10.4269/ajtmh.1964.13.346"
"14125210","DRUG ADDICTION: A REVIEW","MEYERSTEIN AN.","J Sch Health. 1964 Feb;34:77-87. doi: 10.1111/j.1746-1561.1964.tb00462.x.","MEYERSTEIN AN","J Sch Health","1964","1964/02/01","","","10.1111/j.1746-1561.1964.tb00462.x"
"14111353","[EFFECT OF MORPHINE AND SIMILAR ANALGESICS ON THE ACTIVITY OF NICOTINE AND 5-HYDROXYTRYPTAMINE]","BANIC B, MEDAKOVIC M.","Acta Med Iugosl. 1963;17:175-86.","BANIC B","Acta Med Iugosl","1963","1963/01/01","","",""
"14090997","THERAPY OF CARDIOGENIC SHOCK","AGRESS CM.","Prog Cardiovasc Dis. 1963 Nov;6:236-54. doi: 10.1016/s0033-0620(63)80037-7.","AGRESS CM","Prog Cardiovasc Dis","1963","1963/11/01","","","10.1016/s0033-0620(63)80037-7"
"14090539","ESSAY ON PAEDIATRIC PRE-ANAESTHETIC MEDICATION","STETSON JB.","Br J Anaesth. 1963 Dec;35:811-6. doi: 10.1093/bja/35.12.811.","STETSON JB","Br J Anaesth","1963","1963/12/01","","","10.1093/bja/35.12.811"
"14081825","THE CONTROL OF SEVERE PAIN WITH ORAL OXYMORPHONE HYDROCHLORIDE","CASS LJ, FREDERIK WS.","Curr Ther Res Clin Exp. 1963 Nov;5:579-86.","CASS LJ","Curr Ther Res Clin Exp","1963","1963/11/01","","",""
"14065101","DEATH IN STATUS ASTHMATICUS. ROLE OF SEDATION","NEDER GA Jr, DERBES VJ, CARPENTER CL Jr, ZISKIND MM.","Dis Chest. 1963 Sep;44:263-7. doi: 10.1378/chest.44.3.263.","NEDER GA Jr","Dis Chest","1963","1963/09/01","","","10.1378/chest.44.3.263"
"14047809","EVALUATION OF OPIATES FOR PAIN AND PREMEDICATION","STEINHAUS JE, LEE WJ.","J Med Assoc Ga. 1963 Sep;52:396-8.","STEINHAUS JE","J Med Assoc Ga","1963","1963/09/01","","",""
"14035049","Oxymorphone during parturition, its effect on the newborn","KOSTYAL JL.","Pa Med J. 1963 May;66:30-2.","KOSTYAL JL","Pa Med J","1963","1963/05/01","","",""
"14033551","Clinical evaluation of a new analgesic in obstetrics and gynecology","KLINGES KG, GIBBONS JM, PISANI BJ.","N Y State J Med. 1962 Dec 15;62:3918-22.","KLINGES KG","N Y State J Med","1962","1962/12/15","","",""
"14005121","A review of oxymorphone hydrochloride (Numorphan) analgesia employed for general surgery, including clinical experience with five hundred and twenty-eight patients","WASMUTH CE, HOMI J.","Cleve Clin Q. 1961 Oct;28:262-9. doi: 10.3949/ccjm.28.4.262.","WASMUTH CE","Cleve Clin Q","1961","1961/10/01","","","10.3949/ccjm.28.4.262"
"13996193","[Behavior modifiers inthe study of bile ducts. (Combined action of morphine substances and cholecystokinin)]","VANDENDORP F, PARIS J, U BOIS R.","J Radiol Electrol Med Nucl. 1963 May;44:258-63.","VANDENDORP F","J Radiol Electrol Med Nucl","1963","1963/05/01","","",""
"13996168","Clinical pharmacology of the narcotic analgesics","VANDAM LD.","Clin Pharmacol Ther. 1962 Nov-Dec;3:827-38. doi: 10.1002/cpt196236827.","VANDAM LD","Clin Pharmacol Ther","1962","1962/11/01","","","10.1002/cpt196236827"
"13988810","A simple method for producing tolerance to dihydromorphinone in mice","SHUSTER L, HANNAM RV, BOYLE WE Jr.","J Pharmacol Exp Ther. 1963 May;140:149-54.","SHUSTER L","J Pharmacol Exp Ther","1963","1963/05/01","","",""
"13979697","A study of postoperative pain","SWERDLOW M, MURRAY A, DAW RH.","Acta Anaesthesiol Scand. 1963;7:1-19. doi: 10.1111/j.1399-6576.1963.tb00201.x.","SWERDLOW M","Acta Anaesthesiol Scand","1963","1963/01/01","","","10.1111/j.1399-6576.1963.tb00201.x"
"13949105","Dilaudid in acute cardiac emergencies","GOODMAN RD.","Bull Acad Med N J. 1963 Jun;9:111-9.","GOODMAN RD","Bull Acad Med N J","1963","1963/06/01","","",""
"13942020","[Studies on some habit-forming drugs with column chromatography]","PAULUS W, JANITZKI U, HOCH W.","Arzneimittelforschung. 1962 Sep;12:950-2.","PAULUS W","Arzneimittelforschung","1962","1962/09/01","","",""
"13941429","[Experimental study of the effects of cholecystokinin on bile ducts subjected to the action of morphine-derivative substances]","PARIS J, ROBELET A, SALEHZIER Y, DU BOIS R.","Rev Int Hepatol. 1962;12:1071-92.","PARIS J","Rev Int Hepatol","1962","1962/01/01","","",""
"13914618","Report on oxymorphone in obstetrics","SNOW DL, SATTENSPIEL E.","Am J Obstet Gynecol. 1962 Jan 1;83:22-4. doi: 10.1016/0002-9378(62)90282-x.","SNOW DL","Am J Obstet Gynecol","1962","1962/01/01","","","10.1016/0002-9378(62)90282-x"
"13910705","An evaluation of oxymorphone in labor","SENTNOR MH, SOLOMONS E, KOHL SG.","Am J Obstet Gynecol. 1962 Oct 1;84:956-61. doi: 10.1016/0002-9378(62)90074-1.","SENTNOR MH","Am J Obstet Gynecol","1962","1962/10/01","","","10.1016/0002-9378(62)90074-1"
"13910510","Siderocalciphylactic sensitization to distilled water","SELYE H, DIEUDONNE JM, TUCHWEBER B.","Arch Intern Med. 1962 Sep;110:290-4. doi: 10.1001/archinte.1962.03620210014004.","SELYE H","Arch Intern Med","1962","1962/09/01","","","10.1001/archinte.1962.03620210014004"
"13893795","The respiratory effects of oxymorphone administered alone or in combination with levallorphan","FOLDES FF, LUNN JN, KLEIN S, SIKER ES.","Am J Med Sci. 1962 Apr;243:480-8. doi: 10.1097/00000441-196204000-00009.","FOLDES FF","Am J Med Sci","1962","1962/04/01","","","10.1097/00000441-196204000-00009"
"13879943","A comparison between oxymorphone (Numorphan) and morphine sulfate prior to pentobarbital anesthesia in the dog","CLIFFORD DH, JHA SK.","Anesth Analg. 1961 Nov-Dec;40:645-9.","CLIFFORD DH","Anesth Analg","1961","1961/11/01","","",""
"13866350","An oral narcotic analgesic in private practice","BECKER M.","Med Times. 1961 Dec;89:1317-8.","BECKER M","Med Times","1961","1961/12/01","","",""
"13843543","[The effect of dihydromorphinone-atropine in therapeutic doses on ventilation values, alveolar gas exchange and arterial blood gases]","WEIMANN G, HERMANUZ N.","Arztl Forsch. 1960 Apr 10;14:I/202-8.","WEIMANN G","Arztl Forsch","1960","1960/04/10","","",""
"13843542","[On the effect of dihydromorphinone-atropine on respiration]","WEIMANN G, HERMANUZ N.","Anaesthesist. 1959 Dec;8:351-3.","WEIMANN G","Anaesthesist","1959","1959/12/01","","",""
"13801998","[On the chromatographic evaluation of the purity of dihydromorphinone hydrochloride, dihydrocodeine bitartrate, dihydrocodeinone bitartrate and codeine phosphate. 8. Report on the behavior of alkaloid salt solutions on aluminum oxide columns]","BOEHME H, HOCKE H.","Arch Pharm Ber Dtsch Pharm Ges. 1960 Mar;293/65:342-56. doi: 10.1002/ardp.19602930313.","BOEHME H","Arch Pharm Ber Dtsch Pharm Ges","1960","1960/03/01","","","10.1002/ardp.19602930313"
"13801708","High activity of potent analgesics on conditioned rat tranquilizer test","BLUMBERG H, DAYTON HB.","Proc Soc Exp Biol Med. 1959 Aug-Sep;101:594-6. doi: 10.3181/00379727-101-25029.","BLUMBERG H","Proc Soc Exp Biol Med","1959","1959/08/01","","","10.3181/00379727-101-25029"
"13798620","Relative respiratory depresant effects of oxymorphone (numorphan) and morphine","BELLVILLE JW, ESCARRAGA LA, WALLENSTEIN SL, HOUDE RW, HOWLAND WS.","Anesthesiology. 1960 Jul-Aug;21:397-400. doi: 10.1097/00000542-196007000-00010.","BELLVILLE JW","Anesthesiology","1960","1960/07/01","","","10.1097/00000542-196007000-00010"
"13778580","Comparative toxicities of 14-hydroxydihydromorphinone (oxymorphone) and other narcotic analgesic compounds","TULLAR PE.","Toxicol Appl Pharmacol. 1961 May;3:261-66. doi: 10.1016/0041-008x(61)90065-5.","TULLAR PE","Toxicol Appl Pharmacol","1961","1961/05/01","","","10.1016/0041-008x(61)90065-5"
"13757037","[Oxymorphon-thiopental-nitrous oxide combination anesthesia]","KNAFF M, RONDEAU Y, von KEERI-SZANTO.","Anaesthesist. 1961 Feb;10:53-5.","KNAFF M","Anaesthesist","1961","1961/02/01","","",""
"13757036","[Combined anesthesia with pentothal-numorphan-N2-O]","KNAFF M, RONDEAU Y, von KEERI-SZANTO.","Bull Soc Sci Med Grand Duche Luxemb. 1961 Mar;98:157-60.","KNAFF M","Bull Soc Sci Med Grand Duche Luxemb","1961","1961/03/01","","",""
"13752110","Studies of analgesic drugs. V. The comparative subjective effects of oxymorphone and morphine","KEATS AS, TELFORD J.","Clin Pharmacol Ther. 1960 Nov-Dec;1:703-7.","KEATS AS","Clin Pharmacol Ther","1960","1960/11/01","","",""
"13743120","[Numorphanpentothal-nitrous oxide anesthesia]","RONDEAU Y, KNAFF M, KEERI-SZANTO M.","Union Med Can. 1961 Jan;90:48-51.","RONDEAU Y","Union Med Can","1961","1961/01/01","","",""
"13683909","Clinical evaluation and observation of 14-hydroxydihydromorphinone (Numorphan)","APPLETON JC.","Anesth Analg. 1960 Nov-Dec;39:505-10.","APPLETON JC","Anesth Analg","1960","1960/11/01","","",""
"13635164","Lesions of the retina and macula associated with hypercholesterolemia: a preliminary report","BROWN RA.","South Med J. 1959 Feb;52(2):204-6. doi: 10.1097/00007611-195902000-00014.","BROWN RA","South Med J","1959","1959/02/01","","","10.1097/00007611-195902000-00014"
"13631610","The analgesic equivalence to morphine and relative side action liability of oxymorphone (14-hydroxydihydro morphinone)","EDDY NB, LEE LE Jr.","J Pharmacol Exp Ther. 1959 Feb;125(2):116-21.","EDDY NB","J Pharmacol Exp Ther","1959","1959/02/01","","",""
"13568714","[A clinical lecture]","HADORN W.","Schweiz Med Wochenschr. 1958 Jun 14;88(24):583-7.","HADORN W","Schweiz Med Wochenschr","1958","1958/06/14","","",""
"13369700","The analgesic properties of numorphan (14-hydroxy dihydromorphinone), a new synthetic narcotic","BIERMAN HR, COBLENTZ A.","N Engl J Med. 1956 Oct 11;255(15):694-8. doi: 10.1056/NEJM195610112551504.","BIERMAN HR","N Engl J Med","1956","1956/10/11","","","10.1056/NEJM195610112551504"
"13319082","Preparation and properties of 8-chlorotheophylline salts of some nitrogen bases","LAMB DJ, BOPE FW.","J Am Pharm Assoc Am Pharm Assoc. 1956 Mar;45(3):178-81. doi: 10.1002/jps.3030450314.","LAMB DJ","J Am Pharm Assoc Am Pharm Assoc","1956","1956/03/01","","","10.1002/jps.3030450314"
"13299274","[Analgesic results with dilaudid-atropine suppositories]","MASSIER J.","Ther Ggw. 1955 Dec;94(12):458-9.","MASSIER J","Ther Ggw","1955","1955/12/01","","",""
"13291778","Effect of chlorpromazine on addiction; a preliminary report of two cases of dilaudid, morphine and codeine addictions","CHU J.","W V Med J. 1956 Jan;52(1):5-6.","CHU J","W V Med J","1956","1956/01/01","","",""
"13239385","[Preanesthesia medication for children in ORL surgery]","FIOR R.","Arch Ital Otol Rinol Laringol. 1955 Mar-Apr;66(2):275-9.","FIOR R","Arch Ital Otol Rinol Laringol","1955","1955/03/01","","",""
"13198194","[Toxicological determination of dromoran, morphine, dilaudid, cardiazol, coramine and atropine by means of paper chromatography]","KAISER H, JORI H.","Arch Pharm Ber Dtsch Pharm Ges. 1954;287(5):253-8; concl. doi: 10.1002/ardp.19542870502.","KAISER H","Arch Pharm Ber Dtsch Pharm Ges","1954","1954/01/01","","","10.1002/ardp.19542870502"
"13198191","[Toxicological determination of dromoran, morphine, dilaudid, cardiazol coramine and atropine by means of paper chromatography]","KAISER H, JORI H.","Arch Pharm Ber Dtsch Pharm Ges. 1954;287(4):224-42; contd. doi: 10.1002/ardp.19542870409.","KAISER H","Arch Pharm Ber Dtsch Pharm Ges","1954","1954/01/01","","","10.1002/ardp.19542870409"
"13176132","[Dilaudid-atropine, a new combined pre-anesthetic especially indicated for pre-anesthesia in operations with local anesthesia]","DAMIA G.","Minerva Anestesiol. 1954 Mar;20(3):108-10.","DAMIA G","Minerva Anestesiol","1954","1954/03/01","","",""
"13171480","Diastematomyelia","SANDS WW, CLARK WK.","Am J Roentgenol Radium Ther Nucl Med. 1954 Jul;72(1):64-7.","SANDS WW","Am J Roentgenol Radium Ther Nucl Med","1954","1954/07/01","","",""
"13153952","[Dilaudid-atropine and its clinical use as a preanesthetic]","MARTINOLI F.","Minerva Anestesiol. 1954 Jan;20(1):14-6.","MARTINOLI F","Minerva Anestesiol","1954","1954/01/01","","",""
"13110797","[Clinical trial of a new preanesthetic, dihydromorphinone with atropine sulfate]","AROSIO G.","Minerva Anestesiol. 1953 Jul;19(7):201-2.","AROSIO G","Minerva Anestesiol","1953","1953/07/01","","",""
"13110271","[Further experiences in an unusual case of renal osteoporosis with aminoaciduria treated with dihydrotachysterol]","VAN CREVELD S, ARONS P.","Maandschr Kindergeneeskd. 1953 Sep;21(9):294-300.","VAN CREVELD S","Maandschr Kindergeneeskd","1953","1953/09/01","","",""
"13107352","[Latent tetany as cause of habitual abortion]","RIML O, TSCHERNE E.","Dtsch Med Wochenschr. 1953 Oct 16;78(42):1429-30. doi: 10.1055/s-0028-1114966.","RIML O","Dtsch Med Wochenschr","1953","1953/10/16","","","10.1055/s-0028-1114966"
"13092605","[Use of sterols with a hypercalcemic action in the treatment of chronic hypocalcemic]","MARTIN E, RILLIET B.","Ann Endocrinol (Paris). 1953;14(2):157-76.","MARTIN E","Ann Endocrinol (Paris)","1953","1953/01/01","","",""
"13077167","[Dihydromorphinone]","EHRLEN I.","Sven Farm Tidskr. 1953 Feb 10;57(4):57-61.","EHRLEN I","Sven Farm Tidskr","1953","1953/02/10","","",""
"13062086","Analgesic power and the question of acute tolerance to narcotics in man","BEECHER HK.","J Pharmacol Exp Ther. 1953 Jun;108(2):158-67.","BEECHER HK","J Pharmacol Exp Ther","1953","1953/06/01","","",""
"13040360","The chemistry of drugs of addiction","MAY EL.","Am J Med. 1953 May;14(5):540-5. doi: 10.1016/0002-9343(53)90369-6.","MAY EL","Am J Med","1953","1953/05/01","","","10.1016/0002-9343(53)90369-6"
"12990361","N-allylnormorphine in treatment of dihydromorphinone and methorphinan overdosage; report of a case","CHASE HF, BOYD RS, ANDREWS PM.","J Am Med Assoc. 1952 Nov 15;150(11):1103-4. doi: 10.1001/jama.1952.63680110001013.","CHASE HF","J Am Med Assoc","1952","1952/11/15","","","10.1001/jama.1952.63680110001013"
"12901434","In vivo pain relief effectiveness of an analgesic-anesthetic carrying biodegradable controlled release rod systems","Sendil-Keskin D, Altunay H, Wise DL, Hasirci V.","J Biomater Sci Polym Ed. 2003;14(6):497-514. doi: 10.1163/15685620360674218.","Sendil-Keskin D","J Biomater Sci Polym Ed","2003","2003/08/07","","","10.1163/15685620360674218"
"12899977","Comparison of morphine and hydromorphone analysis on reversed phase columns with different diameters","Baeyens WR, Van der Weken G, Smet E, García-Campaña AM, Remon JP.","J Pharm Biomed Anal. 2003 Aug 8;32(4-5):913-20. doi: 10.1016/s0731-7085(03)00250-4.","Baeyens WR","J Pharm Biomed Anal","2003","2003/08/06","","","10.1016/s0731-7085(03)00250-4"
"12859317","Is the analgesic effect of systemic lidocaine mediated through opioid receptors?","Cohen SP, Mao J.","Acta Anaesthesiol Scand. 2003 Aug;47(7):910-1. doi: 10.1034/j.1399-6576.2003.00163.x.","Cohen SP","Acta Anaesthesiol Scand","2003","2003/07/16","","","10.1034/j.1399-6576.2003.00163.x"
"12850649","Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations","Ackerman LL, Follett KA, Rosenquist RW.","J Pain Symptom Manage. 2003 Jul;26(1):668-77. doi: 10.1016/s0885-3924(03)00144-1.","Ackerman LL","J Pain Symptom Manage","2003","2003/07/10","","","10.1016/s0885-3924(03)00144-1"
"12818953","Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteers","Coda BA, Rudy AC, Archer SM, Wermeling DP.","Anesth Analg. 2003 Jul;97(1):117-23, table of contents. doi: 10.1213/01.ane.0000066311.40978.4f.","Coda BA","Anesth Analg","2003","2003/06/24","","","10.1213/01.ane.0000066311.40978.4f"
"12745417","Using saccadic eye movements as objective measures of tolerance in methadone dependent individuals during the hydromorphone challenge test","Melichar JK, Myles JS, Eap CB, Nutt DJ.","Addict Biol. 2003 Mar;8(1):59-66. doi: 10.1080/1355621031000069891.","Melichar JK","Addict Biol","2003","2003/05/15","","","10.1080/1355621031000069891"
"12710006","Morphine and hydromorphone for postoperative analgesia: focus on safety","Golembiewski JA.","J Perianesth Nurs. 2003 Apr;18(2):120-2. doi: 10.1053/jpan.2003.50015.","Golembiewski JA","J Perianesth Nurs","2003","2003/04/24","","","10.1053/jpan.2003.50015"
"12692192","Embolized crospovidone (poly[N-vinyl-2-pyrrolidone]) in the lungs of intravenous drug users","Ganesan S, Felo J, Saldana M, Kalasinsky VF, Lewin-Smith MR, Tomashefski JF Jr.","Mod Pathol. 2003 Apr;16(4):286-92. doi: 10.1097/01.MP.0000062653.65441.DA.","Ganesan S","Mod Pathol","2003","2003/04/15","","","10.1097/01.MP.0000062653.65441.DA"
"12690618","Opioid equianalgesic conversion: the right dose","Brant JM.","Clin J Oncol Nurs. 2001 Jul-Aug;5(4):163-5.","Brant JM","Clin J Oncol Nurs","2001","2003/04/15","","",""
"12641847","Changes in intraocular pressure and pupil size following intramuscular administration of hydromorphone hydrochloride and acepromazine in clinically normal dogs","Stephan DD, Vestre WA, Stiles J, Krohne S.","Vet Ophthalmol. 2003 Mar;6(1):73-6. doi: 10.1046/j.1463-5224.2003.t01-1-00273.x.","Stephan DD","Vet Ophthalmol","2003","2003/03/19","","","10.1046/j.1463-5224.2003.t01-1-00273.x"
"12618536","Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality, part I","Armstrong SC, Cozza KL.","Psychosomatics. 2003 Mar-Apr;44(2):167-71. doi: 10.1176/appi.psy.44.2.167.","Armstrong SC","Psychosomatics","2003","2003/03/06","","","10.1176/appi.psy.44.2.167"
"12615487","Antinociceptive effects of hydromorphone, bupivacaine and biphalin released from PLGA polymer after intrathecal implantation in rats","Sendil D, Bonney IM, Carr DB, Lipkowski AW, Wise DL, Hasirci V.","Biomaterials. 2003 May;24(11):1969-76. doi: 10.1016/s0142-9612(02)00567-7.","Sendil D","Biomaterials","2003","2003/03/05","","","10.1016/s0142-9612(02)00567-7"
"12590032","A systematic review of hydromorphone in acute and chronic pain","Quigley C, Wiffen P.","J Pain Symptom Manage. 2003 Feb;25(2):169-78. doi: 10.1016/s0885-3924(02)00643-7.","Quigley C","J Pain Symptom Manage","2003","2003/02/19","","","10.1016/s0885-3924(02)00643-7"
"12587803","Hydromorphone transfer into breast milk after intranasal administration","Edwards JE, Rudy AC, Wermeling DP, Desai N, McNamara PJ.","Pharmacotherapy. 2003 Feb;23(2):153-8. doi: 10.1592/phco.23.2.153.32081.","Edwards JE","Pharmacotherapy","2003","2003/02/18","","","10.1592/phco.23.2.153.32081"
"12570846","Opioid ligands having delayed long-term antagonist activity: potential pharmacotherapies for opioid abuse","Husbands SM, Lewis JW.","Mini Rev Med Chem. 2003 Mar;3(2):137-44. doi: 10.2174/1389557033405395.","Husbands SM","Mini Rev Med Chem","2003","2003/02/07","","","10.2174/1389557033405395"
"12564595","Postoperative hypoxemia and hypercarbia in healthy dogs undergoing routine ovariohysterectomy or castration and receiving butorphanol or hydromorphone for analgesia","Campbell VL, Drobatz KJ, Perkowski SZ.","J Am Vet Med Assoc. 2003 Feb 1;222(3):330-6. doi: 10.2460/javma.2003.222.330.","Campbell VL","J Am Vet Med Assoc","2003","2003/02/05","","","10.2460/javma.2003.222.330"
"12513698","Activity of opioid ligands in cells expressing cloned mu opioid receptors","Gharagozlou P, Demirci H, David Clark J, Lameh J.","BMC Pharmacol. 2003 Jan 4;3:1. doi: 10.1186/1471-2210-3-1. Epub 2003 Jan 4.","Gharagozlou P","BMC Pharmacol","2003","2003/01/07","PMC140036","","10.1186/1471-2210-3-1"
"12477234","Opioid rotation in the treatment of joint pain. A review of 67 cases","Grilo RM, Bertin P, Scotto di Fazano C, Coyral D, Bonnet C, Vergne P, Treves R.","Joint Bone Spine. 2002 Oct;69(5):491-4. doi: 10.1016/s1297-319x(02)00435-9.","Grilo RM","Joint Bone Spine","2002","2002/12/13","","","10.1016/s1297-319x(02)00435-9"
"12357147","Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers","Drover DR, Angst MS, Valle M, Ramaswamy B, Naidu S, Stanski DR, Verotta D.","Anesthesiology. 2002 Oct;97(4):827-36. doi: 10.1097/00000542-200210000-00013.","Drover DR","Anesthesiology","2002","2002/10/03","","","10.1097/00000542-200210000-00013"
"12113823","A convenient synthesis of delta(7,8)-morphinan-6-one and its direct oxidation to 14-hydroxy-delta(7,8)-morphinan-6-one","Passarella D, Consonni A, Giardini A, Lesma G, Silvani A.","Bioorg Med Chem Lett. 2002 Aug 5;12(15):1981-3. doi: 10.1016/s0960-894x(02)00280-9.","Passarella D","Bioorg Med Chem Lett","2002","2002/07/13","","","10.1016/s0960-894x(02)00280-9"
"12067873","The addition of hydromorphone to epidural fentanyl does not affect analgesia in early labour","Parker RK, Connelly NR, Lucas T, Faheem U, Rizvi AS, El-Mansouri M, Thakkar N, Kamasumadram R, Dixon K, Dunn SM, Gibson C.","Can J Anaesth. 2002 Jun-Jul;49(6):600-4. doi: 10.1007/BF03017388.","Parker RK","Can J Anaesth","2002","2002/06/18","","","10.1007/BF03017388"
"12065064","Hydromorphone metabolites: isolation and identification from pooled urine samples of a cancer patient","Zheng M, McErlane KM, Ong MC.","Xenobiotica. 2002 May;32(5):427-39. doi: 10.1080/00498250110119090.","Zheng M","Xenobiotica","2002","2002/06/18","","","10.1080/00498250110119090"
"12057002","Separating politics and scientific research on heroin prescription","Wodak AD, Ritter AJ, Watson CR.","Med J Aust. 2002 May 6;176(9):449; author reply 450.","Wodak AD","Med J Aust","2002","2002/06/12","","",""
"12032023","The role of spinal opioid receptors in antinociceptive effects produced by intrathecal administration of hydromorphone and buprenorphine in the rat","Tejwani GA, Rattan AK.","Anesth Analg. 2002 Jun;94(6):1542-6, table of contents. doi: 10.1097/00000539-200206000-00031.","Tejwani GA","Anesth Analg","2002","2002/05/29","","","10.1097/00000539-200206000-00031"
"12027962","Pain and suffering in an adolescent with neuroblastoma","Paice JA.","Cancer Pract. 2002 May-Jun;10 Suppl 1:S4-8. doi: 10.1046/j.1523-5394.10.s.1.4.x.","Paice JA","Cancer Pract","2002","2002/05/25","","","10.1046/j.1523-5394.10.s.1.4.x"
"12007754","Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain","Palangio M, Northfelt DW, Portenoy RK, Brookoff D, Doyle RT Jr, Dornseif BE, Damask MC.","J Pain Symptom Manage. 2002 May;23(5):355-68. doi: 10.1016/s0885-3924(02)00390-1.","Palangio M","J Pain Symptom Manage","2002","2002/05/15","","","10.1016/s0885-3924(02)00390-1"
"12003071","Assessment of biodegradable controlled release rod systems for pain relief applications","Sendil D, Wise DL, Hasirci V.","J Biomater Sci Polym Ed. 2002;13(1):1-15. doi: 10.1163/156856202753525891.","Sendil D","J Biomater Sci Polym Ed","2002","2002/05/11","","","10.1163/156856202753525891"
"11991534","The simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, 6-acetylmorphine, and oxycodone in hair and oral fluid","Jones J, Tomlinson K, Moore C.","J Anal Toxicol. 2002 Apr;26(3):171-5. doi: 10.1093/jat/26.3.171.","Jones J","J Anal Toxicol","2002","2002/05/07","","","10.1093/jat/26.3.171"
"11973924","[New opioid preparations in the treatment of pain]","Kalso E.","Duodecim. 1999;115(20):2211-4.","Kalso E","Duodecim","1999","2002/04/27","","",""
"11973209","Continuous epidural infusion of 0.05% bupivacaine plus hydromorphone for labor analgesia: an observational assessment in 1830 parturients","Sinatra RS, Eige S, Chung JH, Chung KS, Sevarino FB, Lobo A, Fermo L, Ocampo CA.","Anesth Analg. 2002 May;94(5):1310-1, table of contents. doi: 10.1097/00000539-200205000-00047.","Sinatra RS","Anesth Analg","2002","2002/04/26","","","10.1097/00000539-200205000-00047"
"11973005","Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain","Moryl N, Santiago-Palma J, Kornick C, Derby S, Fischberg D, Payne R, Manfredi PL.","Pain. 2002 Apr;96(3):325-8. doi: 10.1016/s0304-3959(01)00465-1.","Moryl N","Pain","2002","2002/04/26","","","10.1016/s0304-3959(01)00465-1"
"11963297","[Opioid rotation in pain therapy. Case report]","Kefalianakis F, Kugler M, van der Auwera R, Kugler G.","Anaesthesist. 2002 Jan;51(1):28-32. doi: 10.1007/s101-002-8368-9.","Kefalianakis F","Anaesthesist","2002","2002/04/20","","","10.1007/s101-002-8368-9"
"11936695","Simultaneous determination of hydrocodone and hydromorphone in human plasma by liquid chromatography with tandem mass spectrometric detection","Chen YL, Hanson GD, Jiang X, Naidong W.","J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Mar 25;769(1):55-64. doi: 10.1016/s1570-0232(01)00616-x.","Chen YL","J Chromatogr B Analyt Technol Biomed Life Sci","2002","2002/04/09","","","10.1016/s1570-0232(01)00616-x"
"11936289","Breaking the deadlock over an Australian trial of injectable opioid maintenance","Hall WD, Kimber J, Mattick RP.","Med J Aust. 2002 Jan 21;176(2):72-3.","Hall WD","Med J Aust","2002","2002/04/09","","",""
"11886060","Use of continuous ambulatory infusions of concentrated subcutaneous (s.q.) hydromorphone versus intravenous (i.v.) morphine: cost implications for palliative care","Fudin J, Smith HS, Toledo-Binette CS, Kenney E, Yu AB, Boutin R.","Am J Hosp Palliat Care. 2000 Sep-Oct;17(5):347-53. doi: 10.1177/104990910001700513.","Fudin J","Am J Hosp Palliat Care","2000","2002/03/12","","","10.1177/104990910001700513"
"11886040","Nebulized hydromorphone for dyspnea in hospice care of advanced cancer","Sarhill N, Walsh D, Khawam E, Tropiano P, Stahley MK.","Am J Hosp Palliat Care. 2000 Nov-Dec;17(6):389-91. doi: 10.1177/104990910001700609.","Sarhill N","Am J Hosp Palliat Care","2000","2002/03/12","","","10.1177/104990910001700609"
"11869661","Hydromorphone for acute and chronic pain","Quigley C.","Cochrane Database Syst Rev. 2002;(1):CD003447. doi: 10.1002/14651858.CD003447.","Quigley C","Cochrane Database Syst Rev","2002","2002/03/01","","","10.1002/14651858.CD003447"
"11868970","LC-MS-MS analysis of hydromorphone and hydromorphone metabolites with application to a pharmacokinetic study in the male Sprague-Dawley rat","Zheng M, McErlane KM, Ong MC.","Xenobiotica. 2002 Feb;32(2):141-51. doi: 10.1080/00498250110091767.","Zheng M","Xenobiotica","2002","2002/03/01","","","10.1080/00498250110091767"
"11862344","Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine","Strain EC, Walsh SL, Bigelow GE.","Psychopharmacology (Berl). 2002 Jan;159(2):161-6. doi: 10.1007/s002130100920. Epub 2001 Oct 12.","Strain EC","Psychopharmacology (Berl)","2002","2002/02/28","","","10.1007/s002130100920"
"11859695","[New Level III opioids of the World Health Organization]","Laval G, Sang B, Mallaret M, Villard ML.","Rev Med Interne. 2002 Jan;23(1):55-70. doi: 10.1016/s0248-8663(01)00515-x.","Laval G","Rev Med Interne","2002","2002/02/28","","","10.1016/s0248-8663(01)00515-x"
"11817492","Effects of an opioid taper algorithm in hematopoietic progenitor cell transplant recipients","Parran L, Pederson C.","Oncol Nurs Forum. 2002 Jan-Feb;29(1):41-50. doi: 10.1188/02.ONF.41-50.","Parran L","Oncol Nurs Forum","2002","2002/01/31","","","10.1188/02.ONF.41-50"
"11794005","Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in subjects with moderate hepatic impairment","Durnin C, Hind ID, Ghani SP, Yates DB, Molz KH.","Proc West Pharmacol Soc. 2001;44:83-4.","Durnin C","Proc West Pharmacol Soc","2001","2002/01/17","","",""
"11794004","Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in subjects with renal impairment","Durnin C, Hind ID, Wickens MM, Yates DB, Molz KH.","Proc West Pharmacol Soc. 2001;44:81-2.","Durnin C","Proc West Pharmacol Soc","2001","2002/01/17","","",""
"11794003","Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in young and elderly subjects","Durnin C, Hind ID, Ghani SP, Yates DB, Cross M.","Proc West Pharmacol Soc. 2001;44:79-80.","Durnin C","Proc West Pharmacol Soc","2001","2002/01/17","","",""
"11794002","Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in male and female subjects","Durnin C, Hind ID, Ghani SP, Yates DB, Gegg J.","Proc West Pharmacol Soc. 2001;44:77-8.","Durnin C","Proc West Pharmacol Soc","2001","2002/01/17","","",""
"11794001","Effect of food on the pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR)","Durnin C, Hind ID, Channon E, Yates DB, Cross M.","Proc West Pharmacol Soc. 2001;44:75-6.","Durnin C","Proc West Pharmacol Soc","2001","2002/01/17","","",""
"11794000","Dose proportionality of the pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR)","Durnin C, Hind ID, Ghani SP, Yates DB, Cross M.","Proc West Pharmacol Soc. 2001;44:73-4.","Durnin C","Proc West Pharmacol Soc","2001","2002/01/17","","",""
"11755345","Synthesis and biological activity of 8beta-substituted hydrocodone indole and hydromorphone indole derivatives","Yu H, Prisinzano T, Dersch CM, Marcus J, Rothman RB, Jacobson AE, Rice KC.","Bioorg Med Chem Lett. 2002 Jan 21;12(2):165-8. doi: 10.1016/s0960-894x(01)00689-8.","Yu H","Bioorg Med Chem Lett","2002","2002/01/05","","","10.1016/s0960-894x(01)00689-8"
"11738167","Stability and compatibility of hydromorphone hydrochloride in an implantable infusion system","Hildebrand KR, Elsberry DE, Anderson VC.","J Pain Symptom Manage. 2001 Dec;22(6):1042-7. doi: 10.1016/s0885-3924(01)00364-5.","Hildebrand KR","J Pain Symptom Manage","2001","2001/12/12","","","10.1016/s0885-3924(01)00364-5"
"11707825","A randomized, placebo-controlled study of outpatient premedication for bone marrow biopsy in adults with lymphoma","Wolanskyj AP, Schroeder G, Wilson PR, Habermann TM, Inwards DJ, Witzig TE.","Clin Lymphoma. 2000 Sep;1(2):154-7. doi: 10.3816/clm.2000.n.014.","Wolanskyj AP","Clin Lymphoma","2000","2001/11/15","","","10.3816/clm.2000.n.014"
"11702324","[Postoperative pain therapy with hydromorphone and metamizole. A prospective randomized study in intravenous patient-controlled analgesia (PCA)]","Lehmann KA, Paral F, Sabatowski R.","Anaesthesist. 2001 Oct;50(10):750-6. doi: 10.1007/s001010100206.","Lehmann KA","Anaesthesist","2001","2001/11/13","","","10.1007/s001010100206"
"11696132","Anisocoria from transdermal scopolamine","Lin YC.","Paediatr Anaesth. 2001;11(5):626-7. doi: 10.1046/j.1460-9592.2001.00744.x.","Lin YC","Paediatr Anaesth","2001","2001/11/07","","","10.1046/j.1460-9592.2001.00744.x"
"11594439","Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans","Walsh SL, Strain EC, Abreu ME, Bigelow GE.","Psychopharmacology (Berl). 2001 Sep;157(2):151-62. doi: 10.1007/s002130100788.","Walsh SL","Psychopharmacology (Berl)","2001","2001/10/12","","","10.1007/s002130100788"
"11587115","Stability, compatibility, and safety of intrathecal bupivacaine administered chronically via an implantable delivery system","Hildebrand KR, Elsberry DD, Deer TR.","Clin J Pain. 2001 Sep;17(3):239-44. doi: 10.1097/00002508-200109000-00009.","Hildebrand KR","Clin J Pain","2001","2001/10/06","","","10.1097/00002508-200109000-00009"
"11535415","Engineering novel biocatalytic routes for production of semisynthetic opiate drugs","Boonstra B, Rathbone DA, Bruce NC.","Biomol Eng. 2001 Sep;18(2):41-7. doi: 10.1016/s1389-0344(01)00084-3.","Boonstra B","Biomol Eng","2001","2001/09/06","","","10.1016/s1389-0344(01)00084-3"
"11459432","Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide","Wright AW, Mather LE, Smith MT.","Life Sci. 2001 Jun 15;69(4):409-20. doi: 10.1016/s0024-3205(01)01133-x.","Wright AW","Life Sci","2001","2001/07/19","","","10.1016/s0024-3205(01)01133-x"
"11389401","Postoperative pain control using epidural catheters after anterior spinal fusion for adolescent scoliosis","Lowry KJ, Tobias J, Kittle D, Burd T, Gaines RW.","Spine (Phila Pa 1976). 2001 Jun 1;26(11):1290-3. doi: 10.1097/00007632-200106010-00024.","Lowry KJ","Spine (Phila Pa 1976)","2001","2001/06/05","","","10.1097/00007632-200106010-00024"
"11351930","Effects of buprenorphine/naloxone in opioid-dependent humans","Stoller KB, Bigelow GE, Walsh SL, Strain EC.","Psychopharmacology (Berl). 2001 Mar;154(3):230-42. doi: 10.1007/s002130000637.","Stoller KB","Psychopharmacology (Berl)","2001","2001/05/16","","","10.1007/s002130000637"
"11318359","Effects of hydromorphone or oxymorphone, with or without acepromazine, on preanesthetic sedation, physiologic values, and histamine release in dogs","Smith LJ, Yu JK, Bjorling DE, Waller K.","J Am Vet Med Assoc. 2001 Apr 1;218(7):1101-5. doi: 10.2460/javma.2001.218.1101.","Smith LJ","J Am Vet Med Assoc","2001","2001/04/25","","","10.2460/javma.2001.218.1101"
"11305075","Hydromorphone: pharmacology and clinical applications in cancer patients","Sarhill N, Walsh D, Nelson KA.","Support Care Cancer. 2001 Mar;9(2):84-96. doi: 10.1007/s005200000183.","Sarhill N","Support Care Cancer","2001","2001/04/18","","","10.1007/s005200000183"
"11292009","Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans","Abreu ME, Bigelow GE, Fleisher L, Walsh SL.","Psychopharmacology (Berl). 2001 Feb;154(1):76-84. doi: 10.1007/s002130000624.","Abreu ME","Psychopharmacology (Berl)","2001","2001/04/09","","","10.1007/s002130000624"
"11291670","The diagnosis and treatment of cough","Kakaiya R, Wamhoff J.","N Engl J Med. 2001 Apr 5;344(14):1097-8. doi: 10.1056/NEJM200104053441413.","Kakaiya R","N Engl J Med","2001","2001/04/09","","","10.1056/NEJM200104053441413"
"11240879","A dual epidural catheter technique to provide analgesia following posterior spinal fusion for scoliosis in children and adolescents","Tobias JD, Gaines RW, Lowry KJ, Kittle D, Bildner C.","Paediatr Anaesth. 2001 Mar;11(2):199-203. doi: 10.1046/j.1460-9592.2001.00632.x.","Tobias JD","Paediatr Anaesth","2001","2001/03/10","","","10.1046/j.1460-9592.2001.00632.x"
"11237376","Morphine and alternative opioids in cancer pain: the EAPC recommendations","Hanks GW, Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier J, Poulain P, Ripamonti C, Radbruch L, Casas JR, Sawe J, Twycross RG, Ventafridda V; Expert Working Group of the Research Network of the European Association for Palliative Care.","Br J Cancer. 2001 Mar 2;84(5):587-93. doi: 10.1054/bjoc.2001.1680.","Hanks GW","Br J Cancer","2001","2001/03/10","PMC2363790","","10.1054/bjoc.2001.1680"
"11227223","Hydromorphone","Pasero C, McCaffery M.","Am J Nurs. 2001 Feb;101(2):22-3. doi: 10.1097/00000446-200102000-00027.","Pasero C","Am J Nurs","2001","2001/03/03","","","10.1097/00000446-200102000-00027"
"11212464","Retrospective study of the use of hydromorphone in palliative care patients with normal and abnormal urea and creatinine","Lee MA, Leng ME, Tiernan EJ.","Palliat Med. 2001 Jan;15(1):26-34. doi: 10.1191/026921601669626431.","Lee MA","Palliat Med","2001","2001/02/24","","","10.1191/026921601669626431"
"11198720","Pretreatment with hydromorphone, a mu-opioid agonist, does not alter the acute behavioral and physiological effects of ethanol in humans","Rush CR.","Alcohol Clin Exp Res. 2001 Jan;25(1):9-17.","Rush CR","Alcohol Clin Exp Res","2001","2001/02/24","","",""
"11194479","[Opioids. Pharmacology, clinic, prospectives for an extensive use]","Ginobbi P, Tirelli W, D'Angiolino G, Ciocca F, Centulio F, Pelagalli L, Marcelli ME, Arcuri E.","Recenti Prog Med. 2000 Dec;91(12):621-7.","Ginobbi P","Recenti Prog Med","2000","2001/02/24","","",""
"11190708","Effect of pre-emptive hydromorphone administration on postoperative pain relief--a randomized controlled trial","Kopp A, Wachauer D, Hoerauf KH, Zulus E, Reiter WJ, Steltzer H.","Wien Klin Wochenschr. 2000 Dec 7;112(23):1002-6.","Kopp A","Wien Klin Wochenschr","2000","2001/02/24","","",""
"11153786","Successful treatment of erythromelalgia with intrathecal hydromorphone and clonidine","Macres S, Richeimer S.","Clin J Pain. 2000 Dec;16(4):310-3. doi: 10.1097/00002508-200012000-00006.","Macres S","Clin J Pain","2000","2001/01/12","","","10.1097/00002508-200012000-00006"
"11150979","Radial entrapment neuropathy due to chronic injection-induced triceps fibrosis","Midroni G, Moulton R.","Muscle Nerve. 2001 Jan;24(1):134-7. doi: 10.1002/1097-4598(200101)24:1<134::aid-mus21>3.0.co;2-a.","Midroni G","Muscle Nerve","2001","2001/01/11","","","10.1002/1097-4598(200101)24:1<134::aid-mus21>3.0.co;2-a"
"11135723","Pharmacodynamics of orally administered sustained- release hydromorphone in humans","Angst MS, Drover DR, Lötsch J, Ramaswamy B, Naidu S, Wada DR, Stanski DR.","Anesthesiology. 2001 Jan;94(1):63-73. doi: 10.1097/00000542-200101000-00014.","Angst MS","Anesthesiology","2001","2001/01/03","","","10.1097/00000542-200101000-00014"
"11097884","Cofactor regeneration by a soluble pyridine nucleotide transhydrogenase for biological production of hydromorphone","Boonstra B, Rathbone DA, French CE, Walker EH, Bruce NC.","Appl Environ Microbiol. 2000 Dec;66(12):5161-6. doi: 10.1128/aem.66.12.5161-5166.2000.","Boonstra B","Appl Environ Microbiol","2000","2000/12/01","PMC92438","","10.1128/aem.66.12.5161-5166.2000"
"11041313","Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers","Hill JL, Zacny JP.","Psychopharmacology (Berl). 2000 Sep;152(1):31-9. doi: 10.1007/s002130000500.","Hill JL","Psychopharmacology (Berl)","2000","2000/10/21","","","10.1007/s002130000500"
"11027904","Pain responses in methadone-maintained opioid abusers","Compton P, Charuvastra VC, Kintaudi K, Ling W.","J Pain Symptom Manage. 2000 Oct;20(4):237-45. doi: 10.1016/s0885-3924(00)00191-3.","Compton P","J Pain Symptom Manage","2000","2000/10/12","","","10.1016/s0885-3924(00)00191-3"
"10991968","Effects of agonist-antagonist opioids in humans trained in a hydromorphone/not hydromorphone discrimination","Preston KL, Bigelow GE.","J Pharmacol Exp Ther. 2000 Oct;295(1):114-24.","Preston KL","J Pharmacol Exp Ther","2000","2000/09/19","","",""
"10975245","Development and validation of a sensitive method for hydromorphone in human plasma by normal phase liquid chromatography-tandem mass spectrometry","Naidong W, Jiang X, Newland K, Coe R, Lin P, Lee J.","J Pharm Biomed Anal. 2000 Sep;23(4):697-704. doi: 10.1016/s0731-7085(00)00352-6.","Naidong W","J Pharm Biomed Anal","2000","2000/09/07","","","10.1016/s0731-7085(00)00352-6"
"10956427","Endogenous generation of cyanide in neuronal tissue: involvement of a peroxidase system","Gunasekar PG, Borowitz JL, Turek JJ, Van Horn DA, Isom GE.","J Neurosci Res. 2000 Sep 1;61(5):570-5. doi: 10.1002/1097-4547(20000901)61:5<570::AID-JNR12>3.0.CO;2-V.","Gunasekar PG","J Neurosci Res","2000","2000/08/24","","","10.1002/1097-4547(20000901)61:5<570::AID-JNR12>3.0.CO;2-V"
"10928310","Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers","Strain EC, Stoller K, Walsh SL, Bigelow GE.","Psychopharmacology (Berl). 2000 Mar;148(4):374-83. doi: 10.1007/s002130050066.","Strain EC","Psychopharmacology (Berl)","2000","2000/08/06","","","10.1007/s002130050066"
"10874511","Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites","Smith MT.","Clin Exp Pharmacol Physiol. 2000 Jul;27(7):524-8. doi: 10.1046/j.1440-1681.2000.03290.x.","Smith MT","Clin Exp Pharmacol Physiol","2000","2000/06/30","","","10.1046/j.1440-1681.2000.03290.x"
"10852454","Endocrine consequences of long-term intrathecal administration of opioids","Abs R, Verhelst J, Maeyaert J, Van Buyten JP, Opsomer F, Adriaensen H, Verlooy J, Van Havenbergh T, Smet M, Van Acker K.","J Clin Endocrinol Metab. 2000 Jun;85(6):2215-22. doi: 10.1210/jcem.85.6.6615.","Abs R","J Clin Endocrinol Metab","2000","2000/06/14","","","10.1210/jcem.85.6.6615"
"10852088","Hypertensive crisis and myocardial infarction following massive clonidine overdose","Frye CB, Vance MA.","Ann Pharmacother. 2000 May;34(5):611-5. doi: 10.1345/aph.19257.","Frye CB","Ann Pharmacother","2000","2000/06/14","","","10.1345/aph.19257"
"10838761","[Evaluation of methods of trace analysis of various opiates including hydrocodone and hydromorphone in the blood and urine using gas chromatography-mass spectrometry]","Balíková M, Maresová V, Habrdová V.","Soud Lek. 2000 Jan;45(1):11-6.","Balíková M","Soud Lek","2000","2000/06/06","","",""
"10755497","Trends in medical use and abuse of opioid analgesics","Joranson DE, Ryan KM, Gilson AM, Dahl JL.","JAMA. 2000 Apr 5;283(13):1710-4. doi: 10.1001/jama.283.13.1710.","Joranson DE","JAMA","2000","2001/02/07","","","10.1001/jama.283.13.1710"
"10736080","Continuous epidural butorphanol relieves pruritus associated with epidural morphine infusions in children","Gunter JB, McAuliffe J, Gregg T, Weidner N, Varughese AM, Sweeney DM.","Paediatr Anaesth. 2000;10(2):167-72. doi: 10.1046/j.1460-9592.2000.00447.x.","Gunter JB","Paediatr Anaesth","2000","2000/03/29","","","10.1046/j.1460-9592.2000.00447.x"
"10723604","Hydromorphone: a cost-effective alternative to the use of oxymorphone","Pettifer G, Dyson D.","Can Vet J. 2000 Feb;41(2):135-7.","Pettifer G","Can Vet J","2000","2000/03/21","PMC1476286","",""
"10701990","Distinction among eight opiate drugs in urine by gas chromatography-mass spectrometry","Nowatzke W, Zeng J, Saunders A, Bohrer A, Koenig J, Turk J.","J Pharm Biomed Anal. 1999 Sep;20(5):815-28. doi: 10.1016/s0731-7085(99)00086-2.","Nowatzke W","J Pharm Biomed Anal","1999","2000/03/04","","","10.1016/s0731-7085(99)00086-2"
"10642529","Mechanistic studies of morphine dehydrogenase and stabilization against covalent inactivation","Walker EH, French CE, Rathbone DA, Bruce NC.","Biochem J. 2000 Feb 1;345 Pt 3(Pt 3):687-92.","Walker EH","Biochem J","2000","2000/01/22","PMC1220805","",""
"10547561","Opioid rotation for cancer pain: rationale and clinical aspects","Mercadante S.","Cancer. 1999 Nov 1;86(9):1856-66. doi: 10.1002/(sici)1097-0142(19991101)86:9<1856::aid-cncr30>3.0.co;2-g.","Mercadante S","Cancer","1999","1999/11/05","","","10.1002/(sici)1097-0142(19991101)86:9<1856::aid-cncr30>3.0.co;2-g"
"10542852","Opioid conversion guidelines for managing adult cancer pain","Derby SA.","Am J Nurs. 1999 Oct;99(10):62-5.","Derby SA","Am J Nurs","1999","1999/10/30","","",""
"10529021","Opioid reinforcement in heroin-dependent volunteers during outpatient buprenorphine maintenance","Greenwald MK, Johanson CE, Schuster CR.","Drug Alcohol Depend. 1999 Oct 1;56(3):191-203. doi: 10.1016/s0376-8716(99)00032-0.","Greenwald MK","Drug Alcohol Depend","1999","1999/10/21","","","10.1016/s0376-8716(99)00032-0"
"10515308","Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans","Kollins SH, Rush CR.","Pharmacol Biochem Behav. 1999 Oct;64(2):319-26. doi: 10.1016/s0091-3057(99)00084-2.","Kollins SH","Pharmacol Biochem Behav","1999","1999/10/09","","","10.1016/s0091-3057(99)00084-2"
"10465924","Comparison of subcutaneous hydromorphone with intramuscular meperidine for immediate postoperative analgesia","Chan WH, Lin CJ, Sun WZ, Tsai SP, Tsai SK, Hsieh CY.","Kaohsiung J Med Sci. 1999 Jul;15(7):419-27.","Chan WH","Kaohsiung J Med Sci","1999","1999/08/31","","",""
"10463317","Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans","Schuh KJ, Walsh SL, Stitzer ML.","Psychopharmacology (Berl). 1999 Jul;145(2):162-74. doi: 10.1007/s002130051045.","Schuh KJ","Psychopharmacology (Berl)","1999","1999/08/27","","","10.1007/s002130051045"
"10447905","Comparison of epidural morphine, hydromorphone and fentanyl for postoperative pain control in children undergoing orthopaedic surgery","Goodarzi M.","Paediatr Anaesth. 1999;9(5):419-22. doi: 10.1046/j.1460-9592.1999.00370.x.","Goodarzi M","Paediatr Anaesth","1999","1999/08/14","","","10.1046/j.1460-9592.1999.00370.x"
"10439568","Continuous subcutaneous infusion of morphine vs. hydromorphone: a controlled trial","Miller MG, McCarthy N, O'Boyle CA, Kearney M.","J Pain Symptom Manage. 1999 Jul;18(1):9-16. doi: 10.1016/s0885-3924(99)00036-6.","Miller MG","J Pain Symptom Manage","1999","1999/08/10","","","10.1016/s0885-3924(99)00036-6"
"10422926","The relationship between the visual analog pain intensity and pain relief scale changes during analgesic drug studies in chronic pain patients","Angst MS, Brose WG, Dyck JB.","Anesthesiology. 1999 Jul;91(1):34-41. doi: 10.1097/00000542-199907000-00009.","Angst MS","Anesthesiology","1999","1999/07/28","","","10.1097/00000542-199907000-00009"
"10372797","Inhibitors of cytochrome P450 differentially modify discriminative-stimulus and antinociceptive effects of hydrocodone and hydromorphone in rhesus monkeys","Lelas S, Wegert S, Otton SV, Sellers EM, France CP.","Drug Alcohol Depend. 1999 May 3;54(3):239-49. doi: 10.1016/s0376-8716(98)00169-0.","Lelas S","Drug Alcohol Depend","1999","1999/06/18","","","10.1016/s0376-8716(98)00169-0"
"10369327","GC-MS confirmation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in urine","Meatherall R.","J Anal Toxicol. 1999 May-Jun;23(3):177-86. doi: 10.1093/jat/23.3.177.","Meatherall R","J Anal Toxicol","1999","1999/06/16","","","10.1093/jat/23.3.177"
"10342892","Use of combined oral narcotic and benzodiazepine for control of pain associated with bone marrow examination","Dunlop TJ, Deen C, Lind S, Voyle RJ, Prichard JG.","South Med J. 1999 May;92(5):477-80. doi: 10.1097/00007611-199905000-00005.","Dunlop TJ","South Med J","1999","1999/05/26","","","10.1097/00007611-199905000-00005"
"10336539","Subjective, psychomotor, and physiological effects of cumulative doses of opioid mu agonists in healthy volunteers","Walker DJ, Zacny JP.","J Pharmacol Exp Ther. 1999 Jun;289(3):1454-64.","Walker DJ","J Pharmacol Exp Ther","1999","1999/05/21","","",""
"10336526","Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure","Jones HE, Bigelow GE, Preston KL.","J Pharmacol Exp Ther. 1999 Jun;289(3):1350-61.","Jones HE","J Pharmacol Exp Ther","1999","1999/05/21","","",""
"10228449","[Production of morphinone as a metabolite of morphine and its physiological role]","Toki S, Yamano S.","Yakugaku Zasshi. 1999 Apr;119(4):249-67. doi: 10.1248/yakushi1947.119.4_249.","Toki S","Yakugaku Zasshi","1999","1999/05/06","","","10.1248/yakushi1947.119.4_249"
"10196915","Analgesics in the management of chronic pain. Part four: Step 3 oral analgesic drug therapy","MacConnachie AM.","Intensive Crit Care Nurs. 1998 Dec;14(6):318-9. doi: 10.1016/s0964-3397(98)80693-9.","MacConnachie AM","Intensive Crit Care Nurs","1998","1999/04/10","","","10.1016/s0964-3397(98)80693-9"
"10030533","Stability of tacrolimus with morphine sulfate, hydromorphone hydrochloride, and ceftazidime during simulated intravenous coadministration","Johnson CE, VandenBussche HL, Chio CC, Jacobson PA.","Am J Health Syst Pharm. 1999 Jan 15;56(2):164-9. doi: 10.1093/ajhp/56.2.164.","Johnson CE","Am J Health Syst Pharm","1999","1999/02/25","","","10.1093/ajhp/56.2.164"
"9919868","Opioid-induced itching: morphine sulfate and hydromorphone hydrochloride","Katcher J, Walsh D.","J Pain Symptom Manage. 1999 Jan;17(1):70-2. doi: 10.1016/s0885-3924(98)00115-8.","Katcher J","J Pain Symptom Manage","1999","1999/01/27","","","10.1016/s0885-3924(98)00115-8"
"9862079","Opioid discrimination in humans: discriminative and subjective effects of progressively lower training dose","Preston KL, Bigelow GE.","Behav Pharmacol. 1998 Nov;9(7):533-43. doi: 10.1097/00008877-199811000-00009.","Preston KL","Behav Pharmacol","1998","1998/12/23","","","10.1097/00008877-199811000-00009"
"9848042","A comparison of oral transmucosal fentanyl citrate and oral hydromorphone for inpatient pediatric burn wound care analgesia","Sharar SR, Bratton SL, Carrougher GJ, Edwards WT, Summer G, Levy FH, Cortiella J.","J Burn Care Rehabil. 1998 Nov-Dec;19(6):516-21. doi: 10.1097/00004630-199811000-00010.","Sharar SR","J Burn Care Rehabil","1998","1998/12/16","","","10.1097/00004630-199811000-00010"
"9755025","Comment on Manfredi et al.,Pain, 70 (1997) 199-101","River Y, Belgrade M.","Pain. 1998 Jul;77(1):103-4.","River Y","Pain","1998","1998/10/01","","",""
"9714427","Hydromorphone-3-glucuronide: biochemical synthesis and preliminary pharmacological evaluation","Wright AW, Nocente ML, Smith MT.","Life Sci. 1998;63(5):401-11. doi: 10.1016/s0024-3205(98)00288-4.","Wright AW","Life Sci","1998","1998/08/26","","","10.1016/s0024-3205(98)00288-4"
"9634804","Biological production of semisynthetic opiates using genetically engineered bacteria","French CE, Hailes AM, Rathbone DA, Long MT, Willey DL, Bruce NC.","Biotechnology (N Y). 1995 Jul;13(7):674-6. doi: 10.1038/nbt0795-674.","French CE","Biotechnology (N Y)","1995","1995/07/01","","","10.1038/nbt0795-674"
"9608349","Hydromorphone-naloxone combinations in opioid-dependent humans under a naloxone novel-response discrimination procedure","Oliveto AH, Rosen MI, Kosten TA, Hameedi FA, Woods SW, Kosten TR.","Exp Clin Psychopharmacol. 1998 May;6(2):169-78. doi: 10.1037//1064-1297.6.2.169.","Oliveto AH","Exp Clin Psychopharmacol","1998","1998/06/03","","","10.1037//1064-1297.6.2.169"
"9588567","Spinal cord compression by catheter granulomas in high-dose intrathecal morphine therapy: case report","Cabbell KL, Taren JA, Sagher O.","Neurosurgery. 1998 May;42(5):1176-80; discussion 1180-1. doi: 10.1097/00006123-199805000-00142.","Cabbell KL","Neurosurgery","1998","1998/05/20","","","10.1097/00006123-199805000-00142"
"9580575","Dose-response analysis of opioid cross-tolerance and withdrawal suppression during LAAM maintenance","Houtsmuller EJ, Walsh SL, Schuh KJ, Johnson RE, Stitzer ML, Bigelow GE.","J Pharmacol Exp Ther. 1998 May;285(2):387-96.","Houtsmuller EJ","J Pharmacol Exp Ther","1998","1998/05/15","","",""
"9545990","Site of opioid action in the human brain: mu and kappa agonists' subjective and cerebral blood flow effects","Schlaepfer TE, Strain EC, Greenberg BD, Preston KL, Lancaster E, Bigelow GE, Barta PE, Pearlson GD.","Am J Psychiatry. 1998 Apr;155(4):470-3. doi: 10.1176/ajp.155.4.470.","Schlaepfer TE","Am J Psychiatry","1998","1998/04/18","","","10.1176/ajp.155.4.470"
"9541687","Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences","Ripamonti C, De Conno F, Groff L, Belzile M, Pereira J, Hanson J, Bruera E.","Ann Oncol. 1998 Jan;9(1):79-83. doi: 10.1023/a:1008263910494.","Ripamonti C","Ann Oncol","1998","1998/05/30","","","10.1023/a:1008263910494"
"9539612","Diaphragmatic paralysis complicating alcohol splanchnic nerve block","Rosenthal JA.","Anesth Analg. 1998 Apr;86(4):845-6. doi: 10.1097/00000539-199804000-00030.","Rosenthal JA","Anesth Analg","1998","1998/04/16","","","10.1097/00000539-199804000-00030"
"9437625","Hydromorphone polymer implant. A potential alternative to methadone maintenance","Rhodes DJ, Grossman SA.","J Subst Abuse Treat. 1997 Nov-Dec;14(6):535-42. doi: 10.1016/s0740-5472(97)00117-7.","Rhodes DJ","J Subst Abuse Treat","1997","1998/01/23","","","10.1016/s0740-5472(97)00117-7"
"9369328","Hydrogen cyanide generation by mu-opiate receptor activation: possible neuromodulatory role of endogenous cyanide","Borowitz JL, Gunasekar PG, Isom GE.","Brain Res. 1997 Sep 12;768(1-2):294-300. doi: 10.1016/s0006-8993(97)00659-8.","Borowitz JL","Brain Res","1997","1997/11/22","","","10.1016/s0006-8993(97)00659-8"
"9354041","Nebulized opioids in the treatment of dyspnea","Quelch PC, Faulkner DE, Yun JW.","J Palliat Care. 1997 Autumn;13(3):48-52.","Quelch PC","J Palliat Care","1997","1997/11/14","","",""
"9313274","Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation","Coda BA, O'Sullivan B, Donaldson G, Bohl S, Chapman CR, Shen DD.","Pain. 1997 Sep;72(3):333-46. doi: 10.1016/s0304-3959(97)00059-6.","Coda BA","Pain","1997","1997/10/06","","","10.1016/s0304-3959(97)00059-6"
"9301669","7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands","Fang X, Larson DL, Portoghese PS.","J Med Chem. 1997 Sep 12;40(19):3064-70. doi: 10.1021/jm970283e.","Fang X","J Med Chem","1997","1997/09/25","","","10.1021/jm970283e"
"9272790","Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study","Lawlor P, Turner K, Hanson J, Bruera E.","Pain. 1997 Aug;72(1-2):79-85. doi: 10.1016/s0304-3959(97)00018-3.","Lawlor P","Pain","1997","1997/08/01","","","10.1016/s0304-3959(97)00018-3"
"9260070","Effects of abused drugs on psychomotor performance","Pickworth WB, Rohrer MS, Fant RV.","Exp Clin Psychopharmacol. 1997 Aug;5(3):235-41. doi: 10.1037//1064-1297.5.3.235.","Pickworth WB","Exp Clin Psychopharmacol","1997","1997/08/01","","","10.1037//1064-1297.5.3.235"
"9253142","In vivo and in vitro formation of morphinone from morphine in rat","Yamano S, Takahashi A, Todaka T, Toki S.","Xenobiotica. 1997 Jul;27(7):645-56. doi: 10.1080/004982597240244.","Yamano S","Xenobiotica","1997","1997/07/01","","","10.1080/004982597240244"
"9249122","Effect of the intensity of transcutaneous acupoint electrical stimulation on the postoperative analgesic requirement","Wang B, Tang J, White PF, Naruse R, Sloninsky A, Kariger R, Gold J, Wender RH.","Anesth Analg. 1997 Aug;85(2):406-13. doi: 10.1097/00000539-199708000-00029.","Wang B","Anesth Analg","1997","1997/08/01","","","10.1097/00000539-199708000-00029"
"9237407","Oral narcotic protocol to reduce narcotic injections in refractory migraine patients","Von Seggern RL, Adelman JU.","Headache. 1997 Jun;37(6):341-5. doi: 10.1046/j.1526-4610.1997.3706341.x.","Von Seggern RL","Headache","1997","1997/06/01","","","10.1046/j.1526-4610.1997.3706341.x"
"9231864","Differences among patients in opioid self-administration during bone marrow transplantation","Chapman CR, Donaldson GW, Jacobson RC, Hautman B.","Pain. 1997 Jul;71(3):213-23. doi: 10.1016/s0304-3959(97)03355-1.","Chapman CR","Pain","1997","1997/07/01","","","10.1016/s0304-3959(97)03355-1"
"9208156","Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study","Sacerdote P, Manfredi B, Mantegazza P, Panerai AE.","Br J Pharmacol. 1997 Jun;121(4):834-40. doi: 10.1038/sj.bjp.0701138.","Sacerdote P","Br J Pharmacol","1997","1997/06/01","PMC1564723","","10.1038/sj.bjp.0701138"
"9200172","Hydromorphone analgesia after intravenous bolus administration","Coda B, Tanaka A, Jacobson RC, Donaldson G, Chapman CR.","Pain. 1997 May;71(1):41-8. doi: 10.1016/s0304-3959(97)03336-8.","Coda B","Pain","1997","1997/05/01","","","10.1016/s0304-3959(97)03336-8"
"9184729","Compatibility of hydromorphone and prochlorperazine, and irritation due to subcutaneous prochlorperazine infusion","Trinkle R.","Ann Pharmacother. 1997 Jun;31(6):789-90. doi: 10.1177/106002809703100624.","Trinkle R","Ann Pharmacother","1997","1997/06/01","","","10.1177/106002809703100624"
"9143356","Purification, characterization and partial primary structure of morphine 6-dehydrogenase from rabbit liver cytosol","Yamano S, Ito K, Ogata S, Toki S.","Arch Biochem Biophys. 1997 May 1;341(1):81-8. doi: 10.1006/abbi.1997.9961.","Yamano S","Arch Biochem Biophys","1997","1997/05/01","","","10.1006/abbi.1997.9961"
"9134180","Headache, circumoral paresthesia, and facial flushing associated with high-dose carmustine infusion","Woo MH, Ippoliti C, Bruton J, Mehra R, Champlin R, Przepiorka D.","Bone Marrow Transplant. 1997 Apr;19(8):845-7. doi: 10.1038/sj.bmt.1700743.","Woo MH","Bone Marrow Transplant","1997","1997/04/01","","","10.1038/sj.bmt.1700743"
"9121813","Clinical analgesic equivalence for morphine and hydromorphone with prolonged PCA","Dunbar PJ, Chapman CR, Buckley FP, Gavrin JR.","Pain. 1996 Dec;68(2-3):265-70. doi: 10.1016/s0304-3959(96)03213-7.","Dunbar PJ","Pain","1996","1996/12/01","","","10.1016/s0304-3959(96)03213-7"
"9106815","Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: clinical observations","Manfredi PL, Borsook D, Chandler SW, Payne R.","Pain. 1997 Mar;70(1):99-101. doi: 10.1016/s0304-3959(96)03313-1.","Manfredi PL","Pain","1997","1997/03/01","","","10.1016/s0304-3959(96)03313-1"
"9103485","Inhibition of cytochrome P450 2D6 metabolism of hydrocodone to hydromorphone does not importantly affect abuse liability","Kaplan HL, Busto UE, Baylon GJ, Cheung SW, Otton SV, Somer G, Sellers EM.","J Pharmacol Exp Ther. 1997 Apr;281(1):103-8.","Kaplan HL","J Pharmacol Exp Ther","1997","1997/04/01","","",""
"9085953","Patient-controlled epidural analgesia: interactions between nalbuphine and hydromorphone","Parker RK, Holtmann B, White PF.","Anesth Analg. 1997 Apr;84(4):757-63. doi: 10.1097/00000539-199704000-00011.","Parker RK","Anesth Analg","1997","1997/04/01","","","10.1097/00000539-199704000-00011"
"9085402","The effects of buprenorphine in buprenorphine-maintained volunteers","Strain EC, Walsh SL, Preston KL, Liebson IA, Bigelow GE.","Psychopharmacology (Berl). 1997 Feb;129(4):329-38. doi: 10.1007/s002130050199.","Strain EC","Psychopharmacology (Berl)","1997","1997/02/01","","","10.1007/s002130050199"
"9083166","Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain","Hagen NA, Babul N.","Cancer. 1997 Apr 1;79(7):1428-37.","Hagen NA","Cancer","1997","1997/04/01","","",""
"9052302","Effects of ketorolac versus bupivacaine coadministration during patient-controlled hydromorphone epidural analgesia after thoracotomy procedures","Singh H, Bossard RF, White PF, Yeatts RW.","Anesth Analg. 1997 Mar;84(3):564-9. doi: 10.1097/00000539-199703000-00018.","Singh H","Anesth Analg","1997","1997/03/01","","","10.1097/00000539-199703000-00018"
"8958101","Engineering pathways in Escherichia coli for the synthesis of morphine alkaloid analgesics and antitussives","Hailes AM, French CE, Rathbone DA, Bruce NC.","Ann N Y Acad Sci. 1996 Oct 12;799:391-6. doi: 10.1111/j.1749-6632.1996.tb33230.x.","Hailes AM","Ann N Y Acad Sci","1996","1996/10/12","","","10.1111/j.1749-6632.1996.tb33230.x"
"8958080","Morphinone reductase. Characterization, cloning, and application to biocatalytic hydromorphone production","French CE, Hailes AM, Rathbone DA, Bruce NC.","Ann N Y Acad Sci. 1996 Oct 12;799:97-101. doi: 10.1111/j.1749-6632.1996.tb33185.x.","French CE","Ann N Y Acad Sci","1996","1996/10/12","","","10.1111/j.1749-6632.1996.tb33185.x"
"8930155","N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist","Xu JY, Seyed-Mozaffari A, Archer S, Bidlack JM.","J Pharmacol Exp Ther. 1996 Nov;279(2):539-47.","Xu JY","J Pharmacol Exp Ther","1996","1996/11/01","","",""
"8930154","Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans","Walsh SL, Sullivan JT, Preston KL, Garner JE, Bigelow GE.","J Pharmacol Exp Ther. 1996 Nov;279(2):524-38.","Walsh SL","J Pharmacol Exp Ther","1996","1996/11/01","","",""
"8926748","The detection of hydrocodone in meconium: two case studies","Moore CM, Deitermann D, Lewis D, Leikin J.","J Anal Toxicol. 1995 Oct;19(6):514-8. doi: 10.1093/jat/19.6.514.","Moore CM","J Anal Toxicol","1995","1995/10/01","","","10.1093/jat/19.6.514"
"8917240","Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone","Collins JJ, Geake J, Grier HE, Houck CS, Thaler HT, Weinstein HJ, Twum-Danso NY, Berde CB.","J Pediatr. 1996 Nov;129(5):722-8. doi: 10.1016/s0022-3476(96)70156-7.","Collins JJ","J Pediatr","1996","1996/11/01","","","10.1016/s0022-3476(96)70156-7"
"8895238","Individualized use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicators","Vigano A, Fan D, Bruera E.","Pain. 1996 Sep;67(1):115-9. doi: 10.1016/0304-3959(96)03112-0.","Vigano A","Pain","1996","1996/09/01","","","10.1016/0304-3959(96)03112-0"
"8893076","21-day compatibility of hydromorphone hydrochloride and promethazine hydrochloride in a cassette","Henderson F.","Am J Health Syst Pharm. 1996 Oct 1;53(19):2338-9. doi: 10.1093/ajhp/53.19.2338.","Henderson F","Am J Health Syst Pharm","1996","1996/10/01","","","10.1093/ajhp/53.19.2338"
"8861402","Stability of opioid craving over time as measured by visual analog scales","McMillan DE, Gilmore-Thomas K.","Drug Alcohol Depend. 1996 Mar;40(3):235-9. doi: 10.1016/0376-8716(96)01218-5.","McMillan DE","Drug Alcohol Depend","1996","1996/03/01","","","10.1016/0376-8716(96)01218-5"
"8835667","Lack of hydrocodone and hydromorphone interference in the GC-MS detection of morphine and codeine","Brooks KE, Smith NB.","J Anal Toxicol. 1996 Jul-Aug;20(4):269-70. doi: 10.1093/jat/20.4.269.","Brooks KE","J Anal Toxicol","1996","1996/07/01","","","10.1093/jat/20.4.269"
"8826555","Stability and compatibility of fluorouracil with morphine sulfate and hydromorphone hydrochloride","Xu QA, Trissel LA, Martinez JF.","Ann Pharmacother. 1996 Jul-Aug;30(7-8):756-61. doi: 10.1177/106002809603000709.","Xu QA","Ann Pharmacother","1996","1996/07/01","","","10.1177/106002809603000709"
"8826516","In vitro and in vivo studies of subcutaneous hydromorphone implants designed for the treatment of cancer pain","Lesser GJ, Grossman SA, Leong KW, Lo H, Eller S.","Pain. 1996 May-Jun;65(2-3):265-72. doi: 10.1016/0304-3959(95)00248-0.","Lesser GJ","Pain","1996","1996/05/01","","","10.1016/0304-3959(95)00248-0"
"8823239","Opioid antagonist effects of dezocine in opioid-dependent humans","Strain EC, Preston KL, Liebson IA, Bigelow GE.","Clin Pharmacol Ther. 1996 Aug;60(2):206-17. doi: 10.1016/S0009-9236(96)90137-X.","Strain EC","Clin Pharmacol Ther","1996","1996/08/01","","","10.1016/S0009-9236(96)90137-X"
"8819513","Effects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys","Gatch MB, Negus SS, Mello NK, Archer S, Bidlack JM.","J Pharmacol Exp Ther. 1996 Sep;278(3):1282-9.","Gatch MB","J Pharmacol Exp Ther","1996","1996/09/01","","",""
"8809281","Stability of deferoxamine mesylate, floxuridine, fluorouracil, hydromorphone hydrochloride, lorazepam, and midazolam hydrochloride in polypropylene infusion-pump syringes","Stiles ML, Allen LV Jr, Prince SJ.","Am J Health Syst Pharm. 1996 Jul 1;53(13):1583-8. doi: 10.1093/ajhp/53.13.1583.","Stiles ML","Am J Health Syst Pharm","1996","1996/07/01","","","10.1093/ajhp/53.13.1583"
"8773867","Epidural morphine vs hydromorphone in post-caesarean section patients","Halpern SH, Arellano R, Preston R, Carstoniu J, O'Leary G, Roger S, Sandler A.","Can J Anaesth. 1996 Jun;43(6):595-8. doi: 10.1007/BF03011773.","Halpern SH","Can J Anaesth","1996","1996/06/01","","","10.1007/BF03011773"
"8756381","Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine","Bruera E, Pereira J, Watanabe S, Belzile M, Kuehn N, Hanson J.","Cancer. 1996 Aug 15;78(4):852-7. doi: 10.1002/(SICI)1097-0142(19960815)78:4<852::AID-CNCR23>3.0.CO;2-T.","Bruera E","Cancer","1996","1996/08/15","","","10.1002/(SICI)1097-0142(19960815)78:4<852::AID-CNCR23>3.0.CO;2-T"
"8664465","Beta-selective monoamine oxidase inhibitors and cardiac anesthesia","Cerza RF.","J Cardiothorac Vasc Anesth. 1995 Dec;9(6):717-9. doi: 10.1016/s1053-0770(05)80235-6.","Cerza RF","J Cardiothorac Vasc Anesth","1995","1995/12/01","","","10.1016/s1053-0770(05)80235-6"
"8653484","Stability of bupivacaine hydrochloride and hydromorphone hydrochloride during simulated epidural coadministration","Christen C, Johnson CE, Walters JR.","Am J Health Syst Pharm. 1996 Jan 15;53(2):170-3. doi: 10.1093/ajhp/53.2.170.","Christen C","Am J Health Syst Pharm","1996","1996/01/15","","","10.1093/ajhp/53.2.170"
"8622092","A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain. Canadian Palliative Care Clinical Trials Group","Bruera E, Sloan P, Mount B, Scott J, Suarez-Almazor M.","J Clin Oncol. 1996 May;14(5):1713-7. doi: 10.1200/JCO.1996.14.5.1713.","Bruera E","J Clin Oncol","1996","1996/05/01","","","10.1200/JCO.1996.14.5.1713"
"8614375","Pain palliation with strontium-89 in children with metastatic disease","Charron M, Brown M, Rowland P, Mirro J.","Med Pediatr Oncol. 1996 Jun;26(6):393-6. doi: 10.1002/(SICI)1096-911X(199606)26:6<393::AID-MPO4>3.0.CO;2-C.","Charron M","Med Pediatr Oncol","1996","1996/06/01","","","10.1002/(SICI)1096-911X(199606)26:6<393::AID-MPO4>3.0.CO;2-C"
"8610865","A multidimensional comparison of morphine and hydromorphone patient-controlled analgesia","Rapp SE, Egan KJ, Ross BK, Wild LM, Terman GW, Ching JM.","Anesth Analg. 1996 May;82(5):1043-8. doi: 10.1097/00000539-199605000-00029.","Rapp SE","Anesth Analg","1996","1996/05/01","","","10.1097/00000539-199605000-00029"
"8594121","Use of patient-controlled analgesia for pain control for children receiving bone marrow transplant","Dunbar PJ, Buckley P, Gavrin JR, Sanders JE, Chapman CR.","J Pain Symptom Manage. 1995 Nov;10(8):604-11. doi: 10.1016/0885-3924(95)00122-0.","Dunbar PJ","J Pain Symptom Manage","1995","1995/11/01","","","10.1016/0885-3924(95)00122-0"
"8547554","Pain outcomes after thoracotomy: lumbar epidural hydromorphone versus intrapleural bupivacaine","Gaeta RR, Macario A, Brodsky JB, Brock-Utne JG, Mark JB.","J Cardiothorac Vasc Anesth. 1995 Oct;9(5):534-7. doi: 10.1016/s1053-0770(05)80136-3.","Gaeta RR","J Cardiothorac Vasc Anesth","1995","1995/10/01","","","10.1016/s1053-0770(05)80136-3"
"8545138","Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain","Bruera E, Watanabe S, Fainsinger RL, Spachynski K, Suarez-Almazor M, Inturrisi C.","Pain. 1995 Aug;62(2):141-6. doi: 10.1016/0304-3959(94)00257-f.","Bruera E","Pain","1995","1995/08/01","","","10.1016/0304-3959(94)00257-f"
"7694857","Antinociceptive evaluation of 14 beta-(bromoacetamido)-7,8-dihydro- N(cyclopropylmethyl)-normorphinone in mice","Jiang Q, Seyed-Mozaffari A, Archer S, Bidlack JM.","Eur J Pharmacol. 1993 Aug 24;240(2-3):201-6. doi: 10.1016/0014-2999(93)90899-s.","Jiang Q","Eur J Pharmacol","1993","1993/08/24","","","10.1016/0014-2999(93)90899-s"
"7694538","Pain measurement in hospitalized adults with sickle cell painful episodes","Ballas SK, Delengowski A.","Ann Clin Lab Sci. 1993 Sep-Oct;23(5):358-61.","Ballas SK","Ann Clin Lab Sci","1993","1993/09/01","","",""
"7693944","14 beta-[(p-nitrocinnamoyl)amino]morphinones, 14 beta-[(p-nitrocinnamoyl)amino]-7,8-dihydromorphinones, and their codeinone analogues: synthesis and receptor activity","Sebastian A, Bidlack JM, Jiang Q, Deecher D, Teitler M, Glick SD, Archer S.","J Med Chem. 1993 Oct 15;36(21):3154-60. doi: 10.1021/jm00073a015.","Sebastian A","J Med Chem","1993","1993/10/15","","","10.1021/jm00073a015"
"7693389","CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone","Otton SV, Schadel M, Cheung SW, Kaplan HL, Busto UE, Sellers EM.","Clin Pharmacol Ther. 1993 Nov;54(5):463-72. doi: 10.1038/clpt.1993.177.","Otton SV","Clin Pharmacol Ther","1993","1993/11/01","","","10.1038/clpt.1993.177"
"7690122","The distribution of medication along the spinal canal after chronic intrathecal administration","Kroin JS, Ali A, York M, Penn RD.","Neurosurgery. 1993 Aug;33(2):226-30; discussion 230.","Kroin JS","Neurosurgery","1993","1993/08/01","","",""
"7689317","Biological synthesis of the analgesic hydromorphone, an intermediate in the metabolism of morphine, by Pseudomonas putida M10","Hailes AM, Bruce NC.","Appl Environ Microbiol. 1993 Jul;59(7):2166-70.","Hailes AM","Appl Environ Microbiol","1993","1993/07/01","PMC182252","",""
"7688888","Opioid hyperexcitability: the application of alternate opioid therapy","MacDonald N, Der L, Allan S, Champion P.","Pain. 1993 Jun;53(3):353-5. doi: 10.1016/0304-3959(93)90232-e.","MacDonald N","Pain","1993","1993/06/01","","","10.1016/0304-3959(93)90232-e"
"7687147","Affinity labeling of the mu opioid receptor in bovine striatal membranes with [3H]-14 beta-(bromoacetamido)-7,8-dihydromorphine","Bidlack JM, Kaplan RA, Subbramanian RA, Seyed-Mozaffari A, Archer S.","Biochemistry. 1993 Jul 6;32(26):6703-11. doi: 10.1021/bi00077a025.","Bidlack JM","Biochemistry","1993","1993/07/06","","","10.1021/bi00077a025"
"7686955","A single case study using high-dose hydromorphone to control severe pain and serial psychometric testing to assess effects","Hays H, Mayo P.","J Pain Symptom Manage. 1993 Apr;8(3):173-6. doi: 10.1016/0885-3924(93)90146-m.","Hays H","J Pain Symptom Manage","1993","1993/04/01","","","10.1016/0885-3924(93)90146-m"
"7686279","Comparison of hydromorphone continuous subcutaneous infusion and basal rate subcutaneous infusion plus PCA in cancer pain: a pilot study","Vanier MC, Labrecque G, Lepage-Savary D, Poulin E, Provencher L, Lamontagne C.","Pain. 1993 Apr;53(1):27-32. doi: 10.1016/0304-3959(93)90051-p.","Vanier MC","Pain","1993","1993/04/01","","","10.1016/0304-3959(93)90051-p"
"7684078","Palliative care round: cognitive failure and coma after renal failure in a patient receiving captopril and hydromorphone","Fainsinger R, Schoeller T, Boiskin M, Bruera E.","J Palliat Care. 1993 Spring;9(1):53-5.","Fainsinger R","J Palliat Care","1993","1993/01/01","","",""
"7683827","Stroke following injection of a melted suppository","Bitar S, Gomez CR.","Stroke. 1993 May;24(5):741-3. doi: 10.1161/01.str.24.5.741.","Bitar S","Stroke","1993","1993/05/01","","","10.1161/01.str.24.5.741"
"7680715","Pharmacological study of 14 beta-(thioglycolamido)-7,8-dihydro-N(cyclopropylmethyl)-normor phinone (N-CPM-TAMO)","Jiang Q, Seyed-Mozaffari A, Archer S, Bidlack JM.","J Pharmacol Exp Ther. 1993 Mar;264(3):1021-7.","Jiang Q","J Pharmacol Exp Ther","1993","1993/03/01","","",""
"7679737","Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers","Preston KL, Bigelow GE.","J Pharmacol Exp Ther. 1993 Feb;264(2):813-23.","Preston KL","J Pharmacol Exp Ther","1993","1993/02/01","","",""
"7679076","5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone: a long-lasting mu-opioid receptor antagonist devoid of agonist properties","Jiang Q, Sebastian A, Archer S, Bidlack JM.","Eur J Pharmacol. 1993 Jan 5;230(1):129-30. doi: 10.1016/0014-2999(93)90423-f.","Jiang Q","Eur J Pharmacol","1993","1993/01/05","","","10.1016/0014-2999(93)90423-f"
"7574067","Epidural and intravenous opioid-induced neuroexcitation","Rozan JP, Kahn CH, Warfield CA.","Anesthesiology. 1995 Oct;83(4):860-3. doi: 10.1097/00000542-199510000-00027.","Rozan JP","Anesthesiology","1995","1995/10/01","","","10.1097/00000542-199510000-00027"
"7545736","Hydromorphone and metabolite pharmacokinetics in children","Babul N, Darke AC, Hain R.","J Pain Symptom Manage. 1995 Jul;10(5):335-7. doi: 10.1016/0885-3924(95)90012-8.","Babul N","J Pain Symptom Manage","1995","1995/07/01","","","10.1016/0885-3924(95)90012-8"
"7543126","Hydromorphone metabolite accumulation in renal failure","Babul N, Darke AC, Hagen N.","J Pain Symptom Manage. 1995 Apr;10(3):184-6. doi: 10.1016/0885-3924(94)00121-Z.","Babul N","J Pain Symptom Manage","1995","1995/04/01","","","10.1016/0885-3924(94)00121-Z"
"7542336","Acute administration of buprenorphine in humans: partial agonist and blockade effects","Walsh SL, Preston KL, Bigelow GE, Stitzer ML.","J Pharmacol Exp Ther. 1995 Jul;274(1):361-72.","Walsh SL","J Pharmacol Exp Ther","1995","1995/07/01","","",""
"7541438","Use of methadone in a highly tolerant patient receiving parenteral hydromorphone","Thomas Z, Bruera E.","J Pain Symptom Manage. 1995 May;10(4):315-7. doi: 10.1016/0885-3924(95)00011-M.","Thomas Z","J Pain Symptom Manage","1995","1995/05/01","","","10.1016/0885-3924(95)00011-M"
"7541310","Comparison of hydromorphone and meperidine for ureteral colic","Jasani NB, O'Conner RE, Bouzoukis JK.","Acad Emerg Med. 1994 Nov-Dec;1(6):539-43. doi: 10.1111/j.1553-2712.1994.tb02549.x.","Jasani NB","Acad Emerg Med","1994","1994/11/01","","","10.1111/j.1553-2712.1994.tb02549.x"
"7538514","Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphone","Hagen N, Thirlwell MP, Dhaliwal HS, Babul N, Harsanyi Z, Darke AC.","J Clin Pharmacol. 1995 Jan;35(1):37-44. doi: 10.1002/j.1552-4604.1995.tb04743.x.","Hagen N","J Clin Pharmacol","1995","1995/01/01","","","10.1002/j.1552-4604.1995.tb04743.x"
"7536861","Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry","Smith ML, Hughes RO, Levine B, Dickerson S, Darwin WD, Cone EJ.","J Anal Toxicol. 1995 Jan-Feb;19(1):18-26. doi: 10.1093/jat/19.1.18.","Smith ML","J Anal Toxicol","1995","1995/01/01","","","10.1093/jat/19.1.18"
"7533484","Intravenous versus epidural administration of hydromorphone. Effects on analgesia and recovery after radical retropubic prostatectomy","Liu S, Carpenter RL, Mulroy MF, Weissman RM, McGill TJ, Rupp SM, Allen HW.","Anesthesiology. 1995 Mar;82(3):682-8. doi: 10.1097/00000542-199503000-00010.","Liu S","Anesthesiology","1995","1995/03/01","","","10.1097/00000542-199503000-00010"
"7533480","Compatibility of hydromorphone hydrochloride with haloperidol lactate and ketorolac tromethamine","Huang E, Anderson RP.","Am J Hosp Pharm. 1994 Dec 1;51(23):2963.","Huang E","Am J Hosp Pharm","1994","1994/12/01","","",""
"7531852","Effects of diazepam and hydromorphone in triazolam-trained humans under a novel-response drug discrimination procedure","Oliveto AH, Bickel WK, Kamien JB, Hughes JR, Higgins ST.","Psychopharmacology (Berl). 1994 Apr;114(3):417-23. doi: 10.1007/BF02249331.","Oliveto AH","Psychopharmacology (Berl)","1994","1994/04/01","","","10.1007/BF02249331"
"7529849","Study of drug distribution in hair by infrared microscopy visualization","Kalasinsky KS, Magluilo J Jr, Schaefer T.","J Anal Toxicol. 1994 Oct;18(6):337-41. doi: 10.1093/jat/18.6.337.","Kalasinsky KS","J Anal Toxicol","1994","1994/10/01","","","10.1093/jat/18.6.337"
"7527184","Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22, and 32 degrees C","Trissel LA, Xu Q, Martinez JF, Fox JL.","Am J Hosp Pharm. 1994 Sep 1;51(17):2138-42.","Trissel LA","Am J Hosp Pharm","1994","1994/09/01","","",""
"7525929","Drug discrimination assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphone-butorphanol procedure","Preston KL, Bigelow GE.","J Pharmacol Exp Ther. 1994 Oct;271(1):48-60.","Preston KL","J Pharmacol Exp Ther","1994","1994/10/01","","",""
"7525741","Local tolerance to subcutaneous infusions of high concentrations of hydromorphone: a prospective study","Bruera E, MacEachern T, Macmillan K, Miller MJ, Hanson J.","J Pain Symptom Manage. 1993 May;8(4):201-4. doi: 10.1016/0885-3924(93)90128-i.","Bruera E","J Pain Symptom Manage","1993","1993/05/01","","","10.1016/0885-3924(93)90128-i"
"7522977","A comparison of pentamorphone and fentanyl in balanced anaesthesia during general surgery","Kelly WB, Howie MB, Romanelli VA, Duarte JA, Rezaei H, McSweeney TD.","Can J Anaesth. 1994 Aug;41(8):703-9. doi: 10.1007/BF03015625.","Kelly WB","Can J Anaesth","1994","1994/08/01","","","10.1007/BF03015625"
"7521784","Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain","Hays H, Hagen N, Thirlwell M, Dhaliwal H, Babul N, Harsanyi Z, Darke AC.","Cancer. 1994 Sep 15;74(6):1808-16. doi: 10.1002/1097-0142(19940915)74:6<1808::aid-cncr2820740625>3.0.co;2-y.","Hays H","Cancer","1994","1994/09/15","","","10.1002/1097-0142(19940915)74:6<1808::aid-cncr2820740625>3.0.co;2-y"
"7520516","Hydromorphone and hydrocodone interference in GC/MS assays for morphine and codeine","Fenton J, Mummert J, Childers M.","J Anal Toxicol. 1994 May-Jun;18(3):159-64. doi: 10.1093/jat/18.3.159.","Fenton J","J Anal Toxicol","1994","1994/05/01","","","10.1093/jat/18.3.159"
"7519977","Buprenorphine: duration of blockade of effects of intramuscular hydromorphone","Rosen MI, Wallace EA, McMahon TJ, Pearsall HR, Woods SW, Price LH, Kosten TR.","Drug Alcohol Depend. 1994 Apr;35(2):141-9. doi: 10.1016/0376-8716(94)90121-x.","Rosen MI","Drug Alcohol Depend","1994","1994/04/01","","","10.1016/0376-8716(94)90121-x"
"7518312","Clinical application of nebulized opioids for treatment of dyspnoea in patients with malignant disease","Farncombe M, Chater S.","Support Care Cancer. 1994 May;2(3):184-7. doi: 10.1007/BF00417478.","Farncombe M","Support Care Cancer","1994","1994/05/01","","","10.1007/BF00417478"
"7517691","Polyarthralgia and amenorrhea as a complication of intrathecally infused morphine and Dilaudid in the treatment of chronic benign back pain","Chambers FA, McCarroll M, MacSullivan R.","Br J Anaesth. 1994 Jun;72(6):734. doi: 10.1093/bja/72.6.734.","Chambers FA","Br J Anaesth","1994","1994/06/01","","","10.1093/bja/72.6.734"
"7517429","Altered sexual function and decreased testosterone in patients receiving intraspinal opioids","Paice JA, Penn RD, Ryan WG.","J Pain Symptom Manage. 1994 Feb;9(2):126-31. doi: 10.1016/0885-3924(94)90166-x.","Paice JA","J Pain Symptom Manage","1994","1994/02/01","","","10.1016/0885-3924(94)90166-x"
"7516635","Towards engineering pathways for the synthesis of analgesics and antitussives","Bruce NC, Caswell DA, French CE, Hailes AM, Long MT, Willey DL.","Ann N Y Acad Sci. 1994 May 2;721:85-99. doi: 10.1111/j.1749-6632.1994.tb47380.x.","Bruce NC","Ann N Y Acad Sci","1994","1994/05/02","","","10.1111/j.1749-6632.1994.tb47380.x"
"7515442","14 alpha,14' beta-[Dithiobis[(2-oxo-2,1-ethanediyl)imino]]bis (7,8-dihydromorphinone) and 14 alpha,14' beta-[dithiobis[(2-oxo-2,1- ethanediyl)imino]]bis[7,8-dihydro-N-(cyclopropylmethyl)normorphinone]: chemistry and opioid binding properties","Archer S, Seyed-Mozaffari A, Jiang Q, Bidlack JM.","J Med Chem. 1994 May 27;37(11):1578-85. doi: 10.1021/jm00037a008.","Archer S","J Med Chem","1994","1994/05/27","","","10.1021/jm00037a008"
"7514506","Hydromorphone patient-controlled analgesia (PCA) after coronary artery bypass surgery","Searle NR, Roy M, Bergeron G, Perrault J, Roof J, Heermans C, Courtemanche M, Demers C, Cartier R.","Can J Anaesth. 1994 Mar;41(3):198-205. doi: 10.1007/BF03009831.","Searle NR","Can J Anaesth","1994","1994/03/01","","","10.1007/BF03009831"
"7513346","Human d-amphetamine drug discrimination: methamphetamine and hydromorphone","Lamb RJ, Henningfield JE.","J Exp Anal Behav. 1994 Mar;61(2):169-80. doi: 10.1901/jeab.1994.61-169.","Lamb RJ","J Exp Anal Behav","1994","1994/03/01","PMC1334405","","10.1901/jeab.1994.61-169"
"7511163","5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone and its corresponding N-cyclopropylmethyl analog, N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone: mu-selective irreversible opioid antagonists","Jiang Q, Sebastian A, Archer S, Bidlack JM.","J Pharmacol Exp Ther. 1994 Mar;268(3):1107-13.","Jiang Q","J Pharmacol Exp Ther","1994","1994/03/01","","",""
"7511126","Hair analysis by infrared microscopy for drugs of abuse","Kalasinsky KS, Magluilo J Jr, Schaefer T.","Forensic Sci Int. 1993 Dec;63(1-3):253-60. doi: 10.1016/0379-0738(93)90278-i.","Kalasinsky KS","Forensic Sci Int","1993","1993/12/01","","","10.1016/0379-0738(93)90278-i"
"7510936","Comparative spinal neuropathology of hydromorphone and morphine after 9- and 30-day epidural administration in sheep","Coombs DW, Colburn RW, DeLeo JA, Hoopes PJ, Twitchell BB.","Anesth Analg. 1994 Apr;78(4):674-81. doi: 10.1213/00000539-199404000-00010.","Coombs DW","Anesth Analg","1994","1994/04/01","","","10.1213/00000539-199404000-00010"
"7505420","Equianalgesic dosing: oral to i.v. conversions","Sheidler UR.","Nursing. 1993 Dec;23(12):12.","Sheidler UR","Nursing","1993","1993/12/01","","",""
"7504098","Precipitated withdrawal by pentazocine in methadone-maintained volunteers","Strain EC, Preston KL, Liebson IA, Bigelow GE.","J Pharmacol Exp Ther. 1993 Nov;267(2):624-34.","Strain EC","J Pharmacol Exp Ther","1993","1993/11/01","","",""
"7503886","Lipid solubility and epidural opioid efficacy","Boswell MV.","Anesthesiology. 1995 Aug;83(2):427-8. doi: 10.1097/00000542-199508000-00027.","Boswell MV","Anesthesiology","1995","1995/08/01","","","10.1097/00000542-199508000-00027"
"7500616","Facilitation of thin-layer chromatographic identification of opiates by derivatization with acetic anhydride or methoxyamine","Dietzen DJ, Koenig J, Turk J.","J Anal Toxicol. 1995 Sep;19(5):299-303. doi: 10.1093/jat/19.5.299.","Dietzen DJ","J Anal Toxicol","1995","1995/09/01","","","10.1093/jat/19.5.299"
"6209395","Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligand","Koolpe GA, Nelson WL, Gioannini TL, Angel L, Simon EJ.","J Med Chem. 1984 Dec;27(12):1718-23. doi: 10.1021/jm00378a032.","Koolpe GA","J Med Chem","1984","1984/12/01","","","10.1021/jm00378a032"
"6208826","Cystometry in dogs under oxymorphone and acepromazine restraint","Barsanti JA, Mahaffey MB, Crowell WA, Barber DL.","Am J Vet Res. 1984 Oct;45(10):2152-3.","Barsanti JA","Am J Vet Res","1984","1984/10/01","","",""
"6208570","Analgesic consultation","Rogers AG.","PRN Forum. 1984 Nov-Dec;3(5):3.","Rogers AG","PRN Forum","1984","1984/11/01","","",""
"6207431","Irreversible and reversible narcotic agonists: discriminative and analgesic effects of buprenorphine, oxymorphazone, and morphine","France CP, Jacobson AE, Woods JH.","NIDA Res Monogr. 1984 Mar;49:136-42.","France CP","NIDA Res Monogr","1984","1984/03/01","","",""
"6207298","Activities of morphinone and N-(cyclopropylmethyl)normorphinone at opioid receptors","Fang S, Takemori AE, Portoghese PS.","J Med Chem. 1984 Oct;27(10):1361-3. doi: 10.1021/jm00376a026.","Fang S","J Med Chem","1984","1984/10/01","","","10.1021/jm00376a026"
"6206435","Tritiated-6-beta-fluoro-6-desoxy-oxymorphone: a highly selective ligand for the opiate mu receptor whose binding is characterized by low nonspecific binding","Rothman RB, Danks JA, Jacobson AE, Burke TR Jr, Rice KC, Pert CB.","Neuropeptides. 1984 Jun;4(4):311-7. doi: 10.1016/0143-4179(84)90005-2.","Rothman RB","Neuropeptides","1984","1984/06/01","","","10.1016/0143-4179(84)90005-2"
"6206224","Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine","France CP, Jacobson AE, Woods JH.","J Pharmacol Exp Ther. 1984 Sep;230(3):652-7.","France CP","J Pharmacol Exp Ther","1984","1984/09/01","","",""
"6204830","Extraordinary analgesic requirement in a patient previously unexposed to narcotics","Graves DA, Baumann TJ, Bennett RL, Batenhorst RL, Griffen WO, Plumlee JE, Foster TS.","Drug Intell Clin Pharm. 1984 Jul-Aug;18(7-8):598-600. doi: 10.1177/106002808401800708.","Graves DA","Drug Intell Clin Pharm","1984","1984/07/01","","","10.1177/106002808401800708"
"6204757","Oxymorphazone: a long-acting opiate analgesic","Ling GS, Galetta S, Pasternak GW.","Cell Mol Neurobiol. 1984 Mar;4(1):1-13. doi: 10.1007/BF00710938.","Ling GS","Cell Mol Neurobiol","1984","1984/03/01","","","10.1007/BF00710938"
"6204005","How the addict gets his prescription","Lindberg DK.","J Fla Med Assoc. 1984 Apr;71(4):240-3.","Lindberg DK","J Fla Med Assoc","1984","1984/04/01","","",""
"6202821","A hydromorphone and ethanol fatality","Levine B, Saady J, Fierro M, Valentour J.","J Forensic Sci. 1984 Apr;29(2):655-9.","Levine B","J Forensic Sci","1984","1984/04/01","","",""
"6202532","Local inhibition of inflammatory pain by naloxone and its N-methyl quaternary analogue","Rios L, Jacob JJ.","Eur J Pharmacol. 1983 Dec 23;96(3-4):277-83. doi: 10.1016/0014-2999(83)90317-5.","Rios L","Eur J Pharmacol","1983","1983/12/23","","","10.1016/0014-2999(83)90317-5"
"6199340","Xylazine-ketamine-oxymorphone: an injectable anesthetic combination in swine","Breese CE, Dodman NH.","J Am Vet Med Assoc. 1984 Jan 15;184(2):182-3.","Breese CE","J Am Vet Med Assoc","1984","1984/01/15","","",""
"6199090","Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors","Zukin SR, Brady KT, Slifer BL, Balster RL.","Brain Res. 1984 Feb 27;294(1):174-7. doi: 10.1016/0006-8993(84)91326-x.","Zukin SR","Brain Res","1984","1984/02/27","","","10.1016/0006-8993(84)91326-x"
"6198981","An etorphine-evoked vagal reflex in rats is inhibited by naloxone, N-methylnaloxone, and SMS 201-995","Dashwood MR, Kiang JG, Wei ET.","Arch Int Pharmacodyn Ther. 1983 Nov;266(1):77-82.","Dashwood MR","Arch Int Pharmacodyn Ther","1983","1983/11/01","","",""
"6198696","Fluid consumption in water-deprived rats after administration of naloxone or quaternary naloxone","Turkish S, Cooper SJ.","Prog Neuropsychopharmacol Biol Psychiatry. 1983;7(4-6):835-9. doi: 10.1016/0278-5846(83)90078-7.","Turkish S","Prog Neuropsychopharmacol Biol Psychiatry","1983","1983/01/01","","","10.1016/0278-5846(83)90078-7"
"6198219","Drugs in dentistry. Analgesics","Ciancio SG.","Dent Manage. 1984 Jan;24(1):52-3 contd.","Ciancio SG","Dent Manage","1984","1984/01/01","","",""
"6197910","High-dose hydromorphone (Dilaudid) for coronary artery bypass surgery","Welti RS, Moldenhauer CC, Hug CC Jr, Kaplan JA, Holbrook GW.","Anesth Analg. 1984 Jan;63(1):55-9.","Welti RS","Anesth Analg","1984","1984/01/01","","",""
"6197862","[Synthesis of long-acting analgesic hydrazone derivatives of 14-hydroxycodeinone and 14-hydroxymorphine]","Liu MQ, Chi CJ, Guo YM, Zhu CL.","Yao Xue Xue Bao. 1983 Jun;18(6):475-7.","Liu MQ","Yao Xue Xue Bao","1983","1983/06/01","","",""
"6197313","Quaternary opiate antagonists lower blood pressure and inhibit leucine-enkephalin responses","Giles T, Sander G, Merz H.","Eur J Pharmacol. 1983 Nov 25;95(3-4):247-52. doi: 10.1016/0014-2999(83)90641-6.","Giles T","Eur J Pharmacol","1983","1983/11/25","","","10.1016/0014-2999(83)90641-6"
"6196992","Early respiratory depression with epidural narcotic and intravenous droperidol","Cohen SE, Rothblatt AJ, Albright GA.","Anesthesiology. 1983 Dec;59(6):559-60. doi: 10.1097/00000542-198312000-00014.","Cohen SE","Anesthesiology","1983","1983/12/01","","","10.1097/00000542-198312000-00014"
"6194952","Oxymorphone metabolism and urinary excretion in human, rat, guinea pig, rabbit, and dog","Cone EJ, Darwin WD, Buchwald WF, Gorodetzky CW.","Drug Metab Dispos. 1983 Sep-Oct;11(5):446-50.","Cone EJ","Drug Metab Dispos","1983","1983/09/01","","",""
"6193028","Morphine tissue levels and reduction of gastrointestinal transit in rats. Correlation supports primary action site in the gut","Bianchi G, Ferretti P, Recchia M, Rocchetti M, Tavani A, Manara L.","Gastroenterology. 1983 Oct;85(4):852-8.","Bianchi G","Gastroenterology","1983","1983/10/01","","",""
"6192340","Intravenous hydromorphone: effects in opiate-free and methadone maintenance subjects","McCaul ME, Stitzer ML, Bigelow GE, Liebson IA.","NIDA Res Monogr. 1983 Apr;43:238-44.","McCaul ME","NIDA Res Monogr","1983","1983/04/01","","",""
"6191919","Incapacitating childhood-onset insomnia","Regestein QR, Reich P.","Compr Psychiatry. 1983 May-Jun;24(3):244-8. doi: 10.1016/0010-440x(83)90075-5.","Regestein QR","Compr Psychiatry","1983","1983/05/01","","","10.1016/0010-440x(83)90075-5"
"6189500","Cynomolgus monkeys do not develop tolerance to opioids","Ternes JW, Ehrman R, O'Brien CP.","Behav Neurosci. 1983 Apr;97(2):327-30. doi: 10.1037//0735-7044.97.2.327.","Ternes JW","Behav Neurosci","1983","1983/04/01","","","10.1037//0735-7044.97.2.327"
"6188822","Comparison of buprenorphine and methadone effects on opiate self-administration in primates","Mello NK, Bree MP, Mendelson JH.","J Pharmacol Exp Ther. 1983 May;225(2):378-86.","Mello NK","J Pharmacol Exp Ther","1983","1983/05/01","","",""
"6188019","Opiates and their antagonists modulate luteinizing hormone acting outside the blood brain barrier","Panerai AE, Martini A, Casanueva F, Petraglia F, Di Giulio AM, Mantegazza P.","Life Sci. 1983 Apr 11;32(15):1751-6. doi: 10.1016/0024-3205(83)90838-x.","Panerai AE","Life Sci","1983","1983/04/11","","","10.1016/0024-3205(83)90838-x"
"6187025","Effects of naloxone and its quaternary form on fluid consumption in rats","Hemmer RC, Olson GA, Kastin AJ, McLean JH, Olson RD.","Pharmacol Biochem Behav. 1982 Dec;17(6):1287-90. doi: 10.1016/0091-3057(82)90136-8.","Hemmer RC","Pharmacol Biochem Behav","1982","1982/12/01","","","10.1016/0091-3057(82)90136-8"
"6186879","Pharmacological actions of levallorphan allyl bromide (CM 32191), a new peripheral narcotic antagonist","Bianchetti A, Giudice A, Picerno N, Carminati P.","Life Sci. 1982 Nov 15-22;31(20-21):2261-4. doi: 10.1016/0024-3205(82)90133-3.","Bianchetti A","Life Sci","1982","1982/11/15","","","10.1016/0024-3205(82)90133-3"
"6185965","Rapid acquisition of conditioned responses to hydromorphone in detoxified heroin addicts","Ternes JW, O'Brien CP, Testa TT.","Psychopharmacol Bull. 1982 Oct;18(4):215-9.","Ternes JW","Psychopharmacol Bull","1982","1982/10/01","","",""
"6184546","Rapid, simultaneous quantification of morphine, codeine, and hydromorphone by GC/MS","Saady JJ, Narasimhachari N, Blanke RV.","J Anal Toxicol. 1982 Sep-Oct;6(5):235-7. doi: 10.1093/jat/6.5.235.","Saady JJ","J Anal Toxicol","1982","1982/09/01","","","10.1093/jat/6.5.235"
"6183553","Effect of morphinone on opiate receptor binding and morphine-elicited analgesia","Nagamatsu K, Kido Y, Terao T, Ishida T, Toki S.","Life Sci. 1982 Oct 4;31(14):1451-7. doi: 10.1016/0024-3205(82)90006-6.","Nagamatsu K","Life Sci","1982","1982/10/04","","","10.1016/0024-3205(82)90006-6"
"6183551","Receptor binding and analgesic properties of oxymorphazone","Galetta S, Ling GS, Wolfin L, Pasternak GW.","Life Sci. 1982 Sep 20-27;31(12-13):1389-92. doi: 10.1016/0024-3205(82)90388-5.","Galetta S","Life Sci","1982","1982/09/20","","","10.1016/0024-3205(82)90388-5"
"6183550","Inhibition of gastrointestinal transit by morphine and FK 33-824 in the rat and comparative narcotic antagonist properties of naloxone and its N-methyl quaternary analog","Manara L, Bianchi G, Fiocchi R, Notarnicola A, Peracchia F, Tavani A.","Life Sci. 1982 Sep 20-27;31(12-13):1271-4. doi: 10.1016/0024-3205(82)90359-9.","Manara L","Life Sci","1982","1982/09/20","","","10.1016/0024-3205(82)90359-9"
"6183549","Effects of N-methylnaloxone and N-methylnaltrexone on nociception and precipitated abstinence in mice","Ramabadran K.","Life Sci. 1982 Sep 20-27;31(12-13):1253-6. doi: 10.1016/0024-3205(82)90355-1.","Ramabadran K","Life Sci","1982","1982/09/20","","","10.1016/0024-3205(82)90355-1"
"6183548","Inhibition of inflammatory pain by naloxone and its N methyl quaternary analogue","Rios L, Jacob JJ.","Life Sci. 1982 Sep 20-27;31(12-13):1209-12. doi: 10.1016/0024-3205(82)90344-7.","Rios L","Life Sci","1982","1982/09/20","","","10.1016/0024-3205(82)90344-7"
"6181414","Comparison of the effects of buprenorphine and methadone on opiate self-administration in primates","Mello NK, Bree MP, Mendelson JH.","NIDA Res Monogr. 1982 Apr;41:67-73.","Mello NK","NIDA Res Monogr","1982","1982/04/01","","",""
"6181413","Psychological and physiological response to hydromorphone: an opponent process view of addiction","Ternes JW, O'Brien CP.","NIDA Res Monogr. 1982 Apr;41:497-503.","Ternes JW","NIDA Res Monogr","1982","1982/04/01","","",""
"6181412","Physiological and subjective effects of hydromorphone in postaddict volunteers","McCaul M, Stitzer M, Bigelow G, Liebson I.","NIDA Res Monogr. 1982 Apr;41:301-8.","McCaul M","NIDA Res Monogr","1982","1982/04/01","","",""
"6181411","14-alkoxy dihydrocodeinones, dihydromorphinones, and morphinanones--a new class of narcotic analgesics","Ghosh AC, Lavoie RL, Herlihy P, Howes JF, Razdan RK.","NIDA Res Monogr. 1982 Apr;41:105-11.","Ghosh AC","NIDA Res Monogr","1982","1982/04/01","","",""
"6181259","Novel opiates and antagonists. 4. 7-Alkanoylhydromorphones","Quick J, Herlihy P, Razdan RK, Howes JF.","J Med Chem. 1982 Aug;25(8):983-6. doi: 10.1021/jm00350a019.","Quick J","J Med Chem","1982","1982/08/01","","","10.1021/jm00350a019"
"6181247","Operation of long-range substituent effects in rigid opiates: protonated and unprotonated oxymorphone","Darling SD, Kolb VM, Mandel GS, Mandel NS.","J Pharm Sci. 1982 Jul;71(7):763-7. doi: 10.1002/jps.2600710711.","Darling SD","J Pharm Sci","1982","1982/07/01","","","10.1002/jps.2600710711"
"6181053","Coma vigil masquerading as psychiatric illness","Shraberg D, D'Souza T.","J Clin Psychiatry. 1982 Sep;43(9):375-6.","Shraberg D","J Clin Psychiatry","1982","1982/09/01","","",""
"6178789","Hydromorphone detected in bile following hydrocodone ingestion","Park JI, Nakamura GR, Griesemer EC, Noguchi TT.","J Forensic Sci. 1982 Jan;27(1):223-4.","Park JI","J Forensic Sci","1982","1982/01/01","","",""
"6176696","Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines","Hahn EF, Carroll-Buatti M, Pasternak GW.","J Neurosci. 1982 May;2(5):572-6. doi: 10.1523/JNEUROSCI.02-05-00572.1982.","Hahn EF","J Neurosci","1982","1982/05/01","PMC6564265","","10.1523/JNEUROSCI.02-05-00572.1982"
"6176658","Doctors & drug abusers","Gallinatti JJ.","J Indiana State Med Assoc. 1982 Mar;75(3):168.","Gallinatti JJ","J Indiana State Med Assoc","1982","1982/03/01","","",""
"6176227","Increased biological activity of dimers of oxymorphone and enkephalin: possible role of receptor crosslinking","Hazum E, Chang KJ, Leighton HJ, Lever OW Jr, Cuatrecasas P.","Biochem Biophys Res Commun. 1982 Jan 15;104(1):347-53. doi: 10.1016/0006-291x(82)91981-7.","Hazum E","Biochem Biophys Res Commun","1982","1982/01/15","","","10.1016/0006-291x(82)91981-7"
"6174044","Compatibility of hydromorphone hydrochloride in large-volume parenterals","Cutie MR, Waranis R.","Am J Hosp Pharm. 1982 Feb;39(2):307-8.","Cutie MR","Am J Hosp Pharm","1982","1982/02/01","","",""
"6173906","Furosemide, Patella vulgata beta-glucuronidase and drug analysis: conditions for enhancement of the TLC detection of apomorphine, butorphanol, hydromorphone, nalbuphine, oxymorphone and pentazocine in equine urine","Combie J, Blake JW, Nugent TE, Tobin T.","Res Commun Chem Pathol Pharmacol. 1982 Jan;35(1):27-41.","Combie J","Res Commun Chem Pathol Pharmacol","1982","1982/01/01","","",""
"6173260","[Metabolite activity of morphine and other narcotic analgesics (a review of the literature)]","Ul'iankina TI, Shapoval NV.","Farmakol Toksikol. 1982 Jan-Feb;45(1):95-9.","Ul'iankina TI","Farmakol Toksikol","1982","1982/01/01","","",""
"6166748","Analgesic narcotic antagonists. 5. 7,7-Dimethyldihydrocodeinones and 7,7-dimethyldihydromorphinones","Leland DL, Kotick MP.","J Med Chem. 1981 Jun;24(6):717-21. doi: 10.1021/jm00138a015.","Leland DL","J Med Chem","1981","1981/06/01","","","10.1021/jm00138a015"
"6166740","Drug--disintegrant interactions: binding of oxymorphone derivatives","Chien YW, Van Nostrand P, Hurwitz AR, Shami EG.","J Pharm Sci. 1981 Jun;70(6):709-10. doi: 10.1002/jps.2600700641.","Chien YW","J Pharm Sci","1981","1981/06/01","","","10.1002/jps.2600700641"
"6166089","Liver damage from narcotics in mice","Needham WP, Shuster L, Kanel GC, Thompson ML.","Toxicol Appl Pharmacol. 1981 Apr;58(2):157-70. doi: 10.1016/0041-008x(81)90420-8.","Needham WP","Toxicol Appl Pharmacol","1981","1981/04/01","","","10.1016/0041-008x(81)90420-8"
"6165742","Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects","Vallner JJ, Stewart JT, Kotzan JA, Kirsten EB, Honigberg IL.","J Clin Pharmacol. 1981 Apr;21(4):152-6. doi: 10.1002/j.1552-4604.1981.tb05693.x.","Vallner JJ","J Clin Pharmacol","1981","1981/04/01","","","10.1002/j.1552-4604.1981.tb05693.x"
"6164499","Dilaudid use: trends and characteristics of users","McBride DC, McCoy CB, Rivers JE, Lincoln CA.","Chem Depend. 1980;4(1-2):85-100.","McBride DC","Chem Depend","1980","1980/01/01","","",""
"6162947","Pharmacological studies with an alkylating narcotic agonist, chloroxymorphamine, and antagonist, chlornaltrexamine","Caruso TP, Larson DL, Portoghese PS, Takemori AE.","J Pharmacol Exp Ther. 1980 Jun;213(3):539-44.","Caruso TP","J Pharmacol Exp Ther","1980","1980/06/01","","",""
"6161013","Morphine analgesia after intrathecal administration of a narcotic agonist, chloroxymorphamine and antagonist, chlornaltrexamine","Larson AA, Armstrong MJ.","Eur J Pharmacol. 1980 Nov 7;68(1):25-31. doi: 10.1016/0014-2999(80)90056-4.","Larson AA","Eur J Pharmacol","1980","1980/11/07","","","10.1016/0014-2999(80)90056-4"
"6158568","Radioimmunoassay of hydromorphone and hydrocodone in human plasma","Honigberg IL, Stewart JT.","J Pharm Sci. 1980 Oct;69(10):1171-3. doi: 10.1002/jps.2600691013.","Honigberg IL","J Pharm Sci","1980","1980/10/01","","","10.1002/jps.2600691013"
"6157270","[Analgesic activity of various morphine derivatives on the Afghan pika (Ochotona rufescens rufescens): tolerance of the acute effects of morphine]","Puget A.","Zentralbl Veterinarmed A. 1980 Apr;27(2):157-64.","Puget A","Zentralbl Veterinarmed A","1980","1980/04/01","","",""
"6156472","Zinc tannate salts of heroin, LAAM and hydromorphone attenuate opiate withdrawal syndrome","Brands B, Baskerville JC, Hirst M, Gowdey CW.","Psychopharmacology (Berl). 1980;68(3):311-4. doi: 10.1007/BF00428122.","Brands B","Psychopharmacology (Berl)","1980","1980/01/01","","","10.1007/BF00428122"
"6156423","Sparingly-soluble narcotic zinc tannates cause protracted analgesia in rats","Brands B, Baskerville JC, Herne R, Hirst M, Gowdey CW.","Neuropharmacology. 1980 May;19(5):443-6. doi: 10.1016/0028-3908(80)90051-9.","Brands B","Neuropharmacology","1980","1980/05/01","","","10.1016/0028-3908(80)90051-9"
"6156240","Long-acting opiate agonists and antagonists: 14-hydroxydihydromorphinone hydrazones","Pasternak GW, Hahn EF.","J Med Chem. 1980 Jun;23(6):674-6. doi: 10.1021/jm00180a019.","Pasternak GW","J Med Chem","1980","1980/06/01","","","10.1021/jm00180a019"
"6155387","Clinical effects of parenteral narcotics in hospitalized medical patients","Miller RR.","J Clin Pharmacol. 1980 Apr;20(4):165-71. doi: 10.1002/j.1552-4604.1980.tb01692.x.","Miller RR","J Clin Pharmacol","1980","1980/04/01","","","10.1002/j.1552-4604.1980.tb01692.x"
"6154139","Opiates and thermoregulation in mice. I. Agonists","Rosow CE, Miller JM, Pelikan EW, Cochin J.","J Pharmacol Exp Ther. 1980 May;213(2):273-83.","Rosow CE","J Pharmacol Exp Ther","1980","1980/05/01","","",""
"6153723","Analgesic narcotic antagonists. 1. 8 beta-Alkyl-, 8 beta-acyl-, and 8 beta-(tertiary alcohol)dihydrocodeinones and -dihydromorphinones","Kotick MP, Leland DL, Polazzi JO, Schut RN.","J Med Chem. 1980 Feb;23(2):166-74. doi: 10.1021/jm00176a012.","Kotick MP","J Med Chem","1980","1980/02/01","","","10.1021/jm00176a012"
"6085768","Three-choice discrimination in methadone maintenance patients: hydromorphone, naloxone, and saline","Preston KL, Bigelow GE, Stitzer ML, Liebson IA.","NIDA Res Monogr. 1984;55:151-7.","Preston KL","NIDA Res Monogr","1984","1984/01/01","","",""
"6084569","The effect of quaternary naloxone on the increased naloxone potency induced by morphine","Wong CL, Wai MK.","Clin Exp Pharmacol Physiol. 1984 Sep-Oct;11(5):467-71. doi: 10.1111/j.1440-1681.1984.tb00854.x.","Wong CL","Clin Exp Pharmacol Physiol","1984","1984/09/01","","","10.1111/j.1440-1681.1984.tb00854.x"
"6083576","Hydromorphone effects on human conversational speech","Stitzer ML, McCaul ME, Bigleow GE, Liebson IA.","Psychopharmacology (Berl). 1984;84(3):402-4. doi: 10.1007/BF00555221.","Stitzer ML","Psychopharmacology (Berl)","1984","1984/01/01","","","10.1007/BF00555221"
"4193894","Application of enzyme kinetics to a problem in pharmacology: receptor affinities and efficacies in the action of morphine and related drugs on human serum esterase","Gero A.","Enzymologia. 1970 May 31;38(5):283-307.","Gero A","Enzymologia","1970","1970/05/31","","",""
"4190489","[Permeation of active morphine-like substances at their sites of antinociceptive action in the brain as a function of their lipid-solubility following intravenous and intraventricular application]","von Cube B, Teschemacher H, Herz A, Hess R.","Naunyn Schmiedebergs Arch Pharmakol. 1970;265(5):455-73.","von Cube B","Naunyn Schmiedebergs Arch Pharmakol","1970","1970/01/01","","",""
"4190432","A method of identifying narcotic analgesics in human urine after therapeutic doses","Fujimoto JM, Wang RI.","Toxicol Appl Pharmacol. 1970 Jan;16(1):186-93. doi: 10.1016/0041-008x(70)90175-4.","Fujimoto JM","Toxicol Appl Pharmacol","1970","1970/01/01","","","10.1016/0041-008x(70)90175-4"
"4186198","[Analgesics. 32]","Röthig J.","Pharm Prax. 1969;5:97-115.","Röthig J","Pharm Prax","1969","1969/01/01","","",""
"4184976","[A comparison of the analgetic action of intravenously and intraventricularly injected morphine-like substances, taking into account their fat solubility]","von Cube B, Teschemacher HJ, Herz A.","Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1969;263(1):199-200.","von Cube B","Naunyn Schmiedebergs Arch Exp Pathol Pharmakol","1969","1969/01/01","","",""
"4184629","[On the therapy of recent myocardial infarct 25 years ago and today]","Wuhrmann F.","Schweiz Med Wochenschr. 1969 Jul 12;99(28):1012-4.","Wuhrmann F","Schweiz Med Wochenschr","1969","1969/07/12","","",""
"4181148","Dental evaluation of hydromorphone (Dilaudid) for oral and maxillo-facial surgery","Nasits BJ.","Tex Dent J. 1969 May;87(5):4-6.","Nasits BJ","Tex Dent J","1969","1969/05/01","","",""
"4180165","Studies of drugs given before anaesthesia. XVII: The natural and semi-synthetic opiates","Loan WB, Morrison JD, Dundee JW, Clarke RS, Hamilton RC, Brown SS.","Br J Anaesth. 1969 Jan;41(1):57-63. doi: 10.1093/bja/41.1.57.","Loan WB","Br J Anaesth","1969","1969/01/01","","","10.1093/bja/41.1.57"
"4177607","Postoperative analgesia with hydromorphone and meperidine: a double-blind comparison","Deutsch EV.","Anesth Analg. 1968 Nov-Dec;47(6):669-71.","Deutsch EV","Anesth Analg","1968","1968/11/01","","",""
"4177155","Adrenal function in tropical sprue","Baker SJ, Jacob R, Mathan VI, Richard J, Vaish SK.","Indian J Med Res. 1968 May;56(5):686-700.","Baker SJ","Indian J Med Res","1968","1968/05/01","","",""
"4174062","Transformations in the morphine series. II. A new position isomer of dihydromorphinone","Sargent LJ, Joshi BC.","J Med Chem. 1968 Mar;11(2):336-9. doi: 10.1021/jm00308a033.","Sargent LJ","J Med Chem","1968","1968/03/01","","","10.1021/jm00308a033"
"4168648","[Modifications of the contractility of the sphincter of Oddi under the influence of central analgesics]","Juvara I, Radulesco D.","Rev Int Hepatol. 1967;17(1):55-63.","Juvara I","Rev Int Hepatol","1967","1967/01/01","","",""
"4168063","Detection of morphine and related alkaloids in mice homogenates by thin layer chromatography","Huidobro F, Miranda H.","Acta Physiol Lat Am. 1966;16(4):335-42.","Huidobro F","Acta Physiol Lat Am","1966","1966/01/01","","",""
"4166084","Transport of narcotic analgesics by choroid plexus and kidney tissue in vitro","Hug CC Jr.","Biochem Pharmacol. 1967 Feb;16(2):345-59. doi: 10.1016/0006-2952(67)90035-4.","Hug CC Jr","Biochem Pharmacol","1967","1967/02/01","","","10.1016/0006-2952(67)90035-4"
"4165953","Interactions of narcotics and their antagonists with human serum esterase. I: sites of action and nature of the inhibitory effect","Ettinger MJ, Gero A.","Arch Int Pharmacodyn Ther. 1966 Nov;164(1):96-119.","Ettinger MJ","Arch Int Pharmacodyn Ther","1966","1966/11/01","","",""
"4165952","Interactions of narcotics and their antagonists with human serum esterase. II: nature of the antagonism","Ettinger MJ, Gero A.","Arch Int Pharmacodyn Ther. 1966 Nov;164(1):111-9.","Ettinger MJ","Arch Int Pharmacodyn Ther","1966","1966/11/01","","",""
"4164735","[Drug therapy of cholelithiasis]","Heinkel K.","Dtsch Med Wochenschr. 1967 May 26;92(21):978-80. doi: 10.1055/s-0028-1103733.","Heinkel K","Dtsch Med Wochenschr","1967","1967/05/26","","","10.1055/s-0028-1103733"
"4163617","Synthesis and pharmacology of 6-methylenedihydrodesoxymorphine","Abdel-Rahman MA, Elliott HW, Binks R, Küng W, Rapoport H.","J Med Chem. 1966 Jan;9(1):1-6. doi: 10.1021/jm00319a001.","Abdel-Rahman MA","J Med Chem","1966","1966/01/01","","","10.1021/jm00319a001"
"4163177","Urine screening techniques employed in the detection of users of narcotics and their correlation with the nalorphine test","Parker KD, Hine CH, Nomof N, Elliott HW.","J Forensic Sci. 1966 Apr;11(2):152-66.","Parker KD","J Forensic Sci","1966","1966/04/01","","",""
"4162906","Narcotic blockade--a medical technique for stopping heroin use by addicts","Dole VP, Nyswander ME, Kreek MJ.","Trans Assoc Am Physicians. 1966;79:122-36.","Dole VP","Trans Assoc Am Physicians","1966","1966/01/01","","",""
"4162686","Narcotic blockade","Dole VP, Nyswander ME, Kreek MJ.","Arch Intern Med. 1966 Oct;118(4):304-9.","Dole VP","Arch Intern Med","1966","1966/10/01","","",""
"4159230","Stop-flow analysis of the renal excretion of tritium-labeled dihydromorphine","Hug CC Jr, Mellett LB, Cafruny EJ.","J Pharmacol Exp Ther. 1965 Nov;150(2):259-69.","Hug CC Jr","J Pharmacol Exp Ther","1965","1965/11/01","","",""
"4159199","Changes in morphine- and chlorpromazine-N-demethylase during the development of tolerance to chlorpromazine in mice","Shuster L, Hannam RV.","Can J Biochem. 1965 Jul;43(7):899-908. doi: 10.1139/o65-103.","Shuster L","Can J Biochem","1965","1965/07/01","","","10.1139/o65-103"
"4142154","[Analgesia in myocardial infarct]","Spiller P, Kreuzer H.","Z Kardiol. 1974 Dec;63(12):1060-7.","Spiller P","Z Kardiol","1974","1974/12/01","","",""
"4132633","Contribution of 'receptor' affinity to analgesic potency","Terenius L.","J Pharm Pharmacol. 1974 Feb;26(2):146-8. doi: 10.1111/j.2042-7158.1974.tb09245.x.","Terenius L","J Pharm Pharmacol","1974","1974/02/01","","","10.1111/j.2042-7158.1974.tb09245.x"
"4131940","Narcotic receptor sites in morphine-dependent rats","Klee WA, Streaty RA.","Nature. 1974 Mar 1;248(5443):61-3. doi: 10.1038/248061a0.","Klee WA","Nature","1974","1974/03/01","","","10.1038/248061a0"
"4131395","A chromatographic investigation of morphine metabolism in rats. Confirmation of N-demethylation of morphine and isolation of a new metabolite","Klutch A.","Drug Metab Dispos. 1974 Jan-Feb;2(1):23-30.","Klutch A","Drug Metab Dispos","1974","1974/01/01","","",""
"4130418","Evaluation of immunoassay methods for detection, in urine, of drugs subject to abuse","Mulé SJ, Bastos ML, Jukofsky D.","Clin Chem. 1974 Feb;20(2):243-8.","Mulé SJ","Clin Chem","1974","1974/02/01","","",""
"4128958","Stereospecific uptake of narcotic analgesics by a subcellular fraction of the guinea-pig ileum. A preliminary communication","Terenius L.","Ups J Med Sci. 1973 Jul;78(3):150-2. doi: 10.3109/03009737309178620.","Terenius L","Ups J Med Sci","1973","1973/07/01","","","10.3109/03009737309178620"
"4128222","Opiate agonists and antagonists discriminated by receptor binding in brain","Pert CB, Pasternak G, Snyder SH.","Science. 1973 Dec 28;182(4119):1359-61. doi: 10.1126/science.182.4119.1359.","Pert CB","Science","1973","1973/12/28","","","10.1126/science.182.4119.1359"
"4127942","Rapid methods of screening micro-quantities of abused drugs from urine samples for microcrystal tests","Huang JC, Baden MM.","Clin Toxicol. 1973;6(3):325-50. doi: 10.3109/15563657308990534.","Huang JC","Clin Toxicol","1973","1973/01/01","","","10.3109/15563657308990534"
"4127185","Regional distribution of opiate receptor binding in monkey and human brain","Kuhar MJ, Pert CB, Snyder SH.","Nature. 1973 Oct 26;245(5426):447-50. doi: 10.1038/245447a0.","Kuhar MJ","Nature","1973","1973/10/26","","","10.1038/245447a0"
"4124625","Is the uptake of narcotic analgesics by cerebral cortical slices mediated in part by active transport?","Vasko MR, Hug CC Jr.","J Pharm Pharmacol. 1973 Feb;25(2):180-3. doi: 10.1111/j.2042-7158.1973.tb10618.x.","Vasko MR","J Pharm Pharmacol","1973","1973/02/01","","","10.1111/j.2042-7158.1973.tb10618.x"
"4123997","The search for a better analgesic","Eddy NB, May EL.","Science. 1973 Aug 3;181(4098):407-14. doi: 10.1126/science.181.4098.407.","Eddy NB","Science","1973","1973/08/03","","","10.1126/science.181.4098.407"
"4121478","Respiratory effects of hydromorphone in man","Brown CR Jr, Forest WH, Hayden J, James KE.","Clin Pharmacol Ther. 1973 May-Jun;14(3):331-7. doi: 10.1002/cpt1973143331.","Brown CR Jr","Clin Pharmacol Ther","1973","1973/05/01","","","10.1002/cpt1973143331"
"4118258","Premedication for peroral endoscopy. Two double-blind studies","Petersen H, Myren J.","Scand J Gastroenterol. 1972;7(7):583-7. doi: 10.3109/00365527209180960.","Petersen H","Scand J Gastroenterol","1972","1972/01/01","","","10.3109/00365527209180960"
"4118115","[Effect of various drugs on NMRI mice damaged by radiation and combined noxas]","Messerschmidt O, Heppeler G.","Fortschr Geb Rontgenstr Nuklearmed. 1972:Suppl:61-2.","Messerschmidt O","Fortschr Geb Rontgenstr Nuklearmed","1972","1972/01/01","","",""
"4117468","Sensitivity of thin-layer chromatography for detection of 16 opioids, cocaine and quinine","Gorodetzky CW.","Toxicol Appl Pharmacol. 1972 Nov;23(3):511-8. doi: 10.1016/0041-008x(72)90053-1.","Gorodetzky CW","Toxicol Appl Pharmacol","1972","1972/11/01","","","10.1016/0041-008x(72)90053-1"
"4106755","Practical considerations in the management of shock complicating acute myocardial infarction. A summary of current practice","Shubin H, Weil MH.","Am J Cardiol. 1970 Dec;26(6):603-8. doi: 10.1016/0002-9149(70)90413-3.","Shubin H","Am J Cardiol","1970","1970/12/01","","","10.1016/0002-9149(70)90413-3"
"4105659","Quantitative determination of morphine in serum by radioimmunoassay","Spector S.","J Pharmacol Exp Ther. 1971 Aug;178(2):253-8.","Spector S","J Pharmacol Exp Ther","1971","1971/08/01","","",""
"4102559","Uptake of dihydromorphine-3H by synaptosomes","Hug CC Jr, Oka T.","Life Sci I. 1971 Feb 15;10(4):201-13. doi: 10.1016/0024-3205(71)90249-9.","Hug CC Jr","Life Sci I","1971","1971/02/15","","","10.1016/0024-3205(71)90249-9"
"4098207","Interactions of narcotics and their antagonists with human serum esterase. 3. Structure-activity studies","Ferko AP, Gero A.","Arch Int Pharmacodyn Ther. 1970 Oct;187(2):213-35.","Ferko AP","Arch Int Pharmacodyn Ther","1970","1970/10/01","","",""
"4098039","Agonists--antagonists derived from desomorphine and metopon","Sargent LJ, May EL.","J Med Chem. 1970 Nov;13(6):1061-3. doi: 10.1021/jm00300a009.","Sargent LJ","J Med Chem","1970","1970/11/01","","","10.1021/jm00300a009"
"2582304","Chloroacryloyl amides and alpha-methylenelactones from naltrexone, oxymorphone and fentanyl","Archer S, Michael J, Michael M, Simon EJ, Abdelhamid EM, Nelson WL, Koolpe GA.","Neuropeptides. 1985 Feb;5(4-6):395-8. doi: 10.1016/0143-4179(85)90037-x.","Archer S","Neuropeptides","1985","1985/02/01","","","10.1016/0143-4179(85)90037-x"
"2580834","Purification and characterization of guinea pig liver morphine 6-dehydrogenase","Yamano S, Kageura E, Ishida T, Toki S.","J Biol Chem. 1985 May 10;260(9):5259-64.","Yamano S","J Biol Chem","1985","1985/05/10","","",""
"2579319","A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site","Rothman RB, Bowen WD, Herkenham M, Jacobson AE, Rice KC, Pert CB.","Mol Pharmacol. 1985 Mar;27(3):399-409.","Rothman RB","Mol Pharmacol","1985","1985/03/01","","",""
"2578752","Comparison of histamine release in human skin mast cells induced by morphine, fentanyl, and oxymorphone","Hermens JM, Ebertz JM, Hanifin JM, Hirshman CA.","Anesthesiology. 1985 Feb;62(2):124-9. doi: 10.1097/00000542-198502000-00005.","Hermens JM","Anesthesiology","1985","1985/02/01","","","10.1097/00000542-198502000-00005"
"2578261","Segmental effect of lumbar epidural hydromorphone: a case report","Horan CT, Beeby DG, Brodsky JB, Oberhelman HA.","Anesthesiology. 1985 Jan;62(1):84-5. doi: 10.1097/00000542-198501000-00019.","Horan CT","Anesthesiology","1985","1985/01/01","","","10.1097/00000542-198501000-00019"
"2484268","Human d-amphetamine drug discrimination: testing with d-amphetamine and hydromorphone","Lamb RJ, Henningfield JE.","NIDA Res Monogr. 1989;95:423-4.","Lamb RJ","NIDA Res Monogr","1989","1989/01/01","","",""
"2483328","A comparison of oxymorphone and fentanyl as narcotic supplements in general anesthesia","Sinatra RS, Harrison DM.","J Clin Anesth. 1989;1(4):253-8. doi: 10.1016/0952-8180(89)90022-6.","Sinatra RS","J Clin Anesth","1989","1989/01/01","","","10.1016/0952-8180(89)90022-6"
"2482683","Naloxone reversal of oxymorphone effects in dogs","Copland VS, Haskins SC, Patz J.","Am J Vet Res. 1989 Nov;50(11):1854-8.","Copland VS","Am J Vet Res","1989","1989/11/01","","",""
"2481703","Home intravenous opioid therapy in a toddler with advanced cancer","Rogers AG.","J Pain Symptom Manage. 1989 Dec;4(4):230-1. doi: 10.1016/0885-3924(89)90046-8.","Rogers AG","J Pain Symptom Manage","1989","1989/12/01","","","10.1016/0885-3924(89)90046-8"
"2481029","Opioid drug discrimination in humans: stability, specificity and relation to self-reported drug effect","Bickel WK, Bigelow GE, Preston KL, Liebson IA.","J Pharmacol Exp Ther. 1989 Dec;251(3):1053-63.","Bickel WK","J Pharmacol Exp Ther","1989","1989/12/01","","",""
"2478994","Brain and plasma kinetics of the opioid 11C-hydromorphone in two macaque species","Hartvig P, Neil A, Terenius L, Antoni G, Rimland A, Ulin J, Långström B.","Pharmacol Toxicol. 1989 Sep;65(3):214-6. doi: 10.1111/j.1600-0773.1989.tb01159.x.","Hartvig P","Pharmacol Toxicol","1989","1989/09/01","","","10.1111/j.1600-0773.1989.tb01159.x"
"2478049","An evaluation of morphine and oxymorphone administered via patient-controlled analgesia (PCA) or PCA plus basal infusion in postcesarean-delivery patients","Sinatra R, Chung KS, Silverman DG, Brull SJ, Chung J, Harrison DM, Donielson D, Weinstock A.","Anesthesiology. 1989 Oct;71(4):502-7. doi: 10.1097/00000542-198910000-00005.","Sinatra R","Anesthesiology","1989","1989/10/01","","","10.1097/00000542-198910000-00005"
"2478048","Outpatient premedication: use of midazolam and opioid analgesics","Shafer A, White PF, Urquhart ML, Doze VA.","Anesthesiology. 1989 Oct;71(4):495-501.","Shafer A","Anesthesiology","1989","1989/10/01","","",""
"2477864","A spirohydantoin derivative of oxymorphone: an agonist with delayed antagonist activity","Alexander GJ, Chatterjie N, Wisniewski HM.","Pharmacol Biochem Behav. 1989 Apr;32(4):939-43. doi: 10.1016/0091-3057(89)90062-2.","Alexander GJ","Pharmacol Biochem Behav","1989","1989/04/01","","","10.1016/0091-3057(89)90062-2"
"2477388","Simultaneous extraction and chromatographic analysis of morphine, dilaudid, naltrexone and naloxone in biological fluids by high-performance liquid chromatography with electrochemical detection","O'Connor EF, Cheng SW, North WG.","J Chromatogr. 1989 Jun 30;491(1):240-7. doi: 10.1016/s0378-4347(00)82839-x.","O'Connor EF","J Chromatogr","1989","1989/06/30","","","10.1016/s0378-4347(00)82839-x"
"2476953","Antinociceptive activity of pentamorphone, a 14-beta-aminomorphinone derivative, compared to fentanyl and morphine","Rudo FG, Wynn RL, Ossipov M, Ford RD, Kutcher BA, Carter A, Spaulding TC.","Anesth Analg. 1989 Oct;69(4):450-6.","Rudo FG","Anesth Analg","1989","1989/10/01","","",""
"2475628","Opioid agonist and antagonist activities of peripherally selective derivatives of naltrexamine and oxymorphamine","Botros S, Lipkowski AW, Larson DL, Stark PA, Takemori AE, Portoghese PS.","J Med Chem. 1989 Sep;32(9):2068-71. doi: 10.1021/jm00129a009.","Botros S","J Med Chem","1989","1989/09/01","","","10.1021/jm00129a009"
"2475287","Oxymorphone in patient-controlled analgesia","Sinatra RS, Harrison DM.","Clin Pharm. 1989 Aug;8(8):541, 544.","Sinatra RS","Clin Pharm","1989","1989/08/01","","",""
"2473187","Drug discrimination in human postaddicts: agonist-antagonist opioids","Preston KL, Bigelow GE, Bickel WK, Liebson IA.","J Pharmacol Exp Ther. 1989 Jul;250(1):184-96.","Preston KL","J Pharmacol Exp Ther","1989","1989/07/01","","",""
"2472540","Effects of oxymorphazone in frogs: long lasting antinociception in vivo, and apparently irreversible binding in vitro","Benyhe S, Hoffmann G, Varga E, Hosztafi S, Toth G, Borsodi A, Wollemann M.","Life Sci. 1989;44(24):1847-57. doi: 10.1016/0024-3205(89)90302-0.","Benyhe S","Life Sci","1989","1989/01/01","","","10.1016/0024-3205(89)90302-0"
"2471291","Depression of hepatic glutathione by opioid analgesic drugs in mice","Skoulis NP, James RC, Harbison RD, Roberts SM.","Toxicol Appl Pharmacol. 1989 Jun 1;99(1):139-47. doi: 10.1016/0041-008x(89)90119-1.","Skoulis NP","Toxicol Appl Pharmacol","1989","1989/06/01","","","10.1016/0041-008x(89)90119-1"
"2470568","(8S)-(glutathion-S-yl)dihydromorphinone, a novel metabolite of morphine from guinea pig bile","Ishida T, Kumagai Y, Ikeda Y, Ito K, Yano M, Toki S, Mihashi K, Fujioka T, Iwase Y, Hachiyama S.","Drug Metab Dispos. 1989 Jan-Feb;17(1):77-81.","Ishida T","Drug Metab Dispos","1989","1989/01/01","","",""
"2470073","Pharmacokinetics and bioavailability of hydromorphone: effect of various routes of administration","Chang SF, Moore L, Chien YW.","Pharm Res. 1988 Nov;5(11):718-21. doi: 10.1023/a:1015959912021.","Chang SF","Pharm Res","1988","1988/11/01","","","10.1023/a:1015959912021"
"2469053","Failure of epidural opioid to control cancer pain in a patient previously treated with massive doses of intravenous opioid","Tanelian DL, Cousins MJ.","Pain. 1989 Mar;36(3):359-62. doi: 10.1016/0304-3959(89)90096-1.","Tanelian DL","Pain","1989","1989/03/01","","","10.1016/0304-3959(89)90096-1"
"2467983","Antagonist effects of nalbuphine in opioid-dependent human volunteers","Preston KL, Bigelow GE, Liebson IA.","J Pharmacol Exp Ther. 1989 Mar;248(3):929-37.","Preston KL","J Pharmacol Exp Ther","1989","1989/03/01","","",""
"2467954","Focal subdermal toxicity with subcutaneous opioid infusion in patients with cancer pain","Adams F, Cruz L, Deachman MJ, Zamora E.","J Pain Symptom Manage. 1989 Mar;4(1):31-3. doi: 10.1016/0885-3924(89)90061-4.","Adams F","J Pain Symptom Manage","1989","1989/03/01","","","10.1016/0885-3924(89)90061-4"
"2467588","A comparison of morphine, meperidine, and oxymorphone as utilized in patient-controlled analgesia following cesarean delivery","Sinatra RS, Lodge K, Sibert K, Chung KS, Chung JH, Parker A Jr, Harrison DM.","Anesthesiology. 1989 Apr;70(4):585-90. doi: 10.1097/00000542-198904000-00005.","Sinatra RS","Anesthesiology","1989","1989/04/01","","","10.1097/00000542-198904000-00005"
"2465709","Epidural hydromorphone with and without epinephrine for post-operative analgesia after cesarean delivery","Dougherty TB, Baysinger CL, Henenberger JC, Gooding DJ.","Anesth Analg. 1989 Mar;68(3):318-22.","Dougherty TB","Anesth Analg","1989","1989/03/01","","",""
"2465708","Evaluation of pentamorphone in humans: a new potent opiate","Glass PS, Camporesi EM, Shafron D, Quill T, Reves JG.","Anesth Analg. 1989 Mar;68(3):302-7.","Glass PS","Anesth Analg","1989","1989/03/01","","",""
"2465531","Combined neurogenic and nociceptive pain in a patient with Pancoast tumor managed by epidural hydromorphone and oral carbamazepine","Tanelian DL, Cousins MJ.","Pain. 1989 Jan;36(1):85-8. doi: 10.1016/0304-3959(89)90114-0.","Tanelian DL","Pain","1989","1989/01/01","","","10.1016/0304-3959(89)90114-0"
"2463060","Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats","Hand TH, Koob GF, Stinus L, Le Moal M.","Brain Res. 1988 Dec 6;474(2):364-8. doi: 10.1016/0006-8993(88)90452-0.","Hand TH","Brain Res","1988","1988/12/06","","","10.1016/0006-8993(88)90452-0"
"2462789","Plaques may complicate subcutaneous opioid infusions","Adams F, Cruz L, Deachman MJ, Zamora E.","Am J Nurs. 1989 Jan;89(1):109-10.","Adams F","Am J Nurs","1989","1989/01/01","","",""
"2461929","Emergency intravenous sedation of the delirious, medically ill patient","Adams F.","J Clin Psychiatry. 1988 Dec;49 Suppl:22-7.","Adams F","J Clin Psychiatry","1988","1988/12/01","","",""
"2461428","Heroin, morphine, and hydromorphone determination in postmortem material by high performance liquid chromatography","Sawyer WR, Waterhouse GA, Doedens DJ, Forney RB.","J Forensic Sci. 1988 Sep;33(5):1146-55.","Sawyer WR","J Forensic Sci","1988","1988/09/01","","",""
"2461130","Comparison of histamine release induced by morphine and oxymorphone administration in dogs","Robinson EP, Faggella AM, Henry DP, Russell WL.","Am J Vet Res. 1988 Oct;49(10):1699-701.","Robinson EP","Am J Vet Res","1988","1988/10/01","","",""
"2459370","Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans","Bickel WK, Stitzer ML, Bigelow GE, Liebson IA, Jasinski DR, Johnson RE.","J Pharmacol Exp Ther. 1988 Oct;247(1):47-53.","Bickel WK","J Pharmacol Exp Ther","1988","1988/10/01","","",""
"2458878","Hydromorphone levels and pain control in patients with severe chronic pain","Reidenberg MM, Goodman H, Erle H, Gray G, Lorenzo B, Leipzig RM, Meyer BR, Drayer DE.","Clin Pharmacol Ther. 1988 Oct;44(4):376-82. doi: 10.1038/clpt.1988.167.","Reidenberg MM","Clin Pharmacol Ther","1988","1988/10/01","","","10.1038/clpt.1988.167"
"2458208","Sublingual absorption of selected opioid analgesics","Weinberg DS, Inturrisi CE, Reidenberg B, Moulin DE, Nip TJ, Wallenstein S, Houde RW, Foley KM.","Clin Pharmacol Ther. 1988 Sep;44(3):335-42. doi: 10.1038/clpt.1988.159.","Weinberg DS","Clin Pharmacol Ther","1988","1988/09/01","","","10.1038/clpt.1988.159"
"2458059","Patient-controlled analgesia: a comparison of intravenous versus subcutaneous hydromorphone","Urquhart ML, Klapp K, White PF.","Anesthesiology. 1988 Sep;69(3):428-32.","Urquhart ML","Anesthesiology","1988","1988/09/01","","",""
"2457710","Patient-controlled subcutaneous hydromorphone versus continuous subcutaneous infusion for the treatment of cancer pain","Bruera E, Brenneis C, Michaud M, MacMillan K, Hanson J, MacDonald RN.","J Natl Cancer Inst. 1988 Sep 21;80(14):1152-4. doi: 10.1093/jnci/80.14.1152.","Bruera E","J Natl Cancer Inst","1988","1988/09/21","","","10.1093/jnci/80.14.1152"
"2457160","Drug discrimination in human post-addicts: agonist/antagonist opioids","Preston K, Bigelow G, Bickel W, Liebson I.","NIDA Res Monogr. 1988;81:209-15.","Preston K","NIDA Res Monogr","1988","1988/01/01","","",""
"2457074","Butorphanol-precipitated withdrawal in opioid-dependent human volunteers","Preston KL, Bigelow GE, Liebson IA.","J Pharmacol Exp Ther. 1988 Aug;246(2):441-8.","Preston KL","J Pharmacol Exp Ther","1988","1988/08/01","","",""
"2456407","Leads from the MMWR. Dilaudid-related deaths--District of Columbia, 1987","","JAMA. 1988 Aug 19;260(7):903-4.","","JAMA","1988","1988/08/19","","",""
"2455216","Dilaudid-related deaths--District of Columbia, 1987","Centers for Disease Control (CDC).","MMWR Morb Mortal Wkly Rep. 1988 Jul 15;37(27):425-7.","Centers for Disease Control (CDC)","MMWR Morb Mortal Wkly Rep","1988","1988/07/15","","",""
"2454724","Use of the subcutaneous route for the administration of narcotics in patients with cancer pain","Bruera E, Brenneis C, Michaud M, Bacovsky R, Chadwick S, Emeno A, MacDonald N.","Cancer. 1988 Jul 15;62(2):407-11. doi: 10.1002/1097-0142(19880715)62:2<407::aid-cncr2820620227>3.0.co;2-t.","Bruera E","Cancer","1988","1988/07/15","","","10.1002/1097-0142(19880715)62:2<407::aid-cncr2820620227>3.0.co;2-t"
"2453895","Buprenorphine and naloxone alone and in combination in opioid-dependent humans","Preston KL, Bigelow GE, Liebson IA.","Psychopharmacology (Berl). 1988;94(4):484-90. doi: 10.1007/BF00212842.","Preston KL","Psychopharmacology (Berl)","1988","1988/01/01","","","10.1007/BF00212842"
"2453226","Pharmacokinetics of hydromorphone after intravenous, peroral and rectal administration to human subjects","Parab PV, Ritschel WA, Coyle DE, Gregg RV, Denson DD.","Biopharm Drug Dispos. 1988 Mar-Apr;9(2):187-99. doi: 10.1002/bod.2510090207.","Parab PV","Biopharm Drug Dispos","1988","1988/03/01","","","10.1002/bod.2510090207"
"2452249","Irreversible opiate agonists and antagonists. IV. Analgesic actions of 14-hydroxydihydromorphinone hydrazones","Williams CL, Bodnar RJ, Clark JE, Hahn EF, Burks TF, Pasternak GW.","J Pharmacol Exp Ther. 1988 Apr;245(1):8-12.","Williams CL","J Pharmacol Exp Ther","1988","1988/04/01","","",""
"2451699","When all oral opioids cause nausea and vomiting","Rogers AG.","J Pain Symptom Manage. 1988 Spring;3(2):114. doi: 10.1016/0885-3924(88)90170-4.","Rogers AG","J Pain Symptom Manage","1988","1988/01/01","","","10.1016/0885-3924(88)90170-4"
"2451454","Delayed postoperative respiratory depression associated with oxymorphone","Patt RB.","Anesth Analg. 1988 Apr;67(4):403-4.","Patt RB","Anesth Analg","1988","1988/04/01","","",""
"2451097","[Pain treatment during pregnancy and opiate addiction in both mother and child]","","Lakartidningen. 1988 Feb 3;85(5):346-7.","","Lakartidningen","1988","1988/02/03","","",""
"2449618","A clinical trial of buprenorphine: I. Comparison with methadone in the detoxification of heroin addicts. II. Examination of its opioid blocking properties","Bickel WK, Johnson RE, Stitzer ML, Bigelow GE, Liebson IA, Jasinski DR.","NIDA Res Monogr. 1987;76:182-8.","Bickel WK","NIDA Res Monogr","1987","1987/01/01","","",""
"2449617","Butorphanol-precipitated withdrawal in opioid-dependent human volunteers","Preston KL, Bigelow GE, Liebson IA.","NIDA Res Monogr. 1987;76:157-61.","Preston KL","NIDA Res Monogr","1987","1987/01/01","","",""
"2449616","Abuse liability assessment of buprenorphine-naloxone combinations","Bigelow GE, Preston KL, Liebson IA.","NIDA Res Monogr. 1987;76:145-9.","Bigelow GE","NIDA Res Monogr","1987","1987/01/01","","",""
"2449102","Oxymorphone: cardiovascular, pulmonary, and behavioral effects in dogs","Copland VS, Haskins SC, Patz JD.","Am J Vet Res. 1987 Nov;48(11):1626-30.","Copland VS","Am J Vet Res","1987","1987/11/01","","",""
"2449073","Disseminated granulomatosis through a patent foramen ovale in an intravenous drug user with pulmonary hypertension","Riddick L.","Am J Forensic Med Pathol. 1987 Dec;8(4):326-33. doi: 10.1097/00000433-198712000-00013.","Riddick L","Am J Forensic Med Pathol","1987","1987/12/01","","","10.1097/00000433-198712000-00013"
"2448633","Effects of opioid analgesics on local cerebral glucose utilization","London E, Fanelli R, Szikszay M, Jasinski D.","NIDA Res Monogr. 1986;75:379-81.","London E","NIDA Res Monogr","1986","1986/01/01","","",""
"2448626","Preparation of [3H]-oxymorphazone and its binding to rat brain membranes","Borsodi A, Varga E, Toth G, Hosztafi S.","NIDA Res Monogr. 1986;75:220-3.","Borsodi A","NIDA Res Monogr","1986","1986/01/01","","",""
"2448326","Method for determination of morphinone in urine and bile of guinea pig by high-performance liquid chromatography","Kumagai Y, Ishida T, Toki S.","J Chromatogr. 1987 Oct 9;421(1):155-60. doi: 10.1016/0378-4347(87)80391-2.","Kumagai Y","J Chromatogr","1987","1987/10/09","","","10.1016/0378-4347(87)80391-2"
"2447262","Three-choice drug discrimination in opioid-dependent humans: hydromorphone, naloxone and saline","Preston KL, Bigelow GE, Bickel W, Liebson IA.","J Pharmacol Exp Ther. 1987 Dec;243(3):1002-9.","Preston KL","J Pharmacol Exp Ther","1987","1987/12/01","","",""
"2446534","Experience with epidural hydromorphone for post-thoracotomy pain relief","Shulman MS, Wakerlin G, Yamaguchi L, Brodsky JB.","Anesth Analg. 1987 Dec;66(12):1331-3.","Shulman MS","Anesth Analg","1987","1987/12/01","","",""
"2445789","Absolute bioavailability of hydromorphone after peroral and rectal administration in humans: saliva/plasma ratio and clinical effects","Ritschel WA, Parab PV, Denson DD, Coyle DE, Gregg RV.","J Clin Pharmacol. 1987 Sep;27(9):647-53. doi: 10.1002/j.1552-4604.1987.tb03082.x.","Ritschel WA","J Clin Pharmacol","1987","1987/09/01","","","10.1002/j.1552-4604.1987.tb03082.x"
"2445439","Differential effects of mu and kappa opioid analgesics on cerebral glucose utilization in the rat","Fanelli RJ, Szikszay M, Jasinski DR, London ED.","Brain Res. 1987 Oct 6;422(2):257-66. doi: 10.1016/0006-8993(87)90932-2.","Fanelli RJ","Brain Res","1987","1987/10/06","","","10.1016/0006-8993(87)90932-2"
"2445202","Specific effects of sedative/hypnotic drugs in the treatment of incapacitating chronic insomnia","Regestein QR.","Am J Med. 1987 Nov;83(5):909-16. doi: 10.1016/0002-9343(87)90650-4.","Regestein QR","Am J Med","1987","1987/11/01","","","10.1016/0002-9343(87)90650-4"
"2444704","Hybrid bivalent ligands with opiate and enkephalin pharmacophores","Portoghese PS, Larson DL, Ronsisvalle G, Schiller PW, Nguyen TM, Lemieux C, Takemori AE.","J Med Chem. 1987 Nov;30(11):1991-4. doi: 10.1021/jm00394a010.","Portoghese PS","J Med Chem","1987","1987/11/01","","","10.1021/jm00394a010"
"2443397","Drugs in dentistry. Narcotic analgesics: the opioids","Ciancio SG.","Dent Manage. 1987 Aug;27(8):48, 55.","Ciancio SG","Dent Manage","1987","1987/08/01","","",""
"2443242","Continuous Sc infusion of narcotics for the treatment of cancer pain: an update","Bruera E, Brenneis C, MacDonald RN.","Cancer Treat Rep. 1987 Oct;71(10):953-8.","Bruera E","Cancer Treat Rep","1987","1987/10/01","","",""
"2441722","Nondependent monkeys self-administer hydromorphone","Ternes JW, Ehrman RN, O'Brien CP.","Behav Neurosci. 1985 Jun;99(3):583-8. doi: 10.1037//0735-7044.99.3.583.","Ternes JW","Behav Neurosci","1985","1985/06/01","","","10.1037//0735-7044.99.3.583"
"2441221","Oxymorphone-naltrexonazine, a mixed opiate agonist-antagonist","Galetta S, Hahn EF, Nishimura S, Pasternak GW.","Life Sci. 1987 Aug 10;41(6):783-7. doi: 10.1016/0024-3205(87)90459-0.","Galetta S","Life Sci","1987","1987/08/10","","","10.1016/0024-3205(87)90459-0"
"2438965","Epidural hydromorphone: a double-blind comparison with intramuscular hydromorphone for postcesarean section analgesia","Henderson SK, Matthew EB, Cohen H, Avram MJ.","Anesthesiology. 1987 Jun;66(6):825-30.","Henderson SK","Anesthesiology","1987","1987/06/01","","",""
"2438964","Delayed respiratory arrest after epidural hydromorphone","Wüst HJ, Bromage PR.","Anaesthesia. 1987 Apr;42(4):404-6. doi: 10.1111/j.1365-2044.1987.tb03982.x.","Wüst HJ","Anaesthesia","1987","1987/04/01","","","10.1111/j.1365-2044.1987.tb03982.x"
"2438361","How to manage incident pain","Rogers AG.","J Pain Symptom Manage. 1987 Spring;2(2):99. doi: 10.1016/s0885-3924(87)80023-4.","Rogers AG","J Pain Symptom Manage","1987","1987/01/01","","","10.1016/s0885-3924(87)80023-4"
"2438292","Distribution of excitatory junction potential amplitude in cat cerebral arteries: examination of its quantal nature and modulation by opiates","Madden JA, Kalbfleisch JH, Harder DR.","J Cell Physiol. 1987 May;131(2):262-6. doi: 10.1002/jcp.1041310217.","Madden JA","J Cell Physiol","1987","1987/05/01","","","10.1002/jcp.1041310217"
"2438040","Continuous sc infusion of narcotics using a portable disposable device in patients with advanced cancer","Bruera E, Brenneis C, Michaud M, Chadwick S, MacDonald RN.","Cancer Treat Rep. 1987 Jun;71(6):635-7.","Bruera E","Cancer Treat Rep","1987","1987/06/01","","",""
"2436019","Synthesis and binding of 3H-oxymorphazone to rat brain membranes","Varga E, Toth G, Benyhe S, Hosztafi S, Borsodi A.","Life Sci. 1987 Apr 20;40(16):1579-88. doi: 10.1016/0024-3205(87)90123-8.","Varga E","Life Sci","1987","1987/04/20","","","10.1016/0024-3205(87)90123-8"
"2435750","Electrochemical determination of oxymorphone in rat plasma by ion-pair reversed-phase high-performance liquid chromatography","Lam G, Williams RM, Whitney CC.","J Chromatogr. 1987 Jan 23;413:309-14. doi: 10.1016/0378-4347(87)80245-1.","Lam G","J Chromatogr","1987","1987/01/23","","","10.1016/0378-4347(87)80245-1"
"2434113","High-pressure liquid chromatographic method for the determination of hydromorphone in human plasma with electrochemical detection","Wetzelsberger N, Lücker PW, Erking W.","Arzneimittelforschung. 1986 Nov;36(11):1707-10.","Wetzelsberger N","Arzneimittelforschung","1986","1986/11/01","","",""
"2433098","Effects of oral narcotics on sleep-disordered breathing in healthy adults","Robinson RW, Zwillich CW, Bixler EO, Cadieux RJ, Kales A, White DP.","Chest. 1987 Feb;91(2):197-203. doi: 10.1378/chest.91.2.197.","Robinson RW","Chest","1987","1987/02/01","","","10.1378/chest.91.2.197"
"2430762","Single-patient randomized clinical trial. Opiates for intractable dyspnea","Robin ED, Burke CM.","Chest. 1986 Dec;90(6):888-92. doi: 10.1378/chest.90.6.888.","Robin ED","Chest","1986","1986/12/01","","","10.1378/chest.90.6.888"
"2430752","Exceptionally high narcotic analgesic requirements in a terminally ill cancer patient","Lo SL, Coleman RR.","Clin Pharm. 1986 Oct;5(10):828-32.","Lo SL","Clin Pharm","1986","1986/10/01","","",""
"2430031","Controlled release morphine","Rogers AG.","J Pain Symptom Manage. 1986 Spring;1(2):95. doi: 10.1016/s0885-3924(86)80005-7.","Rogers AG","J Pain Symptom Manage","1986","1986/01/01","","","10.1016/s0885-3924(86)80005-7"
"2429666","Morphine metabolism in isolated rat hepatocytes and its implications for hepatotoxicity","Nagamatsu K, Ohno Y, Ikebuchi H, Takahashi A, Terao T, Takanaka A.","Biochem Pharmacol. 1986 Oct 15;35(20):3543-8. doi: 10.1016/0006-2952(86)90624-6.","Nagamatsu K","Biochem Pharmacol","1986","1986/10/15","","","10.1016/0006-2952(86)90624-6"
"2428428","Antagonism of stress-induced analgesia by quaternary naloxone","Chance WT, Nelson JL.","Brain Res. 1986 Aug 20;380(2):394-6. doi: 10.1016/0006-8993(86)90243-x.","Chance WT","Brain Res","1986","1986/08/20","","","10.1016/0006-8993(86)90243-x"
"2427951","Three-way drug discrimination in post-addict volunteers: hydromorphone, pentazocine, and saline","Bickel WK, Preston KL, Bigelow GE, Liebson IA.","NIDA Res Monogr. 1986;67:177-83.","Bickel WK","NIDA Res Monogr","1986","1986/01/01","","",""
"2426995","Nalbuphine augmentation of analgesia and reversal of side effects following epidural hydromorphone","Henderson SK, Cohen H.","Anesthesiology. 1986 Aug;65(2):216-8. doi: 10.1097/00000542-198608000-00017.","Henderson SK","Anesthesiology","1986","1986/08/01","","","10.1097/00000542-198608000-00017"
"2426794","Making doctors","Takos R, Jackson P.","South Med J. 1986 Aug;79(8):1002-4. doi: 10.1097/00007611-198608000-00020.","Takos R","South Med J","1986","1986/08/01","","","10.1097/00007611-198608000-00020"
"2425315","Epidural hydromorphone for postcesarean analgesia","Chestnut DH, Choi WW, Isbell TJ.","Obstet Gynecol. 1986 Jul;68(1):65-9.","Chestnut DH","Obstet Gynecol","1986","1986/07/01","","",""
"2423236","I.v. infusion of opioids for cancer pain: clinical review and guidelines for use","Portenoy RK, Moulin DE, Rogers A, Inturrisi CE, Foley KM.","Cancer Treat Rep. 1986 May;70(5):575-81.","Portenoy RK","Cancer Treat Rep","1986","1986/05/01","","",""
"2422925","Narcotic withdrawal syndrome in young adults after the therapeutic use of opiates","Miser AW, Chayt KJ, Sandlund JT, Cohen PS, Dothage JA, Miser JS.","Am J Dis Child. 1986 Jun;140(6):603-4. doi: 10.1001/archpedi.1986.02140200113039.","Miser AW","Am J Dis Child","1986","1986/06/01","","","10.1001/archpedi.1986.02140200113039"
"2422332","Continuous intrathecal hydromorphone and clonidine for intractable cancer pain","Coombs DW, Saunders RL, Fratkin JD, Jensen LE, Murphy CA.","J Neurosurg. 1986 Jun;64(6):890-4. doi: 10.3171/jns.1986.64.6.0890.","Coombs DW","J Neurosurg","1986","1986/06/01","","","10.3171/jns.1986.64.6.0890"
"2421012","Denial and split identity: timely issues in the psychoanalytic psychotherapy of compulsive drug users","Wurmser L.","J Subst Abuse Treat. 1985;2(2):89-96. doi: 10.1016/0740-5472(85)90032-7.","Wurmser L","J Subst Abuse Treat","1985","1985/01/01","","","10.1016/0740-5472(85)90032-7"
"2420426","The therapeutic use of heroin: a review of the pharmacological literature","Sawynok J.","Can J Physiol Pharmacol. 1986 Jan;64(1):1-6. doi: 10.1139/y86-001.","Sawynok J","Can J Physiol Pharmacol","1986","1986/01/01","","","10.1139/y86-001"
"2420241","Pulmonary function in dogs after intercostal thoracotomy: comparison of morphine, oxymorphone, and selective intercostal nerve block","Berg RJ, Orton EC.","Am J Vet Res. 1986 Feb;47(2):471-4.","Berg RJ","Am J Vet Res","1986","1986/02/01","","",""
"2419770","Agonist-antagonist properties of fluorescent opioid probes in the guinea-pig myenteric plexus-longitudinal muscle preparation","Koman A, Einarsson M, Terenius L.","Naunyn Schmiedebergs Arch Pharmacol. 1985 Dec;331(4):355-8. doi: 10.1007/BF00500819.","Koman A","Naunyn Schmiedebergs Arch Pharmacol","1985","1985/12/01","","","10.1007/BF00500819"
"2417263","Social conflict analgesia: studies on naloxone antagonism and morphine cross-tolerance in male DBA/2 mice","Rodgers RJ, Randall JI.","Pharmacol Biochem Behav. 1985 Nov;23(5):883-7. doi: 10.1016/0091-3057(85)90087-5.","Rodgers RJ","Pharmacol Biochem Behav","1985","1985/11/01","","","10.1016/0091-3057(85)90087-5"
"2416910","Irreversible opiate agonists and antagonists. III. Phenylhydrazone derivatives of naloxone and oxymorphone","Hahn EF, Itzhak Y, Nishimura S, Johnson N, Pasternak GW.","J Pharmacol Exp Ther. 1985 Dec;235(3):846-50.","Hahn EF","J Pharmacol Exp Ther","1985","1985/12/01","","",""
"2416909","Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones","Hahn EF, Nishimura S, Goodman RR, Pasternak GW.","J Pharmacol Exp Ther. 1985 Dec;235(3):839-45.","Hahn EF","J Pharmacol Exp Ther","1985","1985/12/01","","",""
"2415705","Opioid receptor interactions and conformations of the 6 alpha and 6 beta epimers of oxymorphamine. Solid-state conformation of 6 alpha-oxymorphamine","Lever OW Jr, Bhatia AV, Chang KJ.","J Med Chem. 1985 Nov;28(11):1652-6. doi: 10.1021/jm00149a019.","Lever OW Jr","J Med Chem","1985","1985/11/01","","","10.1021/jm00149a019"
"2413818","Clonidine in morphine withdrawal. Differential effects on signs and symptoms","Jasinski DR, Johnson RE, Kocher TR.","Arch Gen Psychiatry. 1985 Nov;42(11):1063-6. doi: 10.1001/archpsyc.1985.01790340041006.","Jasinski DR","Arch Gen Psychiatry","1985","1985/11/01","","","10.1001/archpsyc.1985.01790340041006"
"2411166","Accidental epidural overdose of hydromorphone","Moon RE, Clements FM.","Anesthesiology. 1985 Aug;63(2):238-9. doi: 10.1097/00000542-198508000-00042.","Moon RE","Anesthesiology","1985","1985/08/01","","","10.1097/00000542-198508000-00042"
"2410939","Analgesic consultation","Rogers AG.","PRN Forum. 1985 Jul-Aug;4(4):2-3, 6.","Rogers AG","PRN Forum","1985","1985/07/01","","",""
"2410213","Cynomolgus monkeys and morphine tolerance and dependence","Aceto MD, Harris LS.","Drug Alcohol Depend. 1985 May;15(1-2):15-8. doi: 10.1016/0376-8716(85)90025-0.","Aceto MD","Drug Alcohol Depend","1985","1985/05/01","","","10.1016/0376-8716(85)90025-0"
"2410178","Self-administration of clonidine, oxazepam, and hydromorphone by patients undergoing methadone detoxification","Preston KL, Bigelow GE, Liebson IA.","Clin Pharmacol Ther. 1985 Aug;38(2):219-27. doi: 10.1038/clpt.1985.162.","Preston KL","Clin Pharmacol Ther","1985","1985/08/01","","","10.1038/clpt.1985.162"
"2409281","10-Ketonaltrexone and 10-ketooxymorphone","Archer S, Seyed-Mozaffari A, Ward S, Kosterlitz HW, Paterson SJ, McKnight AT, Corbett AD.","J Med Chem. 1985 Jul;28(7):974-6. doi: 10.1021/jm00145a024.","Archer S","J Med Chem","1985","1985/07/01","","","10.1021/jm00145a024"
"2409280","Opioid agonists and antagonists. 6-Desoxy-6-substituted lactone, epoxide, and glycidate ester derivatives of naltrexone and oxymorphone","Koolpe GA, Nelson WL, Gioannini TL, Angel L, Appelmans N, Simon EJ.","J Med Chem. 1985 Jul;28(7):949-57. doi: 10.1021/jm00145a018.","Koolpe GA","J Med Chem","1985","1985/07/01","","","10.1021/jm00145a018"
"1725555","Continuous subcutaneous infusions. New use for an old route","McLaughlin-Hagan M.","Nursing. 1991 Jul;21(7):58-9. doi: 10.1097/00152193-199107000-00020.","McLaughlin-Hagan M","Nursing","1991","1991/07/01","","","10.1097/00152193-199107000-00020"
"1723940","In vivo formation of codeinone and morphinone from codeine. Isolation and identification from guinea pig bile","Ishida T, Yano M, Toki S.","Drug Metab Dispos. 1991 Sep-Oct;19(5):895-9.","Ishida T","Drug Metab Dispos","1991","1991/09/01","","",""
"1723578","Compatibility of dexamethasone sodium phosphate with hydromorphone hydrochloride or diphenhydramine hydrochloride","Walker SE, DeAngelis C, Iazzetta J, Eppel JG.","Am J Hosp Pharm. 1991 Oct;48(10):2161-6.","Walker SE","Am J Hosp Pharm","1991","1991/10/01","","",""
"1723443","A closer look at acetyl and pentafluoropropionyl derivatives for quantitative analysis of morphine and codeine by gas chromatography/mass spectrometry","Grinstead GF.","J Anal Toxicol. 1991 Nov-Dec;15(6):293-8. doi: 10.1093/jat/15.6.293.","Grinstead GF","J Anal Toxicol","1991","1991/11/01","","","10.1093/jat/15.6.293"
"1722340","Nurse fails to follow ""doctor's policy"": death results. Case in point: Hartman v. Riverside Methodist Hosp. (577 N.E.2d 112--OH (1989))","Tammelleo AD.","Regan Rep Nurs Law. 1991 Nov;32(6):2.","Tammelleo AD","Regan Rep Nurs Law","1991","1991/11/01","","",""
"1720033","Cardiovascular effects of large doses of pentamorphone in the dog","Ho WM, Ashburn MA, Liu WS, McJames S, Stanley TH, Ackerman E, Pace NL.","J Cardiothorac Anesth. 1990 Jun;4(3):326-31. doi: 10.1016/0888-6296(90)90040-m.","Ho WM","J Cardiothorac Anesth","1990","1990/06/01","","","10.1016/0888-6296(90)90040-m"
"1720030","Systemic tumor embolism following thoracotomy partially masked by postoperative epidural analgesia","Brodsky JB, Brose WG, Cannon WB, McKlveen RE.","J Cardiothorac Anesth. 1990 Feb;4(1):95-6. doi: 10.1016/0888-6296(90)90454-n.","Brodsky JB","J Cardiothorac Anesth","1990","1990/02/01","","","10.1016/0888-6296(90)90454-n"
"1717195","Pharmacokinetics of rectal drug administration, Part I. General considerations and clinical applications of centrally acting drugs","van Hoogdalem E, de Boer AG, Breimer DD.","Clin Pharmacokinet. 1991 Jul;21(1):11-26. doi: 10.2165/00003088-199121010-00002.","van Hoogdalem E","Clin Pharmacokinet","1991","1991/07/01","","","10.2165/00003088-199121010-00002"
"1716855","Compatibility of hydromorphone hydrochloride and tetracaine hydrochloride","Neels JT.","Am J Hosp Pharm. 1991 Aug;48(8):1682-3.","Neels JT","Am J Hosp Pharm","1991","1991/08/01","","",""
"1716829","Histamine release induced by opioid analgesics: a comparative study using porcine mast cells","Ennis M, Schneider C, Nehring E, Lorenz W.","Agents Actions. 1991 May;33(1-2):20-2. doi: 10.1007/BF01993116.","Ennis M","Agents Actions","1991","1991/05/01","","","10.1007/BF01993116"
"1716756","Subcutaneous infusions for cancer pain","Moulin D.","Nurs Times. 1991 Sep 18-24;87(38):53.","Moulin D","Nurs Times","1991","1991/09/18","","",""
"1715035","The effects of buprenorphine in methadone-dependent volunteers","Strain EC, Bigelow GE, Preston KL, Liebson I.","NIDA Res Monogr. 1990;105:584.","Strain EC","NIDA Res Monogr","1990","1991/01/01","","",""
"1713663","CSF and blood pharmacokinetics of hydromorphone and morphine following lumbar epidural administration","Brose WG, Tanelian DL, Brodsky JB, Mark JB, Cousins MJ.","Pain. 1991 Apr;45(1):11-5. doi: 10.1016/0304-3959(91)90158-t.","Brose WG","Pain","1991","1991/04/01","","","10.1016/0304-3959(91)90158-t"
"1711240","Extubation after transsternal thymectomy for myasthenia gravis: a prospective analysis","Gorback MS, Moon RE, Massey JM.","South Med J. 1991 Jun;84(6):701-6. doi: 10.1097/00007611-199106000-00007.","Gorback MS","South Med J","1991","1991/06/01","","","10.1097/00007611-199106000-00007"
"1711119","Sensitive and specific radioimmunoassays for opiates using commercially available materials. I: Methods for the determinations of morphine and hydromorphone","Lee JW, Pedersen JE, Moravetz TL, Dzerk AM, Mundt AD, Shepard KV.","J Pharm Sci. 1991 Mar;80(3):284-8. doi: 10.1002/jps.2600800319.","Lee JW","J Pharm Sci","1991","1991/03/01","","","10.1002/jps.2600800319"
"1710429","Epidural opioid requirements","de Leon-Casasola OA, Lema MJ.","Anesthesiology. 1991 Jun;74(6):1158-9. doi: 10.1097/00000542-199106000-00035.","de Leon-Casasola OA","Anesthesiology","1991","1991/06/01","","","10.1097/00000542-199106000-00035"
"1709943","Sensitive method for the determination of pentamorphone in serum by liquid chromatography-mass spectrometry with thermospray interface","Keswani SR, Edfort MJ, Wilhelm JA, Kvavlo LT, Venturella VS.","J Chromatogr. 1990 Dec 14;534:77-86. doi: 10.1016/s0378-4347(00)82150-7.","Keswani SR","J Chromatogr","1990","1990/12/14","","","10.1016/s0378-4347(00)82150-7"
"1708214","Pentamorphone for management of postoperative pain","Wong HY, Parker RK, Fragen R, White PF.","Anesth Analg. 1991 May;72(5):656-60.","Wong HY","Anesth Analg","1991","1991/05/01","","",""
"1708145","Discrimination of butorphanol and nalbuphine in opioid-dependent humans","Preston KL, Bigelow GE, Liebson IA.","Pharmacol Biochem Behav. 1990 Nov;37(3):511-22. doi: 10.1016/0091-3057(90)90021-9.","Preston KL","Pharmacol Biochem Behav","1990","1990/11/01","","","10.1016/0091-3057(90)90021-9"
"1706767","Improved method for morphine determination in biological fluids and tissues: rapid, sensitive and selective","McLean CF, Mather LE, Odontiadis J, Sloan PA.","J Pharm Pharmacol. 1990 Sep;42(9):669-71. doi: 10.1111/j.2042-7158.1990.tb06632.x.","McLean CF","J Pharm Pharmacol","1990","1990/09/01","","","10.1111/j.2042-7158.1990.tb06632.x"
"1706579","Electronic control of iontophoretic drug delivery","Lattin GA, Padmanabhan RV, Phipps JB.","Ann N Y Acad Sci. 1991;618:450-64. doi: 10.1111/j.1749-6632.1991.tb27264.x.","Lattin GA","Ann N Y Acad Sci","1991","1991/01/01","","","10.1111/j.1749-6632.1991.tb27264.x"
"1705938","Spinal narcotics for postoperative analgesia in total joint arthroplasty. A prospective study","Drakeford MK, Pettine KA, Brookshire L, Ebert F.","J Bone Joint Surg Am. 1991 Mar;73(3):424-8.","Drakeford MK","J Bone Joint Surg Am","1991","1991/03/01","","",""
"1705692","The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions","Portenoy RK, Foley KM, Inturrisi CE.","Pain. 1990 Dec;43(3):273-86. doi: 10.1016/0304-3959(90)90025-9.","Portenoy RK","Pain","1990","1990/12/01","","","10.1016/0304-3959(90)90025-9"
"1704690","Multiple-dose evaluation of intravenous hydromorphone pharmacokinetics in normal human subjects","Hill HF, Coda BA, Tanaka A, Schaffer R.","Anesth Analg. 1991 Mar;72(3):330-6. doi: 10.1213/00000539-199103000-00009.","Hill HF","Anesth Analg","1991","1991/03/01","","","10.1213/00000539-199103000-00009"
"1704089","Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain","Moulin DE, Kreeft JH, Murray-Parsons N, Bouquillon AI.","Lancet. 1991 Feb 23;337(8739):465-8. doi: 10.1016/0140-6736(91)93401-t.","Moulin DE","Lancet","1991","1991/02/23","","","10.1016/0140-6736(91)93401-t"
"1703651","Decreased local toxicity with subcutaneous diamorphine (heroin): a preliminary report","Bruera E, Macmillan K, Selmser P, MacDonald RN.","Pain. 1990 Oct;43(1):91-4. doi: 10.1016/0304-3959(90)90053-g.","Bruera E","Pain","1990","1990/10/01","","","10.1016/0304-3959(90)90053-g"
"1701625","Microbial degradation of the morphine alkaloids: identification of morphine as an intermediate in the metabolism of morphine by Pseudomonas putida M10","Bruce NC, Wilmot CJ, Jordan KN, Trebilcock AE, Gray Stephens LD, Lowe CR.","Arch Microbiol. 1990;154(5):465-70. doi: 10.1007/BF00245229.","Bruce NC","Arch Microbiol","1990","1990/01/01","","","10.1007/BF00245229"
"1701073","Epidural opioid infusion: an unusual problem","Kreitzman TR, Samuels SI.","Anesthesiology. 1990 Dec;73(6):1272-3. doi: 10.1097/00000542-199012000-00031.","Kreitzman TR","Anesthesiology","1990","1990/12/01","","","10.1097/00000542-199012000-00031"
"1700815","A new metabolic pathway of morphine: in vivo and in vitro formation of morphinone and morphine-glutathione adduct in guinea pig","Kumagai Y, Todaka T, Toki S.","J Pharmacol Exp Ther. 1990 Nov;255(2):504-10.","Kumagai Y","J Pharmacol Exp Ther","1990","1990/11/01","","",""
"1700682","Continuous epidural hydromorphone for postthoracotomy pain relief","Brodsky JB, Chaplan SR, Brose WG, Mark JB.","Ann Thorac Surg. 1990 Dec;50(6):888-93. doi: 10.1016/0003-4975(90)91113-p.","Brodsky JB","Ann Thorac Surg","1990","1990/12/01","","","10.1016/0003-4975(90)91113-p"
"1700681","Epidural analgesia: different strokes for different folks","Faber LP.","Ann Thorac Surg. 1990 Dec;50(6):862-3. doi: 10.1016/0003-4975(90)91108-n.","Faber LP","Ann Thorac Surg","1990","1990/12/01","","","10.1016/0003-4975(90)91108-n"
"1698665","Opioid analgesics","Ciancio SG.","Dent Manage. 1990 Aug;30(8):50-1.","Ciancio SG","Dent Manage","1990","1990/08/01","","",""
"1698268","Quaternary naloxone blocks morphine analgesia in spinal but not intact rats","Milne RJ, Coddington JM, Gamble GD.","Neurosci Lett. 1990 Jul 13;114(3):259-64. doi: 10.1016/0304-3940(90)90573-r.","Milne RJ","Neurosci Lett","1990","1990/07/13","","","10.1016/0304-3940(90)90573-r"
"1698039","Depression of ventilatory responses to hypoxia and hypercapnia after pentamorphone","Afifi MS, Glass PS, Cohen NA, Shook JE, Camporesi EM.","Anesth Analg. 1990 Oct;71(4):377-83. doi: 10.1213/00000539-199010000-00010.","Afifi MS","Anesth Analg","1990","1990/10/01","","","10.1213/00000539-199010000-00010"
"1695950","Inpatient narcotic infusions for patients with cancer pain","Ferris FD, Kerr IG, De Angelis C, Sone M, Hume S.","J Palliat Care. 1990 Summer;6(2):51-9.","Ferris FD","J Palliat Care","1990","1990/01/01","","",""
"1693762","Clinical analgesic assay of repeated and single doses of heroin and hydromorphone","Wallenstein SL, Houde RW, Portenoy R, Lapin J, Rogers A, Foley KM.","Pain. 1990 Apr;41(1):5-13. doi: 10.1016/0304-3959(90)91102-o.","Wallenstein SL","Pain","1990","1990/04/01","","","10.1016/0304-3959(90)91102-o"
"1690960","Myoclonic seizure activity with chronic high-dose spinal opioid administration","Parkinson SK, Bailey SL, Little WL, Mueller JB.","Anesthesiology. 1990 Apr;72(4):743-5. doi: 10.1097/00000542-199004000-00025.","Parkinson SK","Anesthesiology","1990","1990/04/01","","","10.1097/00000542-199004000-00025"
"1688995","Affinity labeling of mu opioid receptors by sulfhydryl alkylating derivatives of morphine and morphinone","Bidlack JM, Frey DK, Kaplan RA, Seyed-Mozaffari A, Archer S.","Mol Pharmacol. 1990 Jan;37(1):50-9.","Bidlack JM","Mol Pharmacol","1990","1990/01/01","","",""
"1384579","Evaluation of a respiratory rate monitor in postsurgical patients","Anderson W, Brock-Utne AJ, Brock-Utne JG, Brodsky JB.","J Clin Anesth. 1992 Jul-Aug;4(4):289-91. doi: 10.1016/0952-8180(92)90131-j.","Anderson W","J Clin Anesth","1992","1992/07/01","","","10.1016/0952-8180(92)90131-j"
"1384397","Epidural patient-controlled analgesia: influence of bupivacaine and hydromorphone basal infusion on pain control after cesarean delivery","Parker RK, Sawaki Y, White PF.","Anesth Analg. 1992 Nov;75(5):740-6. doi: 10.1213/00000539-199211000-00015.","Parker RK","Anesth Analg","1992","1992/11/01","","","10.1213/00000539-199211000-00015"
"1384246","Hydroxyl radical-mediated conversion of morphine to morphinone","Kumagai Y, Ikeda Y, Toki S.","Xenobiotica. 1992 May;22(5):507-13. doi: 10.3109/00498259209053113.","Kumagai Y","Xenobiotica","1992","1992/05/01","","","10.3109/00498259209053113"
"1384078","Conditioned tolerance in human opiate addicts","Ehrman R, Ternes J, O'Brien CP, McLellan AT.","Psychopharmacology (Berl). 1992;108(1-2):218-24. doi: 10.1007/BF02245311.","Ehrman R","Psychopharmacology (Berl)","1992","1992/01/01","","","10.1007/BF02245311"
"1383825","Development of buprenorphine for the treatment of opioid dependence","Johnson RE, Fudala PJ.","NIDA Res Monogr. 1992;121:120-41.","Johnson RE","NIDA Res Monogr","1992","1992/01/01","","",""
"1383252","Simultaneous solid-phase extraction and chromatographic analysis of morphine and hydromorphone in plasma by high-performance liquid chromatography with electrochemical detection","Bouquillon AI, Freeman D, Moulin DE.","J Chromatogr. 1992 Jun 10;577(2):354-7. doi: 10.1016/0378-4347(92)80258-r.","Bouquillon AI","J Chromatogr","1992","1992/06/10","","","10.1016/0378-4347(92)80258-r"
"1382448","Model systems in iontophoresis--transport efficacy","Sage BH Jr.","Acta Pharm Nord. 1992;4(2):123.","Sage BH Jr","Acta Pharm Nord","1992","1992/01/11","","",""
"1381871","Compatibility of bupivacaine hydrochloride with hydromorphone hydrochloride or morphine sulfate","Neels JT.","Am J Hosp Pharm. 1992 Sep;49(9):2149.","Neels JT","Am J Hosp Pharm","1992","1992/09/01","","",""
"1380079","Antinociceptive properties of two alkylating derivatives of morphinone: 14 beta-(thioglycolamido)-7,8-dihydromorphinone (TAMO) and 14 beta-(bromoacetamido)-7,8-dihydromorphinone (H2BAMO)","Jiang Q, Seyed-Mozaffari A, Archer S, Bidlack JM.","J Pharmacol Exp Ther. 1992 Aug;262(2):526-31.","Jiang Q","J Pharmacol Exp Ther","1992","1992/08/01","","",""
"1378707","Epidural patient-controlled analgesia: an alternative to intravenous patient-controlled analgesia for pain relief after cesarean delivery","Parker RK, White PF.","Anesth Analg. 1992 Aug;75(2):245-51. doi: 10.1213/00000539-199208000-00016.","Parker RK","Anesth Analg","1992","1992/08/01","","","10.1213/00000539-199208000-00016"
"1378679","Reaction time in cancer patients receiving peripherally acting analgesics alone or in combination with opioids","Banning A, Sjøgren P, Kaiser F.","Acta Anaesthesiol Scand. 1992 Jul;36(5):480-2. doi: 10.1111/j.1399-6576.1992.tb03501.x.","Banning A","Acta Anaesthesiol Scand","1992","1992/07/01","","","10.1111/j.1399-6576.1992.tb03501.x"
"1377371","Doctor was thinking of the wrong drug","Cohen MR.","Nursing. 1992 Jun;22(6):25.","Cohen MR","Nursing","1992","1992/06/01","","",""
"1376887","Clonazepam treatment of myoclonic contractions associated with high-dose opioids: case report","Eisele JH Jr, Grigsby EJ, Dea G.","Pain. 1992 May;49(2):231-2. doi: 10.1016/0304-3959(92)90146-3.","Eisele JH Jr","Pain","1992","1992/05/11","","","10.1016/0304-3959(92)90146-3"
"1376362","Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers","Strain EC, Preston KL, Liebson IA, Bigelow GE.","J Pharmacol Exp Ther. 1992 Jun;261(3):985-93.","Strain EC","J Pharmacol Exp Ther","1992","1992/06/01","","",""
"1375574","Pathophysiology and management of phantom limb pain","Harwood DD, Hanumanthu S, Stoudemire A.","Gen Hosp Psychiatry. 1992 Mar;14(2):107-18. doi: 10.1016/0163-8343(92)90035-9.","Harwood DD","Gen Hosp Psychiatry","1992","1992/03/01","","","10.1016/0163-8343(92)90035-9"
"1373660","Pharmacodynamics of pentamorphone during coronary artery bypass grafting in humans","Falinski BA, Sebel PS, Hug CC Jr, Klochany A.","J Cardiothorac Vasc Anesth. 1992 Apr;6(2):168-72. doi: 10.1016/1053-0770(92)90192-a.","Falinski BA","J Cardiothorac Vasc Anesth","1992","1992/04/11","","","10.1016/1053-0770(92)90192-a"
"1373356","Survey of pain management therapy provided for children with sickle cell disease","Pegelow CH.","Clin Pediatr (Phila). 1992 Apr;31(4):211-4. doi: 10.1177/000992289203100404.","Pegelow CH","Clin Pediatr (Phila)","1992","1992/04/01","","","10.1177/000992289203100404"
"1373189","Discrimination of agonist-antagonist opioids in humans trained on a two-choice saline-hydromorphone discrimination","Preston KL, Liebson IA, Bigelow GE.","J Pharmacol Exp Ther. 1992 Apr;261(1):62-71.","Preston KL","J Pharmacol Exp Ther","1992","1992/04/01","","",""
"1371946","Subcutaneous narcotic infusions for cancer pain: treatment outcome and guidelines for use","Moulin DE, Johnson NG, Murray-Parsons N, Geoghegan MF, Goodwin VA, Chester MA.","CMAJ. 1992 Mar 15;146(6):891-7.","Moulin DE","CMAJ","1992","1992/03/15","PMC1488669","",""
"1284136","A solid phase extraction technique for the isolation and identification of opiates in urine","Huang W, Andollo W, Hearn WL.","J Anal Toxicol. 1992 Sep-Oct;16(5):307-10. doi: 10.1093/jat/16.5.307.","Huang W","J Anal Toxicol","1992","1992/09/01","","","10.1093/jat/16.5.307"
"1283011","Putative role of hydromorphone metabolites in myoclonus","Babul N, Darke AC.","Pain. 1992 Nov;51(2):260-1. doi: 10.1016/0304-3959(92)90270-l.","Babul N","Pain","1992","1992/11/01","","","10.1016/0304-3959(92)90270-l"
"1281625","Morphine and hydromorphone epidural analgesia. A prospective, randomized comparison","Chaplan SR, Duncan SR, Brodsky JB, Brose WG.","Anesthesiology. 1992 Dec;77(6):1090-4. doi: 10.1097/00000542-199212000-00008.","Chaplan SR","Anesthesiology","1992","1992/12/01","","","10.1097/00000542-199212000-00008"
"1280549","Systemic contact dermatitis from subcutaneous hydromorphone","de Cuyper C, Goeteyn M.","Contact Dermatitis. 1992 Oct;27(4):220-3. doi: 10.1111/j.1600-0536.1992.tb03249.x.","de Cuyper C","Contact Dermatitis","1992","1992/10/01","","","10.1111/j.1600-0536.1992.tb03249.x"
"95243","Dental offices as a source of controlled substances","Newton CW.","Alumni Bull Sch Dent Indiana Univ. 1979 Fall:32-4, 125.","Newton CW","Alumni Bull Sch Dent Indiana Univ","1979","1979/01/01","","",""
"95038","8 beta-alkyl-N-cycloalkyl-dihydro-codeinones and -morphinones as analgesic narcotic antagonists","Kotick MP, Leland DL, Polazzi JO, Schut RN.","NIDA Res Monogr. 1979;27:93-8.","Kotick MP","NIDA Res Monogr","1979","1979/01/01","","",""
"95036","Conditioned drug responses to naturalistic stimuli","Ternes JW, O'Brien CP, Grabowski J, Wellerstein H, Jordan-Hayes J.","NIDA Res Monogr. 1979;27:282-8.","Ternes JW","NIDA Res Monogr","1979","1979/01/01","","",""
"95035","Unreinforced self-injections: effects on rituals and outcome in heroin addicts","O'Brien CP, Greenstein R, Ternes J, McLellan AT, Grabowski J.","NIDA Res Monogr. 1979;27:275-81.","O'Brien CP","NIDA Res Monogr","1979","1979/01/01","","",""
"92035","Dependence in rats after one injection of heroin-, LAAM- or hydromorphone-zinc tannate","Brands B, Baskerville JC, Hirst M, Gowdey CW.","Pharmacol Biochem Behav. 1979 Sep;11(3):279-82. doi: 10.1016/0091-3057(79)90135-7.","Brands B","Pharmacol Biochem Behav","1979","1979/09/01","","","10.1016/0091-3057(79)90135-7"
"88710","Drugs or drums: what relieves postoperative pain?","Keeri-Szanto M.","Pain. 1979 Apr;6(2):217-30. doi: 10.1016/0304-3959(79)90129-5.","Keeri-Szanto M","Pain","1979","1979/04/01","","","10.1016/0304-3959(79)90129-5"
"88586","Selective epidural analgesia","Leslie J, Camporesi E, Urban B, Bromage P.","Lancet. 1979 Jul 21;2(8134):151.","Leslie J","Lancet","1979","1979/07/21","","",""
"88501","A word of warning: marked increase in hydromorphone (Dilaudid) addiction","Lindberg DK.","J Fla Med Assoc. 1978 Oct;65(10):822.","Lindberg DK","J Fla Med Assoc","1978","1978/10/01","","",""
"86208","Chloroxymorphamine, and opioid receptor site-directed alkylating agent having narcotic agonist activity","Caruso TP, Takemori AE, Larson DL, Portoghese PS.","Science. 1979 Apr 20;204(4390):316-8. doi: 10.1126/science.86208.","Caruso TP","Science","1979","1979/04/20","","","10.1126/science.86208"
"83655","10-oxomorphine, a decomposition product of morphine","Proksa B, Votický Z, Molnár L, Putek J, Stefek M.","Pharmazie. 1978 Sep;33(9):609.","Proksa B","Pharmazie","1978","1978/09/01","","",""
"83167","The biology of social attachments: opiates alleviate separation distress","Panksepp J, Herman B, Conner R, Bishop P, Scott JP.","Biol Psychiatry. 1978 Oct;13(5):607-18.","Panksepp J","Biol Psychiatry","1978","1978/10/01","","",""
"79434","Interaction of phencyclidines with the muscarinic and opiate receptors in the central nervous system","Vincent JP, Cavey D, Kamenka JM, Geneste P, Lazdunski M.","Brain Res. 1978 Aug 18;152(1):176-82. doi: 10.1016/0006-8993(78)90145-2.","Vincent JP","Brain Res","1978","1978/08/18","","","10.1016/0006-8993(78)90145-2"
"76483","Simultaneous determination of hydromorphone, hydrocodone and their 6alpha- and 6beta-hydroxy metabolites in urine using selected ion recording with methane chemical ionization","Cone EJ, Darwin WD.","Biomed Mass Spectrom. 1978 Apr;5(4):291. doi: 10.1002/bms.1200050404.","Cone EJ","Biomed Mass Spectrom","1978","1978/04/01","","","10.1002/bms.1200050404"
"74199","Azidomorphines and homopyrimidazols: a new approach to the ideal analgetic","Knoll J.","Acta Physiol Pharmacol Bulg. 1977;3(2):3-11.","Knoll J","Acta Physiol Pharmacol Bulg","1977","1977/01/01","","",""
"73588","Quantum chemical studies of N-substituent variation in the oxymorphone series of opiate narcotics","Loew GH, Berkowitz DS.","J Med Chem. 1978 Jan;21(1):101-6. doi: 10.1021/jm00199a018.","Loew GH","J Med Chem","1978","1978/01/01","","","10.1021/jm00199a018"
"72817","Urinary excretion of hydromorphone and metabolites in humans, rats, dogs, guinea pigs, and rabbits","Cone EJ, Phelps BA, Gorodetzky CW.","J Pharm Sci. 1977 Dec;66(12):1709-13. doi: 10.1002/jps.2600661213.","Cone EJ","J Pharm Sci","1977","1977/12/01","","","10.1002/jps.2600661213"
"72687","Preparation and properties of lipotropin C-fragment with anionic substituents attached to the lysine residues","Geisow MJ, Smyth DG.","FEBS Lett. 1977 Sep 15;81(2):431-4. doi: 10.1016/0014-5793(77)80571-1.","Geisow MJ","FEBS Lett","1977","1977/09/15","","","10.1016/0014-5793(77)80571-1"
"72642","[Hydromorphon injection in pronouced obesity]","Heidenreich O.","Dtsch Med Wochenschr. 1977 Dec 2;102(48):1789-90.","Heidenreich O","Dtsch Med Wochenschr","1977","1977/12/02","","",""
"70327","Biotransformation of morphine to dihydromorphinone and normorphine in the mouse, rat, rabbit, guinea pig, cat, dog, and monkey","Yeh SY, McQuinn RL, Gorodetzky CW.","Drug Metab Dispos. 1977 Jul-Aug;5(4):335-42.","Yeh SY","Drug Metab Dispos","1977","1977/07/01","","",""
"69716","Stereospecific opiate binding in human erythrocyte membranes and changes in heroin addicts","Abood LG, Atkinson GH, MacNeil M.","J Neurosci Res. 1976;2(5-6):427-31. doi: 10.1002/jnr.490020511.","Abood LG","J Neurosci Res","1976","1976/01/01","","","10.1002/jnr.490020511"
"69441","Enhancement of opiate binding by various molecular forms of phosphatidylserine and inhibition by other unsaturated lipids","Abood LG, Salem N Jr, MacNeil M, Bloom L, Abood ME.","Biochim Biophys Acta. 1977 Jul 4;468(1):51-62. doi: 10.1016/0005-2736(77)90150-x.","Abood LG","Biochim Biophys Acta","1977","1977/07/04","","","10.1016/0005-2736(77)90150-x"
"69027","Diastereoisomeric N-tetrahydrofurfurylnoroxymorphones with opioid agonist--antagonist properties","Merz H, Stockhaus K, Wick H.","J Med Chem. 1977 Jun;20(6):844-6. doi: 10.1021/jm00216a023.","Merz H","J Med Chem","1977","1977/06/01","","","10.1021/jm00216a023"
"67128","A comparison of the analgesic effect of oxymorphone by rectal suppository and intramuscular injection in patients with postoperative pain","Beaver WT, Feise GA.","J Clin Pharmacol. 1977 May-Jun;17(5-6):276-91. doi: 10.1002/j.1552-4604.1977.tb04607.x.","Beaver WT","J Clin Pharmacol","1977","1977/05/01","","","10.1002/j.1552-4604.1977.tb04607.x"
"66306","Orientation of the oxygen atom at C-6 as a determinant of agonistic activity in the oxymorphone series","Ronai AZ, Foldes FF, Hahn EF, Fishman J.","J Pharmacol Exp Ther. 1977 Mar;200(3):496-500.","Ronai AZ","J Pharmacol Exp Ther","1977","1977/03/01","","",""
"66240","Comparisons of the analgesic effects of oral and intramuscular oxymorphone and of intramuscular oxymorphone and morphine in patients with cancer","Beaver WT, Wallenstein SL, Houde RW, Rogers A.","J Clin Pharmacol. 1977 Apr;17(4):186-98. doi: 10.1177/009127007701700402.","Beaver WT","J Clin Pharmacol","1977","1977/04/01","","","10.1177/009127007701700402"
"65466","Identification of diacetylmorphine metabolites in humans","Yeh SY, McQuinn RL, Gorodetzky CW.","J Pharm Sci. 1977 Feb;66(2):201-4. doi: 10.1002/jps.2600660217.","Yeh SY","J Pharm Sci","1977","1977/02/01","","","10.1002/jps.2600660217"
"63915","Naltrexone in a behavioral treatment program","O'Brien C, Greenstein R.","NIDA Res Monogr. 1976 Sep;(9):136-40. doi: 10.1037/e497452006-024.","O'Brien C","NIDA Res Monogr","1976","1976/09/01","","","10.1037/e497452006-024"
"63912","Morphine-like peptides, leucine enkephalin and methionine enkephalin: interactions with the opiate receptor","Simantov R, Snyder SH.","Mol Pharmacol. 1976 Nov;12(6):987-98.","Simantov R","Mol Pharmacol","1976","1976/11/01","","",""
"63911","Temperature and ionic influences on opiate receptor binding","Simantov R, Snowman AM, Snyder SH.","Mol Pharmacol. 1976 Nov;12(6):977-86.","Simantov R","Mol Pharmacol","1976","1976/11/01","","",""
"63284","Sympathetic ganglion cell C neuroblastoma hybrids with opiate receptors","Blosser J, Abbott J, Shain W.","Biochem Pharmacol. 1976 Nov 1;25(21):2395-9. doi: 10.1016/0006-2952(76)90035-6.","Blosser J","Biochem Pharmacol","1976","1976/11/01","","","10.1016/0006-2952(76)90035-6"
"60774","The binding of the optical isomers of methadone, alpha-methadol, alpha-acetylmethadol and their N-demethylated derivatives to the opiate receptors of rat brain","Horng JS, Smits SE, Wong DT.","Res Commun Chem Pathol Pharmacol. 1976 Aug;14(4):621-9.","Horng JS","Res Commun Chem Pathol Pharmacol","1976","1976/08/01","","",""
"60091","Evaluation of propranolol in opiate dependence","Resnick RB, Kestenbaum RS, Schwartz LK, Smith A.","Arch Gen Psychiatry. 1976 Aug;33(8):993-7. doi: 10.1001/archpsyc.1976.01770080111011.","Resnick RB","Arch Gen Psychiatry","1976","1976/08/01","","","10.1001/archpsyc.1976.01770080111011"
"58561","Management of surgical problems in patients on methadone maintenance","Rubenstein RB, Spira I, Wolff WI.","Am J Surg. 1976 May;131(5):566-9. doi: 10.1016/0002-9610(76)90013-1.","Rubenstein RB","Am J Surg","1976","1976/05/01","","","10.1016/0002-9610(76)90013-1"
"56258","Preliminary characterization of enzymes for reduction of naloxone and naltrexone in rabbit and chicken liver","Roerig S, Fujimoto JM, Wang RI, Pollock SH, Lange D.","Drug Metab Dispos. 1976 Jan-Feb;4(1):53-8.","Roerig S","Drug Metab Dispos","1976","1976/01/01","","",""
"56139","Letter: Treatment of accidental naltrexone-induced withdrawal","Volavka J, Resnick RB.","Am J Psychiatry. 1976 Feb;133(2):233. doi: 10.1176/ajp.133.2.233a.","Volavka J","Am J Psychiatry","1976","1976/02/01","","","10.1176/ajp.133.2.233a"
"54869","Selective enhancement of [3H]opiate agonist binding by divalent cations","Pasternak GW, Snowman AM, Snyder SH.","Mol Pharmacol. 1975 Nov;11(6):735-44.","Pasternak GW","Mol Pharmacol","1975","1975/11/01","","",""
"52996","Comparison between narcotic ""receptors"" in the guinea-pig ileum and the rat brain","Terenius L.","Acta Pharmacol Toxicol (Copenh). 1975 Sep;37(3):211-21. doi: 10.1111/j.1600-0773.1975.tb00837.x.","Terenius L","Acta Pharmacol Toxicol (Copenh)","1975","1975/09/01","","","10.1111/j.1600-0773.1975.tb00837.x"
"51460","Dihydromorphinine ketone reductases","Pollock SH.","Life Sci. 1975 Aug 1;17(3):465-75. doi: 10.1016/0024-3205(75)90499-3.","Pollock SH","Life Sci","1975","1975/08/01","","","10.1016/0024-3205(75)90499-3"
"50766","Effect of morphine, hydromorphone, methadone, mescaline, trypan blue, vitamin A, sodium salicylate, and caffeine on the serum interferon level in response to viral infection","Geber WF, Lefkowitz SS, Hung CY.","Arch Int Pharmacodyn Ther. 1975 Apr;214(2):322-7.","Geber WF","Arch Int Pharmacodyn Ther","1975","1975/04/01","","",""
"49846","Differential effects of protein-modifying reagents on receptor binding of opiate agonists and antagonists","Pasternak GW, Wilson HA, Snyder SH.","Mol Pharmacol. 1975 May;11(3):340-51.","Pasternak GW","Mol Pharmacol","1975","1975/05/01","","",""
"48517","Characterisation and quantitation of morphine in urine using high-pressure liquid chromatography with fluorescence detection","Jane I, Taylor JF.","J Chromatogr. 1975 Jun 4;109(1):37-42. doi: 10.1016/s0021-9673(01)81015-3.","Jane I","J Chromatogr","1975","1975/06/04","","","10.1016/s0021-9673(01)81015-3"
"48348","Combination of delta9-tetrahydrocannabinol with oxymorphone or pentobarbital: Effects on ventilatory control and cardiovascular dynamics","Johnstone RE, Lief PL, Kulp RA, Smith TC.","Anesthesiology. 1975 Jun;42(6):674-84. doi: 10.1097/00000542-197506000-00009.","Johnstone RE","Anesthesiology","1975","1975/06/01","","","10.1097/00000542-197506000-00009"
"48347","Relative analgesic potencies of morphine and hydromorphone in postoperative pain","Mahler DL, Forrest WH Jr.","Anesthesiology. 1975 May;42(5):602-7. doi: 10.1097/00000542-197505000-00021.","Mahler DL","Anesthesiology","1975","1975/05/01","","","10.1097/00000542-197505000-00021"
"47638","Drug-seeking behavior during methadone maintenance","Jones BE, Prada JA.","Psychopharmacologia. 1975;41(1):7-10. doi: 10.1007/BF00421297.","Jones BE","Psychopharmacologia","1975","1975/01/01","","","10.1007/BF00421297"
"46111","Differentiation of opiate agonist and antagonist receptor binding by protein modifying reagents","Wilson HA, Pasternak GW, Snyder SH.","Nature. 1975 Feb 6;253(5491):448-50. doi: 10.1038/253448a0.","Wilson HA","Nature","1975","1975/02/06","","","10.1038/253448a0"
